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Abstract-Part I 
 
Chapter 1. A Shorter and Improved Access to the Bicyclo[3.3.1]nonane core of Sarpagine/-
Macroline/Ajmaline Alkaloids 
Extension of the asymmetric Pictet-Spengler (P-S) reaction to bulkier Nb-alkylated 
tryptophan derivatives resulted in a shorter and improved stereospecific access to the key 
bicyclo[3.3.1]nonane framework of bioactive C-19 methyl substituted sarpagine/macro-
line/ajmaline indole alkaloids with excellent diastereoselectivity via internal asymmetric 
induction. The asymmetric Pictet-Spengler/Dieckmann protocol with bulky Nb-alkyl substituted 
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systems enabled a more direct and two-step shorter route to this key architecture. Complete 
stereocontrol of the C-19 methyl function in either the α- or β-configuration was achieved which 
would enable one to gain rapid access to the crucial intermediates for the total synthesis of any 
member of this group of seventy alkaloids. 
Chapter 2. Unprecedented Stereocontrol in the Synthesis of 1,2,3-Trisubstituted Tetrahyd-
ro-β-carbolines: The Ambidextrous Pictet-Spengler Reaction 
The asymmetric Pictet-Spengler (P-S) reaction of chiral Nb-ethynyl substituted tryptophan 
methyl ester derivatives (from both D- and L-tryptophan) with a simple aliphatic aldehyde, 
exhibited unprecedented stereoselectivity toward either of the diastereomeric products. A simple 
variation of conditions altered the outcome of the cyclization from either 100% trans-selective to 
100% cis-selective originating entirely from internal asymmetric induction under mild conditions. 
This resulted in the highly efficient access to both 1,3-cis-(1,2,3-trisubstituted tetrahydro-β-
carbolines, THβCs) and 1,3-trans-(1,2,3-trisubstituted THβCs). By exploiting this very useful 
ambidextrous-diastereoselectivity, one can set the crucial C-3 and C-5 stereocenters of the C-19 
methyl substituted sarpagine-macroline-ajmaline alkaloids beginning either with the DNA-
encoded and cheaper L-(-)-tryptophan, as well as optionally from commercially available D-(+)-
tryptophan. 
Chapter 3. Access to the (+)- or (-)-Enantiomers of the Bioactive C-19 Methyl Substituted 
Sarpagine/Macroline/Ajmaline Alkaloids from Either D- or L-Tryptophan via the 
Ambidextrous Pictet-Spengler Reaction 
The unnatural enantiomers of bioactive natural alkaloids are potential drug candidates. The 
unnatural enantiomer of alkaloids may have similar drug-like properties or even better than the 
natural counterpart depending on the rate of metabolism. The ambidextrous Pictet-Spengler 
reaction has enabled one to access the key intermediates with the bicyclo[3.3.1] framework starting 
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from either the natural L-tryptophan or the commercially available D-tryptophan. Logically, the 
ambidextrous nature of this P-S process would allow one ready access to the unnatural enantiomers 
of the alkaloids from this subgroup. As the proof of concept, which is important to illustrate the 
full potential of the ambidextrous P-S reaction, both D-tryptophan and L-tryptophan were 
employed to synthesize the key intermediates toward the natural enantiomers of alkaloids. Now 
the enantiomeric series of the same key intermediates could also be synthesized from both D- and 
L-tryptophan in high yield and optical purity via this P-S/Dieckmann protocol. One can make 
either the natural or the unnatural alkaloids from either starting amino acid ester, stereo and 
enantiospecifically at will. 
Abstract-Part II 
Chapter 4. The Total Synthesis of Macrocarpines D and E via an Efficient Copper-Mediated 
Cross-Coupling Process 
After gaining access to the bicyclo[3.3.1] framework via the ambidextrous Pictet-Spengler 
reaction, the focus turned to the completion of the total synthesis of a number of C-19 methyl 
substituted sarpagine/macroline/ajmaline indole alkaloids. As a step towards that, alkaloids with 
Na-H, Nb-CH3 substitution patterns were both of interest via the same route. An enolate driven 
copper-mediated cross-coupling process enabled a cheaper and greener access to the key 
pentacyclic intermediates required for the enantiospecific total synthesis of a number of C-19 
methyl substituted sarpagine/macroline indole alkaloids. Replacement of palladium (60-68% 
yields) with copper iodide (82-89% yields) resulted in a much cleaner process in high yield. The 
formation of an unusual seven-membered cross-coupling product was completely inhibited by 
using TEMPO as a radical scavenger. Further functionalization led to the first enantiospecific total 
synthesis of macrocarpines D and E. 
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Chapter 5. The Total Synthesis of Talcarpine, N4-Methyl-N4,21-secotalpinine, Dihydro-
peraksine, Deoxyperaksine, and Macrocarpines A-C 
After the successful completion of the total synthesis of several C(19)-methyl Na-H, Nb-
CH3 substituted alkaloids, focus turned toward the total synthesis of a number of alkaloids bearing 
the Na-CH3, Nb-CH3 substitution pattern. In addition, a pair of sarpagine alkaloids, termed 
dihydroperaksine and deoxyperaksine bore the C-19 (S)-methyl substitution; this was opposite to 
the chirality in many of the alkaloids of this group. Access to these alkaloids in high yields 
illustrated the versatility of the strategy developed here to access alkaloids with either C-19 (S)- or 
(R)-methyl substituents. This effort resulted in the successful total synthesis of several bioactive 
alkaloids, as well as correction of the literature values for macrocarpine A and N4-methyl-N4,21-
secotalpinine. 
Chapter 6. The Total Synthesis of Macrocarpines F and G, Talpinine, O-Acetyltalpinine, as 
well as N4-Methyltalpinine 
A late stage Nb-demethylation of macrocarpines A and C afforded the Nb-H bearing 
alkaloids macrocarpines F and G, respectively. A similar transformation enabled access to the 
bioactive alkaloid talpinine from both talcarpine and N4-methyl-N4,21-secotalpinine. The other 
bioactive alkaloid O-acetyltalpinine was also prepared from synthetic talpinine in high yield. 
Finally, the unusual quaternary Nb-nitrogen function containing alkaloid N4-methyltalpinine that 
exhibited potent NFκB inhibitory activity was completed via facile transformations in excellent 
yield. 
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1. Introduction 
 
1.1 The Sarpagine-Macroline-Ajmaline Family of Alkaloids 
The sarpagine, macroline, and ajmaline group of alkaloids are a family of structurally and 
biosynthetically related alkaloids.1-4 Collectively, they form a major class of indole alkaloids 
termed here sarpagine/macroline/ajmaline alkaloids. Over the years numerous alkaloids that 
belong to this group have been isolated from various medicinal plants of Alstonia and Rauwolfia 
genera (Apocynaceae) worldwide.5-10 Many of these alkaloids possess useful biological activity 
ranging from anti-hypertensive to anticancer activity and many of these activities correlate well 
with their traditional uses.8,11-14 As a result there has been a significant interest in the isolation, 
biosynthesis, total synthesis, as well as the determination of their biological activity over the years. 
This is evident from the increased number of novel alkaloids reported recently, as well as new 
useful bioactivities.5-8,15 Diversity arises due to variation in configurations, substitution patterns 
and the rearrangement of functional groups around the core-structure of these alkaloids. Often, it 
is observed that a number of alkaloids that belong to the greater sarpagine/macroline/ajmaline 
family can be categorized into smaller subgroups by considering common structural features of 
interest, as expected. Such sub-classification is often quite useful in discussion of their biosynthetic 
origin, structural analysis both in identification and in stereochemical assignments, as well as 
elucidation of a general synthetic strategy to access most of the alkaloids in that subclass. In 
addition, the synthetic and biological studies of the unnatural enantiomers of the bioactive 
alkaloids are widely unexplored. The unnatural enantiomers of natural products may in fact have 
important biological activity or even less toxicity and metabolic properties that are much longer-
lived in vivo than their natural counterparts. Furthermore, natural products have always played a 
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major role in drug-discovery and have been a great source of new drugs.16 The optimization of the 
already bioactive natural products by the synthesis of analogs for better drug-related properties has 
resulted in many clinical candidates which have superior bioactivity, as compared to the parent 
natural products. The discovery of the anti-HIV drugs lamivudine and emtricitabine by Professor 
Liotta has saved millions of lives and helped to ameliorate the global HIV situation by subduing it 
from a death sentence to a manageable chronic disease.17 Both of these anti-HIV drugs were 
developed from unnatural L-nucleoside enantiomers.17,18 On the other hand, structure-activity 
studies on vinblastine analogs by Professor Boger have resulted in better and more-potent drug-
candidates than the natural vinblastine.19,20 Understandably, the exploration of the bioactivity of 
unnatural enantiomers, as well as the optimization of native bioactive natural products can be 
possible only after robust and practical synthetic strategies are developed to avail the alkaloid of 
interest in reasonable quantities. 
 
1.2 The C-19 Methyl Substituted Sarpagine Macroline-Ajmaline Alkaloids 
 
 
The C-19 methyl substituted sarpagine/macroline/ajmaline group of alkaloids is an emerging 
group of alkaloids, which have been populated by an increasing number of members over the 
recent years.6-8 This subgroup was first discussed by Lounasmaa,6,21 which has since been referred 
to as the C-19 methyl substituted sarpagine/-macroline/ajmaline alkaloids, by many.22-27 However, 
a broader definition and collective discussion have not been reported until now. Of course, the 
bioactivity of some of these alkaloids has increased their importance, as well as interest in their 
total synthesis.28-31 In fact, the common structural feature of the C-19 methyl function renders these 
alkaloids distinct from their original family and also makes them accessible via a common 
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synthetic strategy. As a matter of convenience, discussion of their isolation, bioactivity, and 
synthesis has now become important. This chapter is a compilation of the monomeric alkaloids 
which possess the C-19 methyl substituent (as a part of the core ring system) which belongs to 
either the sarpagine, macroline, or ajmaline alkaloid series reported recently. An up to date 
discussion of their isolation from various plant sources (and corresponding plant morphology), 
proposed biosynthetic studies, as well as reported biosynthesis are included. In addition, the partial 
or formal, as well as the total syntheses have also been included. The core-structures of each of 
these subclasses are illustrated in Figure 1.  
 
1.3 The C-19 Methyl Substituted Sarpagine-Macroline-Ajmaline Frameworks 
 
The general structures are numbered according to the biogenetic numbering system proposed by 
Le Men and Taylor and the same numbering system has been followed throughout this chapter.32,33 
Sarpagine alkaloids possess the characteristic C(21)-N4 bond, as well as the C-16 configuration as 
shown in 1-3 where, the C(17) group occupies the α-position at C(16) and the corresponding H-
atom is β. In the sarpagine-type alkaloids, when there is no substitution on the carbon atom adjacent 
to the N4 nitrogen atom (i.e., C-21 in 1), the biogenetic numbering system according to Le Men 
and Taylor is shown in structure 1.32 Even though the ethylidene function contains a methyl group 
at C-19 in 1, it is not considered as a C-19 methyl substituted alkaloid since the methyl function is 
not a substituent on the core-ring system. Similarly, when there is a heteroatom (commonly, O) 
attached at the C(α) position  of N4, it does not alter the biogenetic numbering (see 2). However, 
when there is a C-atom substituent (i.e., CH3) on the carbon atom alpha to N4, it alters the 
biogenetic numbering, as shown in structure 3. As a result, these structures are considered to 
belong to this C-19 methyl substituted subclass of alkaloids. The absolute stereochemistry at C-
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3(S), C-5(S), C-15(β-H), and C-16(β-H) is the same (as depicted in 2) throughout the sarpagine 
group, while the stereochemistry of the C-19 methyl function can either be the β [i.e., (S)], or α 
[i.e., (R)] configuration (see Figure 1). 
The general structure and biogenetic numbering of macroline alkaloids are depicted in Figure 1 
(see 4-6). Configurations at C(3), C(5), C(15), and C(16) are the same as the sarpagine alkaloids, 
except for the absence of the C(21)-N4 bond in the case of the macroline series. Similarly, in the 
case of macroline (or macroline-derived) alkaloids, the type-A macroline (4) alkaloids (including 
the ring-open macroline alkaloids) are not considered as the C-19 methyl substituted variant since 
the methyl function is not directly connected to the core architecture. On the contrary, the type-B 
(see 5) macroline bases contain the methyl function at the C-19 position of the ring system and, 
therefore, are regarded as belonging to this group. In addition to these simple types of sarpagine 
alkaloids, there are a number of macroline alkaloids which possess both the macroline-type core 
with a C-19 methyl substituent, as well as the C(21)-N4 linkage found in those alkaloids 
represented by compound 6. These alkaloids can be considered as the macroline-derived 
sarpagine-type (or simply, sarpagine-macroline) alkaloids. One well-known example of this type 
of alkaloid is talpinine 37 (vide infra). 
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Figure 1. sarpagine/macroline/ajmaline framework (1-11) 
 
The ajmaline group of alkaloids is the other major type of alkaloids that are closely related to the 
sarpagine alkaloids, both structurally and biosynthetically.34,35 In the same fashion as both the 
sarpagine and macroline alkaloids, the ajmaline series bear the same configurations at C(3), C(5), 
and C(15) whereas the C(16) configuration is antipodal to that of the sarpagine and macroline 
bases. In addition, in the ajmaline alkaloids, the C(17) carbon atom is necessarily connected to 
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C(7), see 7-9. Alkaloids which contain the core-skeleton 7 and 8 are not considered as a C-19 
methyl substituted variant, whereas skeleton 9 is considered in the C-19 class for the same reasons, 
as discussed above. 
Additionally, a few oxindole alkaloids with the spirocyclic junction at C-7 (both R and S) possess 
the C-19 methyl substituted sarpagine skeleton (3) or the type-B macroline skeleton (5) or the 
macroline-derived sarpagine-type skeleton (6). They are included in this compilation (see 10 and 
11). These oxindole alkaloids also belong to either the chitosenine (7R) or the alstonisine (7S) 
series of bases.36  
 
2. Occurrence 
 
The sarpagine/macroline/ajmaline family of indole alkaloids are diversely distributed among more 
than a hundred species of 25 major genera of  the Apocynaceae family of plants.8 Alkaloids that 
belong to this C(19)-methyl substituted subgroups are listed in this section as “macroline-related” 
(Table 1), “sarpagine-related” (Table 2), and “ajmaline-related” (Table 3), sub-classifications. 
Illustrated in Table 4 are the plant sources, plant morphologies and references to the isolation of 
these series. 
 
2.1 Macroline-Related C-19 Methyl Substituted Alkaloids 
 
Among macroline-related alkaloids (see Table 1), macrocarpines A-H (12-19)37-39 are primary 
alcohols which contain a hydroxyl group (O-acetyl, in the case of macrocarpine C 1437) at C(21). 
All of these alkaloids 12-19 contain the type-B (see structure 5 in Figure 1) macroline framework 
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with a C-19 β-methyl function, while C-20 can be either α or β. In addition, both of the N1 and N4 
nitrogen functions can possess either a hydrogen atom or a methyl function. Macrocarpines A (12), 
B(13), and C(14) were first reported by Kam.37 Later, N1-demethyl, N4-demethyl, and ring-A 
oxygenated (10-methoxy) variants (macrocarpines D-H, 15-19) have also been isolated from 
various Alstonia species.38,39 Among these, the optical rotation of 12 has been revised recently 
(vide infra, via stereospecific synthesis).23 Alstohentine 20, a C-20 hydroxy macroline alkaloid is 
also known to occur in Alstonia macrophylla.40 Talcarpine 21 and N4-methyl-N4,21-secotalpinine 
22 are C(20)-formyl variants of  macrocarpine A and macrocarpine B, respectively. Talcarpine 21 
has been known since 197241, while 22 has been isolated as a natural product only recently37 but 
appeared in reports on partial synthesis in several instances.3,41,42 The optical rotation of 22 has 
also been revised recently (vide infra, see the total synthesis of this alkaloid).23 Both alkaloids 21 
and 22 occur in A. macrophylla as well as in A. angustifolia, while 21 also occurs in P. talbotii 
(see Table 4 for a detailed list). Recently, the C(19)-antipode of talcarpine, 19-epitalcarpine 23 has 
been isolated from A. angustifolia.39 
A number of alkaloids from this group contain a C(19)-C(20) site of unsaturation, which forms an 
enal function (e.g., see alstonerinal, 24). Alstonerinal 24 is the C(19)-C(20) dehydro variant of 
talcarpine 21 and has been isolated from A. macrophylla and A. angustifolia.50,43 The 10-methoxy 
version, 19-20-dehydro-10-methoxytalcarpine 2544,45 occurs in A. angustifolia and T. dichotoma, 
while the 11-methoxy variant alstophyllal 29 has been isolated from A. macrophylla.38,40 In 
addition, N4-demethyl and N1-demethyl versions of these types of alkaloids have also been isolated 
from plant sources. The N4-demethylalstonerinal 26,
46 N1-demethylalstonerinal 27,
39 and N1-
demethylalstophyllal 3037 were also found in Alstonia species. The oxidized derivative, 6-
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oxoalstophyllal 2840 contains a carbonyl group at C(6), while the N4-oxide, alstoniaphylline C 31,
43 
is an indolenine-containing macroline alkaloid. Both occur in A. macrophylla.  
In addition, as mentioned, there are a few alkaloids which contain an oxindole moiety with a spiro-
C(7) center (32-36 in Table 1). Both N4-demethylalstophyllal oxindole 32
47 and 16-hydroxy-N4-
demethylalstophyllal oxindole 3540 occur in A. macrophylla. These two rearranged alstophyllal 
bases are antipodal to each other at the spiro-center at C(7) with (R) and (S) configurations, 
respectively. Alstonal 33,47 N1-demethylalstonal 34
48 and the 16-hydroxyalstonal 3640 are oxindole 
alkaloids with  the same (S) configuration at the C(7)-spiro center. All three of them occur in A. 
macrophylla, while oxindoles 33 and 34 also occur in T. dichotoma45 and A. angustifolia,46 
respectively.  
 
2.2 Sarpagine-Related C-19 Methyl Substituted Alkaloids 
The majority of sarpagine-related alkaloids of this group bear a β-methyl function at C(19) while 
a few of them contain the opposite configuration (see Table 2). Talpinine 37 is a macroline-derived 
sarpagine alkaloid with a C(21)-N(4) bond. It was first isolated from P. talbotii41 and later from A. 
angustifolia.39 Recently, O-acetyltalpinine 39 has also been isolated from A. angustifolia.39 A 
quaternary Nb-nitrogen containing talpinine variant, N4-methyltalpinine 38, and its C(19)-antipode, 
N4-methyl-19-epitalpinine 40, have been isolated recently from A. angustifolia.
28,39 Peraksine 41 
was first isolated from R. perakensis.49 Since that time, it has been isolated from more than ten 
other Rauwolfia species (see Table 4). Alstoyunines A (42) and B (43) are structurally related to 
base 41 and were isolated from A. yunnanensis in 2009.29  Alstoyunine A 42 bears a cyclic acetal 
group at C(21) and a hemi-acetal substituent at C(17), whereas the related 43  contains a cyclic 
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hemi-acetal function at C(21) and an acetal group at C(17).29 The N1-methyl variant of 42, termed 
alstiyunnanenine A 45, was also isolated from A. yunnanensis Diels, recently.50 The ring-A 
oxygenated and N1-demethyled version of talpinine, 21-hydroxycyclolochnerine 44, was isolated 
from the cell cultures of Catharanthus roseus.51 Verticillatine 46 is a quaternary Nb-nitrogen 
containing alkaloid with a hydroxyl function at C(10) and a cyclic hemi-acetal function at C(17); 
it was isolated from R. verticillata.52,53 The hairy root culture of R. serpentina investigated by 
Stöckigt et al. resulted in the isolation of three alkaloids related to dihydroperaksine (see 47-49).54 
These alkaloids are structurally similar to dihydroperaksine 50, but the configurations at C(19) and 
C(20) are opposite to 50 and thus they represent a novel subgroup of sarpagine alkaloids that have 
the 19(S),20(R) stereochemistry as a common structural feature. Consequently, they were named 
19(S),20(R)-dihydroperaksine 47, 19(S),20(R)-dihydroperaksine-17-al 48, and 10-hydroxy-
19(S),20(R)-dihydroperaksine 49.54 Dihydroperaksine 50 and deoxyperaksine 51 are two 
sarpganie-related alkaloids with the C-19α methyl [i.e., (R)] function that belong to this group. 
Both were isolated from R. perakensis55 while 50 and 51 also occur in R. caffra56,57 and R. 
vomitoria,58 respectively. In several instances, 19(S),20(R)-dihydroperaksine 47 has been 
designated as dihydroperaksine in the literature.25,26,59,60 The names should not be used 
interchangeably since they are different alkaloids with opposite configurations at C(19) and C(20). 
The enantiospecific total synthesis of dihydroperaksine 50 has been reported recently with the 
19(R),20(S) configuration and the optical rotations of the natural and synthetic dihydroperaksine 
are in excellent agreement (natural: [α]D = +40.855; synthetic: [α]D = +40.023), consequently, the 
structure of dihydroperaksine 50 is most probably correct, as drawn in Table 2. Moreover, the 
cyclic-ether linkage between C(17) and C(21) in deoxyperaksine 51 was synthesized from the 
same synthetic dihydroperaksine 50. Consequently, this confirms the structure of deoxyperaksine 
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to be correct as drawn in 51 as well. O-Acetylpreperakine 52 was isolated from the stem bark of 
R. volkensii.61 Macrosalhine 53 is an N4-methyl substituted quaternary sarpagine alkaloid, which 
has been isolated as the chloride and thiocyanate salts from A. macrophylla.62 It contains a cyclic 
hemi-acetal bond formed by linking the C(17) hydroxyl function with the C(21) aldehyde function 
of the sarpagine system. The 7(S)-talpinine oxindole 54 is the only macroline-derived sarpagine 
oxindole alkaloid of this group;39 it was isolated from A. angustifolia.39 Vinmajine F 55 was 
isolated from cultivated V. major.30 
Rauvovertines A-C (56, 58, and 60) and 17-epi-rauvovertines A 57 and B  59 were isolated from 
R. verticillata.59 Rauvovertine A 56 and its 17-epi variant 57 were isolated as an inseparable 
mixture (56:57 ≈ 3:2) while rauvovertine B 58 and its 17-epi version 59 were also isolated as an 
inseparable mixture (58:59 ≈ 2:1). The orientations of the C(17) functional groups were assigned 
by NMR correlation studies, which also revealed that the C-17α  epimer occupied an equatorial 
orientation on the pyran ring which had adopted a chair conformation. This helped to rationalize 
the prevalence of the C-17α epimers 56 and 58.59 On the other hand, rauvovertine C 60 was isolated 
as a single epimer which contained an C-17α methoxy function as determined again by NMR 
correlation experiments. The base contains an unusual imine bridge connecting the C(17) carbon 
atom with C(20) and represents an new class of peraksine alkaloid.59 Rauvomines A 61 and B 62 
are two unusual monoterpenoid indole alkaloids and were isolated along with peraksine 41 and 
alstoyunine A 42 from the aerial parts of R. vomitoria.63 Rauvomine A 60 is a C18 sarpagine-type 
alkaloid with a β-chlorine atom at C(20). Rauvomine B 62, on the other hand, represents a new 
type of sarpagine indole alkaloid with a substituted cyclopropane ring that results in a 6/5/6/6/3/5-
fused hexacyclic sarpagine system (see Table 2). In addition, the C-16 configuration in rauvomine 
B is antipodal to other macroline and sarpagine alkaloids in this group. The structures and absolute 
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configurations of both of these alkaloids were determined by spectroscopic analysis, X-ray 
crystallography,  as well as electronic circular dichroism.63 Vinmajorines C-E (63-65) were 
isolated from V. major.64 All three of these bases contain a methoxy group at C-10 of ring A.  
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Table 1. Macroline-related C-19 methyl substituted alkaloids 
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Table 1. Macroline-related C-19 methyl substituted alkaloids: (Continued: 2) 
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Table 2. Sarpagine-related C-19 substituted alkaloids 
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Table 2. Sarpagine-related C-19 methyl substituted alkaloids (continued: 2) 
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Table 2. Sarpagine-related C-19 methyl substituted alkaloids (continued: 3) 
 
 
 Vinmajorine C 63 resembles alstoyunine B (vide supra, 43) in substitution and stereochemistry at 
C-17 and C-21, while vinmajorine D 64 is similar to peraksine 41. Vinmajorine E 65 is the C-17 
O-acetate of alkaloid 64.  
 
2.3 Ajmaline-Related C-19 Methyl Substituted Alkaloids 
 
All of the ajmaline alkaloids that belong to this group bear a β-methyl [i.e., (S)] function at C(19) 
with an indolenine moiety at C(1)-C(2) (see Table 3). Alstoyunines C 66 and D 67 were isolated 
from A. yunnanensis.29 Both of these bear an N4-oxide function and the C(21)-carboxylic acid 
group. The base 67 contains an N1-oxide function as well. Alstoyunine D 67 has also been isolated 
from A. rupestris and named vinorine N1,N4-dioxide.
31 The name “vinorine N1,N4-dioxide” is a 
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misnomer and may be misleading since vinorine65 (vide infra, 112) does not resemble 67.  
Rauvoloids A-E (68-72) were isolated from R. yunnanensis66 and are perakine-type alkaloids with 
a C18 skeleton and no formyl function at C(20). Rauvoloid A 68 bears no carbon substituent at 
C(20), while rauvoloids B 69 and C 70 contain an α- and β-chloro substituents at C(20), 
respectively. The question remains whether the C(20) chloro substituents 69 and 70 arise on 
isolation or from an unconventional biosynthesis. As far as the authors know this has not been 
determined. In rauvoloid D 71 there is a (1E)-3-oxo-butenyl group at C(20) which makes it the 
first perakine-type alkaloid with a C22 skeleton. The base 71 was also isolated previously from R. 
tetraphylla and was named rauvotetraphylline D.60 Rauvoloid E 72 is the diethoxy acetal analog 
of the C(20)-formyl function and has the same skeleton as perakine 77. The 10-methoxy ajmaline 
alkaloids, vinmajines A 73 and B 75, were isolated from  cultivated V. major.30 Vinmajine A 73 
contains a methoxy-acetamido acetal group at the C-20α formyl group, whereas 75 contains a β-
hydroxymethyl group at C(20). Raucaffrinoline 76 was first isolated from R. caffra67 and later it 
has also been isolated from various Rauwolfia and Alstonia species (see Table 4). Examination of 
the X-ray crystal structure of 76 confirmed its structure as drawn. In the crystal structure it was 
observed that raucaffrinoline formed an intermolecular OH…O hydrogen bond via the C-21 
hydroxyl group with the carbonyl oxygen of the C-17 acetate group which formed an infinite chain 
along the [100] axis.68 Perakine 77 (also known as raucaffrine33,69) was first isolated from R. 
perakensis57 and later from various other Rauwolfia, Alstonia, and Vinca species (see Table 4 for 
details). Perakine dimethyl acetal 82 was isolated from R. sellowii and is considered to be an 
artifact of the isolation process.70 The ring-A oxygenated perakine variant 10-methoxyperakine 81 
was later isolated from V. major.30,71 Vincawajine 78 was isolated from the aerial parts of V. 
major.71 Vincawajine 78 and 10-methoxyperakine 81 were reported as C-20β (acetoxymethyl and 
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formyl substituted bases, respectively). But these are C-20α  substituted alkaloids according to 
Lounasmaa, as drawn here in Table 3.7,21  Perakine N4-oxide 80 and raucaffrinoline N4-oxide 79 
were isolated recently from A. yunnanensis.72 The biogenetic numbering was incorrectly 
represented in that report.72 The correct numbering is as drawn in structures (79 and 80). The base 
10-methoxyraucaffrinoline 74 was isolated from V. herbacea L. and the biogenetic numbering was 
shown incorrectly in that report.73 The correct biogenetic numbering is shown here in structure 74. 
Perakine N1,N4-dioxide 83 was isolated from the aerial parts of A. rupestris.
31 
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Table 3. Ajmaline-related C-19 methyl substituted alkaloids 
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Table 3. Ajmaline-related C-19 methyl substituted alkaloids (continued: 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
Table 4. Plant source(s) and plant morphology of the C-19 methyl substituted sarpagine-
/macroline/ajmaline alkaloids (12-80) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Macroline alkaloids 
Alkaloid Plant Morphology (ref) 
Macrocarpine A (12) Alstonia macrophylla Bark37; Leaves40 
Macrocarpine B (13) Alstonia macrophylla 
Alstonia angustifolia 
 
Bark37,43; Leaves40 
Stem bark and leaves39; 
Stem bark28 
Macrocarpine C (14) Alstonia macrophylla Bark37 
Macrocarpine D (15) Alstonia macrophylla 
Alstonia angustifolia 
Stem bark38,74  
Stem bark38; 
Stem bark and leaves39 
Macrocarpines E-H (16-19) Alstonia angustifolia Stem bark and leaves39 
Alstohentine (20) Alstonia macrophylla Leaves40 
Talcarpine (21) Pleiocarpa talbotii 
Wernham 
Alstonia macrophylla 
 
Alstonia angustifolia 
Stem bark41 
 
Bark37,43,47; Leaves75; 
Root bark76,77 
Stem bark and leaves39 
N4-Methyl-N4,21-
secotalpinine (22) 
Alstonia angustifolia 
Alstonia macrophylla 
Stem bark28 
Bark37 
Sarpagine and macroline-derived sarpagine alkaloids 
Alkaloid Plant Morphology (ref) 
19-Epitalcarpine (23) Alstonia angustifolia Stem bark and leaves39 
Alstonerinal (24) Alstonia angustifolia 
 
Alstonia macrophylla 
Stem bark and leaves39; 
Leaves46; Stem bark28,78 
Bark43 
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Table 4. Continued: 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alkaloid Plant Morphology (ref) 
19,20-Dehydro-10-
methoxytalcarpine (25) 
Alstonia angustifolia 
Tabernaemontana 
dichotoma 
Leaves44 
Bark45 
N4-Demethylalstonerinal 
(26) 
Alstonia angustifolia var. 
latifolia 
Leaves46 
N1-Demethylalstonerinal 
(27) 
Alstonia angustifolia Stem bark and leaves39 
6-Oxoalstophyllal (28) Alstonia macrophylla Leaves40 
Alstophyllal (29) Alstonia macrophylla Bark37,43; Leaves40 
N1-Demethylalstophyllal 
(30) 
Alstonia macrophylla Bark37 
Alstoniaphylline C (31) Alstonia macrophylla Bark43 
N4-Demethylalstophyllal 
oxindole (32) 
Alstonia macrophylla Bark47 
Alstonal (33) Alstonia macrophylla 
 
Tabernaemontana 
dichotoma 
Leaves48; Bark47; 
Stem bark78 
Bark45 
N1-Demethylalstonal (34) Alstonia angustifolia var. 
latifolia 
Alstonia macrophylla 
Leaves 
 
Leaves48 
16-Hydroxy-N4-
demethylalstophyllal 
oxindole (35) 
Alstonia macrophylla Leaves40 
16-Hydroxyalstonal (36) Alstonia macrophylla Leaves40 
Talpinine (37) Alstonia angustifolia 
Pleiocarpa talbotii 
Wernham 
Stem bark and leaves39 
Stem bark41 
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Table 4. Continued: 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alkaloid Plant Morphology (ref) 
N4-Methyltalpine  (38) Alstonia angustifolia Stem bark
28 
O-Acetyltalpinine (39) Alstonia angustifolia Stem bark and leaves 
N4-Methyl-19-epitalpinine 
(40) 
Alstonia angustifolia Stem bark and leaves39 
Peraksine (vomifoline) 
(41) 
Rauwolfia caffra 
Rauwolfia perakensis 
Rauwolfia vomitoria 
 
Rauwolfia volkensii 
Rauwolfia verticillata 
(Lour.) Bail of Hong Kong 
Rauvolfia verticillata 
Rauwolfia mombasiana 
STAPF 
Rauwolfia cumminsii 
Rauwolfia nitida 
Rauwolfia oreogiton 
Rauwolfia sumatrana 
JACK 
Rauvolfia tetraphylla 
Leaves57,79 
Leaves49,55,80 
Stem bark58; Leaves81,82; 
Aerial parts63 
Stem bark61; Leaves83 
Wood84 
 
Stem59 
Leaves85 
 
Stem bark86 
Root bark87 
Leaves88 
Leaves89 
 
Aerial parts60 
Alstoyunine A (42) Alstonia yunnanensis 
Rauvolfia vomitoria 
Whole plant29 
Aerial parts63 
Alstoyunine B (43) Alstonia yunnanensis Whole plant29 
21-Hydroxycyclolochnerine 
(44) 
Catharanthus roseus Cell cultures51,90; Root91 
Alstiyunnanenine A (45) Alstonia yunnanensis Diels Aerial parts50 
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Table 4. Continued: 4 
Alkaloid Plant Morphology (ref) 
Verticillatine (46) Rauwolfia verticillata Root52,53 
19(S),20(R)-
Dihydroperaksine (47) 
Rauvolfia serpentina 
Rauvolfia verticillata 
Rauvolfia tetraphylla 
Hairy root culture54 
Stem59 
Aerial parts60 
19(S),20(R)-
Dihydroperaksine-17-al (48) 
Rauvolfia serpentina Hairy root culture54 
10-Hydroxy-19(S),20(R)-
dihydroperaksine (49) 
Rauvolfia serpentina 
Rauvolfia tetraphylla 
Hairy root culture54 
Aerial parts60 
Dihydroperaksine (50) Rauwolfia caffra 
Rauwolfia perakensis 
Leaves57; stem bark56 
Leaves and stem55 
Deoxyperaksine (51) Rauwolfia vomitoria 
Rauwolfia perakensis 
Stem bark58 
Leaves and stem55 
O-Acetylpreperakine (52) Rauwolfia volkensii Stem bark61 
Macrosalhine chloride and 
thiocyanate (53) 
Alstonia macrophylla Wall. Bark62 
7(S)-Talpinine oxindole (54) Alstonia angustifolia Stem bark and leaves39 
Vinmajine F (55) Vinca major Whole plant30 
Rauvovertine A (56) Rauvolfia verticillata Stem59 
17-Epi-rauvovertine A (57) Rauvolfia verticillata Stem59 
Rauvovertine B (58) Rauvolfia verticillata Stem59 
17-Epi-rauvovertine B (59) Rauvolfia verticillata Stem59 
Rauvovertine C (60) Rauvolfia verticillata Stem59 
Rauvomine A (61) Rauvolfia vomitoria Aerial parts63 
Rauvomine B (62) Rauvolfia vomitoria Aerial parts63 
Vinmajorines C-E (63-65) Vinca major Whole plant64 
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Table 4. Continued: 5 
Ajmaline Alkaloids 
Alkaloid Plant Morphology (ref) 
Alstoyunine C (66) Alstonia yunnanensis Whole plant29 
Alstoyunine D (67) 
(vinorine N1,N4-dioxide) 
Alstonia yunnanensis 
Alstonia rupestris 
Whole plant29 
Aerial parts31 
Rauvoloid A-C, E  
(68-70, 72) 
Rauvolfia yunnanensis Leaves66 
Rauvoloid D (71) 
(Rauvotetraphylline D) 
Rauvolfia yunnanensis 
Rauwolfia tetraphylla 
Leaves66 
Aerial parts60 
Vinmajines A-B (73, 75) Vinca major Whole plant30 
10-Methoxyraucaffrinoline 
(74) 
Vinca major 
Vinca herbacea Waldst. et. 
Kit 
Whole plant30 
Aerial parts73 
Raucaffrinoline (76) 
Rauwolfia caffra 
Rauwolfia caffra Sonder 
Rauvolfia yunnanensis 
Rauwolfia of New 
Calédonia 
Rauwolfia vomitoria 
Rauvolfia serpentina 
Alstonia venenata 
Rauwolfia nitida 
Rauwolfia sellowii 
Rauvolfia bahiensis A. DC. 
Leaves57 
Root bark67 
Leaves66 
Leaves92 
 
Leaves81 
Hairy root culture54 
Leaves93 
Root bark87 
Leaves70  
Aerial parts68 
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Table 4: Continued: 6 
Alkaloid Plant Morphology (ref) 
Perakine (77, raucaffrine) 
Rauwolfia caffra 
Rauvolfia yunnanensis 
Rauwolfia vomitoria 
Rauvolfia serpentina 
Alstonia yunnanensis 
Rauwolfia perakensis 
Vinca major 
Rauwolfia Caffra Sonder 
Alstonia mairei 
Rauwolfia sumatrana 
JACK 
Rauwolfia sellowii 
Rauvolfia biauriculata 
 
Rauwolfia sprucei Muell 
Arg. 
Rauvolfia capixabae 
Leaves57; Stem bark56 
Leaves66 
Leaves81,94 
Hairy root culture54 
Whole plant29 
Root and leaves49,80 
Whole plant30 
Root95 
Leaves and twigs93 
Leaves89 
 
Leaves70 
Leaves, stem and root 
bark96 
Stems and leaves97 
Stem bark98 
Vincawajine (78) Vinca major Aerial parts71 
Raucaffrinoline N4-oxide 
(79) 
Alstonia yunnanesis Whole plant72 
Perakine N4-oxide (80) Alstonia yunnanesis Whole plant
72 
10-Methoxyperakine (81) Vinca major Aerial parts71; Whole 
plant30 
Perakine dimethyl acetal 
(82) 
Rauwolfia sellowii Leaves70  
Perakine N1,N4-dioxide (83) Alstonia rupestris Aerial parts
31 
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3. Bioactivity 
 
The biological activity of the majority of the alkaloids in this chapter has not been reported. We 
presume this is due to the paucity of isolated alkaloids from botanical sources, which hinders 
biological screening. In some cases the geographical location of the plants bearing these alkaloids 
is problematic. Most of the isolated material (if not all of it) is primarily used for isolation and 
characterization purposes by spectroscopic and optical methods, some of which are destructive. 
Sometimes the structural and stereochemical confirmation by derivatizing the isolated alkaloid (if 
required) is the primary focus. For example, some alkaloids, the structures of which have been 
known for several decades, have not had any biological activity reported until recently. With the 
availability of better spectroscopic methods and instruments, it is expected that a lower loading of 
material will be required for characterization and as a result, this will facilitate the studies of 
biology. Although the role(s) of the C-19 methyl function in these secondary metabolites is not 
known yet, a number of indole alkaloids that belong to this group have been reported to possess 
useful and important biological activity ranging from anti-hypertensive to anticancer. These active 
alkaloids can belong to any of the groups described herein i.e., the sarpagine, macroline, and 
ajmaline series (see Table 5 for the list of bioactive alkaloids). 
Examination of the biological activity of talpinine 37 and O-acetyltalpinine 39 has shown moderate 
to weak cytotoxicity in reversing the multidrug resistance of vincristine resistant human cancer 
cell line (KB/VJ300).39  Alstoyunines A-D (42-43, 66-67) were screened for anti-inflammatory 
and cytotoxicity. Among them, alstoyunine C 66 demonstrated selective COX-2 inhibition  
(94.85%), while none of the bases in this series were cytotoxic against human myeloid leukemia 
HL-60, hepatocellular carcinoma SMMC-7721, breast cancer SK-BR-3, pancreatic cancer PANC-
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1, or lung cancer A-549 cell lines.29 Alstiyunnanenine A 45 was screened against eight human 
tumor cell lines. It showed weak activity against the osteosarcoma cell lines Saos-2 and M663 with 
IC50 values of 26.8±4.1 and 27.7±4.0 μM, respectively.50 The19,20-dehydro-10-
methoxytalcarpine 25 and alstonal 33 along with a few related alkaloids isolated from the bark of 
T. dichotoma were screened for their vasorelaxant activity on normotensive rat aortic arteries 
precontracted with phenylephrine. Alstonal 33 showed strong vasorelaxant activity, while 25 did 
not show much relaxation.45  
The new quaternary nitrogen alkaloid N4-methyltalpinine 38 and the known alkaloids N4-methyl-
N4,21-secotalpinine 22, alstonerinal 24, and macrocarpine B 13, along with a few other alkaloids 
isolated from A. angustifolia, were screened for their leishmanicidal activity against promastigotes 
of Leishmania mexicana, as well as their cytotoxic and NF-κB inhibitory activities.28 The N4-
methyl-N4,21-secotalpinine 22 demonstrated potent antileishmanial activity. Alstonerinal 24 
exhibited moderate cytotoxicity against a human colon cancer cell line (HT-29) and weak activity 
against L. Mexicana. The N4-methyltalpinie 38, on the other hand, exhibited very strong NF-κB 
inhibition.28 This is an important activity.99,100 
Perakine N4-oxide 80 and raucaffrinoline N4-oxide 79 along with a few other alkaloids isolated 
from A. yunnanensis were evaluated for their anti-inflammatory (selective COX-2 inhibition) and 
cytotoxicity activity against seven human cancer cell lines.72 Both 79 and 80 showed selective 
COX-2 inhibition (94.77% and 88.09%, respectively) which supports their anti-inflammatory 
properties. On the other hand, both alkaloids exhibited cytotoxicity against astrocytoma (CCF-
STTG1), gliomas (CHG-5, SHG-44, U251), human skin melanoma (SK-MEL-2) and human 
breast cancer (MCF-7) cell lines, while none of these were active against the BEN-MEN-1 
(meningioma) cell line.72 
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Talcarpine 21 exhibited weak antimalarial activity against the Plasmodium falciparum (K1 
strain).77 Vinmajines A-B, F (73, 75, 55) and perakine 77, along with a few other alkaloids isolated 
from cultivated Vinca major, were screened for cytotoxicity against five human cancer cell lines 
(HL-6-, SMMC-7721, A-549, MCF-7, SW480).30 Vinmajine F 55 and perakine 77 demonstrated 
potent cytotoxicity against human lung cancer cell line A-549, while 55 was found more cytotoxic 
against the A-549 cell line (IC50 = 3.1 μM) than the positive control cisplatin (IC50 = 9.24 μM).30 
Perakine N1,N4-dioxide 83 and alstoyunine D 67 were evaluated for their cytotoxic and 
antimicrobial properties.31 In the cytotoxicity screening assay against seven human tumor cell lines 
both alkaloids did not show any significant cytotoxicity. On the other hand, in the antimicrobial 
screen using disk diffusion methods against seven different fungi and bacteria, both of them 
showed potent activity against Staphylococcus aureus with MIC values of 0.49 and 0.83 mM, 
respectively.31 Verticillatine 46 was studied for its effect on mean arterial pressure (MAP), cerebral 
blood flow (CBF), and cerebrovascular resistance (CVR) in pentobarbital anesthetized dogs and 
cats. Verticillatine 46 significantly reduced MAP and CVR in both animals while CBF increased 
in dogs and remained unaltered in cats.101 In another study 46 exhibited ganglionic blocking 
effects.52 Rauvovertine A 56, 17-epi-rauvovertine A 57, rauvovertine B 58, 17-epi-rauvovertine B 
59, and rauvovertine C 60 were screened against five human cancer cell lines by the MTS method 
using cisplatin and taxol as positive controls.59 Among these, only 60 showed moderate 
cytotoxicity against all of the cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW-
480) with IC50 values of 10.76-15.7 μM.59 Rauvomines A 61 and B 62 along with peraksine 41 
and alstoyunine A 42, isolated from R. vomitoria, were screened for their cytotoxic and anti-
inflammatory properties.63 Only alstoyunine A 42 showed weak cytotoxicity against human colon 
cancer cell lines HT-29 and SW480 while the remaining alkaloids did not show any appreciable 
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cytotoxicity. The rauvomine B 62 showed significant inhibition of the macrophage RAW 264.7 
cell line (IC50 = 39.6 μM; positive control celecoxib IC50 = 34.3 μM), while other alkaloids 
exhibited moderate activity.63 Vinmajorines C-E (63-65) were screened for their cytotoxicity 
against five human cancer cell lines (MCF-7, SMMC-7721, HL-60, SW480, and A-549). 
Vinmajorine C 63 exhibited moderate (IC50 = 19.86 μM) and vinmajorine E 65 showed weak (IC50 
= 34.89 μM ) cytotoxicity only against the human lung cancer cell line A-549 while vinmajorine D 
64 was inactive.  
The 19(S),20(R)-dihydroperaksine-17,21-al (see 84), a biosynthetic derivative of perakine by 
acetylesterase (AE)102 was predicted to be an inhibitor of aldose reductase (AR) in a computational 
docking study of 142 Rauvolfia serpentina derived compounds, which would be a potential lead 
for designing novel compounds for the treatment of diabetes and its complications.103 
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Table 5. Biologically active alkaloids from the C-19 methyl substituted subgroup and their activity 
 
Alkaloid Bioactivity Reference 
Talpinine (37) Anticancer: Moderate to weak cytotoxic [IC50 
=14-22 μg/mL) activity in the presence of 0.1 
μg/mL vincristine] activity in reversing multidrug 
resistance in drug-resistant KB/VJ300 cells  
Kam39 
O-acetyltalpinine 
(39) 
Alstoyunine C (66) 
Anti-inflammatory activity: selective inhibition 
of COX-2 (94.84%) enzyme 
Tan29 
Alstiyunnanenine A 
(45) 
Anticancer:  weak cyctoxicity against 
osteosarcoma cell lines Saos-2 and M663, IC50 ≤ 
30 μM 
Shi and 
Wu50 
N4-methyltalpinine 
(38) 
Anticancer: NF-κB (p65) inhibitory activity: 
ED50 = 1.2 μM 
Kinghorn28 
N4-methyl-N4,21-
secotalpinine (22) 
Antileishmanial: active against promastigotes of 
Leishmania mexicana (IC50 = 57.8 μM)   
Kinghorn28 
Alstonerinal (24) 
Anticancer: active against human colon cancer 
cell line (HT-29 cells, ED50 = 8.6 μM) 
Antileishmanial: active against promastigotes of 
Leishmania mexicana (IC50 = 145.4 μM)   
Kinghorn28 
Alstonal (33) 
Antihypertensive: Potent vasorelaxant activity at 
30 μM in precontracted (phenylephrine) rat 
aerotic rings 
Zaima45 
Perakine N4-oxide 
(80) 
Anticancer: Cytotoxic (IC50) against glioma 
(CHG-5, SHG-44, U251: 12.9, 11.8, 12.3 μM 
respectively), astrocytoma (CCF-STTGI: 12.3 
μM), human skin cancer (SK-MEL-2: 33.7 μM), 
and human breast cancer cells (MCF-7: 28.1 
μM).  
Anti-inflammatory: selective inhibition of 
COX-2 (94.77%) enzyme 
Liang72 
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Table 5. Continued: 2 
 
Alkaloid Bioactivity Reference 
Raucaffrinoline N4-
oxide (79) 
Anticancer: Cytotoxic (IC50) against glioma 
(CHG-5, SHG-44, U251: 12.1, 9.2, 9.7 μM 
respectively), astrocytoma (CCF-STTGI: 11.4 
μM), human skin cancer (SK-MEL-2: 34.9 μM), 
and human breast cancer cell (MCF-7: 29.9 μM) 
lines 
Anti-inflammatory: selective inhibition of 
COX-2 (88.09%) enzyme 
Liang72 
Talcarpine (21) 
Antimalarial: active against multidrug-resistant 
Plasmodium falciparum (K1 strain), IC50 = 
40.3±2.9 μM 
Houghton77 
Vinmajine F (55) 
Anticancer: Stronger cytotoxicity against human 
lung cancer cells A-549 than cisplatin (IC50 = 3.1 
μM vs cisplatin IC50 = 9.24 μM) 
Cheng30 
Perakine (77) 
Anticancer: Cytotoxic against human lung 
cancer cells A-549 (IC50 = 14.5 μM vs cisplatin 
IC50 = 9.24 μM) 
Cheng30 
Perakine N1,N4-
dioxide (83) 
Antimicrobial: strong activity against S. aureus, 
MIC = 0.49 mM 
Hua31 
Alstoyunine D (67) 
Antimicrobial: strong activity against S. aureus, 
MIC = 0.83 mM 
Hua31 
Verticillatine (46) 
Antihypertensive: Ganglionic blocking effect 
 
Antihypertensive: Vasodilation effect 
(significant reduction in mean arterial pressure) 
and improved cerebral blood circulation in dogs 
and cats. 
Lin52 
 
Zeng101 
Rauvovertine C (60) 
Anticancer: moderate cytotoxicity (IC50) against 
human cancer cell lines HL-60 (10.76 μM), 
SMMC-7721 (15.02 μM), A-549 (15.70 μM), 
MCF-7 (12.63 μM), and SW-480 (14.02 μM). 
Wang59 
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Table 5: Continued: 3 
 
Alkaloid Bioactivity Reference 
Rauvomine A (61) 
Anti-inflammatory: modest activity in inhibiting 
macrophage RAW 264.7 cell line, IC50 = 55.5 
μM. 
Gao and 
Chen63 
Rauvomine B (62) 
Anti-inflammatory: significant activity in inhibiting 
macrophage RAW 264.7 cell line, IC50 = 39.6 μM. 
Gao and 
Chen63 
Alstoyunine A (42) 
Anticancer: weak cytotoxicity against human colon 
cancer cell lines HT-29 (IC50 = 35.2 μM) and SW480 
(IC50 = 45.3 μM); 
Anti-inflammatory: weak activity against RAW 
264.7 macrophage cell line (IC50 = 75.3 μM) 
Gao and 
Chen63 
Peraksine (41) 
Anti-inflammatory: moderate activity against RAW 
264.7 macrophage cell line (IC50 = 65.2 μM) 
Gao and 
Chen63 
Vinmajorine C (63) 
Anticancer: moderate cytotoxicity against A-549 cell 
line (IC50 = 19.86 μM) 
Li and 
Zhao64 
Vinmajorine E (65) 
Anticancer: weak cytotoxicity against A-549 cell line 
(IC50 = 34.89 μM) 
Li and 
Zhao64 
 
 
4. Biosynthesis and Synthesis (Partial, Formal, and Total Synthesis) of the 
Alkaloids from this Subgroup 
 
4.1 Biosynthesis 
 
For the detailed biosynthetic, structural and chemo-enzymatic significance of sarpagine-ajmaline-
type alkaloids see the Chapter by Stöckigt et al.104 
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4.1.1 Proposed Biosynthesis of Rauvovertine C (60) by Gao et al.59 
 
A plausible biosynthetic pathway was proposed for the formation of the unusual imine bridge 
containing sarpagine-type alkaloid rauvovertine C 6059 (Figure 2). Although no enzymatic 
reactions have been carried out to support this mechanism. The C-16α,C-20β-dialdehyde 85 could 
possibly originate from perakine 77 (which is known to occur in Rauvolfia species) via an 
enzymatic process and this could be followed by the isomerization of the C-20α aldehyde in 84.54,66 
The imine intermediate 86 is proposed to form via an amination reaction of the β-
aminoethanol105,106 with the aldehyde function at C-21. The reaction of the C-21-imine with the 
formyl function at C-17 in the base 86 in the presence of acid would form the iminium ion 
intermediate 87. Rauvovertine C 60 would possibly be generated from the iminium intermediate 
via de-alkylation of the iminium ion and this would be followed by methylation of the C-17-
hydroxyl function. However, there was NH3 in the isolation process which could have led to a 
simple imine, which could cyclize to give 60. 
 
Figure 2. Plausible biosynthetic pathway for rauvovertine C 60 proposed by Gao et al.59 
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Figure 3. Possible origin of the rauvoloids A-E 68-72 from a common intermediate perakine 77 
proposed by Liu66 
 
4.1.2 Proposed Biosynthesis of Rauvoloids A-E (68-72) by Liu66 
 
Liu proposed the possible origin of five new alkaloids, the rauvoloids A-E 68-72 from a common 
precursor, perakine 7766 (Figure 3). As hypothesized by Geng and Liu, biogenetically, a sequence 
of oxidations and decarboxylation of perakine 77 might form rauvoloid A 68. Decarboxylation of 
the oxidized precursor 88 in the presence of HCl might form the C(20)-Cl epimers, rauvoloids B 
69 and C 70. On the other hand, an aldol condensation of the perakine C(21)-formyl function with 
a C3-moiety could be the origin of the C22 skeleton present in rauvoloid D 71. Rauvoloid E 72 
could form by acetalization of the C(21)-formyl function with ethanol in the presence of acid. No 
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biosynthetic experiments have been executed in this work, consequently, these could also possibly 
be considered as artifact alkaloids that formed during the isolation process.60,66 
 
 
Figure 4. Plausible biosynthesis of rauvomines A (61) and B (62) proposed by Zeng et al.63 
 
4.1.3 Proposed Biosynthesis of Rauvomines A (61) and B (62) by Zeng et al.63 
 
A plausible biosynthesis of rauvomines A 61 and B 62 was proposed by Zeng et al. during the 
report of their isolation and structure determination of 61 and 62, along with two other known 
alkaloids peraksine 41 and alstoyunine A 42 from the aerial parts of R. vomitoria63 (Figure 4). The 
C-17,C-21-dialdehyde 89 was known to originate from tryptamine (the authors mentioned 
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tryptophan, which should be tryptamine) and secologanin.59,107 The enolization of aldehyde 89 
could lead to intermediate 90.59 The C-20α hydroxyl function in 92 could form from the enol 
intermediate 90, followed by oxidation to 91 and subsequent NADPH mediated reduction. An 
intramolecular cyclization via the SN2 substitution of the C(20)-hydroxyl by the enolate carbon 
atom at C(16) could form the cyclopropane ring present in rauvomine B (path a, via 93), whereas 
replacement of the hydroxyl function in 92 with a chlorine atom (path b) might generate rauvomine 
A 61. Besides, the C-16(α),C-20(β) dialdehyde 94 could originate from the dialdehyde 89 by 
isomerization. This dialdehyde could react with methanol to generate alstoyunine A 42 while 
partial reduction, followed by intramolecular aldol condensation could generate peraksine (41, not 
shown here).102,108 Again, whether this is related to the biosynthesis of 41 and 42 remains to be 
determined. 
 
4.1.4 Interpretation of the Formation of Nine Artifact Alkaloids Proposed by Lounasmaa21 
 
Lounasmaa proposed the origin of nine alkaloids that could, in fact, be “artifact alkaloids” formed 
during the isolation process (see Figures 5 and 6).21 In that interesting discussion, logical 
arguments were put forward to support the artifactual nature of those alkaloids and their possible 
formation based on organic chemistry. However, it is controversial since no enzymatic studies 
were carried out to support the hypothesis despite the sensible nature of the arguments form a 
chemical point of view. Nevertheless, it is worth considering to promote further studies to either 
confirm or disprove the hypothesis proposed by Lounasmaa. The O-acetylpreperakine 52, 
macrosalhine 53, peraksine 41, 19(S),20(R)-dihydroperaksine 47, perakine 77, and raucaffrinoline 
76 were proposed to form from E-vomilenine (via Z-vomilenine) during the isolation process. On 
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the other hand, verticillatine 46 would be formed from the 10-hydroxy related compounds, whereas 
10-methoxyperakine 81 and vincawajine 78 would be formed form their 10-methoxy counterparts.  
The C-21 hydroxy indolenines 95 and 98 could rearrange to their corresponding tautomeric amino-
aldehyde ring-opened Chano forms 96 and 97 (Figure 5). The Chano forms could interconvert to 
permit the E-and Z-vomilenines (95 and 98) to reach equilibrium favoring the E-vomilenine 95 
(Figure 5).  In addition, acidic or basic conditions during the isolation process might cleave the 
acetyl function of either the E-vomilenine 95 or the Z-vomilenine 98 which would ultimately form 
Z-vellosimine 101 via 16-epi-Z-vellosimine 100. It is important to mention that the Z-ethylidene 
moiety is in fact more stable than the E-ethylidene in vellosimine or related compounds as 
suggested by the predominance of the Z-ethylidene moiety in studies carried out by Wang et al.109 
and Cao et al.110 during the synthesis of vellosimine and koumidine, respectively (not shown here). 
In this regard, another interesting point is that all of these alkaloids form via Z-ethylidene 
derivatives even though the E-ethylidenes (in vomilenines) are thermodynamically favored 
because the Chano form derived from E-vomilenine would generate 19-epi-perakine, which has 
never been isolated (all of these nine alkaloids bear the C-19β-CH3 group). This would mean that 
the E-ethylidenes first isomerize to the corresponding Z-ethylidene counterparts before re-
cyclization, as shown in Figure 5.  
As hypothesized by Lounasmaa, O-acetylpreperakine 52 could form from Z-vellosimine 101, 
which would originate from E-vomilenine 95 via Z-vomilenine 98, as shown in Figure 5. 
Recyclization of the Chano forms from β-side attack (in 103), partial reduction of the C(17)–
formyl group (in 89) and acetylation during isolation could deliver O-acetylpreperakine 52 (Figure 
6). On the other hand, the recyclization of 103 could yield an equilibrium mixture of α- and β- (89 
and 94) aldehydes (in favor of the α-aldehyde 89). Isomerization to the C-20β-aldehyde, followed 
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by partial reduction would provide 105, which after hemiacetal formation, and methylation during 
isolation could afford macrosalhine 53. 
On the contrary, the diol 47 could form by reduction of both of the formyl functions (C-17 and C-
21) of the intermediate 89. On the other hand, peraksine could form in a manner similar to 
macrosalhine 53 via partial reduction and subsequent hemiacetal formation from 94. Similarly, 
verticillatine 46 could form from the 10-hydroxy counterpart via similar transformations analogous 
to peraksine. Similarly, perakine 77 could form via Z-vomilenine 98 after generation of the Chano 
form and cyclization from the β-side. The partial reduction of the C(21)-formyl function would 
afford raucaffrinoline 76. The 10-methoxyperakine 81, 10-methoxyraucaffrinoline 74, and 
vincawajine 78 could form via similar transformations but only from the 10-methoxy variant 110.21 
 
Figure 5. Equilibrium between E-vomilenine and Z-vomilenine via their ring-opened (Chano) 
forms 
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Figure 6. Plausible pathways for the formation of “artifact alkaloids” proposed by Lounasmaa21 
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4.1.5 Putative Biosynthetic Formation of Alkaloids in Rauvolfia serpentina Hairy Root 
Culture Executed by Stöckigt et al.54 
 
On the other hand biosynthetic experiments have been carried out by Stöckigt et al.104 The 
alkaloids isolated from the hairy root culture of Rauvolfia serpentina54 were presumed to be 
derived from perakine 77 or its reduced form raucaffrinoline 76, both of which were isolated from 
the Rauvolfia hairy root culture by Stöckigt et al. (Figure 7).111 Raucaffrinoline 76 could be 
enzymatically prepared from E-vomilenine 95 in the presence of NADPH2 or from perakine.
111 In 
this case, Stöckigt dismissed the possibility of 47 and 48 being artifact alkaloids, which were felt 
to be artifacts of the isolation process, as proposed by Lounasmaa21 since the corresponding 
precursor for 49 was not detected in Rauvolfia plants and cell cultures.111,112 To support their 
hypothesis Stöckigt et al. incubated raucaffrinoline 76 with a crude enzyme preparation from the 
hairy root culture of R. serpentina. A deactivated enzyme mixture (boiled) was used as a negative 
control. After overnight incubation, the 19(S),20(R)-dihydroperaksine-17-al 48 was isolated, while 
in the deactivated enzyme, raucaffrinoline 76 remained unchanged. This suggested that, enzymatic 
deacetylation facilitated the C(17)-C(7) bond cleavage and the formation of 19(S),20(R)-
dihydroperaksine-17-al 48 took place, which upon reduction would form 19(S),20(R)-
dihydroperaksine 47. The 10-hydroxy dihydroperaksine derivative 49 was presumed to be formed 
via a late-stage hydroxylation of 48. The final proof of this concept remains outstanding until the 
isolation and characterization of the appropriate enzymes are performed.54 However, Stöckigt has 
provided enzymatic evidence for the generation of 48 and then 47, which is in agreement with 
previous studies.102,104,113 An enzymatic network is shown in Figure 7 that involves three enzymes; 
perakine reductase (PR), acetylesterase (AE), and an uninvestigated reductase (XR).114,102,104 
These results seem to support the hypothesis that these alkaloids are not artifacts.54  
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Figure 7. Putative biosynthetic formation of the alkaloids 47, 48, and 49 from raucaffrinoline 76 
in R. serpentina hairy root culture by Stöckigt et al.54 
 
4.2 Partial Synthesis 
 
4.2.1 Partial Synthesis of Perakine 77 by Sakai et al.113 
 
Vomilenine 95 is known to play an important role in the biosynthesis of Rauwolfia alkaloids.104,115-
118 Ajmaline 113, perakine 77, raucaffrinoline 76, and related alkaloids are believed to originate 
from strictosidine via polyneuridine aldehyde and its conversion into 16-epi-vellosimine 100 by 
PNA-esterase (Scheme 1).104,113 Acetyl CoA and vinorine synthase are known to convert 16-epi-
vellosimine into vinorine 112, which after the action of a hydroxylase provides vomilenine 95. 
Perakine 77 is also considered to be an artifact alkaloid formed by the effect of acetic acid on 
vomilenine. Sakai et al.113 synthesized both Z- and E-vomilenine (98 and 95, respectively) from 
ajmaline 113 to investigate the role of the ethylidene configuration in the transformation. The 19-
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(Z) and 19-(E) olefins (114 and 115, respectively) were prepared by the degradation of ajmaline. 
Upon removing the carbamate protecting group on the Nb nitrogen atom with Zn/AcOH, the (Z)-
olefin 115 delivered Z-vomilenine 98 in 75% yield, whereas the E-olefin 114 produced E-
vomilenine 95 in 68% yield. The Z-vomilenine was converted into perakine under mild conditions 
on treatment with AcOH at room temperature, while it took treatment with hot AcOH119 to 
transform E-vomilenine into perakine 77. Interestingly, the same material was produced form both 
transformations which suggested that cleavage of the amino-acetal function in Z-vomilenine is 
more facile than in E-vomilenine.113  
 
4.2.2 Partial Synthesis of Talcarpine 21 from Ajmaline 113 by Sakai et al.42 
 
Sakai et al. devised an efficient synthetic route (Scheme 2) to several alkaloids by the degradation 
of ajmaline and confirmed the C-19 stereochemistry of talcarpine 21 to be β i.e., (S).42 The 19(Z) 
and 19(E) olefins (116 and 117) were prepared in a 2 to 1 ratio from ajmaline 113 in several steps. 
The geometry of the olefin was confirmed by NOE experiments. The major (Z) olefin 116 upon 
treatment with 5% aq H2SO4 at room temperature for 26 hours furnished the C-20β aldehyde 21 
as a minor product in 30% yield, accompanied by the C-20α aldehyde 22 as the major product in 
59% yield. The C-19 stereochemistry was concluded to be (S) by NOESY analysis after 
preparation of the C-21-acetyl derivative after reduction of the C-20 aldehyde.  
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4.2.3 Partial Synthesis of Talcarpine 21 and Related Alkaloids from Talpinine 37 by 
Schmid et al.41 
 
During the structure determination of talpinine 37  by chemical degradation, talcarpine 21 was 
synthesized (Scheme 3).41 Talpinine, upon acetylation with acetic anhydride in the presence of 
pyridine, afforded the C-21-O-acetyl derivative 39 (O-acetyltalpinine, later isolated as a natural 
product),39 along with a small amount of its C-21-epimeric derivative 21-epi-O-acetyltalpinine 118 
in 77% combined yield. On the other hand, treatment of 37 with iodomethane in benzene at room 
temperature for 4 hours transformed it into the C-20α aldehyde 22 by the cleavage of N4-C(21) 
bond. This base was further reduced and acetylated to provide the N4-methyl-O-acetyl-N4-21-
dihydrotalpinine 14 which was later isolated from A. macrophylla and named macrocarpine C.37 
The base 22 could be converted into talcarpine 21 by pyrolysis while talcarpine could also be 
converted into 22 by treatment with K2CO3 in methanol.
41 
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Scheme 1. Partial synthesis of perakine 77 from ajmaline 113 via vomilenine 95 by Sakai et 
al.113 
 
Scheme 2. Partial synthesis of talcarpine 21 and N4-methyl-N4,21-secotalpinine 22 from ajmaline 
113 by Sakai et al.42 
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Scheme 3. Partial synthesis of several alkaloids from talpinine by Schmid et al.41 
 
 
 
Scheme 4. Biomimetic transformations between several alkaloids by Le Quesne3 
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4.2.4 Biomimetic Transformations Between Alkaloids by Le Quesne3    
 
During the biomimetic transformations among several monomeric macroline alkaloids, Le 
Quesne3 converted known alstonerine 119 into N4-methyl-N4,21-secotalpinine 22 (Scheme 4). The 
reduction of 119 with sodium borohydride in methanol at 0 °C-rt for 24 hours delivered the C-19-
hydroxy alstonerines 120 as a mixture of epimers in 85% yield. This was followed by acid 
catalyzed rearrangement with 0.2 N aq HCl at room temperature for 24 hours to furnish N4-methyl-
N4,21-secotalpinine 22 in 75% yield. In addition, alstonisine 121 upon reduction with LiAlH4 in 
ether at room temperature for one hour produced several compounds one of which was 37 (5%). 
Treatment of talpinine 37 with iodomethane in benzene at 20 °C for 24 hours provided 22 in 
excellent yield whose properties were identical with the natural product.  
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Scheme 5. Total synthesis of talcarpine and talpinine by Yu et al.120 Reagents and conditions: i) 
a. PhSOCH2Cl, LDA, THF; KOH, THF-H2O, rt, 10 h; b. LiClO4, dioxane, reflux, 4 h, 90%; ii) 
Li/Ph2/BaI2, 124, THF, -78 °C, 90%; iii) KH, dioxane, 18-crown-6, 100 °C, 14 h; MeOH, rt, 4 h, 
88%; iv) NaH, THF, CH3I, rt, 6 h, 95%; v) NaBH4, MeOH, rt, 1 h, 95%; vi) OsO4, Py, NaHSO3; 
NaIO4, H2O, MeOH, 0 °C, 75%; vii) benzene, p-TSA, DST, reflux, 5 h, 95%; viii) p-TSA, MeOH, 
N-(phenylseleno)phthalimide; NaIO4, H2O, MeOH, 0 °C, 20 h, 90%; ix) 5% aq. H2SO4, 3 days, 
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90% combined yield; x) Pd/C, H2, EtOH, rt, 5 h, 92%; xi) Pd/C, H2, MeOH, rt, 5 h, 90%; xii) 
K2CO3, EtOH, rt, 2 days, 85%; xiii) 10
-1 torr/100 °C, 75%. 
 
4.3 Total and Formal Synthesis 
 
In this chapter the reported total synthesis of the C-19 methyl substituted subgroup of 
sarpagine/macroline/ajmaline alkaloids have been compiled. The total synthesis of the greater 
sarpagine/ajmaline-related alkaloids have been enriched by the numerous studies by van 
Tamelen,121,122 Cook,109,123-126 Kluge,127 Le Quesne,3,128 Schmid,41 Martin,129,130 Magnus,131 
Bailey,132,133 and more recently impressive work from Gaich134,135 and others.136-139 Since the 
synthesis of the broader sarpagine-macroline-ajmaline group is out of the scope of this chapter, 
only the synthesis of sarpagine or related alkaloids that bear C-19 methyl functions are described 
here.  
 
4.3.1 Total Synthesis of Talpinine 37 and Talcarpine 21 by Yu et al.120 
 
The first enantiospecific total synthesis of talpinine 37, as well as talcarpine 21 was executed by 
Yu et al. (Scheme 5).120 The conversion of the ketone 122 into the α,β-unsaturated aldehyde 123 
via spirooxiranophenylsulfoxide in 87% yield provided the key intermediate for several alkaloids 
including talcarpine and talpinine. The α,β-unsaturated aldehyde underwent a 1,2-addition upon 
reaction with the barium Grignard reagent, analogous to the work of Yamamoto,140 prepared in 
situ from 124 at very low temperature to provide 125. The allylic alcohol 125 underwent an anionic 
oxy-Cope rearrangement with KH in dioxane in the presence of 18-crown-6. The rearrangement 
took place almost exclusively (30:1) from the bottom face of the C(15)-C(16) double bond to 
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furnish the desired stereochemistry at C(15) and C(16), as shown in aldehyde 126. The minor 
diastereomer which contained the epimeric aldehyde function at C(16) was converted completely 
into the desired aldehyde 126 by stirring the reaction mixture with methanol. This provided the 
more stable aldehyde in 88% yield from the allylic alcohol 129. The indole nitrogen atom in 126 
was methylated via a regiospecific alkylation with NaH and iodomethane in THF at room 
temperature to furnish the N1-methylated indole 127 in 95% yield. This process was followed by 
reduction of the C(17) aldehyde with sodium borohydride in ethanol to provide the alcohol 128 in 
95% yield. The oxidative cleavage of the olefinic double bond by treatment of a pre-prepared 
solution of OsO4-pyridine in THF at 0°C for 8 hours, was followed by treatment with NaIO4 and 
subsequent cyclization of the so formed aldehyde with the C(17) alcohol to furnish the desired 
hemiacetal 125. The hemiacetal underwent dehydration upon heating in refluxing benzene in the 
presence of p-TSA to provide the enol ether 130 as the sole product. The regiospecific 
oxyselenation of the enol ether 130 was performed with N-phenylselenophthalimide in CH2Cl2-
MeOH at 0 °C in the presence of p-TSA to furnish selenoacetals in a 9:1 ratio (not shown). The 
subsequent treatment of the selenoacetals with NaIO4 in THF-H2O-MeOH solution at 0 °C for 10 
hours gave the mixture of selenooxide acetals, which underwent the selenoxide elimination to 
provide the acetals 131 and 132 in a 4:1 ratio in favor of the desired product 131 in 90% yield. The 
acid catalyzed hydrolysis of the major acetal, which was followed by a Michael-type cyclization 
of the alcohol with the so formed α,β-unsaturated aldehyde, resulted in a mixture of N4-benzyl-
N4,21-secotalpinine 134 and Nb-benzyltalcarpine 133 in a 3:5 ratio in 90% yield. The catalytic 
debenzylation of the hydrochloride salt of the C-20α aldehyde 134 went smoothly with 10% Pd/C, 
H2 in ethanol to give talpinine 37 in 92% yield. The optical rotation and spectral properties of 
synthetic 37 were in excellent agreement with talpinine.41 The debenzylated amine (Nb-nitrogen 
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atom with a lone pair of electrons) had immediately attacked the C(21) aldehyde, as planned, to 
form the F-ring of 37. The β-aldehyde, Nb-benzyltalcarpine 133 was treated with 1.5 equivalents 
of Pd/C, H2 in the presence of MeOH to undergo the Nb-benzyl/Nb-methyl exchange reaction, 
which ultimately resulted in the desired alkaloid, talcarpine 21. The β-aldehyde 133 could be 
completely converted into the α-aldehyde 134 by treatment of 133 with K2CO3 in EtOH for 2 days 
(85% yield). The reverse transformation could be done by pyrolysis of 134 and recyclization under 
reduced pressure in 75% yield to give 133, analogous to the earlier work of Schmid.41,120 
 
Scheme 6. Reagents and conditions: i) 136, K2CO3, CH3CN, 65-70 °C, 88%; ii) TBAF. xH2O, 
THF, 0 °C-rt, 96%; iii) I-B(Cy)2, CH2Cl2, 0 °C-rt; AcOH; NaOH/H2O2, 0 °C-rt, 74%; iv) 
Pd2(dba)3, DPEPhos, t-BuONa, THF, 70 °C, 60%; v) Ph3P(Cl)CH2OCH3, t-BuOK, benzene, rt, 
13 h; vi) 2 N aq HCl, THF, 55 °C; vii) ehtyleneglycol, pTSA.H2O, benzene, DST, reflux, 90% 
over 3 steps; viii) BH3.DMS, THF, rt; NaBO3•4H2O, rt; ix) Na2CO3, MeOH, reflux, 5 h, 76% over 
two steps; x) NCS/DMS, CH2Cl2, -5 °C-10 °C, 30 min, cool to -78 °C; Et3N (excess), warm to rt, 
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3 h, 67%; xi) NaBH4, EtOH, 0 °C-rt, 94%; xii) 1.38 N aq HCl, acetone/H2O, 70 °C, 96%; xiii) 
NaBH4, EtOH, 94%.   
 
4.3.2 Total Synthesis of the Alkaloids Isolated from Rauvolfia serpentina Hairy Root Culture 
by Edwankar et al.25,26 
 
The first regiospecific and enantiospecific total synthesis of 19(S),20(R)-dihydroper-aksine 47, and 
19(S),20(R)-dihydroperaksine-17-al 48 was carried out by Edwankar et al.25 In this synthesis 
(Scheme 6), an SN2 alkylation of the Nb-nitrogen atom in amine 135 with the optically active (R)-
tosylate 136 provided the Nb-ethynyl tethered ketone when it was stirred in the presence of 
K2CO3/dry acetonitrile in 88% yield. Subsequent deprotection of the silyl group with 
tetrabutylammonium fluoride furnished the terminal alkyne 137. An interesting haloboration of 
the terminal alkyne in 137 was performed with dicyclohexyl-iodoborane, I-B(Cy)2, which was the 
first example of a haloboration of a terminal alkyne with this iodoborane.25 The flexible nature of 
the two cyclohexyl groups was believed to be responsible for the smooth transformation as 
opposed to the rigid nature of iodo-9BBN.25 The subsequent protodeboronation of the so formed 
iodoborane with acetic acid provided the key vinyl iodide intermediate 138 in a reasonable 74% 
yield with complete regioslectivity. The key pentacyclic ketone 139 was formed via a palladium 
catalyzed intramolecular α-vinylation141 of the ketone in 60% isolated yield. The ketone 139 was 
subjected to a one-carbon homologation process at C(16) via a Wittig-hydrolysis sequence. The 
aldehyde was found to occupy the thermodynamically more stable alpha orientation even in the 
presence of the β-C(19) methyl function (not shown here, see 151). The aldehyde was subsequently 
protected as the cyclic acetal 140 with ethylene glycol in the presence of p-TSA.H2O in refluxing 
benzene in 90% yield over three steps. The olefin in 140 was subjected to a hydroboration-
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oxidation sequence to furnish the required β-primary alcohol 141 in 76% yield over two steps. The 
primary alcohol was accompanied by a small amount of tertiary alcohol (primary: tertiary = 25:1). 
The oxidation of the primary alcohol 141 in the presence of an indole Na-H and Nb-nitrogen atom 
was found to be problematic. Several oxidation protocols were employed and failed due to the 
formation of trace amounts of desired aldehyde, accompanied by the Nb-oxide and over oxidized 
products. A modified Corey-Kim oxidation protocol was employed with a lower reagent loading 
and lower temperature to circumvent the over oxidized byproducts. This method worked very well. 
This furnished the C-20α+β-aldehydes as a mixture of epimers, which was completely converted 
into the α-epimer in the same vessel by stirring with an excess of triethylamine at room temperature 
for 3 hours. The α-aldehyde was then reduced to the primary alcohol 142 with sodium borohydride 
in ethanol in 94% yield. The cyclic acetal in 142 was cleaved under acidic conditions to provide 
the C(17) aldehyde which was identical to 19(S),20(R)-dihydroperaksine-17-al 48. The reduction 
of the aldehyde with sodium borohydride furnished the desired alkaloid 19(S),20(R)-
dihydroperaksine 47 whose properties were in good agreement with the natural product.25  
 
4.3.3 Total Synthesis of Peraksine 41 and Attempted Total Synthesis of Macrosalhine 53 by 
Edwankar et al.26 
In 2014, Edwankar et al. published a general strategy to gain access to the C-19 methyl substituted 
macroline/sarpagine indole alkaloids while reporting the total synthesis of peraksine (Scheme 7).26 
This accompanied by the previously reported total syntheses25 of 47 and 48 (vide supra), provided 
a general strategy which would also be useful in the total synthesis of other alkaloids from this 
subgroup.  
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To furnish the hemiacetal ring present in peraksine 41, the cyclic acetal 141 was hydrolyzed under 
acidic conditions by heating the mixture to reflux for 24 hours in the presence of 1 N aq HCl in 
THF. Under these conditions, only 50% of the acetal cleaved to form the ether 142. This ether 142 
(via the OH group) was in equilibrium with acetal 141 and could not be cleaved to the desired 
aldehyde.26 Additional heating of the ether with additional amounts of 1 N aq HCl for 4 days 
furnished only a trace amount of peraksine 41. Alternatively, the olefinic aldehyde 143 was 
converted into the dimethoxy acetal by refluxing it in the presence of p-TSA•H2O in MeOH for 6 
h in 93% yield. The olefin was subsequently subjected to a hydroboration-oxidation sequence to 
furnish the monol 144 in 35% yield. The dimethoxy acetal 144 was less stable, as compared to the 
cyclic acetal (in 141), and consequently was cleaved under acidic conditions with 1 N aq HCl in 
THF, at reflux (for 24 h) to furnish the alkaloid peraksine 41 as an epimeric mixture in 52% yield. 
It was reported earlier by Arthur et. al., that peraksine was isolated as a mixture of epimers.84  
 
 
Scheme 7. Reagents and conditions: i) 1 N aq HCl (10 equiv), THF, reflux, 1 d, 88%; ii) 1 N HCl 
(additional 10 equiv), reflux, 4 d, trace amount of 41; iii) a. pTSA•H2O, CH3OH, CHCl3, reflux, 6 
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h, 93%;  b. BH3. DMS, THF, rt, 2 h, then NaBO3•4H2O; Na2CO3, CH3OH, reflux, 5 h, 35%; iv) 
1 N aq HCl, THF, reflux, 1 d, 52%. 
 
In the same report,26 Edwankar reported the attempted total synthesis of the quaternary Nb-nitrogen 
containing sarpagine alkaloid macrosalhine 53 and a formal synthesis of talcarpine 21 (Scheme 8). 
To access macrosalhine 53, the Na-methyl containing vinyl iodide 145 was subjected to a palladium 
catalyzed α-vinylation to provide the Na-methylated pentacyclic ketone intermediate 146 in 68% 
yield. A one-carbon homologation of the ketone was achieved by a Wittig-hydrolysis sequence to 
furnish the thermodynamically more stable C-16α-aldehyde in 90% yield. The aldehyde (not 
shown here) was reduced to a primary alcohol in the presence of sodium brorhydride in ethanol in 
excellent yield. The subsequent protection of the primary alcohol with a triisopropylsilyl group 
was done in the presence of triisopropylsilyl triflate and 2,6-lutidine in CH2Cl2 at rt in 95% yield 
to furnish indole 147. The hydroboration-oxidation of the olefin in 147 provided the C-20β-
hydroxymethyl intermediate 148 in 71% yield over two steps. The Nb-nitrogen atom was 
methylated with iodomethane in THF at 0 oC in the dark to provide the methiodide salt 149 in 
quantitative yield. The Dess-Martin oxidation of the quaternary ammonium containing primary 
alcohol was not successful to furnish the C-20β-aldehyde 150. Consequently, as an alternative 
approach, the monol 148 was oxidized with DMP in methylene chloride at rt for 3 ours to provide 
the C-20β-aldehyde 151 in 67% yield, while the Nb-nitrogen formed an N-oxide. Several other 
oxidation protocols were also unsuccessful. The TIPS protection was removed under mild acidic 
conditions and the so formed primary alcohol reacted with the C-20β-aldehyde to furnish the 
desired hemiacetal ring of macrosalhine 152. The last step of the synthesis could not be carried out 
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due to the lack of material, but it was felt that macrosalhine 53 would be available from this  
macrosalhine N4-oxide 152 by a reduction/quaternization sequence.
26  
 
Scheme 8. Reagents and conditions: i) Pd2(dba)3, DPEPhos, t-BuONa, THF, 70 
oC, 68%; ii) 
Ph3P(Cl)CH2OCH3, t-BuOK, PhH, rt, 13 h; then 2 N aq HCl, THF, 55 
oC, 6 h, 90%; iii) NaBH4, 
EtOH, 0 oC-rt, 90%; iv) TIPSOTf, 2,6-lutidine, CH2Cl2, rt, 95%; v) BH3.DMS, THF, rt, 2 h, 
NaBO3.4H2O; vi) Na2CO3, MeOH, reflux, 5 h, 81% over two steps; vii) CH3I, THF, 0 
oC, 
overnight, 99%; viii) DMP, CH2Cl2, 0 
oC-rt, 3 h, 67%; ix) aq 1 N HCl, THF, reflux, 2 h, 75%. 
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Scheme 9. Reagents and conditions: i) NCS/DMS, CH2Cl2, -5 to -10 °C, cool to -78 °C, 2 h, Et3N, 
80%; ii) CH3I, MeOH, rt, 85%; iii) t-BuOK, THF, rt, 60%. 
 
4.3.4 Formal Synthesis of Talcarpine 21 by Edwankar et al.26 
 
In the formal synthesis of talcarpine 21,26 The Milwaukee group converted the Na-methylated C-
20 β-primary alcohol 149 into a mixture of α,β-epimeric aldehydes by Corey-Kim oxidation. This 
was followed by complete epimerization into the thermodynamically more stable C-20α-aldehyde 
153. This took place by treatment of the mixture with excess triethylamine in methanol at room 
temperature in 80% yield (Scheme 9). The quaternization of the Nb-nitrogen function with 
iodomethane in methanol at room temperature furnished the methiodide salt 154 in excellent yield. 
The methiodide salt underwent a retro-Michael ring opening to the α,β-unsaturated aldehyde 155 
as a single isomer, of which the geometry of the olefin was not determined at that time, but was 
later determined to be the (Z)-geometry by Rahman et al.23 This olefin provided the macroline 
framework, which upon desilylation would provide the important macroline equivalent 156 which 
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was used in the partial synthesis of talcarpine 21 by Sakai et al.42 by the degradation of ajmaline 
(vide supra). This was a much better route to talcarpine 21 than the previous routes. 
 
5. Conclusion 
 
Contained in this chapter is a compilation of research on approximately 70 alkaloids that could be 
categorized as C-19 methyl substituted sarpagine-macroline-ajmaline bases. Many of these 
alkaloids have important bioactivity, while the majority remain unexplored. More than a dozen of 
these alkaloids have been prepared in the laboratory, to date.22-26  With the increased number of 
reported C-19 methyl substituted alkaloids and novel bioactivity of the alkaloids, which belong to 
this group, it is anticipated the interest in the synthesis, biosynthesis, and activity of these alkaloids 
will grow. Most of the alkaloids await total synthesis and much exploration is required for the in 
depth bioactivity of these alkaloids including the unnatural enantiomers. 
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PART I. IMPROVED AND SHORTER ACCESS TO THE KEY TETRACYCLIC CORE OF C-
19 METHYL SUBSTITUTED BIOACTIVE SARPAGINE-MACROLINE-AJMALINE INDO-
LE ALKALOIDS VIA A NEW ASYMMETRIC PICTET-SPENGLER REACTION STARTING 
FROM EITHER D-(+)- OR L-(-)-TRYPTOPHAN 
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Chapter 1 
A Shorter and Improved Access to the Bicyclo[3.3.1]nonane Core of Sarpagi-
ne/Macroline/Ajmaline Alkaloids 
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1. Introduction  
Extension of the asymmetric Pictet-Spengler reaction to bulkier Nb-alkylated tryptophan 
derivatives resulted in an improved stereospecific access to the key azabicyclo[3.3.1]nonane core 
of bioactive C-19 methyl substituted sarpagine/macroline/ajmaline indole alkaloids with excellent 
diastereoselectivity via internal asymmetric induction. Complete stereocontrol of the C-19 methyl 
function in either the α- or β-configuration was achieved which enables the total synthesis of any 
member from this group of seventy alkaloids.  
The C-19 methyl substituted macroline/sarpagine and ajmaline alkaloids are an emerging group of 
biosynthetically related indole alkaloids, some of which have historical significance,1 and have 
been primarily isolated from various medicinal plants of the Apocynaceae family. Currently, about 
thirty alkaloids belong to this group. Some of them are depicted in Figure 1. Most of these alkaloids 
have not been tested for their biological activity, presumably, due to the paucity of isolated 
material. Yet, some of these alkaloids have been shown to possess important biological activity 
ranging from anti-hypertensive to anticancer properties. Macrocarpines A-C (1-3) have been 
isolated from the stem bark of Alstonia macrophylla by Kam.2 Talcarpine (4), which was isolated 
from Alstonia macrophylla and Pleiocarpa talbotii, exhibited antimalarial activity.3-5 The N(4)-
methyl-N(4),21-secotalpinine 5, isolated from Pleiocarpa talbotii and Alstonia angustifolia, 
demonstrated promising anti-leishmanial activity.2,4,6 Talpinine 6, another related alkaloid, 
exhibited moderate activity in reversing multidrug resistance in a vincristine–resistant KB/VJ300 
cell line in the presence of 0.12 μM vincristine.4,7 The N(4)-methyltalpinine 7, which contains a 
quaternary Nb-nitrogen atom, is the Nb-methylated version of talpinine 6, and has shown  potent 
and important NFkB inhibition.6 While the majority of these alkaloids have the β methyl 
configuration at C-19, a few contain the α C-19 methyl function (e.g., dihydroperaksine 8, also 
74 
 
known as dihydrovomifoline and deoxyperaksine 9).8-11 All of these alkaloids bear either an Na-
methyl or Na-hydrogen substituted indole nitrogen atom. Similarly, the Nb-nitrogen atom also 
varies in the pattern of substitution. In addition, all of these alkaloids contain 6 or 7 quaternary 
centers with various substitution patterns and configurations, which renders the synthesis of these 
alkaloids of interest. The challenge to access the complex architecture of these alkaloids and their 
promising biological activity stimulated our interest in the total synthesis of these natural products 
via a general strategy. To illustrate the feasibility of this strategy to access either the α or  β C-19 
methyl substituted alkaloids stereospecifically, herein we report the total synthesis of (-)-
macrocarpines A-C (1-3), (-)-talcarpine (4), (+)-N(4)-methyl-N(4),21-secotalpinine (5), (+)-
dihydroperaksine (8) and (-)-deoxyperaksine (9) with complete stereocontrol of the methyl 
function at C-19. 
 
 
Figure 1. Representative examples of chiral C-19 methyl substituted macroline/sarpagine 
alkaloids. 
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The Pictet-Spengler reaction is among the most useful reactions in organic chemistry and probably 
the best one to access the tetrahydro-β-carboline and tetrahydroisoquinoline systems.12-15 The 
asymmetric version of this reaction has been used in numerous instances for stereospecific access 
to this system and has been the key to the total synthesis of numerous indole, bisindole, and 
oxindole alkaloids.16-23 In this vein, the synthesis of numerous alkaloids of the sarpagine, 
macroline, and ajmaline group, have been accessed via the trans-diester/Dieckmann protocol, in 
excellent yield and with 100% diastereoslectivity.13,18,24,25 This diastereospecific cyclization 
reaction sets the required stereochemistry at the C-3 position for the target natural products, 
beginning with commercially available D-(+)-tryptophan.13,24 
 
 
Scheme 1. Stereospecific access to the bicyclo[3.3.1]nonane system 12 
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In the present report extension of the asymmetric Pictet-Spengler reaction to other Nb-alkyl 
systems was explored. The Nb-alkylated compounds (see 12, Scheme 1) are key intermediates that 
have been used in the total synthesis of several sarpagine and macroline related indole alkaloids 
which contain a stereogenic methyl function at the C-19 position of the core structure.26 In the 
strategy developed by Edwankar et al,26 the Nb-alkyl tethered functionality was introduced after 
accessing the bicyclo[3.3.1]nonane system in 11. Despite the robustness of this strategy (Scheme 
1a), it  was felt useful to reduce the number of steps by avoiding some earlier transformations 
while retaining compatibility with various conditions necessary for accessing the desired system 
in high ee and de. In this respect, the strategy was to avoid the initial benzylation and later 
debenzylation by simply alkylating the Nb-nitrogen atom at the beginning of the synthesis (Scheme 
1b). It would be advantageous if this could be done in a stereospecific fashion. This would shorten 
the synthesis by two steps but still retain the robust nature of the route. In addition, as mentioned, 
this would expand the use of the asymmetric Pictet-Spengler reaction and the Dieckmann 
cyclization with the bulky TIPS protected ethinyl Nb-alkyl system. The target system 12 would be 
accessible simply by decarboxylation of the products (see 14) from the Dieckmann cyclization. 
 
2. Results and Discussion 
Retrosynthetically, the E-ring of the macroline system present in e.g., macrocarpines A-C (1-3) 
should originate in a stereocontrolled fashion from the Michael-type ring closure27 of the 
deprotected alcohol onto the α,β-unsaturated aldehyde (15, Scheme 2), which in turn would be 
available from the pentacyclic ketone intermediates 16 [R = H or CH3 and (*) = (S)], according to 
the previously reported route.26,28 On the other hand, the C-19 α–methylated alkaloids 
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dihydroperaksine 8 and deoxyperaksine 9 would be available from the TIPS protected diol 18, 
which in turn would be, available from 17 by a hydroboration-oxidation. The olefin 17 would be 
accessed from the ketone 16 [with R = H and (*) = (R)] in a few steps. The pentacyclic ketone 
intermediates (see 16) would be available via a copper-mediated intramolecular cross-coupling of 
the vinyl iodides 19 with the enolate.28 The vinyl iodides (19) would be available from the TIPS-
deprotected terminal alkyne via a completely regioselective iodoboration, after the decarb-
oxylation of the β-keto ester 14. The trans-diester would originate as a sole product from the 
asymmetric Pictet-Spengler reaction of the Nb-alkylated tryptophan derivative 13 with the acetal 
21 under thermodynamic control. Under these conditions the total synthesis would begin from 
commercially available D-(+)-tryptophan 23 and the optically pure ethinyl tosylates (see 22). 
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Scheme 2. Retrosynthetic analysis for the total synthesis of the C-19 methyl substituted 
macroline/sarpagine-related alkaloids via the asymmetric Pictet-Spengler reaction 
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Scheme 3. Synthesis of the optically pure tosylate units 22a and 22b via Noyori asymmetric 
hydorgenation of ketone S-1 
 
The optically pure tosylate units 22a and 22b were synthesized29 via Noyori asymmetric hydrog-
enation30 of the ketone S-1 with (S, S)-Ru and (R, R)-Ru catalysts to provide the corresponding 
chiral alcohol S-3 and S-2, respectively (Scheme 3). 
Table 1: Pictet-Spengler reaction of 13a or 13b with 21 or 27 under different conditions (see 
Table) 
 
  
 
entry SM (*)  21 or 27 
(equiv) 
conditions trans: cisa 
20a: 28a or 
20b: 28b 
% overall 
yieldb 
1 13a (S) 21 (1.5) CF3COOH, CH2Cl2, rt, 11 d 95: 5 89 
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[a] trans: cis ratio after chromatographic separation; [b] combined isolated yield 
 
According to the plan, The Nb-nitrogen atom was alkylated with the optically pure TIPS protected 
tosylate units 22a or 22b, to introduce the ethinyl functions into indoles 13a (Scheme 4) and 13b 
(Scheme 5), respectively. The tosylate units were synthesized from the corresponding ketone (see 
the Experimental Section for details) via a ruthenium catalyzed Noyori asymmetric hydrogena-
tion,29,31 followed by tosylation of the alcohol with TsCl. Reaction of the tosylate units 22a/22b 
with the amine 23 in the presence of K2CO3 in CH3CN furnished the SN2 substituted products 13a 
or 13b (individually) in high yield, respectively. The structures and stereochemistry of 13a (Figure 
2) and 13b (Figure 3) were confirmed by X-ray analysis (see Appendix A for X-ray data). 
2 13a (S) 21 (1.5) CH3COOH, CH2Cl2, rt- reflux, up 
to 72 h 
NR SM 
3 13a (S) 21 (1.5) CH3COOH, CHCl3, rt- reflux, up 
to 72 h 
NR SM 
4 13a (S) 21 (1.5) CH3SO3H, CH2Cl2, 0 
oC-rt decomposition - 
5 13b (R) 21 (1.5) CF3COOH, CH2Cl2, rt, 10 d inseparable - 
6 13b (R) 21 (1.5) CH3COOH, CHCl3, reflux, up to 
72 h 
NR SM 
7 13b (R) 27 (1.5) CH2Cl2, rt, 36 h NR SM 
8 13b (R) 27 (1.5) CH3COOH, CH2Cl2, rt, up to 70 h 30: 70 95 
9 28a (S) - CF3COOH, CH2Cl2, rt, 8 h 100: 0 84 (20a) 
10 28a (S) - CH3COOH, CH2Cl2, rt, 24 h - SM (28a) 
11 28b (R) - CF3COOH, CH2Cl2, rt, 8 h 100: 0 80 (20b) 
12 28b (R) - CH3COOH, CH2Cl2, rt, 24 h - SM (28b) 
81 
 
 
Figure 2: ORTEP representation of 13a•HCl 
 
Figure 3: ORTEP representation of 13b•HCl 
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When 13a was reacted with the actetal 21 under the thermodynamic conditions of the Pictet-
Spengler reaction developed previously,25 the trans-diester was obtained in >95:5 
diastereoselectivity (Table 1, entry 1). After initial success of the Pictet-Spengler reaction with the 
β-methyl [i.e., (S)] function 13a, the same reaction conditions were then applied to the α-methyl 
[i.e., (R)] version 13b, but this process resulted in incomplete reaction and complex reaction 
mixtures (Table 1, entry 5). At that point, a modified method was required to reduce the reaction 
time in the case of the α-methyl compound 13b in order to obtain conversion before 
decomposition. The use of a weaker acid (acetic acid) than TFA or a stronger acid 
(methanesulfonic acid) were not successful (Table 1, entries 2-4, 6). The lack of conversion was, 
presumably, due to the low acidity of acetic acid and low reactivity of the acetal 21 whereas, 
MeSO3H was too acidic. However, when the acetal 21 was replaced by the aldehyde 27, which 
was freshly prepared by the hydrolysis of the acetal 21, and this mixture was stirred with the amine 
and acetic acid in DCM at room temperature, this gave the cis-diester as the major product (cis: 
trans = 70: 30) and in overall 95% isolated yield (Table 1, entry 8). Both the cis- and trans-diesters 
could easily be purified by chromtography and their stereochemistry was confirmed by NOE 
analysis. Importantly, the isolated cis-diester could be converted into the trans-diester with 100% 
diastereoselectivity on treatment with TFA in DCM at room temperature (Table 1, entries 9, 11). 
If the cis compound was stirred in acetic acid, the stereochemistry of these diastereomers (28a or 
28b) remained unchanged (table 1, entries 10, 12). Nevertheless, having the trans-diester with both 
α and β-methyl functions in hand, with 100% diastereoselectivity, was key to test the feasibility of 
this synthetic strategy. 
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Scheme 4: Reagents and conditions: a) 22a (1.5 equiv), K2CO3 (2.5 equiv), CH3CN, 65 
oC, 12 h, 
85%; b) 21 (1.5 equiv), TFA (2.5 equiv), CH2Cl2, 11 d, dr = >95: 5, 89%; c) NaH (1.1 equiv), 
CH3I (1.1 equiv), DMF, -10 
oC to 0 oC, 3 h, 96%; d) NaH (3 equiv), MeOH (6 equiv), toluene,  
110 oC, 8 h, 80%; e) CH3COOH (glacial), HCl (conc.), H2O, 110-130 
oC, 7 h, 82%; f) TBAF (1.5 
equiv), THF, 0 oC-rt, 3 h, 90%. 
 
The Nb- alkylated intermediate 13a reacted with the actetal 21 under thermodynamically controlled 
conditions of the asymmetric Pictet-Spengler condensation to furnish the desired trans-diester 20a 
in excellent yield (Scheme 4). This trans-transfer of chirality set the required (S) stereochemistry 
at C-3 of the macroline-sarpagine related alkaloids. Methylation of the indole nitrogen with 
iodomethane in the presence of sodium hydride in DMF at 0 oC, yielded the Na-CH3 intermediate 
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24 in 96% yield. Dieckmann cyclization of the trans-diester was felt to be troublesome due to the 
steric congestion surrounding the 1,2,3,-trisubstituted tetrahydro-β-carboline system 24. However, 
when 3 equivalents of NaOMe (produced in situ) was reacted with trans-diester 31 in pre-dried 
toluene at reflux (DST), the Dieckmann cyclization proceeded smoothly to furnish the β-keto ester 
(14a) in 80% yield. The hydrolysis of the ester or deprotection of the TIPS group was not observed 
during the cyclization. This step was crucial for the success of this synthetic route. Subsequently, 
decarboxylation of the β-keto ester under acidic conditions furnished the Nb- ethinyl tethered 
tetracyclic ketone 12a without deprotection of the TIPS function. This route provided an improved 
synthesis of this intermediate 12a by successfully avoiding the initial benzylation/debenzylation 
steps and effectively shortened the route by at least two steps. The spectral properties of this 
intermediate 12a and optical rotation were identical in all respects, to an authentic sample of 12a, 
synthesized via the previously reported route.26 This was further confirmed by X-ray 
crystallography after the deprotection of the TIPS function (25) with TBAF in THF (90% yield). 
An ORTEP drawing of ketone 25 is included in Figure 4 (see Appendix A for X-ray 
crystallographic data). 
 
Figure 4: ORTEP representation of 25 
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Scheme 5: Reagents and conditions: a) 22b (1.5 equiv), K2CO3 (2.5 equiv), MeCN, 65 
oC, 12 h, 
92%; b) OHC(CH2)2CO2Me (27, 1.5 equiv), acetic acid (2.5 equiv), rt, 70 h, 95% overall; c) NaH 
(9 equiv), MeOH (18 equiv), toluene, 110 oC, 72 h; d) HOAc (glacial), HCl (conc), H2O, reflux, 
36 h, 75% in 2 steps; e) TBAF (1.5 equiv), THF, 0 oC, 90%. 
 
The trans-diester 20b was accessed via the process described above (Scheme 5). The Dieckmann 
cyclization of the trans-diester 20b, which contained the α-methyl [(R)] function, in the presence 
of 9 equivalents of sodium hydride and excess methanol in toluene at reflux furnished the cyclized 
product; the desired β-keto ester 14b, which upon subsequent acid mediated decarboxylation 
provided the ketone intermediate 12b in excellent yield (Scheme 5). The optical properties of this 
intermediate were found to be identical with an authentic sample synthesized by the previous 
approach.28 The structure was further confirmed by X-ray crystallography depicted in Figure 5 
(see Appendix A for the X-ray crystallographic data). 
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Figure 5: ORTEP representation of 12b 
 
As depicted in Scheme 6, the current approach (entry b) provided access to the bicyclo[3.3.1] 
framework 12 in 48% (12a) to >65% (12b) from D-tryptophan methylester 23. On the other hand 
the former approach (entry a) provided the same system in 45-54% yield starting from 23.  
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Scheme 6: Comparison between the former and current approach to access the bicyclo[3.3.1] 
framework 12 
 
3. Conclusion  
This work clearly indicated that a large group other than benzyl on the Nb-nitrogen atom of the D-(+)-
tryptophan starting material could still provide 100% trans-diastereoselectivity via internal asymmetric 
induction. It is important to note that use of L-tryptophan would have provided the enantiomers of these 
alkaloids for biological study. This general strategy will be useful to access any member of C-19 methyl 
substituted sarpagine/macroline alkaloids that are potential drug candidates, as indicated by their biological 
activity reported in the literature and presented in the introduction. Furthermore, the 70% selectivity 
towards the cis-diester in the asymmetric Pictet-Spengler reaction was somewhat unexpected and 
encouraging. This unusual cis-selectivity, if optimized, could enable one to begin the total synthesis with 
the naturally occurring and cheaper L-tryptophan as the chiral auxiliary. Much of the future efforts here 
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would be focused on the optimization of the cis-selective P-S cyclization to make it completely cis-
selective, which would be of significance to the synthesis of C-19 methyl substituted indole alkaloids. 
 
4. Experimental Section 
General Experimental Considerations 
All reactions were carried out under an argon atmosphere with dry solvents using anhydrous 
conditions unless otherwise stated. Tetrahydrofuran (THF) and diethyl ether were freshly distilled 
from Na/benzophenone ketyl prior to use. Dichloromethane was distilled from calcium hydride 
prior to use. Methanol was distilled over magnesium sulfate. Benzene and toluene were distilled 
over Na. Acetonitrile was distilled over CaH2 prior to use. Reagents were purchased of the highest 
commercial quality and used without further purification unless otherwise stated. Thin layer 
chromatography (TLC) was performed on UV active silica gel plates, 200 μm, aluminum backed 
and UV active alumina N plates, 200 μm, F-254 aluminum backed plates. Flash and gravity 
chromatography were performed using silica gel P60A, 40-63 μm, basic alumina (Act I, 50-200 
μm) and neutral alumina (Brockman I, ~150 mesh). TLC plates were visualized by exposure to 
short wavelength UV light (254 nm). Indoles were visualized with a saturated solution of ceric 
ammonium sulfate in 50% phosphoric acid. The 1H NMR data are reported as follows: chemical 
shift, multiplicity (br s = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, quin = 
quintet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, td 
= triplet of doublets, qd = quartet of doublets, m = multiplet), integration, and coupling constants 
(Hz). The 13C NMR data are reported in parts per million (ppm) on the δ scale. The low resolution 
mass spectra (LRMS) were obtained either as electron impact (EI, 70eV) or as chemical ionization 
89 
 
(CI) using a magnetic sector (EBE) analyzer. HRMS were recorded by electrospray ionization 
(ESI) using a TOF analyzer, electron impact (EI) was recorded using a trisector analyzer and 
Atmospheric Pressure Chemical Ionization (APCI) using a TOF analyzer. Optical rotations were 
measured on a JASCO Model DIP-370 digital polarimeter.  
Experimental Procedures and Analytical Data 
General Procedure for the Synthesis of 22a or 22b from Ketone S-1 
The (S, S)-Ru Catalyst and (R, R)-Ru catalyst were prepared following the procedure available in 
the literature.29,30 Optically active (R) and (S)-alcohols, S-2 (90%) and S-3 (95%) were synthesized 
following the literature procedure.29,31 A 2 L round bottom flask equipped with a large magnetic 
stir bar was flame dried under a continuous flow of argon and was then allowed to cool. The flask 
was then charged with freshly distilled CH2Cl2 (284 mL) and (R)-alcohol (S-2) or (S)-alcohol (S-
3, 10 g, 44.2 mmol), after which the mixture was cooled to -25 °C (outside bath temperature). 
Triethylamine (17.7 g, 177 mmol) and a catalytic amount of DMAP (0.53 g, 4.4 mmol) were added, 
and after a few minutes of stirring, tosyl chloride (18.53 g, 97.3 mmol, Acros Organics, 99%) was 
added in one portion. The reaction mixture was allowed to stir at -25 °C for 45 min and the solution 
was allowed to slowly warm to rt. After the reaction mixture was stirred for 3 h at rt, analysis by 
TLC (silica gel) was carried out, after which the reaction mixture was quenched with a large excess 
of water (1L) and the mixture was allowed to stir vigorously for 45 min. After 45 min, the two 
layers were separated. The CH2Cl2 layer was dried (MgSO4), filtered and concentrated under 
reduced pressure to furnish 22a (15.97 g, 95%) or 22b (16.64 g, 99%) as a light brown oil, which 
was used without further purification. 
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(R)-4-(Triisopropylsilyl)but-3-yn-2-yl 4-methylbenzenesulfonate (22a) 
1H NMR (300 MHz, CDCl3): δ7.81 (d, 2H, J = 8.1 Hz), 7.30 (d, 2H, J = 8.1 Hz), 
5.20 (q, 1H, J = 6.6 Hz), 2.41 (s, 3H), 1.60 (d, 3H, J = 6.6 Hz), 0.96 (m, 21 H). All 
other spectroscopic data were identical with the published data for 22a.32 The 
material was used for the next step without further characterization. 
 
(S)-4-(Triisopropylsilyl)but-3-yn-2-yl 4-methylbenzenesulfonate (22b) 
1H NMR (300 MHz, CDCl3): δ 7.81 (d, 2H, J = 8.2 Hz), 7.30 (d, 2H, J = 8.1 Hz), 
5.20 (q, 1H, J = 6.6 Hz), 2.42 (s, 3H), 1.60 (d, 3H, J = 6.7 Hz), 0.97 (m, 21H); 13C 
NMR (75 MHz, CDCl3) δ 144.6 (C), 134.1 (C), 129.7 (2x CH), 127.9 (2 x CH), 
103.1 (C), 89.1 (C), 68.4 (CH), 23.3 (CH3), 21.6 (CH3), 18.4 (6 x CH3), 10.9 (3 x 
CH); HRMS (ESI) m/z (M + Na)+ calcd for C20H32O3SSiNa, 403.1734, found 403.1742; []D25 (c 
1.75 CHCl3): – 92.00. 
 
General Procedure for the Synthesis of 13a or 13b from 23 
The synthesis of 13a: D-(+)-tryptophan methyl ester (23, 10.0 g, 45.82 mmol) was dissolved in 
freshly distilled acetonitrile (150 mL) in a 500 mL round bottom flask. The tosylate 22a (26.16 g, 
68.7 mmol) was dissolved in acetonitrile and added into the round bottom flask with a syringe. 
Anhydrous K2CO3 (15.8 g) was added and the mixture, which resulted, was heated to reflux under 
argon for 12 h. After the completion of the reaction as indicated by disappearance of starting 
material (TLC, EtOAc/hexane, 1: 3) and LRMS (M+H+ = 427.35), the reaction was cooled to rt 
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and the K2CO3 was filtered by passing through a bed of celite. The celite was washed with EtOAc 
and the solvent was removed under reduced pressure to furnish crude 13a as brownish oil. The 
residue was purified by flash column chromatography (silica gel, EtOAc/hexanes) to provide 13a 
as light yellowish oil (16.6g, 85%). 
Synthesis of 13b: By following the same procedure with 23 (2.0 g, 9.16 mmol) and 22b (5.23 g, 
13.74 mmol) under the same conditions, this reaction furnished 13b (3.6 g, 92%) yield as light 
yellowish solid.   
 
(R)-Methyl 3-(1H-indol-3-yl)-2-(((S)-4-(triisopropylsilyl)but-3-yn-2-yl)amino)propano-
ate(13a) 
1H NMR (300 MHz, CDCl3): δ 8.31 (br s, 1H), 7.67 (d, 1H, 
J = 7.6 Hz), 7.32 (d, 1H, J = 7.8 Hz), 7.24-7.11 (m, 2H), 7.04 
(d, 1H, J = 1.7 Hz), 4.02 (t, 1H, J = 6.1 Hz), 3.65 (s, 3H), 
3.62 (q, 1 H, J = 6.8 Hz), 3.22 (d, 2H, J = 6.1 Hz), 1.38 (d, 3H, J  = 6.7 Hz), 1.14-1.06 (m, 21H); 
13C NMR (75 MHz, CDCl3): δ 175.1, 136.1, 127.6, 122.9, 121.9, 119.3, 118.8, 111.2, 110.0, 83.1, 
59.5, 51.9, 44.7, 28.9, 22.6, 18.6, 11.2. HRMS (ESI) m/z (M+H)+ calcd for C25H39N2O2Si, 
427.2775, found 427.2776; []25D (c 0.76 CHCl3): – 96.05; Rf: 0.52 (30% EtOAc in Hexane). The 
structure and absolute stereochemistry were confirmed by X-ray crystallographic analysis (see X-
ray data in Appendix A). 
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(R)-Methyl 3-(1H-indol-3-yl)-2-(((R)-4-(triisopropylsilyl)but-3-yn-2-yl)amino)propanoate 
(13b) 
1H NMR (300 MHz, CDCl3): δ 8.67 (brs, 1H), 7.67 
(d, 1H, J = 7.7 Hz), 7.35 (d, 1H, J = 7.9 Hz), 7.25-
7.10 (m, 2H), 7.06 (d, 1H, J = 1.7 Hz), 4.25-4.18 (m, 1H), 3.72 (s, 3H), 3.71-3.64 (m, 1 H), 3.33 
(dd, 1H, J = 14.3, 5.4 Hz), 3.20 (dd, 1H, J = 14.3, 7.9 Hz),  1.37 (d, 3H, J  = 6.7 Hz), 1.12-1.04 
(m, 21H); 13C NMR (75 MHz, CDCl3): δ 175.0, 136.4, 127.5, 123.1, 122.0, 119.4, 118.7, 111.3, 
110.6, 109.4, 83.5, 59.6, 51.8, 44.4, 29.7, 22.8, 18.6, 11.2. HRMS (ESI) m/z (M+H)+ calcd for 
C25H39N2O2Si, 427.2775, found 427.2779; []25D (c 0.91 CHCl3): +49.45, m.p.: 88-89 oC; Rf: 
0.35 (30% EtOAc in hexane). The structure and absolute stereochemistry were confirmed by X-
ray crystallographic analysis (see Appendix A for X-ray data). 
 
Procedure for the Preparation of Diester 20a 
The Nb-alkylated tryptophan 13a (1.0 g, 2.34 mmol) was dissolved in dry DCM (15 mL) in a 100 
mL round bottom flask equipped with a magnetic stir. To that above solution, the acetal 21 (570 
mg, 3.51 mmol) and trifluoroacetic acid (0.45 mL, 5.86 mmol) were added at rt. The solution, 
which resulted, was stirred at rt for 11 d. The progress of the reaction was monitored by TLC 
analysis as indicated by the consumption of the SM and the appearance of two non-polar spots 
(UV and CAN stain). The reaction mixture was diluted with DCM (20 mL) and water (10 mL). 
The organic layer was separated and washed with water (10 mL) and brine (2 x 20 mL) and dried 
(Na2SO4). The solvent was removed under reduced pressure to give a mixture of 20a and 28a in 
>95:5 (HPLC) ratio as a light yellow oil. The trans-diester 20a (LRMS M+H+ = 525.50, Rf = 0.35 
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in 20% EtOAc in hexanes) was purified by column chromatography (silica gel, 10-20% EtOAc in 
hexanes) along with the cis-diester 28a (LRMS M+H+ = 525.45, Rf = 0.25 in 20% EtOAc in 
hexanes) to furnish 20a (1.04 g, 85%) and 28a (49 mg, 4%).  
 
(1S,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (20a) 
1H NMR (300 MHz, CDCl3): δ 7.92 (brs, 1H), 7.45 (d, 1H, J = 7.6 Hz), 7.27 (d, 
1H, J = 7.9 Hz), 7.15-7.02 (m, 2H), 4.17 (dd, 1H, J = 9.7 Hz, 3.7 Hz), 4.05 (dd, 
1H, J = 10 Hz, 4.3 Hz), 3.82 (q, 1H, J = 7.0 Hz, overlapped), 3.80 (s, 3H), 3.73 
(s, 3H), 3.29-3.18 (m, 1H), 3.01 (dd, 1H, J = 15.5 Hz, 4.2 Hz), 2.73-2.50 (m, 2H), 2.23-2.10 (m, 
1H), 2.08-1.92 (m, 1H), 1.39 (d, 3H, J = 6.9 Hz), 0.08-0.71 (m, 18H), 0.62-0.48 (m, 3H); 13C 
NMR (75 MHz, CDCl3): δ 174.4, 173.3, 136.1, 135.1, 127.1, 121.4, 119.1, 118.2, 110.5, 109.1, 
108.7, 83.7, 57.7, 52.5, 52.0, 51.6, 46.1, 30.6, 29.7, 23.1, 21.6, 18.3, 18.3, 10.9; HRMS (ESI) m/z 
(M+H)+ calcd for C30H45N2O4Si 525.3143, found 525.3153; []25D (c 0.80 CHCl3): – 86.25; Rf: 
0.35 (20% EtOAc in hexanes/NH4OH, silica gel). 
 
Procedure for the Preparation of Diester 20b 
The Nb-alkylated tryptophan 13b (1.0 g, 2.34 mmol) was dissolved in 15 mL of dry DCM in a 100 
mL round bottom flask equipped with a magnetic stir. To that above solution, the aldehyde 27 (408 
mg, 3.51 mmol) and acetic acid (335 μL, 5.86 mmol) was added at rt. The solution, which resulted, 
was stirred at rt for 70 h. The progress of the reaction was monitored by TLC analysis as indicated 
by the consumption of SM and appearance of two non-polar spots (UV and CAN stain). The 
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reaction mixture was diluted with DCM (20 mL) and water (10 mL). The organic layer was 
separated and washed with water (10 mL), brine (2 x 20 mL) and dried (Na2SO4). The solvent was 
removed under reduced pressure to give a mixture of 20b and 28b as a light yellow oil. The trans-
diester 20b (LRMS M+H+ = 525.45, Rf = 0.7 in 30% EtOAc in hexanes) was purified by column 
chromatography (silica gel, 10-20% EtOAc in hexanes), accompanied by the cis-diester 28b 
(LRMS M+H+ = 525.45, Rf = 0.57 in 30% EtOAc in hexanes) to furnish (1.17 g,) 95% combined 
yield. The isolated cis-diester (28b, 861 mg, 1.64 mmol) was dissolved in dry DCM (15 mL) and 
treated with trifluoroacetic acid (2.46 mmol, 188 μL). The solution, which resulted, was stirred for 
5 h at rt. After the workup (same as above), drying and evaporation of the solvent and purification 
by column chromatography (silica gel) this furnished the stereospecific trans-diester (20b, 689 
mg, 80%) as a colorless oil. 
 
(1S,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((R)-4-(triisopropylsilyl)but-3-yn-2-yl)-2,3,4,9 
-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (20b) 
1H NMR (500 MHz, CDCl3): δ 8.03 (br s, 1H), 7.48 (d, 1H, J = 7.7 Hz), 7.33 (d, 
1H, J = 7.9 Hz), 7.19-7.14 (m, 1H), 7.13-7.09 (m, 1H), 4.64 (br t, 1H, J = 8.5 
Hz), 4.16 (t, 1H, J = 5.6 Hz), 4.09 (q, 1H, J = 6.8 Hz), 3.65 (s, 3H), 3.64 (s, 3H), 
3.14-3.04 (m, 2H), 2.56-2.48 (m, 1H), 2.37-2.22 (m, 2H), 2.14-2.06 (m, 1H), 1.42 (d, 3H, J = 6.8 
Hz), 1.10-1.08 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 174.8, 173.3, 136.2, 134.9, 127.0, 121.5, 
119.3, 118.0, 110.9, 108.2, 107.6, 84.9, 54.7, 53.2, 51.6, 51.4, 46.8, 29.1, 28.4, 24.8, 21.9, 18.6, 
11.3; HRMS (ESI) m/z (M+H)+ calcd for C30H45N2O4Si 525.3143, found 525.3142; []25D (c 1.2 
CHCl3): +5.0; Rf: 0.7 (30% EtOAc in hexane, silica gel). 
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Procedure for the Conversion of cis-Diesters 28a and 28b into Their Corresponding trans-
Diesters 20a and 20b, Respectively 
To a solution of the pure cis-diester 28a or 28b (30 mg, 0.057 mmol) individually in dry DCM (2 
mL), TFA (6.6 μL, 0.086 mmol) was added at 0 oC and the mixture which resulted was stirred at 
rt until the complete consumption of 28a (Rf: 0.25, 20% EtOAc in hexane, silica gel) or 28b (Rf: 
0.6, 30% EtOAc in hexane, silica gel) and the appearance of the trans-diester 20a (Rf: 0.35, 20% 
EtOAc in hexane) or 20b (Rf: 0.7, 30% EtOAc in hexane) as indicated by TLC (UV and CAN 
stain). After the completion of reaction, the reaction mixture was diluted with DCM and brought 
to pH 8-9 with 14% aq NH4OH. The organic layer was separated, washed with brine (2 x 10 mL) 
and dried (K2CO3). The solvent was removed under reduced pressure to furnish 20a or 20b as a 
light yellow oil which was purified by flash column chromatography on silica gel (10-20 % EtOAc 
in hexane) to provide pure trans-diester 20a (25.2 mg, 84%) or 20b (24.0 mg, 80%) as yellow oils 
individually. 
 
Procedure for the Preparation of 24 from 20a 
To a round-bottom flask (25 mL) that was equipped with a reflux condenser were added Na-H 
trans-diester 20a (512 mg, 0.98 mmol), CH3I (67 μL, 1.07 mmol), and dry DMF (3 mL) and then 
the mixture was cooled to -10 °C with stirring. To this solution was added NaH (60% dispersion 
in mineral oil, 43 mg, 1.07 mmol) at -10 °C. The slurry, which resulted, was allowed to stir at rt 
for 2 h until analysis by TLC indicated the disappearance of 20a and appearance of 24, LRMS of 
the Na-Me product, 24: (M+H)
+ = 539.55. The reaction solution was quenched by careful addition 
of CH3OH (0.5 mL) and was then neutralized with an aq solution of NH4Cl (5 mL) and extracted 
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with EtOAc (2 x 10 mL). The combined organic layers were washed with brine (3 x 10 mL) and 
dried (K2CO3). The solvent was removed under reduced pressure and the residue was subjected to 
a short wash column (silica gel, 20% EtOAc in hexane) to provide the Na-methyl diester 24 (505 
mg, 96%) as a light yellow oil. 
 
(1S,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-9-methyl-2-((S)-4-(triisopropylsilyl)but-3-yn-2-
yl)-2,3,4,9-tetra-hydro-1H-pyrido[3,4-b]indole-3-carboxylate (24) 
1H NMR (500 MHz, CDCl3): δ 7.47 (d, 1H, J = 7.7 Hz), 7.24 (d, 1H, J = 8.1 Hz), 
7.17 (t, 1H, J = 7.5 Hz), 7.07 (t, 1H, J = 7.3 Hz), 4.17 (brd, 1H, J = 10.7 Hz), 4.08 
(dd, 1H, J = 11.6 Hz, 5.1 Hz), 3.88-3.81 (m, 4H), 3.76 (s, 3H), 3.74 (s, 3H), 3.30-
3.22 (m, 1H), 3.04 (dd, 1H, J = 15.4 Hz, 3.9 Hz), 2.86-2.77 (m, 1H), 2.65-2.57 (m, 1H), 2.22-2.14 
(m, 1H), 1.95-1.86 (m, 1H), 1.41 (d, 3H, J = 6.8 Hz), 0.77-0.69 (m, 18H), 0.54-0.46 (m, 3H); 13C 
NMR (125 MHz, CDCl3): δ 174.4, 173.2, 137.3, 136.6, 126.6, 121.0, 118.7, 118.2, 108.8, 108.5, 
107.9, 83.4, 57.2, 52.0, 51.6, 51.2, 45.7, 30.4, 30.1, 28.5, 23.2, 21.4, 18.3, 18.3, 10.9; HRMS (ESI) 
m/z (M+H)+ calcd for C31H47N2O4Si 539.3300, found 539.3314; Rf: 0.5 (20% EtOAc in hexane). 
 
Procedure for the Preparation of 14a from 24 
The trans-diester 24 (412 mg, 0.76 mmol) was dissolved in toluene (25 mL). This solution was 
dried by azeotropic removal of H2O with toluene by use of a DST (refluxed 6 h). To this solution 
was added sodium hydride (91.8 mg, 2.29 mmol of 60% dispersion in mineral oil) at 0 °C. 
Anhydrous CH3OH (186 μL, 4.6 mmol) was then added into the above mixture under Ar at 0 °C. 
The solution, which resulted, was then stirred at rt for 0.5 h and then held at reflux for an additional 
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5 h (the flask was covered with aluminum foil on the top to keep the temperature at reflux without 
carbonizing any compound on the sides of the flask). The reaction mixture was cooled to rt and 
was quenched with ice. The aq layer was extracted with CH2Cl2 (3 x 20 mL). The combined 
organic extracts were washed with brine (2 x 30 mL) and dried (K2CO3). The solvent was removed 
under reduced pressure to provide the crude product (LRMS M+H+ = 507.45) as light brown 
residue (330 mg, 85%) which could be used for the next transformation without purification. The 
residue was purified by flash chromatography (silica gel, EtOAc/hexane) to furnish the Na-Me, β-
ketoester 14a (310 mg, 80%). 
 
(6S,10S)-Methyl 9-hydroxy-5-methyl-12-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-6,7,10,11-
tetrahydro-5H-6,10-epiminocycloocta[b]indole-8-carboxylate (14a) 
1H NMR (500 MHz, CDCl3): δ 12.00 (s, 1H), 7.50 (d, 1H, J = 7.7 Hz), 7.32 
(d, 1H, J = 8.0 Hz), 7.22 (t, 1H, J = 15.0 Hz), 7.13 (t, 1H, J = 7.3 Hz), 4.95 (d, 
1H, J = 5.0 Hz), 4.12 (d, 1H, J = 4.9 Hz), 3.7 (s, 3H), 3.69 (s, 3H), 3.65-3.59 
(m, 1H), 3.10 (dd, 1H, J = 16.1 Hz, 5.1 Hz), 2.99-2.91 (m, 2H), 2.4 (d, 1H, J = 15.3 Hz), 1.55 (d, 
3H, J = 6.3 Hz), 1.11-1.06 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 171.4, 171.5, 137.0, 134.1, 
126.5, 121.3, 119.2, 118.2, 108.8, 108.7, 105.6, 94.4, 84.4, 52.1, 51.5, 48.2, 47.2, 29.2, 28.8, 21.2, 
20.3, 18.7, 18.6, 11.2; HRMS (ESI) m/z (M+H)+ calcd for C30H43N2O3Si 507.3037, found 
507.3043; Rf: 0.6 (20% EtOAc in hexane, silica gel) 
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Procedure for the Preparation of 12a from 14a 
To a round bottom flask (25 mL) which contained the Na-Me, β-ketoester 14a (233 mg, 0.46 mmol) 
was added glacial acetic acid (0.7 mL), hydrochloric acid (1.0 mL, conc.) and water (0.3 mL) with 
stirring (magnetic stir). The solution, which resulted, was heated at reflux for 7 h. After removal 
of the solvent under reduced pressure, the residue was brought to pH = 9 with a cold aq solution 
of NaOH (3 N). The mixture, which resulted, was extracted with CH2Cl2 (3 x 20 mL) and the 
combined organic extracts were washed with a saturated aq solution of NH4Cl (10 mL), brine (2 x 
20 mL) and dried (K2CO3). The removal of the solvent under reduced pressure afforded the ketone 
12a as a brown oil. The residue was purified by column chromatography (silica gel, 20% EtOAc 
in hexanes) to provide pure 12a (LRMS M+H+ = 449.40) as a colorless oil (169 mg, 82%). 
 
(6S,10S)-5-Methyl-12-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-7,8,10,11-tetrahydro-5H-6,10-
epiminocycloocta[b]indol-9(6H)-one (12a) 
1H NMR (300 MHz, CDCl3): δ 7.49 (d, 1H, J = 7.7 Hz), 7.33 (d, 1H, J = 
8.1 Hz), 7.28-7.21 (m, 1H), 7.17-7.10 (m, 1H), 4.96−4.89 (m, 1H), 3.99 (d, 
1H, J = 6.2 Hz), 3.70 (s, 3H), 3.66 (q, 1H, J = 6.5 Hz, overlapped with Na-
Me), 3.17 (dd, 1H, J = 16.7, 6.6 Hz), 2.72 (d, 1H, J = 16.8 Hz), 2.65−2.44 (m, 2H), 2.20−2.01 (m, 
2H), 1.49 (d, 3H, J = 6.6 Hz), 1.08-1.03 (m, 21H); HRMS (ESI) m/z (M+H)+ Calcd for 
C28H41N2OSi 449.2983, found 449.2990. All other spectroscopic data were identical with the 
published data for 12a that was synthesized via the previous route.26 This material was used for 
the next step without further characterization. 
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Procedure for the Preparation of 25 from 12a 
To a solution of 12a (50 mg, 0.11 mmol) in THF (5 mL), TBAF (167 μL, 0.167 mmol, 1.0 M 
solution in THF) was added at 0 oC. The solution, which resulted, was stirred at 0 oC for 30 min 
or until the completion of the reaction, as monitored by TLC (silica gel). After this, the reaction 
mixture was diluted with EtOAc (20 mL) and water (10 mL). The organic layer was separated and 
the aq layer was extracted with EtOAc (5 mL). The combined organic layers were washed with 
brine (3 x 20 mL) and dried (Na2SO4). The solvent was removed under reduced pressure to provide 
the alkyne 25 (LRMS M+H+ = 293.20) as a brown residue (33 mg, 101% crude yield). The residue 
was purified by silica gel column chromatography (30% EtOAc in hexanes) to provide 25 as a 
light brown solid (29.3 mg, 90%). 
 
(6S,10S)-12-((S)-But-3-yn-2-yl)-5-methyl-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta-
[b]indol-9(6H)-one (25) 
1H NMR (300 MHz, CDCl3): δ 7.4 (d, 1H, J = 7.7 
Hz), 7.31 (d, 1H, J = 8.1 Hz), 7.25-7.18 (m,  1H), 
7.14-7.07 (m, 1H), 4.77−4.73 (m, 1H), 3.95 (d, 1H, 
J = 6.6 Hz), 3.70 (s, 3H), 3.61 (qd, 1H, J = 6.7, 2.1 Hz), 3.13 (dd, 1H, J = 16.8, 6.7 Hz), 2.70 (d, 
1H, J = 16.8 Hz), 2.67−2.54 (m, 1H), 2.52− 2.43 (m, 1H), 2.28 (d, 1H, J = 2.2 Hz), 2.18−2.09 (m, 
1H), 2.07-1.98 (m, 1H), 1.45 (d, 3H, J = 6.7 Hz); HRMS (ESI) m/z (M+H)+ Calcd for C19H21N2O 
293.1654, found 293.1656. All other spectroscopic data were identical with the published data for 
25.26 This material was used for the next step without further characterization. The structure of this 
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compound 25 was further confirmed by X-ray crystallographic analysis (see Appendix A for X-
ray data). 
Procedure for the Synthesis of 14b from 20b 
The trans-diester 20b (336 mg, 0.76 mmol) was dissolved in toluene (30 mL). This solution was 
dried by azeotropic removal of H2O by toluene with a DST (refluxed 6 h). To this above mixture, 
sodium hydride (230 mg, 5.76 mmol of 60% dispersion in mineral oil) was added at 0 °C. 
Anhydrous CH3OH (466 μL, 11.5 mmol) was then added into the above mixture under Ar at 0 °C. 
The solution, which resulted, was then stirred at rt for 0.5 h and then held at reflux for an additional 
72 h (the flask was covered with aluminum foil on the top to keep the temperature at reflux without 
carbonizing any compound on the sides of the flask). The reaction was quenched with ice. The aq 
layer was extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were washed with 
brine (3 x 30 mL) and dried (K2CO3). The solvent was removed under reduced pressure to provide 
the crude β-keto ester 14b (LRMS M+H+ = 493.40) as a light brown residue (293 mg, 93% crude) 
which could be used for the next transformation without purification.  
 
(6S,10S)-Methyl 9-hydroxy-12-((R)-4-(triisopropylsilyl)but-3-yn-2-yl)-6,7,10,11-tetrahydro-
5H-6,10-epimi-nocycloocta[b]indole-8-carboxylate (14b) 
1H NMR (500 MHz, CDCl3): δ 11.98 (s, 1H), (7.72 (br s, 1H), 7.51 (d, 1H, 
J = 7.7 Hz), 7.34 (d, 1H, J = 8.0 Hz), 7.18 (t, 1H, J = 7.1 Hz), 7.13 (t, 1H, 
J = 7.1 Hz), 4.49 (d, 1H, J = 5.2 Hz), 4.38 (d, 1H, J = 5.7 Hz), 3.69 (s, 3H), 
3.64 (q, 1H, J = 6.4 Hz), 3.27 (dd, 1H, J = 16.1, 5.9 Hz), 2.97 (br d, 1H, J = 16.6 Hz), 2.93 (dd, 
1H, J = 15.7, 5.6 Hz), 2.43 (br d, 1H, J = 15.6 Hz), 1.50 (d, 3H, J = 6.4 Hz), 1.12-1.08 (m, 21H); 
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13C NMR (125 MHz, CDCl3): δ 172.4, 171.4, 135.7, 132.8, 127.0, 121.9, 119.7, 118.3, 110.8, 
107.6, 107.3, 94.5, 85.4, 53.7, 51.5, 48.2, 46.7, 29.0, 22.7, 20.9, 18.7, 11.2; HRMS (ESI) m/z 
(M+H)+ calcd for C29H41N2O3Si 493.2881, found 493.2890; []D25: +28.95 (c 0.76 CHCl3); Rf: 
0.52 (30% EtOAc in hexane, silica gel). 
 
Procedure for the Synthesis of 12b from 14b 
To a round bottom flask (25 mL) which contained the β-keto ester 14b (290 mg, 0.595 mmol) was 
added glacial acetic acid (0.7 mL), hydrochloric acid (1.0 mL, conc.) and water (0.3 mL) with 
stirring (magnetic stir). The solution, which resulted, was held at reflux for 36 h. After removal of 
the solvent under reduced pressure, the residue was brought to pH = 9 with a cold aq solution of 
NaOH (3 N). The mixture, which resulted, was extracted with CH2Cl2 (3 x 20 mL) and the 
combined organic extracts were washed with a saturated aq solution of NH4Cl (10 mL), brine (2 x 
20 mL) and dried (K2CO3). The removal of the solvent under reduced pressure afforded the ketone 
12b as a brown oil (LRMS M+H+ = 435.40). The residue was purified by column chromatography 
(silica gel, 20% EtOAc in hexanes) to provide pure 12b (209 mg, 75% in two steps). 
 
(6S,10S)-12-((R)-4-(Triisopropylsilyl)but-3-yn-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epimino-
cycloocta[b]indol-9(6H)-one (12b) 
1H NMR (300 MHz, CDCl3): δ 7.92 (br s, 1H), 7.49 
(d, 1H, J = 7.7 Hz), 7.35 (d, 1H, J = 7.9 Hz), 7.23-
7.10 (m, 2H), 4.37 (br d, 2H, J = 5.8 Hz), 3.73 (q, 
1H, J = 6.4 Hz), 3.32 (dd, 1H, J = 16.7, 6.8 Hz), 2.72 (br d, 1H, J = 16.8 Hz), 2.58-2.43 (m, 2H), 
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2.17-2.02 (m, 2H), 1.48 (d, 3H, J = 6.4 Hz), 1.10-1.04 (m, 21H); 13C NMR (75 MHz, CDCl3): δ 
210.6, 135.9, 132.0, 126.9, 122.0, 119.7, 118.3, 110.9, 107.9, 107.6, 85.4, 63.4. 48.5, 47.4, 34.6, 
30.0, 21.7, 21.1, 18.6, 12.2; HRMS (ESI) m/z (M+H)+ calcd for C27H38N2OSi 435.2826, found 
435.2835; Rf: 0.38 (30% EtOAc in hexane, silica gel). This compound was further confirmed by 
X-ray crystallographic analysis (see Appendix A for X-ray data). 
 
Preparation of 29 from 12b 
To a solution of ketone 12b (120 mg, 0.28 mmol) in THF (8 mL), TBAF (414 μL, 0.414 mmol, 
1.0 M solution in THF) was added at 0 oC. The solution, which resulted, was stirred at 0 oC for 30 
min or until the completion of the reaction as monitored by TLC. After that, the reaction was 
diluted with EtOAc (30 mL) and water (10 mL). The organic layer was separated and the aq layer 
was extracted with EtOAc (10 mL). The combined organic layers were washed with brine (3 x 30 
mL) and dried (Na2SO4). The solvent was removed under reduced pressure to provide the alkyne 
29 (LRMS M+H+ = 279.45) as a brown residue (33 mg, 101% crude yield). The residue was 
purified by silica gel column chromatography (30% EtOAc in hexanes, silica gel) to provide 29 as 
a light brown solid (69.2 mg, 90%). 
 
(6S,10S)-12-((R)-But-3-yn-2-yl)-7,8,10,11-Tetrahydro-5H-6,10-epiminocycloocta[b]indol-
9(6H)-one (29) 
1H NMR (300 MHz, CDCl3) δ 7.90 (brs, 1H), 7.48 (dd, 1H, J = 7.7, 0.5 Hz), 
7.36 (d, 1H, J = 8.0 Hz), 7.11-7.23 (m, 2H), 4.37-4.41 (m, 1H), 4.35 (d, 1H, 
J = 6.6Hz),  3.68 (qd, 1H, J = 6.5, 2.1 Hz), 3.30 (dd, 1H, J = 16.9, 6.7 Hz), 
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2.72 (d, 1H, J = 16.9 Hz), 2.44 - 2.57 (m, 2H), 2.33-2.34 (m, 1H), 2.05 - 2.21 (m, 2H), 1.47 (d, 
3H, J = 6.5 Hz); 13C NMR (75 MHz, CDCl3) δ 210.4 (C), 135.9 (C), 131.6(C), 126.8 (C), 122.2 
(CH), 119.8 (CH), 118.3 (CH), 110.9 (CH), 107.8 (C), 83.9 (C), 72.7 (CH), 63.3 (CH), 48.0 (CH), 
46.3 (CH), 34.5 (CH2), 30.1 (CH2), 21.5 (CH2), 20.6 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for 
C18H19N2O, 279.1492, found 279.1498; Rf: 0.15 (30% EtOAc in hexanes, silica gel); m.p.: 158-
61 oC. 
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 (21) Herlé, B.; Wanner, M. J.; van Maarseveen, J. H.; Hiemstra, H. J. Org. Chem. 
2011, 76, 8907. 
 (22) Sewgobind, N. V.; Wanner, M. J.; Ingemann, S.; de Gelder, R.; van Maarseveen, 
J. H.; Hiemstra, H. J. Org. Chem. 2008, 73, 6405. 
 (23) Seayad, J.; Seayad, A. M.; List, B. J. Am. Chem. Soc. 2006, 128, 1086. 
 (24) Czerwinski, K. M.; Cook, J. M. Stereochemical control of the Pictet-Spengler 
reaction in the synthesis of natural products; JAI Press: Greenwich, CT, 1996; Vol. 3. 
 (25) Li, J.; Wang, T.; Yu, P.; Peterson, A.; Weber, R.; Soerens, D.; Grubisha, D.; 
Bennett, D.; Cook, J. J. Am. Chem. Soc. 1999, 121, 6998. 
105 
 
 (26) Edwankar, R. V.; Edwankar, C. R.; Deschamps, J. R.; Cook, J. M. J. Org. Chem. 
2014, 79, 10030. 
 (27) Garnick, R. L.; Le Quesne, P. W. J. Am. Chem. Soc. 1978, 100, 4213. 
 (28) Rahman, M. T.; Deschamps, J. R.; Imler, G. H.; Schwabacher, A. W.; Cook, J. M. 
Org. Lett. 2016, 18, 4174. 
 (29) Marshall, J. A.; Eidam, P.; Eidam, H. S. Org. Syn. 2007, 120. 
 (30) Haack, K. J.; Hashiguchi, S.; Fujii, A.; Ikariya, T.; Noyori, R. Angew. Chem. Int. 
Ed. 1997, 36, 285. 
 (31) Matsumura, K.; Hashiguchi, S.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1997, 
119, 8738. 
 (32) Edwankar, R. V.; Edwankar, C. R.; Deschamps, J.; Cook, J. M. Org. Lett. 2011, 
13, 5216. 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Unprecedented Stereocontrol in the Synthesis of 1,2,3-Trisubstituted 
Tetrahydro-β-carbolines: The Ambidextrous Pictet-Spengler Reaction 
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1. Introduction 
 
The asymmetric Pictet-Spengler (P-S) reaction of chiral Nb-ethynyl substituted tryptophan methyl 
ester derivatives (from both D- and L-tryptophan) with a simple aliphatic aldehyde, exhibited 
unprecedented selectivity towards either of the diastereomeric cis or trans products. A simple 
variation of conditions could alter the outcome of the cyclization from either 100% trans-selective 
to 100% cis-selective originating entirely from internal asymmetric induction under mild 
conditions. This resulted in a highly efficient access to both 1,3-cis-(1,2,3-trisubstituted tetrahydro-
β-carbolines, THβCs) and 1,3-trans-(1,2,3-trisubstituted THβCs). To the best of our knowledge, 
this type of stereocontrol has never been observed from tryptophan methyl ester derivatives (either 
D or L) in accessing either 1,3-disubstituted or 1,2,3-trisubstituted THβCs. By exploiting this very 
useful ambidextrous-diastereoselectivity, the crucial C-3 and C-5 stereocenters of C-19 methyl 
substituted sarpagine-macroline-ajmaline alkaloids has been set beginning with the DNA-encoded 
and cheaper L-(-)-tryptophan, as well as optionally from commercially available D-(+)-tryptophan. 
The Pictet-Spengler (P-S) reaction of tryptophan derivatives with an aldehyde other than 
formaldehyde results in two diastereomeric THβCs (at C-1 and C-3 of the THβC, see Scheme 1). 
The THβC moiety deserves special attention in its own right as it is at the core of numerous 
bioactive alkaloids, as well as medicinally important synthetic analogs. As a consequence, 
numerous studies accessing this moiety by various strategies have been undertaken.1-6 Almost all 
useful compounds containing the THβC core (both natural and synthetic) bear a stereocenter at C-
1. On the other hand, in the vast majority of the sarpagine/ajmaline-type alkaloids, there is cis-1,3-
disubstitution in the THβC core (see cis-3,5 of alkaloids in Figure 1). As a result, the diastereose-
lectivity of the P-S reaction to access the 1,3-cis-THβC core is of special importance. Numerous 
108 
 
attempts have been made to gain control in the selectivity in this process by varying the 
temperature, solvent, chiral catalysts, chiral reactive partners (including chiral aldehyde 
equivalents), and different tryptophan alkyl esters, etc.1,7-10 
The asymmetric P-S reaction has undergone elegant advances by Jacobsen,11-13 Nakagawa,14,15 
Bailey,16-18 Misicka,19,20 Hiemstra,21-24 Van Maarseveen,21-24 List,25-36 and many others.25-36 Cis-
Selectivity in the asymmetric P-S reaction has been reported in the preparation of 1,3-disubstituted 
THβCs.17-19,31,32,37 In the case of 1,3-disubstituted THβC, Bailey, Sato, Misicka, and Shi have made 
notable advances in devising a cis-selective P-S reaction to gain access to the cis-1,3-disubstituted 
THβC system (Scheme 1). These strategies are logical in a chemical sense because of their promise 
to access the C-3 stereochemistry of indole alkaloids, starting from L-tryptophan. The requirement 
of pi-systems either at C-1 or C-3; however, is not desirable since very often these esters or 
aldehyde equivalents are surprisingly hard to prepare and require special processes for removing 
them. Moreover, often the products are not useful toward the synthesis of alkaloids which would 
require complex transformations. To the best of our knowledge, completely cis-selectivity in the 
P-S reaction with tryptophan methyl esters and aliphatic aldehydes have not been reported yet.  
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Scheme 1. Comparison between different methods for access to 1,3-disubstituted and 1,2,3-
trisubstituted THβCs via the asymmetric Pictet-Spengler reaction 
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Scheme 2. Access to 1,3-disubstituted and 1,2,3-trisubstituted THβCs via the asymmetric Pictet-
Spengler reaction 
 
On the other hand, for 1,2,3-trisubstituted THβC systems, the P-S reaction of Nb-benzylated 
tryptophan methyl esters (e.g., 1 in Scheme 2) with aldehydes or acetals (e.g., 2) is well known for 
complete trans-selectivity under thermodynamic conditions yielding 1,3-trans-1,2,3-trisubstituted 
THβCs 3 (Scheme 2, entry 1).1 This robust strategy has been employed on up to a 600 gram scale 
process and in excellent diastereo (100% de) and enantioselectivity (up to 98% ee) in excellent 
yield, while avoiding chromatographic purification. The syntheses of numerous indole and 
oxindole alkaloids with potent biological activity have utilized this trans-specific method.38-40 
Many examples of the preparation of 1,2,3-trisubstituted THβCs are present in the literature via 
thermodynamic control to give mostly (if not exclusively), trans-1,3-disubstitution.29,33,35  To the 
best of our knowledge, cis-specificity in preparing 1,2,3-trisubstituted THβCs from tryptophan 
alkyl esters is absent in the literature. Herein, we report unprecedented stereocontrol in cis- and 
trans-selectivity in accessing 1,2,3-trisubstituted THβCs from chiral Nb-ethynyl substituted 
111 
 
tryptophan derivatives 4 with simple aliphatic aldehydes 5 to furnish either the cis-diastereomer 6 
completely or the trans-isomer 7, controlled by simple changes in reaction conditions (Scheme 2, 
entry 2). This strategy will greatly improve the approach towards the total synthesis of either the 
(+) or (-) enantiomer of a group of more than seventy sarpagine/macroline-/ajmaline indole 
alkaloids. Depicted in Figure 1 are a few representative examples (8-13)41-47 from this group of 
bioactive alkaloids (for more examples see Figure 1A). Furthermore, the complete cis-selectivity 
would permit the synthesis to begin with the natural and cheaper L-tryptophan methyl ester instead 
of D-tryptophan methyl ester which has been used previously. In this version of the P-S reaction, 
it is the ability to prepare both the (+) or (-) enantiomer of these indole alkaloids from either D-
(+)-tryptophan or L-(-)-tryptophan that is of significance and illustrated here for the first time. 
 
 
Figure 1. Representative examples of C-19 methyl substituted sarpagine/ajmaline indole 
alkaloids 8-13 (for more examples, see Figure 1A). 
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Figure 1A. Representative examples of C-19 methyl substituted macroline, sarpagine, and 
ajmaline-type indole alkaloids40,48 
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2. Results and Discussion 
Recently, the total synthesis of a number of sarpagine-related bioactive indole alkaloids was 
published via a better and shorter route for accessing the core-tetracyclic intermediates employing 
an improved P-S strategy.49,50 One of the principal goals of that study was to gain quicker access 
to the key intermediates, improving the previous strategy, and developing a shorter route to the 
tetracyclic-core required for an important group of more than seventy40,48,62 alkaloids. Several 
interesting observations were noted in the P-S/Dieckmann protocol.49 When the D-tryptophan 
methyl ester derivative with an Nb-ethynyl substituent bearing a methyl group with the (S) 
stereochemistry (4a) was reacted with acetal 2 in acidic media (TFA in DCM), excellent 
diastereoselectivity (>95:5) towards the trans-diester (7a) was observed (not shown here).49 On 
the other hand, when the reaction of the tryptophan methyl ester derivative with the (R)-methyl 
substituent (4d) was stirred under the same conditions, this resulted in a complex reaction mixture. 
Afterwards, it was discovered milder reaction conditions using the aldehyde 5 and acetic acid 
instead of the acetal 2 and trifluoroacetic acid altered the chemistry. The asymmetric P-S reaction 
of the amine 4d with aldehyde 5 proceeded smoothly under the modified and milder conditions to 
provide a 70 to 30 mixture of cis to trans-diastereomers in 95% combined isolated yield (Scheme 
3).49,50 The excellent overall yield and diastereoselectivity towards the cis-diester captured our 
attention. A further investigation of this reaction, in order to find conditions for better selectivity, 
became the focus. As a step toward this the same conditions were applied to Nb-(S)-methyl-ethynyl 
substituted tryptophan derivative (4a). To our surprise, the reaction was complete in 10 hours and 
provided the cis-diester 6a with 100% cis-diastereoselectivity. The addition of 3 equivalents of 
TFA, after the initial P-S reaction (at 10 hours), converted the cis-diester 6a completely into the 
corresponding trans-diester 7a (Scheme 3). Furthermore, addition of 4 Å molecular sieves to the 
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reaction had, as expected, a tremendous effect on the rate. The reactions run in the presence of 
molecular sieves were complete in several hours instead of several days. It is felt, the amine 4a 
reacts with the aldehyde 5 in the presence of AcOH to form the kinetic product (cis-diester, 6a) 
while acetic acid is not acidic enough to facilitate cleavage of the C(1)-N(2) bond which previously 
provided (TFA) only the trans-diastereomer.51 Conversely, when the kinetic product (i.e., 6a) was 
treated with TFA in DCM, the cis-diastereomer rearranged completely to the thermodynamically 
more stable product (i.e., the trans-product 7a). To the best of our knowledge, this type of 
selectivity in the formation of completely cis- or trans-THβC from a single tryptophan derivative 
has never been seen in the formation of the 1,2,3-trisubstituted THβC-system. 
 
Scheme 3. Unprecedented stereocontrol in the asymmetric P-S reaction 
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Encouraged by the unprecedented outcome of the P-S reaction, it was felt of importance to 
investigate the underlying reason(s) for this ambidextrous-diastereoselectivity. It was obvious 
exploitation of complete cis-selectivity would permit the synthesis of sarpagine alkaloids with the 
cheaper and natural L-(-)-tryptophan, instead of D-(+)-tryptophan. The optically pure tosylate 
units (18a-d) required for amines 4a-i were synthesized, as depicted in Scheme 4 (see the 
Experimental section for details52-56).  
 
Scheme 4. Different amine-substrates for the P-S reaction and syntheis of tosylate units; 
Reagents and conditions: a) (S, S)-Ru or (R, R)-Ru catalyst (1 mol%), i-PrOH, rt, 3 h, 85-90%; b) 
TsCl (2.5 equiv), Et3N (4 equiv), DMAP (10 mol%), CH2Cl2, -30 
oC to rt, 92-95%. 
 
The synthesis of the tryptophan amine-substrates (4a-i) for the P-S reaction were carried out, as 
shown in Scheme 5. With all the required substrates in hand, the planned reactions were performed 
with 1 equivalent of the amines, 1.5 equivalents of the aldehyde 5, 3 equivalents of acetic acid, 
200 mg 4 Å MS (per mmol of amines). The reactions were performed in parallel at 0 oC and at rt. 
The outcome of these experiments are listed in Table 1. These reaction processes gave excellent 
overall isolated yields (up to 95%) with selectivity towards cis-diesters. All the cis- and trans-
diester products were easily separable by silica gel column chromatography except for entry 6 
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where both cis and trans diastereomers had the same Rf in several solvent systems. Interestingly, 
some clear patterns emerged. For example, when the carbon atoms a and b had the same 
configurations (S,S) or (R,R) (Table 1, entries 2, 4, 6, and 8), reactions were up to 82% cis-
selective. The cis-selectivity improved at lower temperature (e.g., Table 1, entries 2, 8) and the 
bulky TIPS containing amines exhibited better cis-selectivity (compare entry 2 and 8 vs 4 and 6 in 
Table 1) than amines which contained a TMS- or H-substitution. Interestingly, on the other hand, 
when the configurations of carbon atoms a and b in the amine substrates were opposite to each 
other i.e., (R,S) or (S,R), reactions were 100% cis-selective regardless of temperature, and size of 
the alkyne protecting groups (TIPS, TMS and H), as indicated by entries 1, 3, 5, 7, and 9. As 
expected, the P-S reaction with an electron rich tryptophan (4f, 5-MeO) reacted faster. The C-5 
ring-A oxygen function, however, had no effect on the outcome of the diastereoselectivity other 
than speeding up the rate. Similarly, the same pattern was observed with the L-(-)-tryptophan 
derivatives (entries 8 and 9). More importantly, all of the diastereomers could easily be separated 
and the pure, isolated cis-diesters could be converted into the corresponding trans-diesters (100% 
de), simply by treatment with TFA in DCM for 2-20 hours at room temperature (see the 
Experimental section for details). 
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Scheme 5. Synthesis of Pictet-Spengler substrates (4a-i) 
 
Consequently, conditions were designed for selective generation of either the trans- or the cis-
diesters from either D(+)- or L(-)-tryptophan. It is well known that plants or natural sources 
generally produce one enantiomer of the chiral natural products. Due to this, it is possible to isolate 
and screen for bioactivity only one series of the enantiomers. Logically, the unnatural enantiomer 
might actually be as good as the natural enantiomer or even better in activity, as well as in toxicity 
profile depending on the rate of metabolism. The development of the life-saving anti-HIV/AIDS 
drug emtricitabine by Professor Liotta at Emory exemplified the tremendous potential of unnatural 
enantiomers of bioactive molecules in drug discovery.57 As depicted in Scheme 5, the 3,5-cis-
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disubstitution (biogenetic numbering, 24 and 25) of the natural enantiomer of the sarpagine/macr-
oline alkaloids could be furnished from either natural L-tryptophan via a cis-selective P-S reaction 
or alternatively from D-tryptophan via a trans-selective P-S reaction. Conversely, the unnatural 
enantiomer of these alkaloids would also be accessible either from L-tryptophan via a trans-
selective P-S reaction (26 and 27) or alternatively from D-tryptophan via a cis-selective P-S 
reaction (see Scheme 6 for details). This novel ambidextrous approach to the synthesis of both the 
natural and unnatural enantiomers of bioactive sarpagine-type alkaloids would permit the rapid 
screening of the biological activity of both of the enantiomers. To illustrate the usefulness of this 
method, the synthesis of key intermediates for natural product synthesis,49 28 and 30, starting from 
L-tryptophan derivative 21 were undertaken. The β-ketoesters 28, and 30 are key intermediates for 
the total synthesis of a group of sarpagine-related indole alkaloids and were employed previously 
for the total synthesis of natural alkaloids and were synthesized from D-(-)-tryptophan methyl 
ester.49  As shown in Scheme 6, the cis-diester 29 was synthesized from L-(+)-tryptophan methyl 
ester 21 via Nb-alkylation (4h) and the cis-specific P-S reaction (100% cis, Table 1, entry 9). The 
cis-diester 29 upon Dieckmann cyclization provided the β-ketoester 28 in excellent yield. The ester 
28 was previously synthesized from (-)-19.49 The indoles from both routes were identical in all 
respects (Rf, 
1H NMR, and 13C NMR), as well as the optical rotation (see Figure 2). This enabled 
one to access the same group of indole alkaloids starting from L-tryptophan via the unprecedented 
cis-specific P-S reaction reported herein (Scheme 7).  
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Table 1. P-S reaction of amines 4a-i with aldehyde 5  
 
 
[a] Isolated yields; [b] both cis and trans isomers had the same Rf, and were isolated after complete 
conversion into the trans-diester; [c] not done; cis: trans at [d] 0 oC; [e] room temp. 
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Scheme 6. Stereospecific total synthesis of both enantiomers of C-19 methyl substituted 
macroline/sarpagine indole alkaloids from either L-(-)- or D-(+)-tryptophan 
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Scheme 7. Synthesis of the key β-ketoester (+)-28 towards sarpagine-type indole alkaloids from 
either (+)-21 or (-)-19 
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Figure 2. Comparison between the (a) 1H and (b) 13C NMR spectra of (+)-28 from L-tryptophan 
(red) and D-tryptophan (blue) as shown in Scheme 7. 
 
a) 
b
) 
123 
 
 
Scheme 8. Synthesis of (-)-30 from either (+)-21 or (-)-19 
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Figure 3a: Comparison between 1H of (-)-30 prepared from L-tryptophan (red) and D-trypto-
phan (blue) 
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Figure 3b: Comparison between 13C of (-)-30 prepaed from L-tryptophan (red) and D-tryptophan 
(blue) 
 
Similarly, the β-ketoester 30 could be prepared form D-tryptophan via 7a (100% trans-selective 
P-S reaction, which was shown to be >95% dr previously49), as depicted in Scheme 8. Importantly 
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the same β-ketoester 30 could be synthesized from (+)-21 via a cis-selective (82% cis) P-S reaction. 
The spectral properties of (-)-30 from both (+)-21 and (-)-19 are identical in all respects [see 
Figures 3a and 3b). 
 
3. Conclusion 
In summary, we have developed a novel strategy to gain access to the 1,2,3-trisubstituted THβCs 
with the required C-3/C-5 stereochemistry of a group of sarpagine-related indole alkaloids with 
unprecedented control of the asymmetric P-S reaction. This report also illustrates the ability to 
achieve the complete cis-selectivity of the PS reaction to form the 1,2,3-trisubstituted THβC by 
internal asymmetric induction. Key intermediates [(+)-28 and (-)-30] towards the total synthesis 
of a group of seventy C-19 methyl substituted alkaloids have been accessed from the natural and 
cheaper L-(-)-tryptophan now instead of the previously developed route from D-(+)-tryptophan. 
This permits the synthesis of either enantiomer from the same THβC branching point. The total 
synthesis of the unnatural enantiomers of bioactive alkaloids from this group and investigation of 
the mechanism of this Pictet-Spengler reaction is underway and will be reported in due course. 
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4. Experimental Section 
 
General Experimental Considerations 
All reactions were carried out under an argon atmosphere with dry solvents using anhydrous 
conditions unless otherwise stated. Tetrahydrofuran (THF) and diethyl ether were freshly distilled 
from Na/benzophenone ketyl prior to use. Dichloromethane was distilled from calcium hydride 
prior to use. Methanol was distilled over magnesium sulfate. Benzene and toluene were distilled 
over Na. Acetonitrile was distilled over CaH2 prior to use. Reagents were purchased of the highest 
commercial quality and used without further purification unless otherwise stated. Thin layer 
chromatography (TLC) was performed on UV active silica gel plates, 200 μm, aluminum backed 
and UV active alumina N plates, 200 μm, F-254 aluminum backed plates. Flash and gravity 
chromatography were performed using silica gel P60A, 40-63 μm, basic alumina (Act I, 50-200 
μm) and neutral alumina (Brockman I, ~150 mesh). TLC plates were visualized by exposure to 
short wavelength UV light (254 nm). Indoles were visualized with a saturated solution of ceric 
ammonium nitate in 50% phosphoric acid. The 1H NMR data are reported as follows: chemical 
shift, multiplicity (br s = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, quin = 
quintet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, td 
= triplet of doublets, qd = quartet of doublets, m = multiplet), integration, and coupling constants 
(Hz). The 13C NMR data are reported in parts per million (ppm) on the δ scale. The low resolution 
mass spectra (LRMS) were obtained as electron impact (EI, 70eV) and as chemical ionization (CI) 
using a magnetic sector (EBE) analyzer. HRMS were recorded by electrospray ionization (ESI) 
using a TOF analyzer, electron impact (EI) using a trisector analyzer and Atmospheric Pressure 
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Chemical Ionization (APCI) using a TOF analyzer. Optical rotations were measured on a JASCO 
Model DIP-370 digital polarimeter. 
 
Experimental Procedures and Analytical Data 
Procedure for the synthesis of optically active tosylates 21a-d from ketone 19a-b 
 
 
 
RuCl[(S,S)-NTsCH(C6H5)CH(C6H5)NH2(η6-cymene); (S, S)-Ru Catalyst and RuCl[(R, R)-
NTsCH(C6H5)CH(C6-H5)NH2(η6 -cymene); (R, R)-Ru catalyst were prepared following the 
procedure available in the literature.They were dark purple colored solids and were used for the 
subsequent reductions without further purification and characterization.58,59 The optically active 
(R) or (S)-alcohols, 17a (R, 90%) and 17b (S, 95%), 17c (R, 85%), and 17d (S, 90%) were 
synthesized following the literature procedure.53,55,59 
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Representative example, (17c): A 250 mL round bottom flask was flame dried and loaded with 
a magnetic stir bar. The flask was flushed with argon and subsequently charged with dry isopropyl 
alcohol (125 mL) and 4-trimethylsilyl-3butyn-2-one 16b (2.5 g, 2.93 mL, 17.8 mmol, TCI 
America, >97%). The Ru catalyst [(R, R)-Ru cat.] (113 mg, 0.18 mmol) was dissolved in a small 
amount of DCM (2 mL) and added to the above reaction mixture with a syringe, in a single portion. 
The reaction mixture, which resulted, was stirred at rt for 2 hours. The solvent was removed under 
reduced pressure and the dark brown residue was purified by a semi-micro distillation kit to furnish 
the optically active alcohol 17c (2.12 g) in 85% yield as a colorless liquid.  
Similarly, by following the same procedure, 17a (1.7 g, 85%) was synthesized from 16a (2.0 g, 
8.91 mmol) and (R, R)-Ru catalyst (57 mg, 0.09 mmol); 17b (2.2g, 87%) was synthesized from 
16a (2.5 g, 11.1 mmol) and (S, S)-Ru catalyst (71 mg, 0.11 mmol); 17d (2.25 g, 90%) was 
synthesized from 16b (2.5 g, 17.8 mmol) and (S, S)-Ru catalyst (113 mg, 0.18 mmol). 
 
(R)-4-(Triisopropylsilyl)but-3-yn-2-ol (17a) 
 
1H NMR (300 MHz, CDCl3): δ 4.55 (q, 1H, J = 6.39 Hz), 2.07 (br s, 1H), 1.48 
(d, 3H, J = 6.54 Hz), 1.09-1.04 (m, 21H); 13C NMR (75 MHz, CDCl3): δ 109.9, 
84.4, 58.8, 24.5, 18.5, 11.1; []D25  = +22.5 (c 1.6, CHCl3); Rf: 0.6 (10% EtOAc in hexanes, 
KMnO4 stain). The spectral and optical properties were in excellent agreement with the previously 
reported values. [3]  
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(S)-4-(Triisopropylsilyl)but-3-yn-2-ol (17b) 
 
1H NMR (500 MHz, CDCl3): δ 4.55 (q, 1H, J = 6.58 Hz), 2.15 (br s, 1H), 1.48 
(d, 3H, J = 6.60 Hz), 1.10-1.04 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 109.9, 
84.4, 58.8, 24.5, 18.5, 11.10; []D25 = -21.60 (c 1.5, CHCl3); Rf: 0.6 (10% EtOAc in hexanes). The 
spectral and optical properties were in excellent agreement with the previously reported values. [3] 
 
(R)-4-(Trimethylsilyl)but-3-yn-2-ol (17c) 
 
1H NMR (500 MHz, CDCl3): 4.56-4.53 (m, 1H), 2.36-2.19 (m, 1H), 1.48-1.45 
(m, 3H), 0.19 -0.18 (m, 9H); 13C NMR (125 MHz, CDCl3): 107.7, 88.4, 58.7, 
24.2, 0.13; [α]D = +28.26 c 2.30, CHCl3; Lit56 []D25 = +24.7 (c 0.34, CHCl3), Lit54 []D25 = +23.8 
(c 2.02, CHCl3);  Rf: 0.4 (silica gel, 10% EtOAc in hexanes, KMnO4 stain).  
 
(S)-4-(Trimethylsilyl)but-3-yn-2-ol (17d) 
 
1H NMR (500 MHz, CDCl3): 4.55 (m, 1H), 1.78 (d, 1H, J = 5.25 Hz), 1.48 (d, 
3H, J = 6.65 Hz), 0.20 (s, 9H); 13C NMR (125 MHz, CDCl3): 107.7, 88.4, 58.8, 
24.3, -0.12; []25D = -26.96 (c 3.45, CHCl3), Lit52 []D25 = -25.9 (c 3.12, CHCl3); Rf: 0.4 (10% 
EtOAc in hexanes, KMnO4 stain). 
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 The optically pure tosylate-units 18a (95%), 18b (95%), 18c (95%), and 18d (92%) were prepared 
from the corresponding optically pure alcohols 17a-d by following the procedure available in the 
literature.49,60  
Representative Example, 18c: A 250 mL round bottom flask equipped with a large magnetic stir 
bar was flame dried under a continuous flow of argon and was then allowed to cool under argon. 
The flask was then charged with freshly distilled CH2Cl2 (50 mL) and (R)-alcohol (17c, 2.0 g, 
14.06 mmol) after which the mixture was cooled to -25 °C (outside bath temperature). 
Triethylamine (7.84 mL, 56.2 mmol) and a catalytic amount of DMAP (172 mg, 1.4 mmol) were 
added, and after a few minutes of stirring, tosyl chloride (6.7 g, 35.1 mmol, Acros Organics, 99%) 
was added in one portion. The reaction mixture was allowed to stir at -25 °C for 45 min and the 
solution was allowed to slowly warm to rt. After the reaction mixture was stirred for 3 h at rt, 
analysis by TLC (silica gel) was carried out, after which the reaction mixture was quenched with 
a large excess of water (200 mL). The mixture was then allowed to stir vigorously for 45 min. 
After 45 min, the two layers were separated. The CH2Cl2 layer was dried (MgSO4), filtered and 
concentrated under reduced pressure to furnish 18c (3.96 g, 95%) as a light brown oil, which was 
used for the next reaction without further purification. 
 
(R)-4-(Trimethylsilyl)but-3-yn-2-yl 4-methylbenzenesulfonate (18c) 
 
1H NMR (500 MHz, CDCl3): 7.84 (d, 2H, J = 8.30 Hz), 7.35 (d, 2H, J = 8.10 
Hz), 5.20 (q, 1H, J = 6.68 Hz), 2.46 (s, 3H), 1.58 (d, 3H, J = 6.70 Hz), 0.06 (s, 
9H); 13C NMR (125 MHz, CDCl3): 144.6, 134.2, 129.6, 128.1, 100.8, 92.7, 68.5, 22.8, 21.7, -0.5; 
[]D25  = +94.66 (c 2.62, CHCl3). 
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(R)-4-(Triisopropylsilyl)but-3-yn-2-yl 4-methylbenzenesulfonate (18a) 
 
1H NMR (300 MHz, CDCl3): δ7.81 (d, 2H, J = 8.1 Hz), 7.30 (d, 2H, J = 8.1 Hz), 
5.20 (q, 1H, J = 6.6 Hz), 2.41 (s, 3H), 1.60 (d, 3H, J = 6.6 Hz), 0.96 (m, 21 H). 
All other spectroscopic data was identical with the published data for 18a.61 This material was 
used for the next step without further characterization. 
 
(S)-4-(Triisopropylsilyl)but-3-yn-2-yl 4-methylbenzenesulfonate (18b) 
 
1H NMR (300 MHz, CDCl3): δ 7.81 (d, 2H, J = 8.2 Hz), 7.30 (d, 2H, J = 8.1 
Hz), 5.20 (q, 1H, J = 6.6 Hz), 2.42 (s, 3H), 1.60 (d, 3H, J = 6.7 Hz), 0.97 (m, 
21H); []D25 (c 1.75 CHCl3): – 92.00. All other spectroscopic data was identical with the published 
data for 18b.49 This material was used for the next step without further characterization. 
 
(S)-4-(Trimethylsilyl)but-3-yn-2-yl 4-methylbenzenesulfonate (18d) 
 
1H NMR (500 MHz, CDCl3): 7.83 (d, 2H, J = 8.34 Hz), 7.34 (d, 2H, J = 8.04 
Hz), 5.20 (q, 1H, J = 6.68 Hz), 2.46 (s, 3H), 1.58 (d, 3H, J = 6.70 Hz), 0.05 (s, 
9H); 13C NMR (125 MHz, CDCl3): 144.6, 134.2, 129.6, 128.1, 100.8, 92.7, 68.4, 22.8, 21.7, -0.5; 
[]D25 = -92.69, c 2.6, CHCl3). 
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Synthesis of the Nb-alkylated tryptophan derivatives (substrates for the P-S reaction) 
 
General procedure for the synthesis of 4a-b, d-h 
 
Representative example, 4h: L-tryptophan methyl ester hydrochloride (21·HCl, 4.0 g, 15.7 
mmol) was dissolved in freshly distilled acetonitrile (80 mL) in a 250 mL round bottom flask. The 
tosylate 18b (11.36 g, 29.8 mmol) was dissolved in acetonitrile and added into the round bottom 
flask with a syringe. Anhydrous K2CO3 (7.60 g) was added and the mixture, which resulted, was 
heated to reflux under argon for 12 h. After the completion of the reaction as indicated by the 
disappearance of the starting material by TLC (silica gel, EtOAc/hexane, 1: 3) and LRMS (M+H+ 
= 427.35), the reaction was cooled to rt and the K2CO3 was filtered off by passing the solution 
through a bed of celite. The celite was washed with EtOAc and the EtOAc fractions were removed 
under reduced pressure to furnish crude 4h as a brownish oil. The residue was purified by flash 
column chromatography (silica gel, 1-5% EtOAc in hexanes) to provide 4h as a light yellowish-
colored oil (5.83 g, 87%). 
By following the same procedure, 4g (4.98 g, 85%) was prepared from amine 21·HCl (3.5 g, 13.7 
mmol) and tosylate 18a (9.94 g, 26.1 mmol); 4a (16.6 g, 85%) was prepared from amine 19 (10.0 
g, 45.8 mmol) and tosylate 18a (26.2 g, 68.7 mmol); 4d (5.39 g, 92%) was prepared from amine 
19 (3.0 g, 13.7 mmol) and tosylate 18b (9.94 g, 26.1 mmol);  4b (2.45 g, 78%) was prepared from 
amine 19 (2.0 g, 9.2 mmol) and tosylate 18a (5.16 g, 17.4 mmol); 4e (1.9 g, 80%) was prepared 
from amine 19 (1.5 g, 6.9 mmol) and tosylate 18b (3.87 g, 13.0 mmol); 4f  (772 mg, 88%) was 
prepared from amine 20 (0.5 g, 1.81 mmol ) and tosylate 18a (1.31 g, 3.44 mmol). 
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General procedure for the synthesis of 4c and 4i 
 
Representative example, 4c: To a solution of 4a (0.5 g, 1.2 mmol) in THF (10 mL), TBAF (1.76 
mL, 1.76 mmol, 1.0 M solution in THF) was added at 0 oC. The solution, which resulted, was 
stirred at 0 oC for 30 min or until the completion of the reaction, as indicated by TLC. After that, 
the reaction was diluted with EtOAc (20 mL) and water (10 mL). The organic layer was separated 
and the aq layer was extracted with EtOAc (5 mL). The combined organic layers were washed 
with brine (3 x 20 mL) and dried (Na2SO4). The solvent was removed under reduced pressure to 
provide the alkyne 4c (LRMS M+H+ = 271.10) as a brown residue. The residue was purified by 
silica gel column chromatography (30% EtOAc in hexanes) to provide 4c as light brown solid (285 
mg, 90%). 
By following the same procedure, 4i (272 mg, 86%) was prepared from the TIPS-protected alkyne 
4d (500 mg, 1.2 mmol) and TBAF (1.76 mL, 1.76 mmol). 
 
(R)-Methyl 3-(1H-indol-3-yl)-2-(((S)-4-(triisopropylsilyl)but-3-yn-2-yl)amino)propanoate 
(4a) 
 
1H NMR (300 MHz, CDCl3): δ 8.12 (br s, 1H), 7.65 (d, 1H, J = 7.7 Hz), 
7.34 (d, 1H, J = 7.9 Hz), 7.23-7.06 (m, 3H), 3.97 (t, 1H, J = 6.1 Hz), 
3.63 (s, 3H), 3.58 (q, 1 H, J = 6.8 Hz), 3.19 (d, 2H, J = 6.1 Hz), 1.98 (br 
s, 1H), 1.35 (d, 3H, J  = 6.7 Hz), 1.12-1.06 (m, 21H). All other spectroscopic and optical properties 
were identical to the published values.49 
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(R)-Methyl 3-(1H-indol-3-yl)-2-(((S)-4-(trimethylsilyl)but-3-yn-2-yl)amino)propanoate (4b) 
 
1H NMR (300 MHz, CDCl3): 8.39 (br s, 1H), 7.66 (d, 1H, J = 7.65 
Hz), 7.34 (br d, 1H, J = 7.69 Hz), 7.24-7.10 (m, 2H), 7.02 (d, 1H, J = 
2.19 Hz), 3.89 (t, 1H, J = 6.39 Hz), 3.65 (s, 3H), 3.60 (q, 1H, J = 6.75 
Hz, overlapped with CO2CH3 peak), 3.19 (d, 2H, J = 6.36 Hz), 1.96 (br s, 1H), 1.34 (d, 3H, J = 
6.75 Hz), 0.19-0.16 (m, 9H); 13C NMR (75 MHz, CDCl3): 175.3, 136.2, 127.6, 123.0, 121.9, 
119.3, 118.7, 111.2, 111.0, 107.9, 87.3, 59.9, 51.8, 44.7, 29.2, 22.2, 0.07; HRMS (ESI) m/z 
(M+H)+ Calcd for C19H27N2O2Si 343.1836, found 343.1841; []D25 = -77.16 (c 1.27, CHCl3); Rf: 
0.33 (silica gel, 20% EtOAc in hexanes). 
 
(R)-Methyl 2-((S)-but-3-yn-2-ylamino)-3-(1H-indol-3-yl)propanoate (4c) 
 
4c, 1H NMR (500 MHz, CDCl3): 8.28 (br s, 1H), 7.36 (d, 1H, J = 8.09 
Hz), 7.24-7.19 (m, 1H), 7.17-7.14 (m, 1H), 7.05 (d, 1H, J = 2.10 Hz), 
3.87 (t, 1H, J = 6.42 Hz), 3.66 (s, 3H), (qd, 1H, J = 6.78Hz, 2.05 Hz), 
3.19 (d, 2H, J = 6.45 Hz), 2.7 (d, 1H, J = 2.05 Hz), 1.95 (br s, 1H), 1.36 (d, 3H, J = 6.80 Hz); 13C 
NMR (125 MHz, CDCl3): 175.4, 136.2, 127.6, 123.0, 122.0, 119.4, 118.8, 111.2, 111.1, 85.7, 
71.1, 60.0, 51.8, 44.0, 29.1, 22.2; HRMS (ESI) m/z (M+H)+ Calcd for C16H19N2O2 271.1441, 
found 271.1448; []D25 = -66.26 (c 1.66, CHCl3); Rf: 0.30 (silica gel, 40% EtOAc in hexanes).  
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(R)-methyl 3-(1H-indol-3-yl)-2-(((R)-4-(triisopropylsilyl)but-3-yn-2-yl)amino)propanoate 
(4d) 
 
1H NMR (300 MHz, CDCl3): 8.13 (br s, 1H), 7.65 (d, 1H, J = 7.8 Hz), 
7.36 (d, 1H, J = 8.0 Hz), 7.24-7.17 (t, 1H, J = 7.4 Hz), 7.16-7.09 (m, 
2H), 4.17-4.10 (m, 1H), 3.69 (s, 3H), 3.63 (q, 1H, J = 6.7 Hz), 3.32-3.23 (m, 1H), 3.20-3.10 (m, 
1H), 1.34 (d, 3H, J = 6.7 Hz), 1.05-0.99 (m, 21H). All other spectroscopic and optical properties 
were identical to the published values.49  
 
(R)-Methyl 3-(1H-indol-3-yl)-2-(((R)-4-(trimethylsilyl)but-3-yn-2-yl)amino)propanoate (4e) 
 
1H NMR (300 MHZ, CDCl3): 8.45 (br s, 1H), 7.66 (d, 1H, J = 7.71 
Hz), 7.35 (d, 1H, J = 7.92 Hz), 7.24-7.10 (m, 2H), 7.08 (d, 1H, J = 1.59 
Hz), 4.15-4.08 (m, 1H), 3.70 (s, 3H), 3.59 (q, 1H, J = 6.72 Hz), 3.30 
(dd, 1H, J = 14.40 Hz, 5.46 Hz), 3.16 (dd, 1H, J = 14.42 Hz, 8.01 Hz), 1.69 (br s, 1H), 1.31 (d, 
3H, J = 6.72 Hz), 0.13 (s, 9H); 13C NMR (75 MHz, CDCl3): 175.0, 136.4, 127.4, 123.0, 122.1, 
119.5, 118.8, 111.2, 110.8, 107.7, 87.4, 59.3, 51.9, 44.4, 29.6, 22.4, -0.005; HRMS (ESI) m/z 
(M+H)+ Calcd for C19H27N2O2Si 343.1836, found 343.1832; []D25  = +42.62 (c 1.22, CHCl3); Rf: 
0.2 (silica gel, 20% EtOAc in hexanes). 
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(R)-Ethyl 3-(5-methoxy-1-methyl-1H-indol-3-yl)-2-(((S)-4-(triisopropylsilyl)but-3-yn-2-
yl)amino)propanoate (4f) 
 
1H NMR (300 MHz, CDCl3): 7.16 (d, 1H, J = 8.82 Hz), 7.10 (d, 
1H, J = 2.16 Hz), 6.94 (m, 1H), 6.89 (dd, 1H, J = 8.81 Hz, 2.27 
Hz), 4.11 (q, 2H, J = 7.12 Hz), 3.94-3.89 (m, 1H, overlapped 
with CO2Me peak), 3.89 (s, 3H), 3.71 (s, 3H), 3.59 (q, 1H, J = 6.75 Hz), 3.14 (d, 2H, J = 5.94 Hz), 
2.03 (br s, 1H), 1.37 (d, 3H, J = 6.75 Hz), 1.16 (t, 3H, J = 7.13 Hz), 1.11-1.04 (m, 21H); 13C NMR 
(75 MHz, CDCl3): 174.6, 153.8, 132.3, 128.6, 128.1, 111.7, 110.2, 109.8, 109.5, 100.9, 82.8, 60.7, 
59.5, 55.9, 44.6, 32.8, 28.8, 22.6, 18.6, 14.1, 11.2; HRMS (ESI) m/z (M+H)+ Calcd for 
C28H45N2O3Si 485.3194, found 481.3203;  []D25  = -65.78 (c 1.9, CHCl3); Rf: 0.65 (silica gel, 
30% EtOAc in hexanes). 
 
(S)-Methyl 3-(1H-indol-3-yl)-2-(((S)-4-(triisopropylsilyl)but-3-yn-2-yl)amino)propanoate 
(4g) 
 
1H NMR (500 MHz, CDCl3): 8.21 (br s, 1H), 7.66 (d, 1H, J = 7.89 
Hz), 7.37 (d, 1H, J = 8.04 Hz), 7.21 (t, 1H, J = 7.49 Hz), 7.16-7.10 
(m, 2H), 4.18-4.13 (m, 1H), 3.70 (s, 3H), 3.64 (q, 1H, J = 6.53 Hz), 
3.29 (dd, 1H, J = 14.41 Hz, 5.27 Hz), 3.16 (dd, 1H, J = 14.40 Hz, 8.12 Hz), 1.64 (br s, 1H), 1.35 
(d, 3H, J = 6.55 Hz), 1.07-1.01 (m, 21H); 13C NMR( 125 MHz, CDCl3): 174.9, 136.3, 127.5, 
122.8, 122.1, 119.5, 118.8, 111.1, 111.1, 109.5, 83.3, 59.6, 51.8, 44.4, 29.6, 22.8, 18.6, 18.6,11.1; 
HRMS (ESI) m/z (M+H)+ Calcd for C25H39N2O2Si 427.2775, found 427.2774; []D25  = -50.64 (c 
1.56, CHCl3); Rf: 0.31 (silica gel, 30% EtOAc in hexanes); m.p.: 88-89 
oC. 
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(S)-Methyl 3-(1H-indol-3-yl)-2-(((R)-4-(triisopropylsilyl)but-3-yn-2-yl)amino)propanoate 
(4h) 
 
1H NMR, (500 MHz, CDCl3): 8.22 (br s, 1H), 7.67 (d, 1H, J = 7.84 
Hz), 7.35 (d, 1H, J = 8.10 Hz), 7.23-7.18 (m, 1H), 7.16-7.12 (m, 
1H), 7.08-7.06 (m, 1H), 4.00 (t, 1H, J = 6.15 Hz), 3.65 (s, 3H), 3.61 
(q, 1H, J = 6.75 Hz), 3.21 (d, 2H, J = 6.10 Hz), 2.01 (br s, 1H), 1.37 (d, 3H, J = 6.75 Hz), 1.12-
1.07 (m, 21H);  13C NMR (125 MHz, CDCl3): 175.1, 136.1, 127.7, 122.9, 121.9, 119.3, 118.8, 
111.3, 111.1, 110.0, 83.1, 59.5, 51.9, 44.7, 28.9, 22.6, 18.6, 11.2; HRMS (ESI) m/z (M+H)+ Calcd 
for C25H39N2O2Si 427.2775, found 427.2776; []D25  = +88.98 (c 1.18, CHCl3); Rf: 0.45 (silica 
gel, 30% EtOAc in hexanes). 
 
(R)-Methyl 2-((R)-but-3-yn-2-ylamino)-3-(1H-indol-3-yl)propanoate (4i) 
 
1H NMR (500 MHz, CDCl3): 8.32 (br s, 1H), 7.67 (d, 1H, J = 7.84 
Hz), 7.36 (d, 1H, J = 8.09 Hz), 7.24-7.20 (m, 1H), 7.17-7.13 (m, 1H), 
7.10 (d, 1H, J = 2.10 Hz), 4.14-4.10 (m, 1H), 3.71 (s, 3H), 3.59 (qd, 
1H, J = 6.71 Hz, 2.05 Hz), 3.30 (dd, 1H, J = 14.42 Hz, 5.55 Hz), 3.18 
(dd, 1H, J = 14.49 Hz, 7.80 Hz), 2.19 (d, 1H, J = 2.05 Hz), 1.67 (br s, 1H), 1.34 (d, 3H, J = 6.75 
Hz); 13C NMR (125 MHz, CDCl3): 175.0, 136.3, 127.5, 123.0, 122.1, 119.4, 118.9, 111.2, 110.8, 
85.4, 59.3, 51.9, 43.7, 29.5, 22.4; HRMS (ESI) m/z (M+H)+ Calcd for C16H19N2O2 271.1441, 
found 271.1451; []D25  = +51.03 (c 1.45, CHCl3); Rf: 0.42 (silica gel, 50% EtOAc in hexanes). 
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General procedure for the Pictet-Spengler reactions  
 
Synthesis of cis-diesters 6a-c 
 
 
 
Representative example: Procedure for the synthesis of the cis-diester 6a: The Nb-alkylated 
tryptophan 4a (100 mg, 0.23 mmol) was dissolved in 10 mL of dry DCM in a 50 mL round bottom 
flask equipped with a magnetic stir. To that above solution, the aldehyde 5 (41 mg, 0.35 mmol) 
and acetic acid (42 mg, 0.70 mmol), as well as 4 Å MS (46 mg) were added at rt or at 0 oC. The 
solution, which resulted, was stirred at rt or 0 oC for 10 h. The progress of the reaction was 
monitored by TLC (silica gel) analysis, as indicated by the consumption of SM and appearance of 
a less-polar spot (UV and CAN stain). The reaction mixture was diluted with DCM (20 mL), water 
(10 mL) and brought to pH 8-9 with cold aq NaOH (1 N). The organic layer was separated and 
washed with water (10 mL), brine (2 x 20 mL) and dried (Na2SO4). The solvent was removed 
under reduced pressure to give 6a as a light yellow-colored oil. The residue (LRMS M+H+ = 525, 
Rf = 0.6, silica gel, 30% EtOAc in hexanes) was purified by column chromatography (silica gel, 
10-20% EtOAc in hexanes) to furnish pure cis-diester 6a (111 mg, 90%) as a colorless oil. 
By following the same procedure, the cis-diesters 6b (82%), and 6c (85%) were synthesized. The 
cis-diester 29 (88%) was synthesized from the Nb-alkylated L-tryptophan derivative 4h using the 
same procedure described above.  
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(1R,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (6a) 
 
1H NMR (300 MHz, CDCl3): 7.92 (br s, 1H), 7.49 (d, 1H, J = 7.38 
Hz), 7.33-7.28 (m, 1H, overlapped with CDCl3 peak); 7.19-7.04 (m, 
2H), 4.30 (t, 1H, J = 4.40 Hz), 4.12-4.03 (m, 1H), 3.83 (q, 1H, J = 6.81 
Hz), 3.71 (s, 3H), 3.65 (s, 3H), 3.24 (d, 2H, J = 4.38 Hz), 2.80-2.58 (m, 
2H), 2.13-2.00 (m, 1H), 1.98-1.84 (m, 1H), 1.48 (d, 3H, J = 6.78 Hz), 
0.97-0.86 (m, 21H); 1H NMR (500 MHz, CDCl3): 7.92 (br s, 1H), 7.49 (d, 1H, J = 7.70 Hz), 7.31 
(d, 1H, J = 8.0 Hz), 7.15 (t, 1H, J = 7.43 Hz), 7.11-7.07 (m, 1H), 4.30 (t, 1H, J = 4.22 Hz), 4.10-
4.05 (m, 1H), 3.83 (q, 1H, J = 6.80 Hz), 3.72 (s, 3H), 3.65 (s, 3H), 3.24 (d, 2H, J = 4.30 Hz), 2.78-
2.61 (m, 2H), 2.11-2.02 (m, 1H), 1.96-1.86 (m, 1H), 1.48 (d, 3H, J = 6.70 Hz), 0.95-0.85 (m, 21H); 
13C NMR (75 MHz, CDCl3): 174.8 (2xC), 136.1, 133.6, 127.1, 121.5, 119.2, 118.2, 110.6, 108.5, 
107.0, 84.5, 55.6, 54.5, 52.7, 51.8, 51.6, 30.7, 30.4, 21.7, 21.2, 18.4, 18.4, 11.1; HRMS (ESI) m/z 
(M+H)+ Calcd for C30H45N2O4Si 525.3143, found 525.3147; []D25 : -23.52 (c 0.8, CHCl3); Rf: 0.3 
(silica gel, 20% EtOAc in hexane) 
 
(1R,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((S)-4-(trimethylsilyl)but-3-yn-2-yl)-2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (6b) 
 
1H NMR (500 MHz, CDCl3): 8.01 (br s, 1H), 7.53 (d, 1H, J = 7.64 Hz), 
7.33 (d, 1H, J = 7.89 Hz), 7.17 (t, 1H, J = 7.40 Hz), 7.11 (d, 1H, J = 7.20 
Hz), 4.22 (d, 1H, J = 5.0 Hz), 4.11-4.06 (m, 1H), 3.81 (q, 1H, J = 6.40 
Hz), 3.73 (s, 3H), 3.66 (s, 3H), 3.29 (br s, 1H , J = 15.44 Hz), 3.20 (dd, 
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1H, J = 15.53 Hz, 6.29 Hz), 2.79-2.62 (m, 2H), 2.11-2.02 (m, 1H), 1.97-1.87 (m, 1H), 1.44 (d, 3H, 
J = 6.65 Hz), -0.1 (s, 9H); 13C NMR (75 MHz, CDCl3): 174.8, 174.7, 136.0, 133.8, 127.1, 121.5, 
119.2, 118.2, 110.7, 107.0, 88.2, 55.4, 54.8, 52.9, 51.9, 51.6, 30.7, 30.4, 21.3, 21.2, -0.3; HRMS 
(ESI) m/z (M+H)+ Calcd for C24H33N2O4Si 441.2204, found 441.2207; LRMS (M+H
+): 441.25; 
[]D25: -41.67 (c 0.84, CHCl3); Rf: 0.4 (silica gel, 30% EtOAc in hexanes). 
 
(1R,3R)-methyl-2-((S)-but-3-yn-2-yl)-1-(3-methoxy-3-oxopropyl)-2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indole-3-carboxylate (6c) 
 
1H NMR (500 MHz, CDCl3): 8.03 (br s, 1H), 7.54 (d, 1H, J = 7.69 Hz), 7.34 
(d, 1H,  J = 7.99 Hz), 7.20-7.16 (m, 1H), 7.14-7.10 (m, 1H), 4.22 (dd, 1H, J 
= 6.5 Hz, 2.60 Hz), 4.15-4.11 (m, 1H), 3.84 (qd, 1H, J = 6.88 Hz, 2.15 Hz), 
3.73 (s, 3H), 3.67 (s, 3H), 3.29 (dd, 1H, J = 15.58 Hz, 2.50 Hz), 3.21 (dd, 1H, 
J = 6.40 Hz, 1.20 Hz), 3.18 (dd, 1H, J = 6.55 Hz, 1.20 Hz), 2.81-2.73 (m, 1H), 2.67-2.59 (m, 1H), 
2.20 (d, 1H, J = 2.20 Hz), 2.12-2.04 (m, 1H), 1.94-1.86 (m, 1H), 1.45 (d, 3H, J = 6.90 Hz); 13C 
NMR (125 MHz, CDCl3): 174.8, 174.6, 136.0, 133.7, 127.0, 121.7, 119.3, 118.3, 110.8, 106.9, 
84.8, 71.9, 55.1, 54.6, 52.1, 52.0, 51.7, 30.7, 30.3, 21.3, 21.1; HRMS (ESI) m/z (M+H)+ Calcd for 
C21H25N2O4 369.1809, found 369.1815; [α]D25 = -41.97 (c 0.81, CHCl3); Rf: 0.56 (silica gel, 40% 
EtOAc in hexanes). 
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(1S,3S)-methyl 1-(3-methoxy-3-oxopropyl)-2-((R)-4-(triisopropylsilyl)but-3-yn-2-yl)-2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (29) 
 
1H NMR (500 MHz, CDCl3): 7.99 (br s, 1H), 7.51 (d, 1H, J = 7.51 Hz), 
7.31 (d, 1H, J = 7.94 Hz), 7.17-7.13 (m, 1H), 7.12-7.07 (m, 1H), 4.32 (t, 
1H, J = 5.59 Hz), 4.11-4.06 (m, 1H), 3.84 (q, 1H, J = 6.90 Hz), 3.73 (s, 
3H), 3.66 (s, 3H), 3.25 (d, 1H, J = 4.50 Hz), 2.79-2.63 (m, 2H), 2.12-2.04 (m, 1H), 1.96-1.87 (m, 
1H), 1.49 (d, 3H, J = 6.90 Hz), 0.97-0.91 (m, 21H); 13C NMR (125 MHz, CDCl3): 174.9, 174.8, 
136.1, 133.6, 127.1, 121.5, 119.2, 118.3, 110.7, 108.5, 107.0, 84.5, 55.6, 54.5, 52.7, 51.9, 51.7, 
30.7, 30.4, 21.8, 21.2, 18.5, 18.4, 11.1; HRMS (ESI) m/z (M+H)+ Calcd for C30H45N2O4Si 
525.3143, found 525.3149; []D25 = +19.53 (c 1.7, CHCl3); Rf: 0.3 (silica gel, 20% EtOAc in 
hexanes), 0.5 (silica gel, 30% EtOAc in hexanes). 
Synthesis of trans-diesters 7a-c 
 
 
 
Representative example: Procedure for the synthesis of the trans-diester 7a: The Nb-alkylated 
tryptophan 4a (200 mg, 0.47 mmol) was dissolved dry DCM (20 mL) in a 50 mL round bottom 
flask equipped with a magnetic stir. To the above solution, the aldehyde 5 (82 mg, 0.70 mmol) and 
trifluoroacetic acid (160 mg, 1.41 mmol), as well as 4 Å MS (95 mg) was added at rt. The reaction 
solution, which resulted, was stirred at rt for12 h. After complete consumption of the SM as 
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indicated by TLC on silica gel (UV and CAN stain) and LRMS analysis, the reaction mixture was 
diluted with DCM (30 mL) and water (10 mL), as well as brought to pH 8-9 with cold aq NaOH 
(1 N). The organic layer was washed with water (10 mL), brine (2 x 30 mL) and dried (Na2SO4). 
The solvent was removed under reduced pressure to give 7a as a light yellow oil. The residue 
(LRMS M+H+ = 525, Rf = 0.7, silica gel, 30% EtOAc in hexanes) was purified by column 
chromatography (silica gel, 10-15% EtOAc in hexanes) to furnish pure trans-diester 7a (214 mg, 
87%) as a colorless oil. 
By following the same procedure, trans-diesters 7b (80%) and 7c (90%) were synthesized.  
 
(1S,3R)-Methyl-1-(3-methoxy-3-oxopropyl)-2-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (7a) 
 
1H NMR (300 MHz, CDCl3): δ 7.92 (brs, 1H), 7.45 (d, 1H, J = 7.6 Hz), 
7.27 (d, 1H, J = 7.9 Hz), 7.15-7.02 (m, 2H), 4.17 (dd, 1H, J = 9.7 Hz, 3.7 
Hz), 4.05 (dd, 1H, J = 10.0 Hz, 4.3 Hz), 3.82 (q, 1H, J = 7.0 Hz, 
overlapped), 3.80 (s, 3H), 3.73 (s, 3H), 3.29-3.18 (m, 1H), 3.01 (dd, 1H, J 
= 15.5 Hz, 4.2 Hz), 2.73-2.50 (m, 2H), 2.23-2.10 (m, 1H), 2.08-1.92 (m, 1H), 1.39 (d, 3H, J = 6.9 
Hz), 0.08-0.71 (m, 18H), 0.62-0.48 (m, 3H). The spectral data were in excellent agreement with 
the published values.49  
 
(1S,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((S)-4-(trimethylsilyl)but-3-yn-2-yl)-2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (7b) 
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1H NMR (500 MHz, CDCl3): 7.94 (br s, 1H), 7.49 (d, 1H, J = 7.69 Hz), 
7.32 (d, 1H, J = 7.99 Hz), 7.14 (t, 1H, J = 7.37 Hz), 7.09 (t, 1H, J = 7.35 
Hz), 4.13-4.05 (m, 2H), 3.81 (s, 3H), 3.77 (q, 1H, J = 6.90 Hz, overlapped 
with CO2Me methyl peaks), 3.75 (s, 3H), 3.26-3.18 (m, 1H), 3.02 (dd, 
1H, J = 15.49 Hz, 3.90 Hz), 2.72-2.64 (m, 1H), 2.62-2.54 (m, 1H), 2.19-2.10 (m, 1H), 2.08-1.98 
(m, 1H), 1.35 (d, 3H, J = 6.90 Hz), -0.38 (s, 9H); 13C NMR (75 MHz, CDCl3): 174.4, 173.1, 136.1, 
135.4, 126.9, 121.5, 119.3, 118.1, 110.6, 109.1, 106.9, 87.4, 57.5, 52.4, 52.0, 51.7, 45.8, 30.7, 29.6, 
22.3, 21.5, -0.8; HRMS: (ESI) m/z (M+H)+ Calcd for C24H33N2O4Si 441.2204, found 441.2210; 
LRMS (M+H+): 441.30; []D25: -77.61 (c 0.67, CHCl3); Rf: 0.5 (silica gel, 30% EtOAc in 
hexanes). 
 
(1S,3R)-Methyl 2-((S)-but-3-yn-2-yl)-1-(3-methoxy-3-oxopropyl)-2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indole-3-carboxylate (7c) 
 
1H NMR (300 MHz, CDCl3): 7.95 (br s, 1H), 7.51 (d, 1H, J = 7.35 Hz), 7.33 
(d, 1H, J = 7.68 Hz), 7.21-7.10 (m, 2H), 4.27-4.19 (m, 1H), 4.13-4.05 (m, 
1H), 3.88-3.80 (m, 1H, overlapped), 3.78 (s, 3H), 3.72 (s, 3H), 3.26-3.13 (m, 
1H), 3.08-2.98 (m, 1H), 2.72-2.59 (m, 1H), 2.56-2.44 (m, 1H), 2.25-2.11 (m, 1H), 2.10-1.94 (m, 
1H), 1.80 (m, 1H), 1.38 (d, 3H, J = 6.81 Hz); 13C NMR (75 MHz, CDCl3):  δ 174.4, 173.3, 136.0, 
135.3, 126.8, 121.5, 119.3, 118.1, 110.8, 108.9, 84.7, 71.3, 57.3, 52.6, 52.0, 51.6, 45.3, 30.3, 29.5, 
22.3, 21.9; HRMS: (ESI) m/z (M+H)+ Calcd for C21H25N2O4 369.1809, found 369.1815; []D25 = 
-48.61 (c 0.72, CHCl3); Rf: 0.6 (silica gel, 40% EtOAc in hexanes), 0.5 (silica gel, 30% EtOAc in 
hexanes). 
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Procedure for the synthesis of cis-diesters with (a,b) = (S,S) or (R,R) configurations (14, 15, 
and 31) 
 
Representative example: Synthesis of cis-diester 31 
 
By following the same procedure for the preparation 6a (see above) with amine 4g (215 mg, 0.50 
mmol), aldehyde 5 (88 mg, 0.75 mmol), acetic acid (91 mg, 1.51 mmol), and 4 Å MS (100 mg) at 
0 oC for 8 h furnished a mixture of cis- (major) and trans- (minor) diesters as mixture of products. 
After the workup as described above, the residue was subjected to silica gel column 
chromatography to provide the cis-diester 31 (185 mg, 70%) along with the trans-diester (40 mg, 
15%) in 85% combined isolated yield.   
By following the same procedure, the cis-diester 14 (443 mg, 72% along with trans-diester 15, 
172 mg, 28%) was synthesized from the amine 4d and aldehyde 5, respectively. 
(1R,3R)-methyl 1-(3-methoxy-3-oxopropyl)-2-((R)-4-(triisopropylsilyl)but-3-yn-2-yl)-
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (14) 
 
1H NMR (500 MHz, CDCl3): 7.99 (br s, 1H), 7.49 (d, 1H, J = 7.74 Hz), 
7.31-7.27 (m, 1H), 7.17-7.12 (m, 1H), 7.11-7.06 (m, 1H), 4.18-4.14 (m, 
1H), 4.04 (t, 1H, J = 4.92 Hz), 3.81 (q, 1H, J = 6.98 Hz), 3.72 (s, 3H), 3.68 
(s, 3H), 3.22 (d, J = 4.70 Hz), 2.74-2.66 (m, 1H), 2.65-2.57 (m, 1H), 2.11-2.03 (m, 1H), 1.95-1.87 
(m, 1H), 1.46 (d, 3H, J = 7.00 Hz), 0.87-0.83 (m, 18H), 0.79-0.71 (m, 3H);  13C NMR (125 MHz, 
CDCl3): 174.8, 174.0, 136.0, 134.2, 127.0, 121.4, 119.1, 118.2, 110.6, 108.1, 107.2, 84.3, 60.5, 
53.8, 51.9, 51.6, 51.3, 32.1, 30.5, 22.6, 21.7, 18.3, 11.0; HRMS: (ESI) m/z (M+H)+ Calcd for 
C30H45N2O4Si 525.3143, found 525.3142; []D25 = -0.81 (c 1.23, CHCl3); Rf: 0.57 (silica gel, 30% 
EtOAc in hexanes). 
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(1S,3R)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((R)-4-(triisopropylsilyl)but-3-yn-2-yl)-
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (15) 
 
1H NMR (500 MHz, CDCl3): 8.03 (br s, 1H), 7.16 (d, 1H, J = 7.80 Hz), 
7.34 (d, 1H, J = 7.94 Hz), 7.19-7.15 (m, 1H), 7.13-7.10 (b, 1H), 4.66-4.62 
(m, 1H), 4.16 (t, 1H, J = 5.62 Hz), 4.09 (q, 1H, J = 6.83 Hz), 3.65 (s, 3H), 
3.64 (s, 3H), 3.14-3.03 (m, 2H), 2.56-2.48 (m, 1H), 2.37-2.23 (m, 2H), 2.14-2.10 (m, 1H), 1.42 (d, 
3H, J = 6.85 Hz), 1.12-1.03 (m, 21H); 13C NMR (125 MHz, CDCl3): 174.8, 173.3, 136.2, 134.9, 
127.0, 121.5, 119.3, 118.0, 110.9, 84.9, 54.7, 53.2, 51.6, 51.4, 46.8, 29.1, 28.4, 24.8, 21.9, 18.6, 
18.6, 11.3; HRMS (ESI) m/z (M+H)+ Calcd for C30H45N2O4Si 525.3143, found 525.3139; []D25 
= +5.0 (c 1.2, CHCl3); Rf: 0.7 (silica gel, 30% EtOAc in hexanes).  
 
(1S,3S)-Methyl 1-(3-methoxy-3-oxopropyl)-2-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (31) 
 
1H NMR (500 MHz, CDCl3): 8.02 (br s, 1H), 7.49 (d, 1H, J = 7.64 Hz), 
7.30 (d, 1H, J = 4.30 Hz), 7.16-7.12 (m, 1H), 7.11-7.06 (m, 1H), 4.18-
4.14 (m, 1H), 4.05 (t, 1H, J = 4.92 Hz), 3.81 (q, 1H, J = 6.91 Hz), 3.72 
(s, 3H), 3.68 (s, 3H), 3.23 (d, 1H, J = 4.80 Hz), 2.74-2.58 (m, 2H), 2.11-
2.03 (m, 1H), 1.96-1.86 (m, 1H), 1.46 (d, 3H, J = 6.95 Hz), 0.88-0.82 (m, 18H), 0.80-0.71 (m, 
3H); 13C NMR (125 MHz, CDCl3): 174.8, 174.1, 136.5, 134.2, 127.0, 121.4, 119.1, 118.2, 110.6, 
108.1, 107.2, 84.3, 60.5, 53.8, 51.9, 51.6, 51.4, 32.1, 30.5, 22.6, 21.7, 18.3, 18.3, 11.0; HRMS 
(ESI) m/z (M+H)+ Calcd for C30H45N2O4Si 525.3143, found 525.3148; []D25 = +1.2 (c 0.8, 
CHCl3); Rf: 0.5 (silica gel, 30% EtOAc in hexanes). 
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Procedue for the conversion of cis-diesters into their corresponding trans-diesters 
 
 
To a solution of pure cis-diester (0.1 mmol) in dry DCM (5 mL) and TFA (0.2) was added at 0 oC 
and the mixture, which resulted, was stirred at rt until the cis-diester was completely converted 
into the corresponding trans-diester as indicated by TLC on silica gel (UV and CAN stain). After 
that, the reaction mixture was diluted with additional DCM and water and then carefully brought 
to pH 8-9 with cold aq NaOH (1 N). The organic layer was separated and washed with water, brine 
and dried (Na2SO4). The solvent was removed under reduced pressure to provide a light yellow 
residue, which was subjected to silica gel column chromatographic purification to provide the 
correspnonding trans-diester as a colorless oil.  
The cis-diesters with (a,b) = (S, R) or (R, S) configurations were completely converted into their 
corresponding trans-diester diastereomers in 2-4 hours whereas, the cis-diesters with (a, b) = (S, 
S) or (R, R) configurations took up to 20 hours to be converted into the corresponding trans-
diastereomers.  
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Procedure for the Dieckmann cyclization: 
 
 
Representative example: Procedure for the synthesis of 30: The cis-diester 31 (616 mg, 1.17 
mmol) was dissolved in toluene (50 mL). This solution was dried by azeotropic removal of H2O 
with toluene by a DST (refluxed 6 h). To this solution was added sodium hydride (141 mg, 3.52 
mmol of 60% dispersion in mineral oil) at 0 ˚C. Anhydrous CH3OH (285 μL, 7.0 mmol) was then 
added into the above mixture under Ar at 0 ˚C. The solution, which resulted, was then stirred at rt 
for 0.5 h and then held at reflux for an additional 60 h (the flask was covered with aluminum foil 
on the top to keep the temperature at reflux without carbonizing any compound on the sides of the 
flask). The reaction was quenched then with ice. The aq layer was extracted with CH2Cl2 (3 x 20 
mL). The combined organic extracts were washed with brine and dried (K2CO3). The solvent was 
removed under reduced pressure to provide the crude product (LRMS M+H+ = 493.40) as a light 
brown residue. The residue was purified by flash chromatography (silica gel, EtOAc/hexane) to 
provide the β-ketoester 30 (491 mg, 85%) as a colorless oil. 
By following the same procedure with the cis-diester 29 (300 mg, 0.57 mmol), this furnished the 
β-ketoester 28 (231 mg, 82%). 
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(6S,10S)-Methyl 9-hydroxy-12-((R)-4-(triisopropylsilyl)but-3-yn-2-yl)-6,7,10,11-tetrahydro-
5H-6,10-epiminocycloocta[b]indole-8-carboxylate (28) 
 
1H NMR, (500 MHz, CDCl3): 11.98 (s, 1H), 7.73 (br s , 1H), 7.52 (d, 
1H, J = 7.74 Hz), 7.34 (d, 1H, J = 7.80 Hz), 7.21-7.17 (m, 1H), 7.16-
7.11 (m, 1H), 4.49 (d, 1H, J = 5.20 Hz), 4.39 (d, 1H, J = 6.65 Hz), 
3.70 (s, 3H), 3.64 (q, 1H, J = 6.33 Hz), 3.37 (dd, 1H, J = 16.09 Hz, 
5.90 Hz), 2.97 (br d, 1H, J = 16.79 Hz), 2.95-2.89 (m, 1H), 2.43 (d, 1H, J = 15.74 Hz), 1.50 (d, 
3H, J = 6.35 Hz), 1.13-1.05 (m, 21H); 13C NMR (125 MHz, CDCl3): 172.4,  171.4, 135.7, 132.8, 
127.0, 121.9, 119.7, 118.3, 110.8, 107.6, 107.3, 94.5, 85.4, 53.7, 51.5, 48.2, 46.7, 29.0, 22.7, 20.9, 
18.7, 11.2; HRMS (ESI) m/z (M+H)+ Calcd for C29H41N2O3Si 493.2881, found 493.2888; [α]D25 
= +32.86 (c 0.7, CHCl3); Rf: 0.52 (silica gel, 30% EtOAc in hexanes). 
(6S,10S)-Methyl 9-hydroxy-12-((S)-4-(triisopropylsilyl)but-3-yn-2-yl)-6,7,10,11-tetrahydro-
5H-6,10-epiminocycloocta[b]indole-8-carboxylate (30) 
 
1H NMR (500 MHz, CDCl3): 12.00 (s, 1H), 7.75 (br s, 1H), 7.49 (d, 
1H, J = 7.64 Hz), 7.35 (d, 1H, J = 8.04 Hz), 7.20-7.16 (m, 1H), 7.14-
7.10  (m, 1H), 4.78 (br d, 1H, J = 5.04 Hz), 4.14 (d, 1H, J = 5.60 Hz), 
3.69 (s, 3H), 3.66 (q, 1H, J = 6.58 Hz), 3.09 (dd, 1H, J = 16.10 Hz, 
5.75 Hz), 2.97-2.87 (m, 2H), 2.44 (dd, 1H, J = 15.67 Hz, 1.32 Hz), 1.54 (d, 3H, J = 6.65 Hz), 1.09-
1.03 (m, 21H); 13C NMR (125 MHz, CDCl3): 172.4, 171.4, 135.7, 133.2, 127.0, 121.8, 119.7, 
118.2, 110.8, 108.7, 106.8, 94.7, 84.4, 52.5, 51.5, 49.4, 47.3, 29.2, 21.7, 20.5, 18.6, 11.2; HRMS 
(ESI) m/z (M+H)+ Calcd for C29H41N2O3Si 493.2881, found 493.2885;  [α]D25  = -120.0 (c 0.5, 
CHCl3); Rf: 0.6 (silica gel, 30% EtOAc in hexanes). 
 
150 
 
5. References 
 
 (1) Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797. 
 (2) Dalpozzo, R. Molecules 2016, 21, 699. 
 (3) Ingallina, C.; D'Acquarica, I.; Delle Monache, G.; Ghirga, F.; Quaglio, D.; 
Ghirga, P.; Berardozzi, S.; Markovic, V.; Botta, B. Curr. Pharm. Des. 2016, 22, 1808. 
 (4) Larghi, E. L.; Amongero, M.; Bracca, A. B.; Kaufman, T. S. ARKIVOC 2005, 12. 
 (5) Rao, R. N.; Maiti, B.; Chanda, K. ACS Comb. Sci. 2017, 19, 199. 
 (6) Stöckigt, J.; Antonchick, A. P.; Wu, F.; Waldmann, H. Angew. Chem. Int. Ed. 
2011, 50, 8538. 
 (7) Cox, E. D.; Hamaker, L. K.; Li, J.; Yu, P.; Czerwinski, K. M.; Deng, L.; Bennett, 
D. W.; Cook, J. M.; Watson, W. H.; Krawiec, M. J. Org. Chem. 1997, 62, 44. 
 (8) Deng, L.; Czerwinski, K.; Cook, J. M. Tetrahedron letters 1991, 32, 175. 
 (9) Soerens, D.; Sandrin, J.; Ungemach, F.; Mokry, P.; Wu, G.; Yamanaka, E.; 
Hutchins, L.; DiPierro, M.; Cook, J. J. Org. Chem. 1979, 44, 535. 
 (10) Ungemach, F.; DiPierro, M.; Weber, R.; Cook, J. J. Org. Chem. 1981, 46, 164. 
 (11) Klausen, R. S.; Jacobsen, E. N. Org. Lett. 2009, 11, 887. 
 (12) Raheem, I. T.; Thiara, P. S.; Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 
2007, 129, 13404. 
 (13) Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558. 
 (14) Kawate, T.; Yamada, H.; Soe, T.; Nakagawa, M. Tetrahedron: Asymmetry 1996, 
7, 1249. 
 (15) Soe, T.; Kawate, T.; Fukui, N.; Hino, T.; Nakagawa, M. Heterocycles 1996, 42, 
347. 
151 
 
 (16) Alberch, L.; Bailey, P. D.; Clingan, P. D.; Mills, T. J.; Price, R. A.; Pritchard, R. 
G. Eur. J. Org. Chem. 2004, 2004, 1887. 
 (17) Bailey, P. D.; Beard, M. A.; Phillips, T. R. Tetrahedron Lett. 2009, 50, 3645. 
 (18) Bailey, P. D.; Clingan, P. D.; Mills, T. J.; Price, R. A.; Pritchard, R. G. Chem. 
Commun. 2003, 2800. 
 (19) Pulka, K.; Kulis, P.; Tymecka, D.; Frankiewicz, L.; Wilczek, M.; Kozminski, W.; 
Misicka, A. Tetrahedron 2008, 64, 1506. 
 (20) Pulka, K.; Misicka, A. Tetrahedron 2011, 67, 1955. 
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Chapter 3 
Access to the (+)- or (-)-Enantiomers of the Bioactive C-19 Methyl Substituted 
Sarpagine/Macroline/Ajmaline Alkaloids from Either D- or L-Tryptophan via 
the Ambidextrous Pictet-Spengler Reaction 
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1. Introduction 
An important and useful application of the ambidextrous Pictet-Spengler cyclization would be 
accessing the key bicyclo[3.3.1] framework of the sarpagine/ajmaline-related indole alkaloids in a 
convergent fashion from either of the starting chiral auxiliaries D- or L-tryptophan. Depicted in 
the following work is the proof of concept, which is important to illustrate the full potential of the 
ambidextrous Pictet-Spengler (P-S) reaction. Previously, both D-tryptophan and L-tryptophan 
were employed to synthesize the key intermediates toward the natural enantiomers of alkaloids. 
Now the enantiomeric series of the same key intermediates could also be synthesized from both 
D- and L-tryptophan in high yield and optical purity via this P-S/Dieckmann protocol. One can 
either make the natural or unnatural alkaloids from the either of the starting amino acid ester, stereo 
and enantiospecifically. 
Natural products have been an important source of useful drug candidates and as a result natural 
products, as well as compounds derived from or inspired by natural products, play an important 
role in modern drug discovery.1-5 Many compounds with direct natural origin (e.g., reserpine, 
paclitaxel, vinblastine, vincristine, morphine, quinine, and vancomycin) or derived from natural 
products (synthetic analogs) have successfully entered clinical practice and have saved millions of 
lives.6,7 Generally, from a medicinal chemistry point of view, synthetic analogs which are inspired 
by natural scaffolds, exhibit potential, clinically, because many natural products (especially 
alkaloids) possess drug-like properties.8,9 More importantly, their enantiomers, if active will 
normally have a longer duration of action. For example, the life saving anti HIV drug emtricitabine 
was derived from the unnatural L-nucleoside, which was about 100 times more potent than its 
natural D-nucleoside counterpart.10 Furthermore, rationally designed synthetic analogs of natural 
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products have resulted in drug-candidates with superior properties than the native compounds (e.g., 
bryostatin and vinblastine analogs).11,12 In this regard, the unnatural enantiomers of natural 
alkaloids may have important biological properties or even better properties depending on the rate 
of metabolism. 
The C-19 methyl substituted sarpagine/macroline/ajmaline alkaloids are an emerging group of 
structurally and biosynthetically related alkaloids as pointed out in an earlier chapter.13-15 To date, 
there are more than seventy alkaloids that belong to this group.16 About two dozen of these 
alkaloids have been shown to possess important biological activity including antileishmanial, anti-
hypertensive, anti-inflammatory, antimicrobial, and anticancer activity (see General Introdu-
ction).16 Some selected examples (1-12) of bioactive C-19 methyl substituted alkaloids of this 
group are depicted in Figure 1. All of the alkaloids in this group contain the cis-fused (S, S) 
stereochemistry at C-3 and C-5 of the core-structure (C-1 and C-3 of the tetrahydro-β-carboline, 
THβC moiety). Bioactive alkaloids from this group belong to the sarpagine-type, macroline-type 
and ajmaline-type natural products. The structural complexity and important biological activity 
engender this group of alkaloids as an attractive target for synthetic and medicinal chemistry 
studies.  A general strategy for accessing most of the alkaloids (if not all) via a few common 
precursors would be a practical approach to gain entry into these natural products. In addition, 
biological screening of the unnatural enantiomers of the natural alkaloids, which may have useful 
and important bioactivity, is feasible only if a practical and robust synthetic strategy is developed. 
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Furthermore, providing both the natural and unnatural enantiomers of these alkaloids via the same 
route and from the same chiral pool is undoubtedly a better strategy. 
The Asymmetric Pictet-Spengler cyclization has been one of the most effective processes to gain 
access to many natural products containing the THβC and tetrahydroisoquinoline moieties.17-25 In 
the continued effort to develop a practical, enantiospecific, and general strategy for accessing the 
C-19 methyl substituted alkaloids, more than a dozen of these alkaloids have been successfully 
synthesized enantiospecifically (the natural enantiomer) from this subgroup. Some of these exhibit 
important bioactivity as stated earlier (see General Introduction). The asymmetric Pictet-Spengler 
reaction has been employed as one of the key transformations in the total synthesis of these 
alkaloids.26-30 Recently, a shorter and better route to the key tetracyclic-core, which contains the 
azabicyclo[3.3.1]nonane moiety (18-23), has improved the access to a number of alkaloids from 
this group (Figure 2, entry 1).27 Afterwards, the discovery of the unprecedented ambidextrous 
diastereoselectivity in the key asymmetric transformation of the Pictet-Spengler cyclization (P-S), 
permitted access to the crucial and common intermediates (15-17), stereospecifically, from D- as 
well as from L-tryptophan, at will (Figure 2, entry 1).26 The intermediates 15-23 served as the 
common branching point for the synthesis of the majority of the alkaloids in this group.26,27,29,30  
Gratifyingly, the useful cis-specificity (or selectivity) also has enabled one to access the 
enantiomers of the important intermediates from the same starting material, D-tryptophan, as well 
as L-tryptophan, when desired (Figure 2, entry 2). Herein is reported the synthesis of the 
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enantiomers (24-32) of the key-intermediates 15-23 from both L- or D-tryptophan. This provides 
a practical and scalable strategy for accessing the unnatural enantiomers of the bioactive alkaloids 
from this group for biological studies beginning with either of the chiral auxiliaries (L- or D-
tryptophan), which were employed earlier for the natural enantiomers. 
 
Figure 1. Representative examples of bioactive C-19 methyl substituted sarpagine/macroline-
/ajmaline alkaloids.13,15,16,31-40  
 
 
2. Results and Discussion 
      
As depicted in Scheme 1, the (R, R, S) intermediates 26, 31, and 32 were synthesized starting from 
the Nb-ethynyl substituted D-tryptophan derivative 33. A cis-specific P-S reaction, according to 
the previous report,26 provided the cis-diester 35 with 100% diastereoselectivity and 83% isolated 
yield on a 1.7 g scale. This cis-specific P-S cyclization secured the desired unnatural stereocenters 
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(R, R) within the tetrahydro-β-carboline (THβC) framework. The (R, R, S)-THβC intermediate 35 
was subjected to the Dieckmann cyclization conditions in a DST-dried solution of toluene and in 
the presence of sodium methoxide to furnish the β-ketoester 26 in 81% isolated yield. Importantly, 
the β-ketoester 26 could also be accessed easily from the L-tryptophan derivative 39 via the trans-
specific P-S reaction to provide the (R, S, S)-THβC intermediate 40 as the sole product. The 
reaction mixture from the initial acetic acid mediated P-S reaction was subjected to a rapid wash 
column and treated with trifluoroacetic acid in methylene chloride to give the thermodynamically 
more stable trans (at C-1) product 40 (see Scheme 1 for details). The subsequent Dieckmann 
cyclization of the THβC 40 furnished the β-ketoester in excellent yield. This provided the desired 
β-ketoester from both the L-tryptophan and D-tryptophan derivatives 39 and 33, respectively. An 
acid mediated decarboxylation of the β-ketoester 26 provided the ketone 31 in 78% yield. The 
subsequent removal of the TIPS function with TBAF in THF provided the terminal alkyne 32 in 
excellent yield. This series of intermediates 26, 31, and 32 are the enantiomers of the intermediates 
17, 22, and 23, respectively, which were previously synthesized from the same starting material 
33 (see Appendix G for NMR comparisons of the enantiomeric pairs).26,27 These intermediates are 
the key bicyclo[3.3.1] systems required for the total synthesis of the unnatural enantiomers of the 
sarpagine/macroline/ajmaline alkaloids of Figure 1 with the Na-H, C-3(R), C-5(R), and C-19(S) 
stereochemical configurations. 
On the other hand, the (R, R, R) intermediates in either the Na-H or Na-CH3 series (24-25, 27-30) 
were synthesized from the corresponding Nb-ethynyl substituted D-tryptophan derivative 36, 
26,27 
as shown in Scheme 2. The Pictet-Spengler reaction, Na-methylation, Dieckmann cyclization, 
decarboxylation, and TIPS deprotection went smoothly to furnish the desired intermediates in good 
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to excellent yields (Scheme 2). In this case as well, the β-ketoester 24 could be easily prepared via 
the trans- 
 
Figure 2. Access to both the natural and unnatural series of intermediates from D- and L-
tryptophan 
 
 
specific P-S reaction of the L-tryptophan derivative 41 to furnish the (R, S, R)-THβC 42 as the sole 
product (85% isolated yield), following the procedure descibed above. The THβC intermediate 42, 
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upon Dieckmann cyclization, furnished the Na-H (R, R, R) β-ketoester 24 in 80% isolated yield. 
This convergent approach provided access to the (R, R, R) β-ketoesters (24 and 25) from both L-
tryptophan or D-tryptophan derivatives 41 and 36, respectively.   The Na-H or Na-CH3 intermedi-
ates with the (R, R, R) configurations 24, 25, 27, 28, 29, and 30 are the enantiomers of 15, 16, 18, 
20, 19, and 21, respectively, which were previously synthesized from the D-tryptophan derivative 
36.26,27 These intermediates (24-25, 27-30) are the key precursors for the total synthesis of the 
unnatural enantiomers of the sarpagine/macroline/ajmaline alkaloids with Na-H (or CH3), C-3(R), 
C-5(R), and C-19(R) stereochemical centers. 
 
Scheme 1. Access to the (R, R, S) intermediates 26, 31, and 32 toward the unnatural enantiomers 
of C-19 (S)-methyl substituted sarpagine/macroline/ajmaline alkaloids. 
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At this point, an extensive comparison between the enatiomeric pairs (24 vs 15), (25 vs 16), (26 
vs 17), (27 vs 18), (29 vs 19), (28 vs 20), (30 vs 21), (31 vs 22), and (32 vs 23) was performed (see 
Table 1 for details) as proof of concept. As expected, the MS, Rf and NMR (both 1H and 13C) were 
identical for all enantiomeric pairs (see Appendix G for the NMR comparisons). The specific 
optical rotations for all enantiomeric pairs were also found to exhibit the opposite values, as 
expected and in good agreement within experimental error (JASCO polarimeter).     
 
Scheme 2. Access to the (R, R, R) intermediates (24, 25, 27, 28, 29, and 30) toward the unnatural 
enantiomers of C-19 (R)-methyl substituted sarpagine/macroline/ajmaline alkaloids 
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Table 1. Comparison of optical rotations between the natural and unnatural enantiomers of the key 
intermediates towards C-19 methyl substituted sarpagine/macroline/ajmaline alkaloids 
 
[a] = 30% EtOAc in hexanes; [b] = 15% EtOAc in hexanes; [c] = 30% EtOAc in hexanes+NH4OH; [d] = 
see Appendix G for comparison between 1H and 13C NMR spectra for all enantiomeric pairs 
 
 
3. Conclusion 
 
In summary, a series of crucial precursors with the unnatural (R, R, R) and (R, R, S) configurations 
with either the Na-H or Na-CH3 patterns of substitution were accessed enantiospecifically from 
both L- or D-tryptophan which also served as the chiral auxiliary and starting material for the 
natural (S, S, R) and (S, S, S) series. This work confirms the proof of concept for the synthesis of 
the (+) or (-) enantiomers of these alkaloids from either the chiral auxiliary (L- or D-tryptophan) 
enantiomeric 
pairs 
compound comparison among properties 
 
[α]D25 Rf 
co-elution TLC 
1H and 13C NMR 
comparisond 
natural 
unnatural 
15; [Na-H (S,S,S)-enol-TIPS] -120.00 
0.8a 
Identical NMR 
15 vs 24 24; [Na-H (R,R,R)-enol-TIPS] +118.80 
natural 
unnatural 
16; [Na-Me (S,S,S)-enol-TIPS] -149.90 
0.8a 
Identical NMR 
16 vs 25 25; [Na-Me (R,R,R)-enol-TIPS] +143.20 
natural 
unnatural 
17; [Na-H (S,S,R)-enol-TIPS] +32.86 
0.7a 
Identical NMR 
17 vs 26 26; [Na-H (R,R,S)-enol-TIPS] -32.31 
natural 
unnatural 
18; [Na-H (S,S,S)-ketone-TIPS] -166.67 
0.7a 
Identical NMR 
18 vs 27 27; [Na-H (R,R,R)-ketone-TIPS] +161.67  
natural 
unnatural 
19; [Na-Me (S,S,S)-ketone-TIPS] -166.83 
0.6b 
Identical NMR 
19 vs 29 29; [Na-Me (R,R,R)-ketone-TIPS] +170.59 
natural 
unnatural 
20; [Na-H (S,S,S)-ketone-alkyne] -149.00 
0.4c 
Identical NMR 
20 vs 28 28; [Na-H (R,R,R)-ketone-alkyne] +154.78 
natural 
unnatural 
21; [Na-Me (S,S,S)-ketone-alkyne] -191.30 
0.5c 
Identical NMR 
21 vs 30 30; [Na-Me (R,R,R)-ketone-alkyne] +188.89 
natural 
unnatural 
22; [Na-H (S,S,R)-ketone-TIPS] -2.38 
0.5a 
Identical NMR 
22 vs 31 31; [Na-H (R,R,S)-ketone-TIPS] +3.99 
natural 
unnatural 
23; [Na-H (S,S,R)-ketone-alkyne] -48.25 
0.2c 
Identical NMR 
23 vs 32 32; [Na-H (R,R,S)-ketone-alkyne] +50.85 
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via internal asymmetric induction. Furthermore, this unambiguously illustrates the capability of 
the strategy developed here for accessing both the natural and the unnatural enantiomers of the C-
19 methyl substituted sarpagine/macroline/ajmaline alkaloids from the same precursor(s). The 
completion of the total synthesis of the unnatural enantiomers is in progress and will be reported 
in due course.    
 
4. Experimental Section 
 
General Experimental Considerations  
 
All reactions were carried out under an argon atmosphere with dry solvents using anhydrous 
conditions unless mentioned otherwise. The solvents (THF, DMF, toluene, DCM, MeCN, and 
MeOH) were dried using an Innovative Technology Solvent Purification System, Pure SolvTM. 
Occasionally, tetrahydrofuran was freshly distilled from Na/benzophenone ketyl prior to use. 
Dichloromethane was distilled from calcium hydride prior to use. Methanol was distilled over 
magnesium sulfate. Benzene was distilled over CaH2. Reagents were purchased of the highest 
commercial quality and used without further purification unless otherwise stated. Thin layer 
chromatography (TLC) was performed on UV active silica gel plates, 200 μm, aluminum backed 
and UV active alumina N plates, 200 μm, F-254 aluminum backed plates. Flash and gravity 
chromateography were performed using silica gel P60A, 40-63 μm, basic alumina (Act I, 50-200 
μm) and neutral alumina (Brockman I, ~150 mesh). TLC plates were visualized by exposure to 
short wavelength UV light (254 nm). Indoles were visualized with a saturated solution of ceric 
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ammonium nitrate (CAN) in 50% phosphoric acid. The 1H NMR data are reported as follows: 
chemical shift, multiplicity (br s = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, 
quin = quintet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of 
doublets, td = triplet of doublets, qd = quartet of doublets, m = multiplet), integration, and coupling 
constants (Hz). The 13C NMR data are reported in parts per million (ppm) on the δ scale. The low-
resolution mass spectra (LRMS) were obtained as electron impact (EI, 70eV) and as chemical 
ionization (CI) using a magnetic sector (EBE) analyzer. HRMS were recorded by electrospray 
ionization (ESI) using a TOF analyzer, electron impact (EI) using a trisector analyzer and 
Atmospheric Pressure Chemical Ionization (APCI) using a TOF analyzer. Optical rotations were 
measured on a JASCO Model DIP-370 polarimeter. 
 
Procedures 
Procedure for the Pictet-Spengler (P-S) Cyclization 
 
Compounds 35 and 37 were prepared from 33 and 36, respectively following the previously 
reported procedures.26,27  
 
Representative example, 35: The Nb-alkylated tryptophan 33 (1.5 g, 3.51 mmol) was dissolved 
in dry DCM (50 mL) in a 100 mL round bottom flask equipped with a magnetic stir. To that above 
solution, the aldehyde41 34 (612 mg, 5.27 mmol) and acetic acid (633 mg, 10.55 mmol, 603 μL), 
as well as 4 Å MS (0.7 g) were added at rt. The solution, which resulted, was stirred at rt for 10 h. 
The progress of the reaction was monitored by TLC analysis, as indicated by the consumption of 
33 and appearance of a non-polar spot (UV and CAN stain). The reaction mixture was diluted with 
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DCM (50 mL) and water (50 mL) and then brought to pH 8-9 with cold aq NaOH (1 N). The 
organic layer was separated and washed with water (2 x 50 mL), brine (3 x 100 mL) and dried 
(Na2SO4). The solvent was removed under reduced pressure to give 35 as a light yellow-colored 
oil. The residue [LRMS (M+H)+ = 525, Rf = silica gel, 0.3 in 20% EtOAc in hexanes+NH4OH)] 
was purified by column chromatography (silica gel, 10-20% EtOAc in hexanes) to furnish the pure 
cis-diester 35 (1.52 g, 83%) as a colorless oil as the sole product.  
By following the same procedure, the cis-diesters 37 [LRMS (M+H)+ = 525; Rf = silica gel, 0.6, 
30% EtOAc in hexanes)] (1.72 g, 70% along with 0.73 g 30% of the corresponding trans-diester 
[Rf = 0.7 in 30% EtOAc in hexanes], which resulted in a quantitative overall isolated yield) was 
prepared from 3626,27 (2.0 g, 4.69 mmol). Both 35 and 37 were used for the next transformation 
without further characterization. 
 
 
Procedure for the trans-Specific Pictet-Spengler Cyclization 
 
Indoles 40 and 42 were prepared from 39 and 41, respectively according to the previously 
published procedure.26,27  
 
Representative example, 42: The Nb-alkylated tryptophan 41 (1.0 g, 2.34 mmol) was dissolved 
in dry DCM (40 mL) in a 100 mL round bottom flask equipped with a magnetic stir. To that above 
solution, the aldehyde 34 (408 mg, 3.51 mmol) and acetic acid (422 mg, 7.03 mmol, 402 μL), as 
well as 4 Å MS (0.5 g) were added at rt. The solution, which resulted, was stirred at rt for 10 h. 
The progress of the reaction was monitored by TLC analysis (silica gel), as indicated by the 
consumption of 41 and appearance of a non-polar spot (UV and CAN stain). The reaction mixture 
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was diluted with DCM (50 mL) and water (50 mL) and then brought to pH 8-9 with cold aq NaOH 
(1 N). The organic layer was separated and washed with water (2 x 50 mL), brine (3 x 100 mL) 
and dried (Na2SO4). The solvent was removed under reduced pressure to give a light yellow oil. 
The residue was subjected to a short wash column (silica gel) to remove any baseline material. The 
solvent was removed under reduced pressure and the residue, which resulted, was dissolved in dry 
DCM (30 mL). To that above solution, trifluoroacetic acid was added (267 mg, 2.34 mmol, 180 
μL) at rt and the reaction, which resulted, was stirred at rt until complete conversion. After the 
reaction was complete, the reaction was brought to pH 8-9 with cold aq NaOH (1 N). The organic 
layer was separated and the aq layer was extracted with additional DCM (2 x 10 mL). The 
combined organic layers were washed with brine (3 x 100 mL) and dried (Na2SO4). The solvent 
was removed under reduced pressure to give a light yellow oil which was purified by column 
chromatography (silica gel, 0-20% EtOAc in hexanes) to furnish pure trans-diester 42 (1.05 g, 
85%) as a colorless oil as the sole product [LRMS (M+H)+ = 525].  
By following the same procedure with the 39 (1.0 g, 2.34 mmol), this process furnished the trans-
diester 40, [LRMS (M+H)+ = 525] (1.06 g, 86%) as the sole product. 
 
Procedure for the Na-Methylation 
 
Procedure for the preparation of 38 from 37 
 
To a round-bottom flask (50 mL), which was equipped with a reflux condenser, the  Na-H cis-
diester 37 (727 mg, 1.38 mmol), CH3I (95 μL, 1.52 mmol), and dry DMF (10 mL) were added and 
then the mixture was cooled to -10 °C. To this solution was added NaH (60% dispersion in mineral 
oil, 61 mg, 1.52 mmol) at -10 °C. The slurry, which resulted, was allowed to stir at rt for 2 h until 
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analysis by TLC indicated the disappearance of 37 and appearance of 38 [LRMS (M+H)+ = 540]. 
The reaction solution was quenched by careful addition of CH3OH (0.5 mL) and then was 
neutralized with an aq solution of NH4Cl (20 mL) and extracted with EtOAc (3 x 30 mL). The 
combined organic layers were washed with brine (3 x 100 mL) and dried (K2CO3). The solvent 
was removed under reduced pressure and the residue was subjected to a short wash column (silica 
gel, 20% EtOAc in hexane) to provide the Na-CH3-(R, R, R)-diester 38 (688 mg, 92%) as a colorless 
oil. 
 
Procedure for the Dieckmann cyclization 
 
Representative example, 26: The cis-diester 35 (1.5 g, 2.86 mmol) was dissolved in toluene (150 
mL). This solution was dried by azeotropic removal of H2O by toluene with a DST (refluxed 6 h). 
To this mixture sodium hydride (687 mg, 17.1 mmol of 60% dispersion in mineral oil) at 0 °C was 
added. Anhydrous CH3OH (2.1 mL, 51.4 mmol) was then added into the above mixture under Ar 
at 0 °C. The solution, which resulted, was then stirred at rt for 0.5 h and then held at reflux for an 
additional 30 h (the flask was covered with aluminum foil on the top to keep the temperature at 
reflux without carbonizing any compound on the sides of the flask). The reaction mixture was 
cooled to rt and quenched with ice (~50 g). The aq layer was extracted with CH2Cl2 (3 x 50 mL). 
The combined organic extracts were washed with brine and dried (K2CO3). The solvent was 
removed under reduced pressure to provide the crude product [LRMS (M+H)+ = 494] as a light 
brown residue. The residue was purified by flash chromatography (silica gel, EtOAc/hexane) to 
provide the β-ketoester 26 (1.14 g, 81%) as a colorless oil.  
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By following the same procedure with the cis-diester 37 (1.0 g, 1.90 mmol), this process furnished 
the β-ketoester 24, [LRMS (M+H)+ = 494] (713 mg, 76%). The same process with the cis-diester 
38 (300 mg, 0.56 mmol) furnished the β-ketoester 25, [LRMS (M+H)+ = 508] (217 mg, 77%). 
When this process was carried out with the trans-diester 40 (400 mg, 0.76 mmol), this furnished 
the β-ketoester 26, [LRMS (M+H)+  = 493] (312 mg, 83%); with trans-diester 42 (500 mg, 0.95 
mmol), this reaction furnished the β-ketoester 24 [LRMS (M+H)+ = 493] (375 mg, 80%). 
 
Procedure for the acid mediated decarboxylation reaction 
 
Representative example, 31: To a round bottom flask (100 mL), which contained the Na-H (R, R, 
S)-β-ketoester 26 (675 mg, 1.37 mmol), was added glacial acetic acid (2.6 mL), aq HCl (3.8 mL, 
conc.) and water (1 mL) with stirring (magnetic stir). The solution, which resulted, was heated at 
reflux for 20 h. After removal of the solvent under reduced pressure, the residue was brought to 
pH = 9 with a cold aq solution of NaOH (3 N). The mixture, which resulted, was extracted with 
CH2Cl2 (3 x 50 mL) and the combined organic extracts were washed with a saturated aq solution 
of NH4Cl (50 mL), brine (3 x 50 mL) and dried (K2CO3). The removal of the solvent under reduced 
pressure afforded the ketone 31 as a brown oil. The residue was purified by column 
chromatography (silica gel, 20% EtOAc in hexanes) to provide pure 31 [LRMS (M+H)+ = 435] as 
a colorless oil (465 mg, 78%). 
By following the same procedure with the β-ketoester 24 (386 mg, 0.78 mmol), this procedure 
furnished the ketone 27 [LRMS (M+H)+ = 435; 273 mg, 80%] and with the β-ketoester 25 (96 mg, 
0.19 mmol), this process furnished the ketone 29 [LRMS (M+H)+ = 450; 70 mg, 82%]. 
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Procedure for the de-silylation 
 
Representative example, 32: To a solution of 31 (50 mg, 0.11 mmol) in THF (5 mL), TBAF (167 
μL, 0.167 mmol, 1.0 M solution in THF) was added at 0 oC. The solution, which resulted, was 
stirred at 0 oC for 30 min or until the completion of the reaction as monitored by TLC (silica gel). 
After that, the reaction mixture was diluted with EtOAc (20 mL) and water (10 mL). The organic 
layer was separated and the aq layer was extracted with EtOAc (5 mL). The combined organic 
layers were washed with brine (3 x 20 mL) and dried (Na2SO4). The solvent was removed under 
reduced pressure to provide the Na-H (R, R, S)-alkyne 32 (LRMS 279) as a brown residue. The 
residue was purified by silica gel column chromatography (30% EtOAc in hexanes) to provide 32 
as a colorless oil (29.5 mg, 92%). 
By following the same procedure with the ketone 27 (72 mg, 0.17 mmol), this process furnished 
the alkyne 28 (LRMS (M+H)+ = 279, 43 mg, 93%) and with the ketone 29 (31 mg, 0.69 mmol), 
this reaction furnished the alkyne 30 (LRMS 293, 19 mg, 94%). 
 
 
Analytical Data 
 
Compound 24 [Na-H-(R, R, R)-enol-TIPS]: 
 
1H NMR (500 MHz, CDCl3): δ 12.00 (br s, 1H), 7.74 (br s, 1H), 7.49 (d, 1H, J = 7.7 Hz), 7.34 (d, 
1H, J = 8.0 Hz), 7.20-7.16 (m, 1H), 7.14-7.10 (m, 1H), 4.77 (d, 1H, J = 5.1 Hz), 4.14 (d, 1H, J = 
5.4 Hz), 3.69 (s, 3H), 3.66 (q, 1H, J = 6.6 Hz), 3.09 (dd, 1H, J = 16.1 Hz, 5.7 Hz), 2.94 (br d, 1H, 
J = 16.2 Hz), 2.90 (dd, 1H, J = 15.7 Hz, 5.6 Hz), 2.44 (dd, 1H, J = 15.6 Hz, 1.1 Hz), 1.54 (d, 3H, 
J = 6.6 Hz), 1.10-1.00 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 172.4, 171.4, 135.7, 133.2, 127.0, 
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121.8, 119.7, 118.2, 110.8, 108.7, 106.8, 94.8, 84.4, 52.5, 51.4, 49.4, 47.3, 29.1, 21.7, 20.5, 18.6, 
11.2; Rf: 0.8 (silica gel, 30% EtOAc in hexanes); [α]D25 = +118.80 (c 1.41, CHCl3); HRMS: (ESI) 
m/z (M+H)+ calcd for C29H41N2O3Si, 493.2881, found 493.2850.  
 
Compound 25 [Na-Me-(R, R, R)-enol-TIPS]: 
 
1H NMR (500 MHz, CDCl3): δ 11.99 (br s, 1H), 7.50 (d, 1H, J = 7.8 Hz), 7.31 (d, 1H, J = 8.2 Hz), 
7.22 (t, 1H, J = 7.2 Hz), 7.13 (t, 1H, J = 7.2 Hz), 4.94 (d, 1H, J = 5.4 Hz), 4.11 (br d, 1H, J = 5.5 
Hz), 3.70 (s, 3H), 3.68 (s, 3H), 3.61 (q, 1H, J = 6.5 Hz), 3.09 (dd, 1H, J = 16.2 Hz, 5.8 Hz), 2.97-
2.91 (m, 1H), 2.39 (br d, 1H, J = 15.5 Hz), 1.54 (d, 3H, J = 6.6 Hz), 1.10-1.02 (m, 21H); 13C NMR 
(125 MHz, CDCl3): δ 172.4, 171.5, 137.0, 134.1, 126.5, 121.3, 119.2, 118.2, 108.8, 108.7, 105.6, 
94.4, 84.4, 52.1, 51.4, 48.2, 47.2, 29.2, 28.8, 21.2, 20.3, 18.6, 11.2; Rf: 0.85 (silica gel, 30% EtOAc 
in hexanes); [α]D25 = +143.20 (c 1.69, CHCl3); HRMS: (ESI) m/z (M+H)+ calcd for C30H43N2O3Si, 
507.3037, found 507.3013. 
 
Compound 26, [Na-H-(R, R, S)-enol-TIPS]: 
 
1H NMR (500 MHz, CDCl3): δ 11.97 (br s, 1H), 7.77 (br s, 1H), 7.51 (d, 1H, J = 7.7 Hz), 7.33 (d, 
1H, J = 7.9 Hz), 7.20-7.16 (m, 1H), 7.14-7.10 (m, 1H), 4.48 (d, 1H, J = 5.2 Hz), 4.37 (d, 1H, J = 
5.6 Hz), 3.69 (s, 3H), 3.64 (q, 1H, J = 6.3 Hz), 3.26 (dd, 1H, J = 16.1 Hz, 5.9 Hz), 2.96 (br d, 1H, 
J = 16.4 Hz), 2.92 (dd, 1H, J = 14.9 Hz, 5.6 Hz), 2.42 (dd, 1H, J = 15.7 Hz, 1.0 Hz), 1.49 (d, 3H, 
J = 6.3 Hz), 1.13-1.04 (m, 21H);  13C NMR (125 MHz, CDCl3): δ 172.4, 171.4, 135.7, 132.8, 
127.0, 121.9, 119.7, 118.3, 110.8, 107.6, 107.3, 94.5, 85.4, 53.7, 51.4, 48.2, 46.7, 29.0, 22.7, 20.9, 
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18.6, 11.2; Rf: 0.65 (silica gel, 30% EtOAC in hexanes); [α]D25 = -32.31 (c 0.65, CHCl3); HRMS: 
(ESI) m/z (M+H)+ calcd for C29H41N2O3Si, 493.2881, found 439.2854.  
 
Compound 27 [Na-H-(R, R, R)-ketone-TIPS]: 
 
1H NMR (500 MHz, CDCl3): δ 8.01 (br s, 1H), 7.48 (d, 1H, J = 7.7 Hz), 7.34 (d, 1H, J = 8.0 Hz), 
7.22-7.18 (m, 1H), 7.15-7.11 (m, 1H), 4.75-4.72 (m, 1H), 3.99 (d, 1H, J = 6.2 Hz), 3.72 (q, 1H, J 
= 6.7 Hz), 3.18 (dd, 1H, J = 16.5 Hz, 6.4 Hz), 2.74 (br d, 1H, J = 16.4 Hz), 2.62-2.48 (m, 2H), 
2.17-2.05 (m, 2H), 1.50 (d, 3H, J = 6.7 Hz), 1.08-0.96 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 
210.8, 136.0, 132.7, 126.9, 121.9, 119.6, 118.2, 110.9, 108.9, 107.5, 84.7, 62.2, 50.1, 48.0, 34.8, 
29.7, 21.7, 21.0, 18.6, 11.2; Rf: 0.7 (silica gel, 30% EtOAc in hexanes); [α]D25 = +161.67 (c 1.2, 
CHCl3);  
HRMS: (ESI) m/z (M+H)+ calcd for C27H39N2OSi, 435.2826, found 435.2821. 
 
Compound 28 [Na-H-(R, R, R)-ketone-alkyne]: 
 
1H NMR (500 MHz, CDCl3): δ 7.96 (br s, 1H), 7.48 (d, 1H, J = 7.8 Hz), 7.36 (d, 1H, J = 8.0 Hz), 
7.23-7.18 (m, 1H), 7.16-7.12 (m, 1H), 4.70-4.66 (m, 1H), 3.97 (d, 1H, J = 6.4 Hz), 3.66 (qd, 1H, 
J = 6.7 Hz, 2.1 Hz), 3.15 (dd, 1H, J = 16.6 Hz, 6.5 Hz), 2.73 (br d, 1H, J = 16.6 Hz), 2.64-2.56 (m, 
1H), 2.54-2.48 (m, 1H), 2.28 (d, 1H, J = 2.2 Hz), 2.18-2.05 (m, 2H), 1.48 (d, 3H, J = 6.7 Hz); 13C 
NMR (125 MHz, CDCl3): δ 210.7, 135.9, 132.5, 126.8, 122.1, 119.8, 118.2, 111.0, 107.4, 84.9, 
72.4, 61.6, 50.5, 47.2, 34.7, 29.6, 21.7, 20.5; Rf: 0.4 (silica gel, 30% EtOAc in hexanes/NH4OH); 
[α]D25 = +154.78 (c 1.15, CHCl3), HRMS (ESI) m/z (M+H)+ calcd for C18H19N2O, 279.1492, 
found 279.1468. 
 
174 
 
Compound 29 [Na-Me-(R, R, R)-ketone-TIPS]: 
 
1H NMR (500 MHz, CDCl3): δ 7.48 (d, 1H, J = 7.8 Hz), 7.33 (d, 1H, J = 8.2 Hz), 7.26-7.22 (m, 
1H), 7.15-7.11 (m, 1H), 4.94-4.91 (m, 1H), 3.98 (d, 1H, J = 6.5 Hz), 3.69 (s, 3H), 3.66 (q, 1H, J = 
6.7 Hz), 3.16 (dd, 1H, J = 16.7 Hz, 6.6 Hz), 2.71 (br d, 1H, J = 16.7 Hz), 2.63-2.56 (m, 1H), 2.54-
2.47 (m, 1H), 2.18-2.02 (m, 2H), 1.48 (d, 3H, J = 6.6 Hz), 1.08-1.01 (m, 21H); 13C NMR (125 
MHz, CDCl3): δ 210.0, 137.2, 133.6, 126.4, 121.5, 119.2, 118.2, 108.8, 106.2, 84.7, 61.6, 48.8, 
47.7, 34.4, 29.3, 29.2, 21.0, 20.5, 18.6, 18.6, 11.6; Rf: 0.55 (silica gel, 15% EtOAc in hexanes; 
[α]D25 = +170.59 (c 0.34, CHCl3); HRMS: (ESI) m/z (M+H)+ calcd for C28H41N2OSi, 449.2983, 
found 449.2987. 
 
Compound 30 [Na-Me-(R, R, R)-ketone-alkyne]: 
 
1H NMR (500 MHz, CDCl3): δ 7.49 (d, 1H, J = 7.8 Hz), 7.34 (d, 1H, J = 8.2 Hz), 7.25 (t, 1H, J = 
7.6 Hz), 7.13 (t, 1H, J = 7.4 Hz), 4.79-4.76 (m, 1H), 3.97 (d, 1H, J = 6.6 Hz), 3.72 (s, 3H), 6.64 
(qd, 1H, J = 6.7 Hz, 2.1 Hz), 3.16 (dd, 1H, J = 16.7 Hz, 6.7 Hz), 2.73 (br d, 1H, J = 16.6 Hz), 2.68-
2.60 (m, 1H), 2.50 (dd, 1H, J = 16.9 Hz, 6.2 Hz), 2.30 (d, 1H, J = 2.1 Hz), 2.19-2.10 (m, 1H), 2.09-
2.03 (m, 1H), 1.48 (d, 3H, J = 6.7 Hz); 13C NMR (125 MHz, CDCl3): δ 210.2, 137.2, 133.6, 126.3, 
121.6, 119.3, 118.2, 108.9, 106.2, 84.8, 72.5, 61.3, 49.3, 47.2, 34.5, 29.4, 29.0, 21.5, 20.5; Rf: 0.5 
(silica gel, 50% EtOAc in hexanes + NH4OH); [α]D25 = +188.89 (c 1.35, CHCl3); HRMS (ESI) 
m/z (M+H)+ calcd for C19H21N2O, 293.1648, found 293.1624. 
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Compound 31 [Na-H-(R, R, S)-ketone-TIPS]: 
 
1H NMR (500 MHz, CDCl3): δ 7.88 (br s, 1H), 7.49 (d, 1H, J = 7.8 Hz), 7.35 (d, 1H, J = 8.0 Hz), 
7.22-7.18 (m, 1H), 7.15-7.11 (m, 1H), 4.40-4.37 (m, 1H), 4.36 (d, 1H, J = 6.6 Hz), 3.74 (q, 1H, J 
= 6.4 Hz), 3.31 (dd, 1H, J = 16.7 Hz, 6.6 Hz), 2.72 (br d, 1H, J = 16.7 Hz), 2.58-2.45 (m, 2H), 
2.17-2.04 (m, 2H), 1.48 (d, 3H, J = 6.5 Hz), 1.10-1.01 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 
210.5, 135.9, 132.0, 126.9, 122.1, 119.7, 118.3, 110.9, 108.0, 107.6, 85.4, 63.4, 48.5, 47.4, 34.6, 
30.0, 21.7, 21.1, 18.6, 11.2; Rf: 0.5 (silica gel, 30% EtOAc in hexanes); [α]D25 = +3.99 (c 2.0, 
CHCl3); HRMS: (ESI) m/z (M+H)
+ calcd for C27H39N2OSi, 435.2826 found 435.2811. 
 
Compound 32 [Na-H-(R, R, S)-ketone-alkyne]: 
 
1H NMR (500 MHz, CDCl3): δ 7.86 (br s, 1H), 7.49 (d, 1H, J = 7.8 Hz), 7.36 (d, 1H, J = 8.1 Hz), 
7.21 (t, 1H, J = 7.5 Hz), 7.14 (t, 1H, J = 7.7 Hz), 4.41-4.37 (m, 1H), 4.35 (d, 1H, J = 6.6 Hz), 3.68 
(qd, 1H, J = 6.5 Hz, 2.2 Hz), 3.30 (dd, 1H, J = 16.8 Hz, 6.7 Hz), 2.72 (br d, 1H, J = 16.8 Hz), 2.58-
2.46 (m, 2H), 2.33 (d, 1H, J = 2.2 Hz), 2.20-2.06 (m, 2H), 1.47 (d, 3H, J = 6.5 Hz); 13C NMR (125 
MHz, CDCl3): 210.4, 135.9, 131.7, 126.8, 122.2, 119.8, 118.3, 110.9, 107.9, 83.9, 72.6, 63.3, 48.0, 
46.3, 34.5, 30.1, 21.5, 20.6; Rf: 0.2 (silica gel, 30% EtOAc in hexanes+NH4OH); [α]D25 = +50.85 
(c 0.59, CHCl3); HRMS: (ESI) m/z (M+H)
+ calcd for C18H19N2O, 279.1492, found 279.1467. 
 
Compound 38 [Na-Me-(R, R, R)-THβC]: 
 
1H NMR (500 MHz, CDCl3): δ 7.49 (d, 1H, J = 7.8 Hz), 7.25 (d, 1H, J = 8.1 Hz), 7.20-7.16 (m, 
1H), 7.10-7.06 (m, 1H), 4.31-4.26 (m, 1H), 3.96 (t, 1H, J = 5.7 Hz), 3.84-3.78 (m, 1H), 3.72 (s, 
3H), 3.70 (s, 3H), 3.65 (s, 3H), 3.26-3.16 (m, 2H), 2.84-2.77 (m, 1H), 2.53-2.45 (m, 1H), 2.11-
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2.03 (m, 1H), 1.72-1.63 (m, 1H), 1.48 (d, 3H, J = 7.0 Hz), 0.85-0.79 (m, 18H), 0.76-0.68 (m, 3H); 
13C NMR (125 MHz, CDCl3): δ 174.6, 174.4, 137.4, 135.7, 126.4, 121.0, 118.8, 118.1, 108.6, 
107.9, 106.2, 84.0, 60.5, 53.7, 52.0, 51.5, 49.9, 31.1, 29.8, 29.6, 22.4, 21.7, 18.3, 10.9; Rf: 0.8 
(silica gel, 30% EtOAc in hexanes); [α]D25 = +17.0 (c 2.0, CHCl3); HRMS: (ESI) m/z (M+H)+ 
calcd for C31H47N2O4Si, 539.3300, found 539.3292. 
 
Compound 40 [Na-H-(R, S, S)-THβC]: 
 
1H NMR (500 MHz, CDCl3): δ 8.06 (br s, 1H), 7.48 (d, 1H, J = 7.7 Hz), 7.32 (d, 1H, J = 7.9 Hz), 
7.18-7.14 (m, 1H), 7.12-7.08 (m, 1H), 4.64 (t, 1H, J = 4.5 Hz), 4.15 (t, 1H, J = 5.6 Hz), 4.09 (q, 
1H, J = 6.8 Hz), 3.64 (s, 3H), 3.64 (s, 3H), 3.09 (m, 2H), 2.55-2.48 (m, 1H), 2.36-2.22 (m, 2H), 
2.13-2.05 (m, 1H), 1.41 (d, 3H, J = 6.8 Hz), 1.11-1.05 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 
174.8, 173.3, 136.2, 134.9, 127.0, 121.5, 119.3, 118.0, 110.9, 108.2, 107.6, 84.9, 54.7, 53.2, 51.6, 
51.4, 46.8, 29.1, 28.4, 24.8, 21.9, 18.6, 11.3; Rf: 0.6 (silica gel, 20% EtOAc in hexanes); [α]D25 = 
+3.01 (c 1.33, CHCl3); HRMS: (ESI) m/z (M-H)
- calcd for C30H43N2O4Si, 525.2998 found 
525.2971. 
 
Compound 42 [Na-H-(R, S, R)-THβC]: 
 
1H NMR (500 MHz, CDCl3): δ 7.95 (br s, 1H), 7.45 (d, 1H, J = 7.4 Hz), 7.27 (d, 1H, J = 8.0 Hz), 
7.12 (t, 1H, J = 7.1 Hz), 7.08-7.04 (m, 1H), 4.20-4.15 (m, 1H), 4.08-4.03 (m, 1H), 3.83 (q, 1H, J 
= 6.9 Hz), 3.80 (s, 3H), 3.73 (s, 3H), 3.24 (dd, 1H, J = 15.3, 10.9 Hz), 3.02 (dd, 1H, J = 15.4, 4.1 
Hz), 2.71-2.63 (m, 1H), 2.61-2.53 (m, 1H), 2.20-2.12 (m, 1H),  2.05-1.94 (m, 1H), 1.39 (d, 3H, J 
= 6.9 Hz), 0.79-0.73 (m, 18H), 0.59-0.51 (m, 3H); 13C NMR (125 MHz, CDCl3): δ 174.5, 173.3, 
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136.1, 135.1, 127.0, 121.4, 119.1, 118.2, 110.5, 109.0, 108.7, 83.7, 57.7, 52.5, 52.0, 51.7, 46.1, 
30.7, 29.7, 23.1, 21.6, 18.3, 10.9; Rf: 0.55 (silica gel, 20% EtOAc in hexanes); [α]D25 = +88.14 (c 
0.59, CHCl3); HRMS: (ESI) m/z (M-H)
- calcd for C30H43N2O4Si, 525.2998 found 525.2963. 
 
5. References 
 
(1) Dias, D. A.; Urban, S.; Roessner, U. Metabolites 2012, 2, 303. 
(2) Newman, D. J.; Cragg, G. M.; Snader, K. M. Nat. Prod. Rep. 2000, 17, 215. 
(3) Koehn, F. E.; Carter, G. T. Nat. Rev. Drug Discov. 2005, 4, 206. 
(4) Paterson, I.; Anderson, E. A. Science 2005, 310, 451. 
(5) Butler, M. S. Nat. Prod. Rep. 2008, 25, 475. 
(6) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2016, 79, 629. 
(7) Cragg, G. M.; Newman, D. J. Biochim. Biophys. Acta Gen. Subj. 2013, 1830, 3670. 
(8) O’Neil, M.J. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals; RSC 
Publishing: London, UK, 2013. 
(9) Feher, M.; Schmidt, J. M. J. Chem. Inf. Comp. Sci. 2003, 43, 218. 
(10) Liotta, D. C.; Painter, G. R. Acc. Chem. Res. 2016, 49, 2091. 
(11) Wender, P. A.; DeChristopher, B. A.; Schrier, A. J. J. Am. Chem. Soc. 2008, 130, 6658. 
(12) Carney, D. W.; Lukesh, J. C.; Brody, D. M.; Brütsch, M. M.; Boger, D. L. Proc. Natl. Acad. 
Sci. U.S.A. 2016, 113, 9691. 
178 
 
(13) Lounasmaa, M.; Hanhinen, P. In The Alkaloids: Chemistry and Biology; Cordell, G. A., Ed.; 
Academis Press: San Diego, 2001; Vol. 55, pp 1-90. 
(14) Lounasmaa, M.; Hanhinen, P.; Westersund, M.; Halonen, N. In The Alkaloids: Chemistry 
and Biology; Cordell, G. A., Ed.; Academic Press: San Diego, CA: 1999; Vol. 52, p 103. 
(15) Namjoshi, O. A.; Cook, J. M. In The Alkaloids: Chemistry and Biology; Knölker, H.-J., Ed.; 
Academic Press: San Diego, CA: 2016; Vol. 76, p 63. 
(16) Rahman, M. T.; Cook, J. M. In Studies in Natural Products Chemistry; Atta-ur-Rahman, 
Ed.; Elsevier Publications: Amsterdam, Netherlands (In Press). 
(17) Stöckigt, J.; Antonchick, A. P.; Wu, F.; Waldmann, H. Angew. Chem., Int. Ed. 2011, 50, 
8538. 
(18) Klausen, R. S.; Jacobsen, E. N. Org. Lett. 2009, 11, 887. 
(19) Raheem, I. T.; Thiara, P. S.; Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 2007, 129, 
13404. 
(20) Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558. 
(21) Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797. 
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PART II. THE TOTAL SYNTHESIS OF A NUMBER OF BIOACTIVE C-19 METHYL 
SUBSTITUTED MACROLINE-SARPAGINE INDOLE ALKALOIDS INCLUDING MACRO-
CARPINES A-G, TALCARPINE, N(4)-METHYL-N(4),21-SECOTALPININE, DEOXYPER-
AKSINE, DIHYDROPERAKSINE, TALPININE, O-ACETYLTALPININE, AS WELL AS 
N(4)-METHYLTALPININE 
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Chapter 4 
The Total Synthesis of Macrocarpines D and E via an Efficient Copper-
Mediated Cross-Coupling Process 
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1. Introduction 
 
After gaining access to the bicyclo[3.3.1] system via the ambidextrous Pictet-Spengler reaction, 
the focus turned to the completion of the total synthesis of a number of C-19 methyl substituted 
sarpagine/macroline/ajmaline alkaloids. As a step towards that, alkaloids with Na-H and Nb-CH3 
substituents were focused upon. An enolate driven copper-mediated cross-coupling process 
enabled cheaper and greener access to the key pentacyclic intermediates required for the 
enantiospecific total synthesis of a number of C-19 methyl substituted sarpagine/macroline indole 
alkaloids. The replacement of palladium (60-68%) with copper iodide (82-89%) resulted in much 
higher yields. The formation of an unusual seven-membered cross-coupling product was 
completely inhibited by using TEMPO as a radical scavenger. Further functionalization led to the 
first enantiospecific total synthesis of macrocarpines D and E.  
The medicinal plants of the Alstonia (Apocynaceae) genus have been used in traditional medicine 
in many countries of the world from antiquity.1 Their traditional uses include treatment of ulcers, 
dysentery, malaria, anthelmintics, diabetes, rheumatism, snake bites, etc.1 Indole alkaloid 
secondary metabolites of these plants are the most probable source of their medicinal activity.2 
According to a review by Cordell et al., among the 60 plant-derived alkaloids of medicinal 
significance, 39 were directly related to their traditional uses.3 Macroline/sarpagine type indole 
alkaloids are one of the major classes of alkaloids isolated from these species to date by Le-Quesne, 
Elderfield, Schmid, Kam, and others.4-7 Macrocarpines A-C (1-3) were isolated from the bark 
extract of Alstonia macrophylla in 2004.8 Several other alkaloids of the same series, macrocarpine 
D (4) and macrocarpines E-H (5-8), were isolated in 2014 from the stem-bark and leaf extracts of 
A. macrophylla and A. angustifolia respectively by Kam et al.9,10 All of these macroline-type indole 
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alkaloids, macrocarpines A-H (1-8) share the common feature of a β-methyl substituent at the C-
19 position. This is a distinct difference from earlier Alstonia alkaloids isolated by LeQuesne and 
Schmid.5,7 To date, around seventy alkaloids of the sarpagine/macroline/ajmaline family (see 
General Introduction), which bear a diastereomeric methyl function at C-19 have been isolated.4,11 
Macroline related alkaloids N(4)-methyl-N(4),21-secotalpinine (9)8,12, N(4)-methyltalpinine 
(10)12, and 19-epitalcarpine (11),10 as well as the sarpagine-related alkaloids macrosalhine chloride 
(12)13, and deoxyperaksine (13)14 also possess the C-19 methyl substitution. Among these, 11 and 
13 contain a diastereomeric α-methyl group at C-19. The synthesis of these alkaloids (1-13, Figure 
1) has not been reported yet. Moreover, N(4)-methyltalpinine (10) and N(4)-methyl-N(4),21-
secotalpinine (9) have been reported recently to have potent anticancer (NF-ƙB inhibitor, ED50 1.2 
µM) activity and profound leishmanicidal12 activity, respectively. The unique structural features 
and potential medicinal properties prompted attempts at the first total synthesis of this class of 
alkaloids via a general strategy for the entire series. This is the basis of the approach toward 
chemical economy described herein. 
 
Figure 1: Examples of some C-19 methyl substituted sarpagine/macroline indole alkaloids 
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The copper-mediated carbon-carbon bond formation is more than a century old.15 Although 
palladium-catalyzed cross-coupling reactions have been the dominant method in the field of total 
synthesis of complex natural products, copper has proven itself to be an essential alternative, as 
indicated by the increase in copper-mediated cross-coupling processes over the last decade.16 As 
a result, it was decided to investigate a copper cataly-zed, or mediated coupling process to offer a 
less expensive and less toxic alternative to catalytic palladium, while avoiding phosphine based 
ligands for easier purification. Moreover, potential improvements in yields, as well as workup and 
purification would be important.17 
Wang et al.18 in Milwaukee developed an enolate driven palladium catalyzed α-vinylation of a 
ketone in 2000 (Scheme 1, entry 1). This process has been employed in the total synthesis of 
several sarpagine/macroline/ajmaline indole alkaloids.19-21 Although this palladium catalyzed 
process was effective in accessing the key intermediate 15 from vinyl iodide 14, it provided only 
60-68% yield in the case of vinyl iodides 16 or 18 (Scheme 1, entry 2), wherein there was a 
diastereomeric methyl function along with a terminal olefin in place of the ethylidene function in 
14 (internal olefin, Wang, 2000). These features in 16 and 18 make them structurally and 
chemically different than 14. Since the diastereomeric methyl function was essential for the 
synthesis of C-19 methyl substituted alkaloids, further improvement was required for better access 
to the key intermediates 17, 19, 21, and 23. More importantly, replacement of palladium with the 
cheaper and less toxic copper, would greatly facilitate use of this enolate-mediated process by 
others, and formed much of the driving force in this research. 
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2. Results and Discussion 
 
The copper-catalyzed conditions22 that had been used for the α-vinylation of 14 gave lower yields 
along with an unusual, undesired product in the case of 22 (Scheme 3). Numerous attempts were 
made to optimize the desired yield of the olefin 23, eliminate the unusual side product 23' and 
understand the mechanism of multiple competing reactions. The implementation, improvement 
and extension of the scope of this process to access the C-19 methyl substituted 
sarpagine/macroline/ajmaline alkaloids with either an (R) or (S) C-19 methyl substituent in the Na-
H as well as Na-CH3 series (Scheme 1, entry 3) form the basis of this discussion. 
Scheme 1: Regiospecific access to the pentacyclic core system via a palladium and copper-
catalyzed cross-coupling process 
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All of the vinyl iodide intermediates (16, 18, 20, and 22) were prepared according to the previously 
reported procedures21 (Scheme 2) beginning from the tetracyclic ketones 24/25 which had been 
prepared in the standard two pot process on 300 gram scale.23 As depicted in Scheme 2, the Nb 
alkylation via SN2
 substitution of the chiral tosylates (26/27) in CH3CN with K2CO3 and 
subsequent deprotection of the TIPS protecting group with wet TBAF in THF furnished the Nb-
alkylated terminal alkynes (28-31) in excellent yields. Haloboration21 of the terminal alkynes with 
I-B(Cy)2 in DCM followed by protodeboronation with HOAc, resulted in the vinyl iodides (16, 
18, 20, and, 22) in 74-79% yield with complete regioselectivity. The structure and absolute 
configuration of 22 was confirmed by X-ray crystallography. An ORTEP representation of the 
crystal structure of 22 is shown in Figure 2 (see Appendix B for X-ray crystallographic data). 
Initial experiments with vinyl iodide (22) and CuI under the reported conditions22 resulted in the 
desired product (23) in lower yields (~42%) along with an unusual/unexpected cyclization product 
(23'), a seven-membered ring with an internal alkene (Scheme 3). 
 
Figure 2. ORTEP representation of 22 
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The structures of both the desired (23, Figure 3) and unexpected seven-membered ring (23', Figure 
4) cross-coupling products have been confirmed by MS, 1D and 2D NMR, and X-ray 
crystallographic analysis (see Appendix B for X-ray data). In the absence of CuI, the same 
conditions yielded the seven-membered product to a greater extent. Increasing the equivalents of 
CuI and ligand to 1.0 equivalent and the base to 4.0 equivalents (entry 3 of Table 1) resulted in a 
higher overall yield of the desired material (67%), while the unexpected product was still present 
(~21%). 
 
Figure 3. ORTEP representation of 23 
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Figure 4. ORTEP representation of 23ʹ 
 
Scheme 2: Completely Regioselective access to the vinyl iodides 16, 18, 20, and 22 
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Scheme 3: Enolate driven copper mediated cross-coupling of the vinyl iodide (22)  
 
 
It was not surprising that this series of vinyl iodides (16, 18, 20, and 22) would have different 
reactivities with copper iodide than vinyl iodides reported earlier.18  Differences in the substituents 
included the presence of a methylidene (a terminal alkene) instead of the ethylidene in 14 (an 
internal alkene), as well as the presence of the chiral methyl function at C-19 instead of an achiral 
methylene. In order to rationalize this unprecedented seven-membered ring cyclization, it was felt 
that a radical mechanism may have been involved in its formation. To test this hypothesis, it was 
decided to use 2,2,6,6-tetramethylpiperidinyl-1-oxy (TEMPO), the well-known radical 
scavenger24, to inhibit any radical step or species that may have diverted the mechanism. In support 
of this hypothesis, an experiment with 2.5 equivalents of TEMPO (entry 5 of Table 1) resulted in 
almost complete inhibition of the formation of the undesired 7-membered internal alkene (~3% by 
NMR spectroscopy) with 45% overall yield of 23. Increasing the amount of TEMPO to 3.0 
equivalents completely eliminated the undesired cyclization (see the Experimental Section) and 
provided the desired cross-coupling product 23 in 66% yield. After many experiments were 
executed by changing reaction parameters and screening different copper sources (entries 8-15 of 
Table 1), the optimized condition was found to be 1.0 equiv of CuI, 1.0 equiv of ligand, 4.0 equiv 
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of Cs2CO3, and 3.0 equiv of TEMPO. This combination furnished 89% yield of the desired cross-
coupled product to the exclusion of the 7-membered byproduct, as compared to (60-68%) with a 
palladium catalyst.21,25 This modified reaction condition was effective for both stereoisomers of 
the C-19 methyl substitution pattern and in both the Na-H and Na-CH3 series (16, 18, 20 and, 22) 
as well. This permitted the application of this Cu-mediated cross-coupling process to access the 
key intermediates (17, 19, 21, and 23) in gram-quantities toward all of the macroline/sarpagine 
alkaloids discussed above (Scheme 4). The structure and absolute stereochemistry of 19 was 
confirmed with X-ray crystallographic analysis (see Figures 5, see Appendix B for X-ray data). 
While TEMPO was initially chosen as a radical probe, the reason for its useful effect is still under 
investigation. 
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Table 1: Optimization of reaction conditions for the Cu-mediated cross-coupling reaction of 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The unit for all reagent amounts is equivalent (equiv); scv. = TEMPO scavenger; [a] Ratio determined 
by 1H NMR spectroscopy; [b] Overall isolated yield after flash chromatography on neutral alumina; [c] 
Starting material was recovered; ND = not detected; L= cis-1-2-cyclo-hexanediol; cat.-2 = 
Cu(CH3CN)4ClO4; cat.-3 = Cu(CH3CN)4PF6; cat.-4 = Cu(CH3CN)4OTf (see the Experimental Section for 
detailed procedures) 
 
Scheme 4: Access to the key pentacyclic ketone intermediates 17, 19, 21, and 23 via the 
optimized conditions 
 
entry CuI 
or cat. 
L Cs2CO3 scv. 23:23' 
(by NMR)a 
overall yield 
(%)b 
1 0.5 0.5 2.0 - 89:11 47 
2 - 0.5 2.0 - 63:37 45 
3 1.0 1.0 4.0 - 79:21 67 
4 - - 2.0 - 64:36 35 
5 0.5 0.5 2.0 2.5 97:3 45 
6 0.5 0.5 2.0 3.0 100:0 66 
7 1.0 1.0 4.0 3.0 100:0 89 
8 0.1 0.1 4.0 3.0 100:0 25 
9 0.5 0.5 4.0 3.0 100:0 40 
10 1.0 - 4.0 3.0 100:0 11 
11 1.0 1.0 - 3.0 - NDc 
12 - 1.0 4.0 3.0 - ND 
13 cat.-2 (1.0) 1.0 4.0 3.0 100:0 51 
14 cat.-3 (1.0) 1.0 4.0 3.0 100:0 24 
15 cat.-4 (1.0) 1.0 4.0 3.0 100:0 28 
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Surprisingly, it was observed that the base Cs2CO3 alone in DMF (entry 2 of Table 1) yielded both 
of the products in an approximately 2 to 1 ratio but in poor yield. This observation indicated the 
possibility of another competing mechanism wherein the vinyl iodide (22) or intermediate 
underwent an E-2 like elimination or radical process to produce a terminal alkyne (31, in situ). 
This alkyne subsequently could undergo a 6-(enolendo)-exo-dig (process A in Scheme 5) which 
would produce the six-membered external alkene (23) as the major product and a 7-(enolendo)-
endo-dig cyclization (process B in Scheme 5) to produce the seven-membered internal alkene (23') 
as the minor product (Scheme 5). Both of these processes are allowed by Baldwin’s rules for ring 
closure.26,27  This hypothesis has been confirmed by stopping the reaction (at 3 hours) before 
completion. The alkyne 31 was detected along with traces of the cross-coupling products 23 and 
23'. 
The investigation of the competing mechanisms is now ongoing. However, gratifying, excellent 
yields (82-89%) of only the desired six-membered ring were obtained in a stereospecific fashion 
with copper iodide (Scheme 4). 
 
Figure 5. ORTEP representation of pentacyclic intermediate 19 
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Scheme 5: Possible mechanism for the observed base mediated cyclization (Table 1, entries 
2 and 4) 
 
 
Scheme 6: Toward macrocarpines D (4) and E (5) from the key intermediate 17 
 
 
With the pentacyclic ketones in hand in excellent yields, the total synthesis of a series of C-19 
methyl substituted sarpagine macroline indole alkaloids was undertaken. This included the potent 
anticancer alkaloid, N(4)-methyltalpinine (10), as well as the leishmanicidal base (9), 
macrocarpines A-G (1-7), and deoxyperaksine (13). Herein is reported the first total synthesis of 
the Na-H bearing macroline indole alkaloids macrocarpine D (4) and E (5) (Schemes 6 and 7). 
The pentacyclic ketone (17) was subjected to a one-carbon homologation via a Wittig olefination 
process using methoxymethyl triphenylphosphonium chloride and potassium tert-butoxide in 
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benzene to furnish the enol ether, which was hydrolyzed without purification to aldehyde (32) 
under acidic conditions (Scheme 6). The aldehyde was isolated in the more stable α position even 
in the presence of the C-19 β-methyl group. The aldehyde (32) was reduced to alcohol (33) with 
sodium borohydride in ethanol and subsequently protected with a TIPS group to give the silyl ether 
(34). The alkene (34) was subjected to hydroboration (borane dimethyl sulfide) and Kabalka 
oxidation (NaBO3) to provide the primary alcohol (35) in 73% yield. The oxidation of the primary 
alcohol under Corey-Kim conditions at -78 oC produced a mixture of α and β-aldehydes with the 
α isomer as the major 
Scheme 7: Total synthesis of macrocarpines D (4) and E (5) 
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product. This mixture was epimerized entirely to the α-aldehyde (36) with Et3N in methanol added 
to the mixture.  
Quaternization of the Nb-group with iodomethane in methanol gave the iodide salt (37, Scheme 7). 
The quaternary ammonium salt underwent a retro-Michael ring opening in the presence of 
NaHMDS in THF to produce the α,β–unsaturated aldehyde (38) in 78% yield similar to the work 
first reported by LeQuesne.5  
The TIPS group was removed by heating 38 under mildly acidic conditions in THF. The so formed 
alcohol added in a Michael fashion to the α,β-unsaturated aldehyde to produce (39) and (40) as an 
epimeric mixture of aldehydes with the β-methyl group formed stereospecifically. Each of these 
could be isolated by silica gel flash chromatography. The desired aldehydes (39) and (40) upon 
reduction (individually) with sodium borohydride in ethanol gave macrocarpine E (5) and 
macrocarpine D (4) in 96% and 92% yield, respectively. The spectroscopic data and optical 
rotations of the synthetic products are in complete agreement with natural macrocarpine D & E. 
The total synthesis of other alkaloids of interest in the series will be presented in the next chapters. 
 
3. Conclusion 
In summary, the first total synthesis of macrocarpines D (4) and E (5) have been accomplished via 
a key copper-mediated cross-coupling process toward the important key intermediates. This 
general strategy will enable one to access all of the indole alkaloids of the same class with 
stereospecific incorporation of the important β (or α)-methyl function at C-19. Replacement of the 
palladium catalyst with CuI provides a much more useful and cheaper method since the copper 
catalyst, even at stoichiometric amounts, is much cheaper than catalytic palladium. More 
197 
 
importantly, accessing 17 in 83% yield with copper iodide compared to 60% with catalytic 
palladium serves as an example of replacement of palladium in this enolate-mediated process 
which makes it much more useful for others, especially in the pharmaceutical industry. 
 
4. Experimental Section 
General Information 
 
All reactions were carried out under an argon atmosphere with dry solvents using anhydrous 
conditions unless otherwise stated. Tetrahydrofuran (THF) and diethyl ether were freshly distilled 
from Na/benzophenone ketyl prior to use. Dichloromethane was distilled from calcium hydride 
prior to use. Methanol was distilled over magnesium sulfate. Benzene and toluene were distilled 
over Na. Acetonitrile was distilled over CaH2 prior to use. Reagents were purchased of the highest 
commercial quality and used without further purification unless otherwise stated. Thin layer 
chromatography (TLC) was performed on UV active silica gel, 200 μm, or aluminum backed and 
UV active alumina N, 200 μm, or F-254 aluminum backed. Flash and gravity chromatography 
were performed using silica gel P60A, 40-63 μm, or basic alumina (Act I, 50-200 μm) or neutral 
alumina (Brockman I, ~150 mesh). The TLC plates were visualized by exposure to short 
wavelength UV light (254 nm). Indoles were visualized with a 1% solution of ceric ammonium 
nitrate in 50% phosphoric acid. The 1H NMR data are reported as follows: chemical shift, 
multiplicity (brs = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, dd 
= doublet of doublet, dt = doublet of triplet, ddd = doublet of doublet of doublets, td = triplet of 
doublets, qd = quartet of doublets, m = multiplet), integration, and coupling constants (Hz). The 
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13C NMR data are reported in parts per million (ppm) on the δ scale. The low resolution mass 
spectra (LRMS) were obtained as electron impact (EI, 70eV) and as chemical ionization (CI) using 
a magnetic sector (EBE) analyzer. The HRMS were recorded by electrospray ionization (ESI) 
using a TOF analyzer, electron impact (EI) using a trisector analyzer and Atmospheric Pressure 
Chemical Ionization (APCI) using a TOF analyzer. 
 
Experimental Procedures and Analytical Data 
 
General Procedure for Preparation of 28-312 
 
 
An oven dried 1 L flask cooled under argon was charged with optically active Na-H, Nb-H 
tetracyclic ketone 24 or Na-CH3, Nb-H tetracyclic ketone 25 (15.0 g, 0.062 mol). The solid 24/25 
was dissolved (individually) in freshly distilled acetonitrile (1000 mL), after which a solution of 
(R)-4-triisopropylsilyl-3-butyn- 2-ol tosylate 26 (47.57 g, 0.116 mol) in dry acetonitrile (50 mL) 
was added. Anhydrous potassium carbonate (17.27 g, 0.125 mol) was added and the mixture, 
which resulted, was allowed to heat and stirred at 75 °C (outside oil bath temperature) for 12 h 
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under argon. Analysis by TLC (silica gel, CHCl3/EtOH, 9 : 1) indicated the absence of tetracyclic 
ketone 24/25, respectively, after 12 h. The reaction mixture was cooled to rt and the K2CO3 was 
filtered off by passing the solution through a bed of celite using EtOAc as the eluent. After removal 
of the solvent under reduced pressure, the crude product was purified by flash chromatography 
(silca gel, EtOAc/hexanes) to provide the (S)-Na-H, TIPS protected acetylenic tetracyclic ketone 
S-3/ (S)-Na-CH3, or the TIPS protected acetylenic tetracyclic ketone S-4 as a light yellow colored 
solid. The compound was purified by silica gel flash column chromatography using 10-20% 
EtOAc in hexane.  By following the same procedure with 24/25 (individually) and (S)-4-
triisopropylsilyl-3-butyn- 2-ol tosylate 27, this process resulted in (R)-Na-H, TIPS protected 
acetylenic tetracyclic ketone S-5/ (R)-Na-CH3, or the TIPS protected acetylenic tetracyclic ketone 
S-6, respectively. Trace amounts of the other diastereomers were detected in both cases, which 
was due to the ~95% ee of the tosylates 26 and 27.  
A solution of S-3/S-4/S-5/S-6 in THF (1 mmol) was cooled (individually) to 0 oC and TBAF·xH2O 
(1.5 mmol, 1M soln in THF) was added dropwise to the above solution. The solution, which 
resulted, was stirred at 0 oC for 30 min. After that the ice bath was removed and the solution was 
allowed to stir at rt for 2h-3h. At that time analysis by TLC (silica gel) indicated the disappearance 
of the starting material. The reaction solution was then quenched with H2O (30 mL) at rt, followed 
by dilution with EtOAc (80 mL). The two layers were separated. The organic layer was washed 
with water, brine and dried (Na2SO4). The EtOAc was removed under reduced pressure and the 
residue was passed through a small pad of silica gel to give 28/29/30/31, respectively, as off white/ 
yellowish solids. 
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(6S,10S)-12-((S)-But-3-yn-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta[b]indol-
9(6H)-one (28) 
 
1H NMR (300 MHz, CDCl3) δ 8.00 (brs, 1H), 7.48 (d, 1H, J = 7.6 Hz), 7.35 (d, 1H, J = 7.8 Hz), 
7.11-7.23 (m, 2H), 4.67 (d, 1H, J = 3.2 Hz), 3.97 (d, 1H, J = 6.4 Hz), 3.66 (qd, 1H, J = 6.7Hz, 
2.1Hz), 3.15 (dd, 1H, J = 16.7, 6.5 Hz), 2.73 (d, 1H, J = 16.6 Hz), 2.45-2.63 (m, 2H), 2.28 (d, 1H, 
J = 2.1 Hz), 2.04-2.18 (m, 2H), 1.47 (d, 3H, J = 6.7 Hz). All other spectroscopic data were identical 
to the published data for 28.3 The material was used for the next step without further 
characterization. 
(6S,10S)-12-((S)-But-3-yn-2-yl)-5-methyl-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta-
[b]indol-9(6H)-one (29) 
 
1H NMR (300 MHz, CDCl3) δ 7.46 (d, 1H, J = 7.7 Hz), 7.31 (d, 1H, J = 8.1 Hz), 7.19-7.25 (m, 
1H), 7.08-7.13 (m, 1H), 4.75 (d, 1H, J = 3.1 Hz), 3.95 (d, 1H, J = 6.6 Hz), 3.70 (s, 3H), 3.61 (qd, 
1H, J = 6.6Hz, 2.1Hz), 3.13 (dd, 1H, J = 16.8, 6.7 Hz), 2.70 (d, 1H, J = 16.8 Hz), 2.56-2.65 (m, 
1H), 2.44-2.52 (m, 1H), 2.28 (d, 1H, J = 2.2 Hz), 2.10-2.18 (m, 1H), 1.99-2.07 (m,1H),  1.45 (d, 
3H, J = 6.7 Hz). All other spectroscopic data were identical to the published data for 29.2 The 
material was used for the next step without further characterization. 
 
(6S,10S)-12-((R)-But-3-yn-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta[b]indol-
9(6H)-one (30) 
 
 1H NMR (300 MHz, CDCl3) δ 7.90 (brs, 1H), 7.48 (dd, 1H, J = 7.7, 0.5 Hz), 7.36 (d, 1H, J = 8.0 Hz), 
7.11-7.23 (m, 2H), 4.37-4.41 (m, 1H), 4.35 (d, 1H, J = 6.6Hz),  3.68 (qd, 1H, J = 6.5, 2.1 Hz), 3.30 (dd, 
1H, J = 16.9, 6.7 Hz), 2.72 (d, 1H, J = 16.9 Hz), 2.44 - 2.57 (m, 2H), 2.33-2.34 (m, 1H), 2.05 - 2.21 (m, 
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2H), 1.47 (d, 3H, J = 6.5 Hz); 13C NMR (75 MHz, CDCl3) δ 210.4 (C), 135.9 (C), 131.6(C), 126.8 (C), 
122.2 (CH), 119.8 (CH), 118.3 (CH), 110.9 (CH), 107.8 (C), 83.9 (C), 72.7 (CH), 63.3 (CH), 48.0 (CH), 
46.3 (CH), 34.5 (CH2), 30.1 (CH2), 21.5 (CH2), 20.6 (CH3); HRMS (ESI) m/z (M + H)+ calcd for 
C18H19N2O, 279.1492, found 279.1498. 
 
(6S,10S)-12-((R)-But-3-yn-2-yl)-5-methyl-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta-
[b]indol-9(6H)-one (31) 
 
1H NMR (300 MHz, CDCl3) δ 7.54 (d, 1H, J = 7.7 Hz), 7.37 (d, 1H, J = 8.1 Hz), 7.28 (t, 1H, J = 7.5 Hz), 
7.17 (t, 1H, J = 7.3 Hz), 4.49 (brs, 1H),  4.41 (d, 1H, J = 6.6 Hz), 3.74 (s, 3H), 3.65-3.71 (m, 1H), 3.35 (dd, 
1H, J = 16.9, 6.8 Hz), 2.76 (d, 1H, J = 16.9 Hz), 2.48 - 2.65 (m, 2H), 2.40 (d, 1H, J = 1.9 Hz), 2.05 - 2.22 
(m, 2H), 1.52 (d, 3H, J = 6.5 Hz); 13C NMR (75 MHz, CDCl3) δ 210. 1 (C), 137.3 (C), 132.8(C), 126.4 
(C), 121.7 (CH), 119.4 (CH), 118.3 (CH), 109.0 (CH), 106.7 (C), 84.0 (C), 72.8 (CH), 63.3 (CH), 46.7 
(CH), 46.3 (CH), 34.4 (CH2), 29.5 (CH2), 29.4 (CH3), 21.5 (CH2), 20.7 (CH3) ; HRMS (ESI) m/z (M + H)+ 
calcd for C19H21N2O, 293.1492, found 293.1498. 
General procedure for the preparation of 16, 18, 20, 22 (individually) via regiospecific 
haloboration2,3 
 
 
An oven dried flask was fitted with an addition funnel and was cooled under argon. The flask was 
charged either with 28/29/30/31 (2.10 g, 7.55 mmol) dissolved (individually) in freshly distilled 
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CH2Cl2 (52.5 mL) and hexanes (7.0 mL). The flask was cooled to 0 °C with ice and I-B(Cy)2 (30.2 
mL, 15.1 mmol, 0.5 M solution in hexanes) was added dropwise every 0.5 h in three portions, over 
a total period of 1.5 h. After the last addition the reaction mixture was allowed to stir at 0 °C for 
another 0.5 h, after which the ice bath was removed and the mixture was stirred at rt for 2.0 h. 
After stirring at rt for 2.0 h, another 0.5 eq of I-B(Cy)2 (7.6 mL, 3.78 mmol) was added dropwise 
at rt and the mixture was allowed to stir for another 2.0 h. After this 2.0 h, the mixture was treated 
with glacial acetic acid (4.8 ml, 83.1 mmol) at 0 °C and stirred at rt for 1.15 h. At this point the 
flask was again cooled to 0 °C and a solution of cold aq 3 M NaOH (40.3 mL, 121 mmol) and 30% 
H2O2 (2.6 mL, 23 mmol) were added and the stirring was maintained for 1.0 h at rt. The biphasic 
solution, which resulted, was transferred to a bigger flask, diluted with CH2Cl2 (400 mL) and water 
(50 mL), after which the two layers were separated. The original reaction flask still had some 
residual solid attached to the bottom of the flask. The solid was dissolved in acetone (50 mL). The 
acetone was evaporated under reduced pressure to 75% of the original volume and the mixture was 
diluted with CH2Cl2 (50 mL). Again, the two layers were separated and the combined CH2Cl2 
layers were treated with solutions of 5% KF in methanol (160 mL) and 5% aq sodium bisulfite 
(160 mL) under vigorous stirring for 5 min. The aq layer was separated, extracted with CH2Cl2 (2 
x 80 mL), after which the combined organic layers were washed with brine, dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification by chromatography on silica gel 
(ethyl acetate/hexanes, 1 : 4) afforded vinyl iodides  16 (74%) or  18 (77%) or 20 (76%) or 22 
(79%), respectively,  as white solids. 
 
(6S,10S)-12-((S)-3-Iodobut-3-en-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta-
[b]indol-9(6H)-one (16)  
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1H NMR (300 MHz, CDCl3): δ 7.83 (brs), 7.50 (d, 1H, J = 7.6 Hz), 7.36 (d, 1H, J = 7.8 Hz), 7.12-
7.24 (m, 2H), 6.26 (s, 1H), 5.87 (s, 1H), 4.21 (brs, 1H), 4.02 (d, 1H, J = 6.2 Hz), 3.12 (dd, 1H, J = 
16.8, 6.2 Hz), 2.79 (d, 1H, J = 16.8 Hz), 2.66-2.72 (m, 1H), 2.50-2.61 (m, 2H), 2.01-2.20 (m, 2H), 
1.21 (d, 3H, J = 6.2Hz), All other spectroscopic data were identical with the published data for 
16.3 This material was used for the next step without further characterization. 
 
(6S,10S)-12-((S)-3-Iodobut-3-en-2-yl)-5-methyl-7,8,10,11-tetrahydro-5H-6,10-
epiminocycloocta[b]indol-9(6H)-one (18) 
 
13C NMR (75 MHz, CDCl3): δ 210.2, 137.1, 133.0, 126.4, 125.8, 122.6, 121.6, 119.3, 118.2, 108.9, 
106.6, 62.3, 60.7, 47.6, 34.4, 29.7, 29.3, 21.2, 19.7.  All other spectroscopic data were identical 
with the published data for 18.2 This material was used for the next step without further 
characterization. 
 
(6S,10S)-12-((R)-3-Iodobut-3-en-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta-
[b]indol-9(6H)-one (20) 
 
1H NMR (300 MHz, CDCl3) δ 7.98 (brs, 1H), 7.50 (d, 1H, J = 7.6 Hz), 7.37 (d, 1H, J = 7.9 Hz), 
7.13-7.28 (m, 2H), 6.39 (s, 1H) 5.91 (s, 1H), 4.36-4.40 (m, 1H), 3.86 (d, 1H, J = 6.5 Hz), 3.17 (dd, 
1H, J = 17.0, 6.6 Hz), 2.65-2.71 (m, 2H),  2.50-2.60 (m, 2H), 2.04-2.20 (m, 2H), 1.17 (d, 3H, J = 
6.1 Hz); 13C NMR (75 MHz, CDCl3) δ 210.4 (C), 135.8 (C), 132.8 (C), 126.9 (C), 126.2 (CH2), 
122.2 (C), 121.1 (CH), 119.8 (CH), 118.2 (CH), 111.0 (CH), 107.6 (C), 62.3 (CH), 61.7 (CH), 
46.5 (CH), 34.5 (CH2), 30.8 (CH2), 20.7 (CH2), 19.8 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for 
C18H20IN2O 407.0615, found 407.0617 
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(6S,10S)-12-((R)-3-Iodobut-3-en-2-yl)-5-methyl-7,8,10,11-tetrahydro-5H-6,10-epiminocycl-
oocta[b]indol-9(6H)-one (22) 
 
1H NMR (300 MHz, CDCl3) δ 7.51 (d, 1H, J = 7.7 Hz), 7.35  (d, 1H, J = 8.0 Hz), 7.25 (d, 1H, J 
= 8.0 Hz) 7.12-7.17 (m, 1H), 6.40 (s, 1H), 5.91 (s, 1H), 4.43-4.47 (m, 1H), 3.86 (d, 1H, J = 6.7 
Hz), 3.71 (s, 3H), 3.18 (dd, 1H, J = 17.1, 6.8 Hz), 2.52-2.71 (m, 4H), 2.01 – 2.22 (m, 2H), 1.17 (d, 
3H, J = 6.1 Hz); 13C NMR (75 MHz, CDCl3) δ 209.9 (C), 137.1 (C), 133.8 (C), 126.4 (C), 126.1 
(CH2), 121.7 (C), 121.0 (CH), 119.4 (CH), 118.2 (CH), 108.9 (CH), 106.6 (C), 62.1 (CH), 61.6 
(CH), 45.2 (CH), 34.3 (CH2), 30.2 (CH2), 29.3 (CH3), 20.7 (CH2), 19.8 (CH3); EIMS HRMS (ESI) 
m/z (M + H)+ calcd for C19H22IN2O, 421.0777, found 421.0789. 
 
General procedure for copper-mediated cross-coupling reaction (preparation of 17/19/21/23, 
individually) 
 
Condition 1 (Table 1, entries 1-4): In a sealed tube with a magnetic stir bar, a mixture of vinyl 
iodide 22 (1.0 mmol), CuI (0.5 -1.0 equiv), cis-1,2- cyclohexanediol (0.5 – 1.0 equiv), and Cs2CO3 
(2.0 - 4.0 mmol) was added dry DMF (2.0 mL). The mixture was degassed under reduced pressure 
at rt and refilled with argon (3-4 times). The reaction mixture was then placed on a pre-heated oil 
bath (130 oC) and heated under argon for 10 h. At this point TLC (silica gel, EtOAc/hexane = 1:3) 
indicated the absence of starting material 22. The mixture was cooled to rt and diluted with EtOAc 
(10 mL) and water. The aqueous layer was separated and extracted with EtOAc (2 x 10 mL). The 
combined organic layers were washed with water (2 x 50 mL) and brine (3 x 50 mL) and dried 
(Na2SO4). The solvent was removed under reduced pressure and the residue was purified by 
chromatography on neutral alumina (EtOAc/hexane = 1:3) to provide the cross-coupling products 
23 (22-53%) and 23' (5-17%). Pentacyclic ketones 22, 23, and 23' (individually) gave colorless 
crystals from DCM, EtOAc and CHCl3, respectively, and they were used for X-ray analysis (for 
X-ray data see Appendix B). 
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Condition 2: In a sealed tube with a magnetic stir bar, a mixture of vinyl iodide 16/18/20/22 
(individually, 1.0 mmol), CuI or catalyst (0.1 – 1.0 equiv), cis-1,2- cyclohexanediol (0.1 – 1.0 
equiv), and Cs2CO3 (0 - 4.0 equiv) and TEMPO (2.5- 3.0 equiv) was added dry DMF (2.0 mL). 
The mixture was degassed under reduced pressure at rt and refilled with argon (3-4 times). The 
reaction mixtures (individually) were then placed on a pre-heated oil bath (130 oC) and heated 
under argon for 10 h. At this point TLC (silica gel, EtOAc/hexane = 1:3) indicated the absence of 
starting material 16/18/20/22. The mixture was cooled to rt and diluted with EtOAc (10 mL) and 
water. The aq layer was separated and extracted with EtOAc (2 x 10 mL). The combined organic 
layers were washed with water (2 x 50 mL), brine (3 x 50 mL) and dried (Na2SO4). The solvent 
was removed under reduced pressure and the residue was purified by chromatography on neutral 
alumina (EtOAc/hexane = 1:3) to provide the cross-coupling products 17 (83%) /19 (86%) /21 
(82%) /23 (24-89%), individually. Compound 19 gave colorless crystals from EtOAc and was used 
for X-ray analysis (for X-ray data see Appendix B). 
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(6S,8S,11aS)-8-Methyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-methanoindolo[3,2-
b]quinolizin-11(5H)-one (17) 
 
1H NMR (300 MHz, CDCl3): δ 7.76 (brs, 1H), 7.50 (d, 1H, J = 7.5 Hz), 7.27-7.29 (m, 1H), 7.10-
7.19 (m, 2H), 5.12 (d, 1H, J = 2.5 Hz), 5.01 (d, 1H, J = 2.5 Hz), 4.31-4.35 (m, 1H), 3.81-3.90 (m, 
1H), 3.74 (d, 1H, J = 5.6 Hz), 3.34 (dd, 1H, J = 15.6, 1.2 Hz), 3.06-3.10 (dd, 1H, J = 3.6, 1.9 Hz), 
2.93 (dd, 1H, J = 15.6, 6.1 Hz), (2.51-2.60 (m, 1H), 2.16-2.23 (m, 1H), 1.50 (d, 3H, J = 6.8 Hz). 
4.74.84.95.05.15.25.35.45.55.65.75.85.96.06.16.26.36.46.56.66.76.86.9 ppm
4.74.84.95.05.15.25.35.45.55.65.75.85.96.06.16.26.36.46.56.66.76.86.9 ppm
Crude Rx: without TEMPO (condition 1) 
Crude Rx: with TEMPO (condition 2) 
Cross-coupling of 22 under condition 1: 1H NMR δ 4.5–7.0 ppm 
4.74.84.95.05.15.25.35.45.55.65.75.85.96.06.16.26.36.46.56.66.76.86.9 ppm
4.74.84.95.05.15.25.35.45.55.65.75.85.96.06.16.26.36.46.56.66.76.86.9 ppm
4.74.84.95.05.15.25.35.45.55.65.75.85.96.06.16.26.36.46.56.66.76.86.9 ppm
4.74.84.95.05.15.25.35.45.55.65.75.85.96.06.16.26.36.46.56.66.76.86.9 ppm
Crude Rx 
Comparison between conditions 1 and 2 
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All other spectroscopic data were identical with the published data for 17.25 This material was used 
for the next step without further characterization. 
(6S,8S,11aS)-5,8-Dimethyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-methanoindolo[3,2-
b]quinolizin-11(5H)-one (19) 
 
1H NMR (300 MHz, CDCl3): δ 7.50 (d, 1H, J = 7.4 Hz), 7.24-7.26 (m, 1H), 7.18 (td, 1H, J = 7.5, 
0.9 Hz), 7.05-7.10 (m, 1H), 5.1 (d, 1H, J = 2.5 Hz), 5.01 (d, 1H, J = 2.5 Hz), 4.41 (dd, 1H, J = 9.5, 
2.1 Hz), 3.87-3.95 (m, 1H), 3.72 (d, 1H, J = 5.6 Hz), 3.6 (s, 3H), 3.34 (dd, 1H, J = 15.6, 1.3 Hz), 
3.05-3.07 (m, 1H), 2.92 (dd, 1H, J = 15.6, 6.1 Hz), 2.57-2.65 (m, 1H), 2.10-2.17 (m, 1H), 1.49 (d, 
3H, J = 6.7 Hz). All other spectroscopic data were identical with the published data for 19.21 This 
material was used for the next step without further characterization. 
(6S,8S,11aS)-8-Methyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-methanoindolo[3,2-
b]quinolizin-11(5H)-one (21) 
 
1H NMR  (300 MHz, MeOD): δ 7.42 (d, 1H, J = 7.7 Hz), 7.29 (d, 1H, J = 8.0 Hz), 7.06-7.11 (m, 
1H), 6.98-7.03 (m, 1H), 5.14 (d, 1H, J = 2.2 Hz), 5.06 (d, 1H, J = 1.6 Hz), 4.57-4.61 (m, 1H), 3.99-
4.06 (m, 1H), 3.71 (d, 1H, J = 6.0 Hz), 3.25-3.34 (m, 1H, merged with solvent), 2.98-3.05 (m, 2H), 
2.56-2.64 (m, 1H), 2.09-2.16 (m, 1H), 1.66 (d, 3H, J = 7.1 Hz); 13C NMR (75 MHz, CH3OD): δ 
216.7 (C), 147.6 (C), 136.9 (C), 136.0 (C), 126.6 (C), 121.2 (CH), 118.6 (CH), 117.4 (CH), 110.7 
(CH), 110.1(CH2), 104.0 (C), 66.4 (CH), 58.8 (CH), 51.8 (CH), 44.3 (CH), 36.7 (CH2), 21.9 (CH2), 
19.2 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for C18H19N2O, 279.1492, found 279.1491. 
(6S,8R,11aS)-5,8-Dimethyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-
methanoindolo[3,2-b]quinolizin-11(5H)-one (23) 
 
208 
 
1H NMR (300 MHz, CDCl3) δ 7.48 (d, 1H, J = 7.7 Hz), 7.24-7.26 (m, 1H), 7.16-7.21 (m, 1H), 
7.06-7.11 (m, 1H), 5.10 (d, 1H, J = 1.8 Hz), 4.98 (d, 1H, J = 1.8 Hz), 4.57 (dd, 1H, J = 9.3, 1.9 
Hz), 3.92-4.00 (m, 1H), 3.61 (s, 3H) 3.56 (d, 1H, J = 6.1 Hz), 3.29-3.36 (m, 1H), 3.00-3.08 (m, 
2H), 2.51-2.59 (m, 1H), 2.11 (dt, 1H, J = 12.6, 3.2 Hz), 1.67 (d, 3H, J = 7.1 Hz); 13C NMR (75 
MHz, CDCl3) : δ 217.3 (C), 148.0 (C), 137.6 (C), 137.4 (C), 126,6 (C), 121.4 (CH), 119.2 (CH), 
118.5 (CH), 110.9 (CH2), 108.7 (CH), 105.0 (C), 66.9 (CH), 59.1 (CH), 51.7 (CH), 43.2 (CH), 
36.5 (CH2), 29.3 (CH3), 22.6 (CH2), 20.7 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for C19H21N2O, 
293.1654, found 293.1678. 
 
(6S,8R,12aS)-5,8-Dimethyl-8,11,12a,13-tetrahydro-5H-6,11-methanoazepino 
[1',2':1,6]pyrido [3,4-b]indol-12(6H)-one (23') 
 
1H NMR (300 MHz, CDCl3): δ 7.46 (d, 1H, J = 7.7 Hz), 7.23-7.26 (m, 1H), 7.17 (t, 1H, J = 7.4 
Hz), 7.07 (t, 1H, J = 7.3 Hz), 5.9 (t, 1H, J = 9.6 Hz), 5.71 (dd, 1H, J = 10.2, 3.2 Hz), 4.6 (d, 1H, J 
= 8.9 Hz), 4.04-4.13 (m, 1H), 3.89 (d, 1H, J = 5.7 Hz), 3.61 (s, 3H), 3.27 (dd, 1H, J = 15.1, 1.3 
Hz), 2.99 (dd, 1H, J = 15.1, 6.0 Hz), 2.82-2.89 (m, 2H), 2.33 (dd, 1H, J = 13.0, 7.2 Hz), 1.56 (d, 
3H, J = 7.1 Hz); 13C NMR (75 MHz, CDCl3): δ 213.4 (C), 138.5 (C), 137.4 (C), 135.7 (CH), 126.9 
(CH), 126.7(CH), 121.4 (CH), 119.1 (CH), 118.5 (CH), 108.7 (CH), 106.2 (C), 64.2 (CH), 62.4 
(CH), 45.9 (CH), 44.3 (CH), 43.0 (CH2), 29.4 (CH3), 25.2 (CH2), 18.9 (CH3). HRMS (ESI):  m/z 
(M + H)+ calcd for C19H21N2O, 293.1654, found 293.1661. 
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Procedure for synthesis of 32 from 1721 
 
A mixture of anhydrous potassium tert-butoxide (3.18 g, 28.36 mmol) and methoxy-
methyltriphenylphosphonium chloride (8.98 g, 26.21 mmol) in dry benzene (70 mL) was allowed 
to stir at rt for 1 h. The solution turned orange-red. The pentacyclic ketone 17 (1.0 g, 3.59 mmol) 
in THF (20 mL) was then added to the above solution dropwise at 0 °C. The reaction mixture, 
which resulted, was stirred at rt for 12 h. After 12 h at rt analysis of the mixture by TLC indicated 
the absence of starting material 17. The mixture was then diluted with EtOAc (100 mL) and the 
reaction was quenched with water (50 mL). The aq layer was extracted with EtOAc (2 x 15 mL), 
and the combined organic layers were washed with brine (2 x 30 mL) and dried (Na2SO4). The 
solvent was removed under reduced pressure to afford the enol ethers as a brownish red oil. The 
baseline materials (silica gel, TLC) were removed by percolation through a wash column. The 
solvent was removed under reduced pressure and the residue was dissolved (without further 
purification) in a solution of THF/H2O (1:1, 24 mL). To the above mixture a solution of aq 12 N 
conc HCl (4 mL) was added and the mixture which resulted was stirred at 55 °C (oil bath 
temperature) for 6 h. The reaction mixture was then cooled to 0 °C and extracted with hexanes (4 
x 100 mL) to remove the phosphorous byproducts, after which the aq layer was then brought to 
pH 8 with an ice-cold solution of 14% aq NH4OH. The aq layer was extracted with EtOAc (3 x 15 
mL), and the combined organic layers were washed with brine (2 x 30 mL) and dried (Na2SO4). 
The solvent was removed under reduced pressure to afford 32 as a waxy solid (945 mg, 90%).  
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(6S,8S,11R,11aS)-8-methyl-9-methylene-5,6,8,9,10,11,11a,12-octahydro-6,10-
methanoindolo[3,2-b]quinolizine-11-carbaldehyde (32)  
 
1H NMR (300 MHz, CDCl3): δ 9.61 (s, 1H), 8.12 (brs, 1H), 7.46 (d, 1H, J = 7.5 Hz), 7.28-7.32 
(m, 1H), 7.08-7.18 (m, 2H), 4.91 (d, 1H, J = 2.4 Hz), 4.86 (d, 1H, J = 2.0 Hz), 4.23 (d, 1H, J = 9.0 
Hz), 3.82-3.86 (m, 1H), 3.53-3.60 (m, 1H), 3.10 (dd, 1H, J = 15.7, 4.8 Hz), 2.81-2.85 (m, 1H), 
2.61 (d, 1H, J = 15.7 Hz), 2.43 (d, 1H, J = 7.3 Hz),  2.12-2.19 (m, 1H), 1.74-1.82 (m, 1H), 1.42 (d, 
3H, J = 6.8 Hz); All other spectroscopic data was identical with the published data for 32.21 The 
material was used for the next step without further characterization. 
 
 
Procedure for the preparation of 33 from 32 
 
 
The aldehyde 32 (450 mg, 1.53 mmol) was dissolved in EtOH (8 mL). The NaBH4 (87 mg, 2.29 
mmol) was added to the above solution in one portion at 0 C. The mixture was then stirred at 0 
C for 6 h. The reaction mixture was diluted with CH2Cl2 (50 mL) and poured into ice cold water 
(30 mL). The aq layer was extracted with additional CH2Cl2 (3  30 mL), and the combined organic 
layers were washed with brine (2 x 50 mL) and dried (Na2SO4). The solvent was removed under 
reduced pressure to afford the crude product, which was purified by chromatography on silica gel 
(CH2Cl2/CH3OH = 10:1) to provide 33 (430 mg, 95%) as a waxy solid. Rf: 0.2  (silica gel, 5% 
MeOH in DCM).  
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((6S,8S,11R,11aS)-8-Methyl-9-methylene-5,6,8,9,10,11,11a,12-octahydro-6,10-
methanoindolo[3,2-b]quinolizin-11-yl)methanol (33) 
 
1H NMR (300 MHz, CDCl3) δ 8.0 (s, 1H), 7.38 (d, 1H, J = 7.4 Hz), 7.27 (d, 1H, J = 8.8 Hz), 7.05-
7.16 (m, 2H), 4.84-4.88 (m, 2H), 4.02 (d, 1H, J = 9.0 Hz), 3.48-3.53 (m, 1H), 3.43 (d, 1H, J = 6.9 
Hz), 2.86-2.97 (m, 2H), 2.55 (d, 1H, J = 14.3 Hz), 2.39 (bs, 1H), 2.27 (s, 1H), 1.92-2.00 (m, 1H), 
1.59 (q, 1H, J = 6.7 Hz) 1.50 (dt, 1H, J = 12.7, 3.0 Hz), 1.34 (d, 3H, J = 6.8 Hz); 13C NMR (75 
MHz, CDCl3) δ 152.3 (C), 138.0 (C), 136.3 (C), 127.7 (C), 121.3 (CH), 119.3 (CH), 118.1 (CH), 
110.9 (CH), 107.8 (CH2), 104.9 (C), 64.7 (CH2), 57.9 (CH), 51.9 (CH), 48.2 (CH), 44.5 (CH), 36.1 
(CH), 33.7 (CH2), 27.0 (CH2), 16.6 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for C19H23N2O, 
295.1805, found 295.1802.  
Procedure for the preparation of 34 from 33 
 
 
A solution of the alcohol 33 (400 mg, 1.36 mmol) in dry CH2Cl2 (20 mL) was cooled to 0 
oC, after 
which 2, 6-lutidine (0.474 mL, 4.08 mmol) was added, and this was followed by addition of 
TIPSOTf (0.547 mL, 2.04 mmol) to the stirred solution. The mixture was then allowed to stir for 
an additional 2 hours at 0 oC, after which cold water (5 mL) was added to quench the reaction. The 
reaction mixture was diluted with CH2Cl2 (50 mL) and poured into cold water (20 mL). The aq 
layer was extracted with additional CH2Cl2 (2 x 30 mL), and the combined organic layers were 
washed with brine (3 x 30 mL) and dried (Na2SO4). The solvent was removed under reduced 
pressure and the residue was purified by chromatography on silica gel using 2-5% MeOH in DCM 
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to provide the O-TIPS ether 34 as a white colored solid (576 mg, 94%). Rf:  0.35 (silica gel, 5% 
MeOH in DCM); 
(6S,8S,11R,11aS)-8-Methyl-9-methylene-11-(((triisopropylsilyl)oxy)methyl)-5,6,8,9,10,-
11,11a,12-octahydro-6,10-methanoindolo[3,2-b]quinolizine (34) 
 
1H NMR (300MHz, CDCl3): δ 8.35 (brs, 1H), 7.48 (d, 1H, J =7.4 Hz), 7.35 (d, 1H, J = 7.8 Hz), 
7.08-7.18 (m, 2H), 4.88 (dd, 2H, J = 8.2, 2.3 Hz), 4.23 (d, 1H, J = 9.6 Hz), 3.60 (dd, 2H, J = 7.5, 
2.3 Hz), 3.47-3.56 (m, 1H), 3.00-3.12 (m, 2H), 2.78 (d, 1H, J = 15.1 Hz), 2.42 (bs, 1H), 2.12 (t, 
1H, J =11.3 Hz), 1.86 (q, 1H, J = 7.4 Hz), 1.76 (d, 1H, J =12.5  Hz), 1.39 (d, 3H, J = 6.8 Hz), 1.06-
1.07 (m, 21H); 13C NMR (75 MHz, CDCl3): δ 150.7 (C), 137.2 (C), 136.4 (C), 127.6 (C), 121.5 
(CH), 119.3 (CH), 118.1 (CH), 111.1 (CH), 108.2 (CH2), 104.8 (C), 65.5 (CH2), 58.3 (CH), 52.3 
(CH), 49.3 (CH), 44.1 (CH), 35.6 (CH), 33.6 (CH2), 27.0 (CH2), 18.1 (6 x CH3), 16.5 (CH3), 11.9 
(3 x CH); HRMS (ESI) m/z (M + H)+ calcd for C28H43N2OSi, 451.3139, found 451.3122. 
 
Procedure for the preparation of 35 from 34 
 
 
 
To a solution of the TIPS ether 34 (150 mg, 0.332 mmol) in dry THF (5 mL) was added BH3∙DMS 
(2.0 M solution in THF, 1.49 mL, 2.99 mmol) at rt. The mixture which resulted was stirred at rt 
for 3 h. The reaction mixture was then quenched by careful addition of ice cold water (4 mL) at 0 
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°C (initial addition of water resulted in a large amount of effervescence). At this point 
NaBO3∙4H2O (1.22 g, 7.97 mmol) was added to the mixture in one portion at 0 °C. The mixture 
which resulted was allowed to stir at rt for 2 h after which EtOAc (50 mL) and H2O (15 mL) were 
added. The organic layer was separated, washed with water (3 x 10 mL), brine (2 x 20 mL) and 
dried (Na2SO4). The EtOAc was then removed under reduced pressure to provide the Nb-BH3 
complex. The residue was dissolved in freshly distilled MeOH (20 mL) and Na2CO3 (176 mg, 1.66 
mmol) was added. The mixture was then warmed to 60 °C (oil bath) for 5 h under vigorous stirring. 
The reaction mixture which resulted was cooled to rt and this was followed by filtration through a 
bed of celite to remove the solids. The filtrate was concentrated under reduced pressure to provide 
a turbid oil which was redissolved in CH2Cl2. The CH2Cl2 layer was washed with H2O (1 x 10 
mL), brine (4 x 10 mL) and dried (Na2SO4). The solvent was removed under reduced pressure to 
afford a crude solid, which was purified by flash chromatography (silica gel, 5-8% MeOH in 
DCM) and furnished the primary alcohol 35 (113 mg, 73 %). Rf : 0.2 (silica gel, 10 % MeOH in 
DCM). 
 
((6S,8S,9S,11R,11aS)-8-Methyl-11-(((triisopropylsilyl)oxy)methyl)-5,6,8,9,10,11,11a,12-
octahydro-6,10-methanoindolo[3,2-b]quinolizin-9-yl)methanol (35)  
 
1H NMR (300MHz, CDCl3): δ 8.26 (brs, 1H), 7.46 (d, 1H, J = 7.5 Hz), 7.35 (d, 1H, J = 7.8 Hz), 
7.07-7.18 (m, 2H), 4.12-4.18 (m, 1H), 3.86-3.94 (m, 1H), 3.69-3.81 (m, 3H), 3.19-3.32 (m, 2H), 
2.99 (dd, 1H, J = 15.4, 4.8 Hz), 2.69 (d, 1H, J =15.4 Hz), 2.23 (brs, 1H), 1.83-2.07 (m, 3H), 1.62-
1.66 (m, 1H), 1.31 (d, 3H, J = 7.3 Hz), 1.03-1.05 (m, 21H); 13C NMR (75 MHz, CDCl3): δ 137.7 
(C), 136.3 (C), 127.8 (C), 121.3 (CH), 119.2 (CH), 118.1 (CH), 111.0 (CH), 104.9 (C), 66.9 (CH2), 
63.1 (CH2), 54.2 (CH), 52.5 (CH), 49.0 (CH), 41.2 (CH), 40.0 (CH), 36.9 (CH2), 27.5 (CH2), 25.0 
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(CH), 18.0 (6 x CH3), 13.1 (CH3), 11.9 (3 x CH); HRMS (ESI) m/z (M + H)
+ calcd for 
C28H45N2OSi, 469.3245, found 469.3227. 
 
Procedure for the preparation of 36 from 35 
 
 
To a stirred solution of N-chlorosuccinimide (89.7 mg, 0.672 mmol) in dry CH2Cl2 (2.5 mL) was 
added dimethyl sulfide (99 μL, 1.34 mmol) at -5 to -15 °C (outside bath temperature) under argon. 
A white precipitate appeared immediately after addition of the sulfide, which was stirred for an 
additional 0.5 h at the above mentioned temperature range. After 0.5 h, the temperature of the 
reaction mixture was lowered to -78 °C (acetone-dry ice bath). The alcohol 35 (90 mg,  0.192 
mmol) in dry CH2Cl2 (3.0 mL) was also cooled at -78 °C and then added to the white complex, 
and the stirring was continued for 2 h at -78 °C. A solution of distilled triethylamine (105 μL, 0.77 
mmol) was then added to the above mixture dropwise (neat) and the stirring was continued for an 
additional 1 h at -78 °C. Upon completion of the reaction, the reaction mixture was quenched at -
78 °C by addition of excess CH2Cl2 and H2O. The organic layer was separated, washed with brine 
and dried (Na2SO4). The solvent was removed under reduced pressure to provide the mixture of 
crude aldehydes. Analysis of the 1H NMR spectrum of the residue indicated the formation of the 
mixture of epimeric aldehydes, which contained the α-aldehyde as major product. The epimeric 
mixture of aldehydes was dissolved in a solution of MeOH (10 mL) with triethylamine (1.2 mL) 
and the mixture was stirred overnight at rt to effect the epimerization. The methanol was then 
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removed under high vaccum to give aldehyde 36 as an oil (65 mg, 72 %). The complete 
epimerization from the mixture of α and β aldehydes into only the α-aldehyde in high yield was 
confirmed by 1H NMR spectroscopy. This compound was not subjected to chromatographic 
purification and was used for the next step directly. 
(6S,8S,9R,11R,11aS)-8-Methyl-11-(((triisopropylsilyl)oxy)methyl)-5,6,8,9,10,11,11a,12-
octahydro-6,10-methanoindolo[3,2-b]quinolizine-9-carbaldehyde (36)  
 
Rf = 0.3 (silica gel, 10 % MeOH in DCM); 13C NMR (300 MHz, CDCl3): δ203.7 (CH), 138.1 (C), 
136.4 (C), 127.6 (C), 121.1 (CH), 119.1 (CH), 117.9 (CH), 111.1 (CH), 104.9 (C), 64.4 (CH2), 
52.0 (CH), 51.8 (CH), 51.4 (CH), 47.7 (CH), 42.14 (CH), 30.1 (CH2), 26.9 (CH2), 26.8 (CH), 19.1 
(CH3), 18.1 (6 x CH3), 11.9 (3 x CH); HRMS (ESI) m/z (M + H)
+ calcd for C28H43N2O2Si, 
467.3088, found 467.3073. 
 
One-pot conversion of 36 into indolebases 39 and 40 with stereospecific formation of the β-
methyl function 
 
 
 
To a solution of the aldehyde 36 (55 mg, 0. 12 mmol) in MeOH was added an excess of MeI (0.4 
mL) at 0 °C, after which the mixture was allowed to stir in the dark at 0 °C overnight. Upon 
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completion of the reaction, the solvent was removed under high vacuum to provide the N4-methyl 
salt 37 (50.5 mg, 89%): Rf 0.3 (basic alumina, DCM/MeOH, 4.9 : 0.1); LRMS (ESI) m/z (M)
+ 
calcd for C29H45N2O2Si, 481.32, found 481.35; HRMS (ESI) m/z (M+CH3OH)
+ calcd for 
C30H49N2O3Si, 513.3507, found 513.3497. This material was used for the next reaction without 
purification. 
To a solution of 37 (50 mg, 0.104 mmol) in THF (3 mL), NaHMDS (38.1 mg, 0.21 mmol) was 
added at rt. The mixture was allowed to stir at rt overnight. After that time examination of a LCMS 
spectrum indicated the disappearance of 37, LRMS (M+H)+ predicted for C29H45N2O2Si, 481.33, 
found 481.45. The THF was removed under reduced pressure to provide 38 as brownish oil (47.5 
mg, 95% crude yield). HRMS (ESI) m/z (M + H)+ calcd for C29H45N2O2Si, 481.3245, found 
481.3229. This material was used directly for the next step. 
A solution of 38 (30 mg, 0.06 mmol) in 10 mL of aq 0.1 N HCl (THF: H2O = 1: 1) was heated 
overnight at 60 oC. After that time, the solution was cooled to rt and brought to pH 8 with cold aq 
NH4OH. The solution was extracted with DCM (3 x 10 mL). The combined organic layers were 
washed with brine and dried over Na2SO4 to provide a mixture of aldehydes 39 and 40 yellowish 
oil (16.3 mg, 80 % crude yield). This mixture was purified by flash chromatography on silica-gel 
(1-3% MeOH in DCM) to provide pure 39 (7.5 mg) and 40 (7 mg) with 72% combined isolated 
yield. 
 
(3S,4S,4aR,6S,13S,13aR)-3,14-Dimethyl-1,3,4,4a,5,6,7,12,13,13a-decahydro-6,13-
epiminopy-rano[3',4':5,6]cycloocta[1,2-b]indole-4-carbaldehyde (39) 
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1H NMR (300 MHz, CDCl3): δ 9.97 (d, 1H, J = 2.8 Hz), 7.80 (brs, 1H), 7.51 (d, 1H, J = 7.4 Hz), 7.35 (d, 
1H, J = 7.5 Hz), 7.11-7.21 (m, 2H), 4.17 (t, 1H, J = 11.6 Hz), 3.88-4.01 (m, 3H), 3.29 (dd, 1H, J = 16.5, 
7.0 Hz), 2.94 (d, 1H, J = 6.4 Hz), 2.46-2.55 (m, 2H), 2.37 (s, 3H), 2.21-2.26 (m, 1H), 2.07-2.11 (m, 1H), 
1.81 (brs, 1H), 1.51-1.55 (m, 1H), 1.33 (d, 3H, J = 6.7 Hz); 13C NMR (75 MHz, CDCl3): δ 204.6 (CH), 
135.7 (C), 131.3 (C) 126.9 (C), 121.6 (CH), 119.5 (CH), 118.2 (CH), 110.8 (CH), 107.5 (C), 69.5 (CH), 
68.8 (CH2), 54.9 (CH), 54.6 (CH), 54.5 (CH), 41.6 (CH3), 39.4 (CH), 30.5 (CH2), 27.0 (CH), 22.4 (CH2), 
19.2 (CH3); Rf : 0.5 (10% MeOH in DCM);  HRMS (ESI) m/z (M + H)+ calcd for C20H25N2O2, 325.1911, 
found 325.1916. 
(3S,4R,4aR,6S,13S,13aR)-3,14-Dimethyl-1,3,4,4a,5,6,7,12,13,13a-decahydro-6,13-epiminop-
yrano[3',4':5,6]cycloocta[1,2-b]indole-4-carbaldehyde (40) 
 
13C NMR (75 MHz, CDCl3): δ 203.1 (CH), 135.7 (C), 131.6 (C), 126.9 (C), 121.6 (CH), 119.5 
(CH), 118.0 (CH), 111.0 (CH), 107.7 (C), 67.8 (CH), 67.2 (CH2), 57.8 (CH), 55.0 (CH), 54.5 (CH), 
42.6 (CH), 41.6 (CH3), 27.4 (CH2), 26.4 (CH), 22.4 (CH2), 20.3 (CH3); Rf : 0.3 (10% MeOH in 
DCM, silica gel); HRMS (ESI) m/z (M + H)+ calcd for C20H25N2O2, 325.1911, found 325.1917. 
 
Macrocarpine E (5) 
 
 
The aldehyde 39 (5.3 mg, 0.016 mmol) was dissolved in EtOH (1 mL) and cooled to 0 oC. Then 
NaBH4 (0.93mg, 0.024 mmol) was added to the above solution in one portion. The mixture, which 
resulted, was stirred at 0 oC for 5 h. After 5 h, examination of TLC and LCMS indicated the 
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disappearance of the aldehyde. The reaction mixture was diluted with DCM (5 mL) and poured 
into ice cold water. The organic layer was separated and the aq layer was extracted with additional 
DCM (2 x 5 mL). The combined organic layers were washed with brine (2 x 10 mL) and dried 
(Na2SO4). The solvent was removed under reduced pressure and the residue was purified by 
chromatography on silica gel from a Pasteur pipette (2-4 % MeOH in DCM) to give 5.1 mg (96%) 
of macrocarpine E (5) as a white color waxy solid. 
1H NMR (300 MHz, CDCl3): δ 7.74 (brs, 1H), 7.49 (d, 1H, J = 7.4 Hz), 7.33 (d, 1H, J = 7.4 Hz), 
7.09-7.18 (m, 2H), 4.08 (t, 1H, J = 11.7 Hz), 3.94-3.99 (m, 1H), 3.86-3.92 (m, 1H), 3.76-3.84 (m, 
2H), 3.64-3.72 (m,1H), 3.25 (dd, 1H, J = 16.6, 6.7 Hz), 2.86 (d, 1H, J = 6.7 Hz), 2.47 (d, 1H, J = 
16.6 Hz), 2.47 (m, 1H, merged), 2.33 (s, 3H), 2.16 (dd, 1H, J = 11.3, 5.2 Hz), 1.99-2.05 (m, 1H), 
1.44-1.48 (m, 1H), 1.24 (d, 3H, J = 6.6 Hz), 1.06 (brs, 1H); 13C NMR (75 MHz, CDCl3): δ135.7 
(C), 132.0 (C), 127.0 (C), 121.4 (CH), 119.4 (CH), 118.1 (CH), 110.8 (CH), 107.6 (C), 71.3, 68.9 
(CH2), 63.3, 55.0 (CH), 54.6 (CH), 43.5 (CH), 41.6 (CH3), 39.4 (CH), 31.4 (CH2), 28.9 (CH), 22.5 
(CH2), 18.8 (CH3); Rf : 0.4 (10% MeOH in DCM); HRMS (ESI) m/z (M + H)
+ calcd for 
C20H27N2O2, 327.2067, found 327.2072; [α]D25 (c 0.45, CHCl3): -13.33 lit. [α]D25 (c 0.8, CHCl3): 
-12. The spectroscopic data and optical rotation were in excellent agreement with those of natural 
macrocarpine E.10  
 
Macrocarpine D (4) 
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The aldehyde 40 (4.2 mg, 0.013 mmol) was dissolved in EtOH (1mL) and the mixture was cooled 
to 0 oC. Then NaBH4 (0.74 mg, 0.02 mmol) was added to the above solution in one portion. The 
mixture, which resulted, was stirred at 0 oC for 5 h. After 5 h, examination of TLC and LCMS 
indicated the disappearance of the aldehyde. The reaction mixture was diluted with DCM (5 mL) 
and poured into ice-cold water. The organic layer was separated and the aq layer was extracted 
with additional DCM (2 x 5 mL). The combined organic layers were washed with brine and dried 
(Na2SO4). The solvent was removed under reduced pressure and the residue was purified by 
chromatography on silica gel from a Pasteur pipette (1-3 % MeOH in DCM) to give 3.9 mg (92%) 
of macrocarpine D (4) as a white-color waxy solid. 
1H NMR (500 MHz, CDCl3): δ 7.71 (brs, 1H), 7.49 (d, 1H, J = 7.5 Hz), 7.32 (d, 1H, J = 7.7 Hz), 
7.15 (t, 1H, J = 7.1 Hz), 7.14 (t, 1H, J = 7.1 Hz), 4.06 (t, 1H, J = 11.6 Hz), 3.89-3.91 (m, 1H), 3.74 
(dd, 1H, J = 11.4, 4.5 Hz), 3.48-3.53 (m, 2H), 3.35 (dd, 1H, J = 10.7, 8.3 Hz), 3.26 (dd, 1H, J = 
16.5, 6.8 Hz), 2.91 (d, 1H, J = 6.8 Hz), 2.43 (d, 1H, J = 16.5 Hz), 2.32 (s, 3H), 2.26 (td, 1H, J = 
12.8, 4.0 Hz), 1.98-2.02 (m, 1H), 1.85-1.89 (m, 1H), 1.58 (dt, 1H, J = 12.6, 3.8 Hz), 1.47-1.52 (m, 
1H), 1.16 (d, 3H, J = 6.1 Hz); 13C NMR (75 MHz, CDCl3): δ 135.7 (C), 132.2 (C), 127.1 (C), 
121.3 (CH), 119.4 (CH), 117.9 (CH), 110.9 (CH), 107.7 (C), 70.5 (CH), 67.7 (CH2), 61.7 (CH2), 
55.1 (CH), 54.9 (CH), 46.9 (CH), 43.6 (CH), 41.6 (CH3), 27.1 (CH), 26.1 (CH2), 22.5 (CH2), 20.3 
(CH3); Rf : 0.33 (10% MeOD in DCM); HRMS (ESI) m/z (M + H)
+ calcd for C20H27N2O2, 
327.2067, found 327.2060. [α]D25 (c 0.85, CHCl3): -44.71  lit. [α]D25(c 0.89, CHCl3): -43. The 
spectroscopic data and optical rotation were in excellent agreement with that of the natural 
macrocarpine D.9  
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4.1 BIOGENETIC NUMBERING FOR MACROCARPINE D (4) AND MACROCARPINE 
E (5)9,10  
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4.2. COMPARISON TABLES 1 & 2 FOR NATURAL AND SYNTHETIC MACROCA-
RPINE D (4) 
Macrocarpine D (4) 
Specific rotation: 
Natural9: [α]D25 = -43 (c 0.89, CHCl3); Synthetic: [α]D25 = -44.7 (c 0.85, CHCl3) 
 
 
Table 2. Comparison of the 1H NMR Spectral Data for Natural and Synthetic 
Macrocarpine D (4) in CDCl3 
 
H 
 
 
1H Natural9 
(400 MHz) 
1H Synthetic 
(500 MHz) 
3 3.95 m 3.89-3.91 m 
5 2.94 d (7) 2.91 d (6.8) 
6b 2.46 d (16) 2.43 d (16.5) 
6a 3.27 dd (16, 7) 3.26 dd (16.5, 6.8) 
9 7.49 d (7.5) 7.49 d (7.5) 
10 7.11 t (7.5) 7.14t (7.1) 
11 7.15 t (7.5) 7.15 t (7.1 Hz) 
12 7.32 d (7.5) 7.32 d (7.7) 
14b 1.62 dt (13, 4) 1.58 dt (12.6, 3.8) 
14a 2.28 td (13, 4) 2.26 td (12.8, 4.0) 
15 2.01 m 1.98-2.02 m 
16 1.89 dt (12, 4) 1.85-1.89 m 
17b 3.74 dd (12, 5) 3.74 dd (11.4, 4.5) 
17a 4.08 t (12) 4.06 t (11.6) 
18 1.16 d (6) 1.16 d (6.1) 
19 3.50 m 3.48-3.53 m (19 and 
21b merged together) 
20 1.50 m 1.47-1.52  m 
21a 3.34 dd (11, 8) 3.35 dd (10.7, 8.3) 
21b 3.50 dd (11, 5) 3.48-3.53 m  
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Na-H 7.89 br s 7.71 br s 
N4-Me 2.34 s 2.32 s 
 
C# 
 
 
13C Natural9 
(100 MHz) 
13C Synthetic 
(75 MHz) 
2 132.2 132.2 
3 55.0 54.9 
5 55.1 55.1 
6 22.5 22.5 
7 107.7 107.7 
8 127.1 127.1 
9 118.0 117.9 
10 119.4 119.4 
11 121.3 121.3 
12 110.9 110.9 
13 135.5 135.7 
14 26.1 26.1 
15 27.1 27.1 
16 43.6 43.6 
17 67.7 67.7 
18 20.3 20.3 
19 70.5 70.5 
20 46.9 46.9 
21 61.7 61.7 
N4-Me 41.6 41.6 
Table 3. Comparison of the 13C NMR Spectral Data for Natural and Synthetic Macrocarpine 
D (4) in CDCl3 
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4.3. COMPARISON TABLES 4 & 5 FOR NATURAL AND SYNTHETIC MACROCAR-
PINE E (5) 
 
Macrocarpine E (5) 
Specific rotation: 
Natural10: [α]D25 = -12 (c 0.8, CHCl3); Synthetic: [α]D25 = -13.3 (c 0.45, CHCl3) 
 
 
Table 4. Comparison of the 1H NMR Spectral Data for Natural and Synthetic macrocarpine 
E (5) in CDCl3 
 
 
 
H 
 
 
1H Natural10 
(400 MHz) 
1H Synthetic 
(300 MHz) 
3 3.85 br t (3) 3.86-3.92 m 
5 2.82 d (7) 2.86 d (6.7) 
6b 2.43 d (17) 2.47 d (16.6) 
6a 3.23 dd (17, 7) 3.25 dd (16.6, 6.7) 
9 7.48 dd (7, 1)) 7.49 d (7.4) 
10 7.10 td (7, 1)) 7.09-7.18 m 
11 7.14 td (7, 1) 7.09-7.18 m 
12 7.31 dd (7, 1) 7.33 d (7.4) 
14b 1.44 ddd (13, 5, 3) 1.44-1.48 m 
14a 2.43 td (13, 4) Merged with 6b 
15 1.98 dt (13, 5) 1.99-2.05 m 
16 2.08 dd (12, 5) 2.16 dd (11.3, 5.2) 
17b 3.76 dd (12, 5) 3.76-3.84 m 
17a 4.04 t (12) 4.08 t (11.7) 
18 1.21 d (6.7) 1.24 d (6.6) 
19 3.93  (6.7, 2.6) 3.94-3.99 m 
20 1.06 m 1.06 brs 
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Table 5. Comparison of the 13C NMR Spectral Data for Natural and Synthetic macrocarpine 
E (5) in CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21a 3.64 dd (11, 4) 3.64-3.72  m 
21b 3.71 dd (11, 6) 3.76-3.84 m 
N1-H 8.14 br s 7.74 br s 
N4-Me 2.30 s 2.33 s 
 
C# 
 
 
13C Natural10 
(100 MHz) 
13C Synthetic 
(75 MHz) 
2 132.1 132.0 
3 54.9 55.0 
5 54.5 54.6 
6 22.5 22.5 
7 107.4 107.6 
8 126.9 127.0 
9 118.0 118.1 
10 119.3 119.4 
11 121.2 121.4 
12 110.8 110.8 
13 135.7 135.7 
14 31.3 31.4 
15 28.6 28.9 
16 39.2 39.4 
17 68.9 68.9 
18 18.7 18.8 
19 71.1 71.3 
20 43.5 43.5 
21 62.8 63.3 
N4-Me 41.5 41.6 
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5. Spectra and X-ray data: See Appendix B for X-ray data for compounds 22, 23, 23ʹ, and 
19. See Appendix C for the spectra of the synthetic macrocarpines D (4) and E (5). 
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Chapter 5 
The Total Synthesis of Talcarpine, N4-Methyl-N4,21-Secotalpinine, Dihydro-
peraksine, Deoxyperaksine, and Macrocarpines A-C 
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1. Introduction 
 
After the successful completion of the total synthesis of several of the Na-H, Nb-CH3 substituted 
alkaloids, focus turned to the total synthesis of a number of alkaloids bearing the Na-CH3, Nb-CH3 
pattern of susbstitution. In addition, a pair of sarpagine alkaloids, termed dihydroperaksine and 
deoxyperaksine bear the C-19 (S)-methyl substituent in the opposite configuration to many of the 
alkaloids of this group. Accessing these two alkaloids was envisaged to illustrate the ability of the 
strategy developed here to access alkaloids with either the C-19 (S)- or (R)-methyl substitution.  
The C-19 methyl substituted macroline/sarpagine and ajmaline alkaloids, as mentioned are an 
emerging group of biosynthetically related indole alkaloids, some of which have historical 
significance,1 and have been primarily isolated from various medicinal plants of the Apocynaceae 
family. Currently, about seventy alkaloids belong to this group (see General Introduction). Some 
of them are depicted in Figure 1. Most of these alkaloids have not been tested for their biological 
activity, presumably, due to the paucity of isolated material. Yet, some of these alkaloids have 
been shown to possess important biological activity ranging from anti-hypertensive to anticancer 
properties. Macrocarpines A-C (1-3) have been isolated from the stem bark of Alstonia 
macrophylla by Kam.2 Talcarpine (4), which was isolated from Alstonia macrophylla and 
Pleiocarpa talbotii, exhibited antimalarial activity.3-5 The N(4)-methyl-N(4),21-secotalpinine 5, 
isolated from Pleiocarpa talbotii, and Alstonia angustifolia, demonstrated promising anti-
leishmanial activity.2,4,6 Talpinine 6, another related alkaloid, exhibited moderate activity in 
reversing multidrug resistance in a vincristine–resistant KB/VJ300 cell line in the presence of 0.12 
μM vincristine.4,7 The N(4)-methyltalpinine 7, which contains a quaternary Nb-nitrogen atom, is 
the Nb-methylated version of talpinine 6, and has shown  potent and important NFκB inhibition.6 
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While the majority of these alkaloids have the β methyl configuration at C-19, a few contain the α 
C-19 methyl function (e.g., dihydroperaksine 8, also known as dihydrovomifoline and 
deoxyperaksine 9) as mentioned above.8-11 All of these alkaloids bear either an Na-methyl or Na-
hydrogen atom substituted indole nitrogen atom. Similarly, the Nb-nitrogen atom also varies in the 
pattern of substitution. Moreover, all of these alkaloids contain 6 or 7 quaternary centers with 
various substitution patterns and configurations, which render the synthesis of these alkaloids of 
interest. The challenge to access the complex architecture of these alkaloids and their promising 
biological activity stimulated interest in the total synthesis of these natural products via a general 
strategy. To illustrate the feasibility of this strategy to access either the α or  β C-19 methyl 
substituted alkaloids, stereospecifically, herein we report the total synthesis of (-)-macrocarpines 
A-C (1-3), (-)-talcarpine (4), (+)-N(4)-methyl-N(4),21-secotalpinine (5), (+)-dihydroperaksine (8) 
and (-)-deoxyperaksine (9) is reported with complete stereocontrol of the methyl function at C-19. 
 
 
Figure 1. Representative examples of chiral C-19 methyl substituted macroline/sarpagine 
alkaloids 
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Scheme 1. Retrosynthetic analysis for the total synthesis of the C-19 methyl substituted 
sarpagine/macroline alkaloids via the Pictet-Spengler/Dieckmann protocol 
 
Retrosynthetically, the E-ring of the macroline system present in e.g., macrocarpines A-C (1-3) 
should originate in a stereocontrolled fashion from a Michael-type ring closure12 of the deprotected 
alcohol onto the α,β-unsaturated aldehyde (15, Scheme 1), which in turn would be available from 
the pentacyclic ketone intermediates 16 [R = H or CH3 and (*) = (S)], according to the previously 
reported route.13,14 On the other hand, the C-19 α–methylated alkaloids dihydroperaksine 8 and 
deoxyperaksine 9 would be available from the TIPS protected diol 18, which in turn would be 
available from 17 by a hydroboration-oxidation. The olefin 17 would be accessed from the ketone 
16 [with R = H and (*) = (R)] in a few steps. The pentacyclic ketone intermediates 16 would be 
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available via a copper-mediated intramolecular cross-coupling of the vinyl iodides 19 with the 
enolate.13 The vinyl iodides (19) would be available from the TIPS-deprotected terminal alkyne 
via a completely regioselective iodoboration, after the decarboxylation of the β-keto ester 14. The 
trans-diester would originate as a sole product from the asymmetric Pictet-Spengler reaction of 
the Nb-alkylated tryptophan derivative 13 with the acetal 21 under thermodynamic control. Under 
these conditions the total synthesis would begin from commercially available D-(+)-tryptophan 23 
and the optically pure ethinyl tosylates (see 22). 
 
2. Results and Discussion 
After the successful access to ketone 25 via the new route,15,16 the key pentacyclic ketone 
intermediate 16a was prepared from the terminal alkyne 25 by conversion into the vinyl iodide 
[see Scheme 1; 19a, R = CH3, (*) = (S)], and this was followed by a copper-mediated enolate-
driven cross-coupling process similar to that reported earlier.13 The advanced intermediate, 
quaternary ammonium salt 26, which was required for accessing the macroline system, was 
synthesized by the same procedure reported previously by Edwankar.14 A retro-Michael ring 
opening of the quaternary salt 26 by treatment with sodium hexamethyldisilazane in THF 
produced, stereospecifically, the α, β-unsaturated aldehyde 15a similar to the earlier work of Le 
Quesne et al.12 In the previous report, the geometry of the olefin was not determined. We have 
confirmed the geometry of the olefin to be (Z) by the NOE observed upon irradiation of the 
aldehyde hydrogen atom  with the β-methyl group and vice versa, as shown in Scheme 2. 
Deprotection of the TIPS function under mildly acidic conditions and subsequent Michael reaction 
of the so formed alcohol onto the α, β-unsaturated aldehyde, formed the E-ring of the macroline 
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type alkaloids in excellent yield. The stereochemistry of the C-19 methyl group was found to be 
exclusively the β-stereochemistry by NMR experiments, which gave (+)-N(4)-methyl-N(4),21-
secotalpinine 5 (major) and (-)-talcarpine 4 (minor). Upon aqueous workup after deprotection of 
the TIPS group under mildly acidic conditions (0.1 N aq HCl), and subsequent treatment with t-
BuOK in THF, the desired (+)-N(4)-methyl-N(4),21-secotalpinine (5) was isolated as the exclusive 
product. This indicated the aldehyde at C-20 was in the thermodynamically more stable position 
in the α-configuration. 
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Scheme 2. Reagents and conditions: a) see ref15,16; b) see ref13; c) see ref14; d) NaHMDS (2 equiv), 
THF, rt, 12 h, 81%; e) i. 0.1 N HCl, THF, reflux, 3 h; ii. KOt-Bu (2 equiv), THF, rt, 10 h, 84%; f) 
NaBH4 (1.5 equiv), EtOH, 0 
oC, 5 h, 99%; g) Ac2O (1.5 equiv), Py (3 equiv), CH2Cl2, rt, 6 h, 92%; 
h) 0.1 N HCl, THF, reflux, 3 h, 85%; i) KOt-Bu (2 equiv), THF, rt, 10 h, 82%; j) NaBH4 (1.5 
equiv), EtOH, 0 oC, 5 h, 99%; 
 
 
Both (-)-4 and (+)-5 could easily be separated by silica gel chromatography with 1-5% methanol 
in CH2Cl2 (saturated with NH4OH). (-)-Talcarpine 4 could also be converted completely into (+)-
5 upon treatment with base (Et3N or K2CO3 in MeOH or tert-BuOK in THF). The spectral 
properties of (-)-talcarpine 4 and (+)-N(4)-methyl-N(4),21-secotalpinine 5 were in excellent 
agreement with the corresponding natural products.2 The optical rotation of (+)-5 has been revised 
by a personal communication with Professor Toh-Seok Kam [original value, Tetrahedron, 2004, 
[α]D25 = +19 (CHCl3, c 0.45); revised value: 2017 [α]D25 = +36 (CHCl3, c 0.33); synthetic sample 
in this report: [α]D25 = +34.4 (CHCl3, c 0.61)].17 The properties of synthetic sample (-)-4 in this 
report are in excellent agreement with the 1H and 13C NMR spectra of natural (-)-4. The optical 
rotation was found to be in agreement with the optical rotation reported by Kam et al2 (see later 
for details). 
After obtaining the pure aldehydes (-)-4 and (+)-5, completion of the total synthesis of (-)-
macrocarpines A-C (1-3) was undertaken. Aldehyde (-)-4 was reduced with sodium borohydride 
in ethanol to produce (-)-macrocarpine A 1 in 99% isolated yield (Scheme 2). The 1H, 13C, 2D 
NMR, UV and MS spectra of synthetic (-)-1 were in excellent agreement with the reported material 
1, except for the optical rotation ([α]D25 = +117 (CHCl3, c 0.11)].2 The original optical rotation of 
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(-)-1 has been revised by a personal communication with Professor Toh-Seok Kam and was in 
complete accord with a recent natural sample of (-)-1 [natural: Lim, 2014, unpublished, [α]D25 = -
28 (CHCl3, c 0.25);
18 synthetic, this report: [α]D25 = -28 (CHCl3, c 0.25)] and hence, the optical 
rotation of the synthetic (-)-macrocarpine A (1) and the natural product are in excellent agreement. 
The reduction of (+)-5 with sodium borohydride in ethanol furnished the natural product (-)-
macrocarpine B (2), the spectral properties and optical rotation of which were again in agreement 
with that of the natural product.2 Acetylation of alcohol (-)-2 with acetic anhydride and pyridine 
in DCM, produced (-)-macrocarpine C (3), whose properties were also in excellent agreement with 
those of the natural alkaloid (-)-3.2 
 
 
Scheme 3: Reagents and conditions: a) see ref13,15,16 ; b) Ph3P(Cl)CH2OCH3, t-BuOK, benzene, rt, 
13 h; 2 N aq HCl, THF, 55 oC, 6 h, 80% in 2 steps; c) NaBH4, EtOH, 0 
oC, 3 h, 90%; d) 2,6-
lutidine, TIPS-OTf, 0 oC to rt, 2 h, 92%; e) i. BH3·DMS, THF, rt 2 h; NaBO3.4H2O, 2 h;  ii. 
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Na2CO3, MeOH, reflux, 5 h, 76% over 2 steps; f) HF (aq), CH3CN, 0 
oC, 40 min, 89%; g) TsCl, 
Et3N, DMAP, DCM, 2 h, 85%; h) TBAF, THF, -30 
oC to rt, 1 h, 82%; 
 
After the completion of the total synthesis of the C-19 β-methyl substituted macroline related 
alkaloids; 1-5, the focus changed to the synthesis of C-19 α-methyl substituted sarpagine alkaloids 
(+)-dihydroperaksine 8, and (-)-deoxyperaksine 9 as mentioned before.  
The pentacyclic key intermediate 16b was accessed from alkyne 29 via the vinyl iodide 19b (see 
Scheme 1) by the previously reported copper-mediated enolate-driven cross-coupling process13 
and its structure was also confirmed by X-ray analysis (see Appendix D for X-ray data). 
 
 
Figure 2. ORTEP representation of 16b 
 
With the ketone 16b in hand, a one-carbon homologation of the ketone function was carried out 
via the Wittig-olefination process with (Ph)3P
+(Cl-)CH2OCH3 and potassium tert-butoxide in 
benzene-THF. This furnished a mixture of enol ethers (structures not shown). The mixture of enol 
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ethers, upon acid mediated hydrolysis (2 N aq HCl in THF), furnished the thermodynamically 
more stable α-aldehyde 30 as the sole product. The reduction of the aldehyde 30 was performed 
with sodium borohydride in ethanol, to produce the primary alcohol 31 in 90% yield. The desired 
product from the Wittig-olefination and hydrolysis could be carried onto the reduction step without 
purification and the alcohol 31 was isolated in this one-pot process. The protection of the hydroxyl 
function at C-17 with a TIPS function (17) was effected with TIPS-trifluoromethane sulfonate in 
DCM with 2, 6-lutidine in 92% yield. The hydroboration with BH3·DMS,  followed by Kabalka 
oxidation with sodium perborate, was performed to access the primary alcohol from the olefin 17 
and this produced the primary alcohol 18 in 76% yield as the exclusive product. The corresponding 
tertiary alcohol was not observed. Formation of the tertiary alcohol, observed in systems with a C-
19 β-methyl function, presumably, was retarded in olefin 17 because of the C-19 α-methyl group. 
(+)-Dihydroperaksine 8 was prepared simply by removing the TIPS function from 18 with a source 
of fluoride anion. The TIPS deprotection with TBAF proceeded smoothly and completely but the 
tetrabutylammonium salt could not be readily removed from the product. The aqueous extraction 
was avoided due to the very polar nature of the alkaloid, which would have resulted in the partial 
loss of material. Consequently, it was decided to use an alternative fluoride source of Corey et al., 
aqueous hydrogen fluoride,19 in order to remove the solvents and TIPS-F together effectively, in 
vacuo. Accordingly, deprotection of the TIPS function in 18 with aqueous HF in CH3CN was 
completed smoothly in 40 minutes at 0 oC and pure synthetic (+)-8 could be isolated after 
chromatography in 89% yield (Scheme 3). The optical rotation and spectral data for this synthetic 
(+)-8 were in complete agreement with the values reported in the literature for (+)-8.10 
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To access the ether linkage present in (-)-deoxyperaksine 9, the primary alcohol in 18 which 
remained, was activated by tosylation in 32 (Scheme 3). The tosylation was effected in excellent 
yield with tosyl chloride and DMAP in DCM in 2 hours. Upon TIPS  deprotection with TBAF in 
THF at -30 oC in 1 hour, the so formed primary alcohol reacted with the tosyl group in situ to 
furnish the ether ring present in (-)-deoxyperaksine 9. The 1H and 13C spectral data of (-)-9 were 
not found in the literature.20 This report represents the first report of the 1H, 13C, 2D NMRs, IR 
and MS characterization of (-)-deoxyperaksine 9. 
 
3. Conclusion 
In summary, the first total synthesis of member of the C-19 methyl substituted 
sarpagine/macroline-related alkaloids have been completed via the shorter and expanded Pictet-
Spengler reaction. The strategy reported here has been illustrated to efficiently access alkaloids 
with both the α and β C-19 methyl function with 100% diastereoselectivity. Examination of this 
report also corrects the optical rotation values of (-)-macrocarpine A (1) and (+)-N(4)-methy, N(4), 
21-secotalpinine (5) reported by others.2 The optical rotation of (-)-talcarpine 4 was found to be in 
agreement with (Kam et al., Tetrahedron, 2004), one of the two different optical rotations present 
in literature.2,5 Examination of this work clearly indicated that a large group other than benzyl on 
the Nb-nitrogen atom of the D-(+)-tryptophan starting material can still provide 100% 
diastereoselectivity via internal asymmetric induction. It is important to note that the use of L-
tryptophan would have provided the enantiomers of these alkaloids for biological study. In 
addition, the syntheses described herein have extended the use of the CuI mediated enolate-driven 
cross-coupling reaction to a completely new system. This general strategy will be useful to access 
any member of the C-19 methyl substituted sarpagine/macroline alkaloids that are potential drug 
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candidates, as indicated by their biological activity reported in the literature and presented in the 
Introduction (see General Introduction). 
 
 
4. Experimental Section 
Preparation of 16a from 2513,14 
 
 
 
An oven dried flask fitted with an addition funnel was cooled under argon and charged with the 
alkyne 25 (2.10 g, 7.55 mmol) and it was dissolved in freshly distilled CH2Cl2 (50 mL) and hexanes 
(7.0 mL). The flask was cooled to 0 °C with ice and I-B(Cy)2 (30.2 mL, 15.1 mmol, 0.5 M solution 
in hexanes) was added dropwise every 0.5 h in three portions, over a total period of 1.5 h. After 
the last addition, the reaction mixture was allowed to stir at 0 °C for another 0.5 h, after which the 
ice bath was removed and the mixture was stirred at rt for 2 h. After stirring at rt for 2 h, another 
0.5 eq of I-B(Cy)2 (7.6 mL, 3.78 mmol) was added dropwise at rt and the mixture was allowed to 
stir for another 2 h. After this 2 h period, the mixture was treated with glacial acetic acid (4.8 ml, 
83.1 mmol) at 0 °C and stirred at rt for 1.15 h. At this point the flask was again cooled to 0 °C and 
a solution of cold aq 3 M NaOH (40.3 mL, 121 mmol) and 30% H2O2 (2.6 mL, 23 mmol) was 
added and the stirring was maintained for 1 h at rt. The biphasic solution which resulted was 
transferred to a larger flask and diluted with CH2Cl2 (200 mL) and water (50 mL), after which the 
two layers were separated. The aq layer was extracted with another 200 mL of CH2Cl2. The 
239 
 
combined CH2Cl2 layers were treated sequentially with solutions of 5% KF in methanol (160 mL) 
and 5% aq sodium bisulfite (160 mL) under vigorous stirring for 5 min. The aq layer was separated, 
extracted with CH2Cl2 (2 x 80 mL), after which the combined organic layers were washed with 
brine, dried (Na2SO4), filtered and concentrated under reduced pressure. Purification by 
chromatography on silica gel (EtOAc/hexane, 1: 4) afforded vinyl iodide 19a (2.32 g, 77%) as a 
white solid. 
 
In a sealed tube with a magnetic stir bar, a mixture of vinyl iodide 19a (420 mg, 1.0 mmol), CuI 
(190 mg, 1.0 mmol), cis-1,2- cyclohexanediol (116 mg, 1.0 mmol), Cs2CO3 (1.30 g, 4.0 mmol) 
and TEMPO (468 mg, 3.0 mmol) was added dry DMF (2.0 mL). The mixture was degassed under 
reduced pressure at rt and refilled with argon (3-4 times). The reaction mixture was then placed on 
a pre-heated oil bath (130 oC) and heated under argon for 10 h. At this point, TLC (silica gel, 
EtOAc/hexane = 1: 3) indicated the absence of starting material 19a. The mixture was cooled to rt 
and diluted with EtOAc (10 mL) and water. The aq layer was separated and extracted with EtOAc 
(2 x 10 mL). The combined organic layer was washed with water (2 x 50 mL), brine (3 x 50 mL) 
and dried (Na2SO4). The solvent was removed under reduced pressure and the residue was purified 
by chromatography on neutral alumina (EtOAc/hexane = 1: 3) to provide the cross-coupling 
product 16a (251 mg) in 86% isolated yield.  
(6S,10S)-12-((S)-3-Iodobut-3-en-2-yl)-5-methyl-7,8,10,11-tetrahydro-5H-6,10-
epiminocycloocta[b]indol-9(6H)-one (19a) 
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13C NMR (75 MHz, CDCl3): δ 210.2, 137.1, 133.0, 126.4, 125.8, 122.6, 121.6, 119.3, 118.2, 108.9, 
106.6, 62.3, 60.7, 47.6, 34.4, 29.7, 29.3, 21.2, 19.7.  All other spectroscopic data were identical 
with the published data for 19a.14 This material was used for the next step without further 
characterization. 
 
 
(6S,8S,11aS)-5,8-Dimethyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-methanoindolo[3,2-
b]quinolizin-11(5H)-one (16a) 
 
1H NMR (300 MHz, CDCl3): δ 7.50 (d, 1H, J = 7.4 Hz), 7.24-7.26 (m, 1H), 7.18 (td, 1H, J = 7.5, 
0.9 Hz), 7.05-7.10 (m, 1H), 5.1 (d, 1H, J = 2.5 Hz), 5.01 (d, 1H, J = 2.5 Hz), 4.41 (dd, 1H, J = 9.5, 
2.1 Hz), 3.87-3.95 (m, 1H), 3.72 (d, 1H, J = 5.6 Hz), 3.6 (s, 3H), 3.34 (dd, 1H, J = 15.6, 1.3 Hz), 
3.05-3.07 (m, 1H), 2.92 (dd, 1H, J = 15.6, 6.1 Hz), 2.57-2.65 (m, 1H), 2.10-2.17 (m, 1H), 1.49 (d, 
3H, J = 6.7 Hz). All other spectroscopic data were identical with the published data for 16a.14 This 
material was used for the next step without further characterization. 
Procedure for the Preparation of 26 from 16a14 
The methiodide salt 26 was prepared from the ketone 16a, according to the previously reported 
method.14 
Procedure for the Preparation of 15a from 26 
To a solution of the methiodide salt 26 (50 mg, 0.10 mmol) in dry THF (5 mL), NaHMDS (37 mg, 
0.2 mmol) was added at 0 oC, after which the mixture was allowed to stir for 12 h at rt. At that 
time, analysis by TLC and LCMS indicated the disappearance of 26. The THF was removed under 
reduced pressure and the residue was purified by flash chromatography (silica gel, 2-5 % MeOH 
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in DCM) to provide the olefin 15a (40.4 mg) in 81% yield as a colorless oil (LRMS M+H+ = 
495.50). 
 
(Z)-2-((6S,8R,9R,10S)-5,12-Dimethyl-9-(((triisopropylsilyl)oxy)methyl)-6,7,8,9,10,11-
hexahydro-5H-6,10-epiminocycloocta[b]indol-8-yl)but-2-enal (15a) 
 
1H NMR (500 MHz, CDCl3): δ 10.08 (s, 1H), 7.6 (d, 1H, J = 7.7 Hz), 7.31-
7.28 (m, 1H, overlapped with chloroform peak), 7.20 (t, 1H, J = 7.5 Hz), 
7.13 (t, 1H, J = 7.3 Hz), 6.37 (q, 1H, J = 7.3 Hz), 4.04 (br s, 1H), 3.94 (t, 1H, 
J = 8.7 Hz), 3.62 (s, 3H), 3.50-3.43 (m, 1H), 3.33 (dd, 1H, J = 16.6 Hz, 7.4 Hz), 2.94 (d, 1H, J = 
12.8 Hz), 2.65 (d, 1H, J = 16.7 Hz), 2.34 (s, 3H), 2.23-2.15 (m, 1H), 2.10 (d, 3H, J = 7.2 Hz), 1.38-
1.31 (m, 1H), 1.07 (s, 21H). HRMS (ESI) m/z (M+H)+ Calcd for C30H47N2O2Si 495.3401, found 
495.3404. Rf: 0.27 (5% MeOH in DCM); []25D (c 0.2 CHCl3): +20.0. The characterization data 
for this compound were in complete agreement with that in the earlier report.14 The geometry of 
the olefin was determined to be (Z) by NMR NOE spectroscopic analysis (see Appendix E for 
NOE spectra). 
Procedure for the preparation of (-)-talcarpine (4) and (+)-N(4)-methyl-N(4), 21-
secotalpinine (5) from (+)-15a 
 
The α, β-unsaturated aldehyde 15a (50 mg, 0.1 mmol) was placed in a round bottom flask equipped 
with a magnetic stir and a reflux condenser. The THF (18 mL) and 2 N aq HCl (2 mL) was added 
to the round bottom flask. The mixture, which resulted, was held at reflux for 5 h. After that, the 
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solvent was removed under reduced pressure and ice cold water was added to the flask. The pH of 
the solution was brought to 8-9 with cold NH4OH. The solution was extracted with DCM (4 x 20 
mL) and the organic layer was washed with brine and dried (Na2SO4). The solvent was removed 
under reduced pressure to provide a mixture of aldehydes as a colorless oil. The residue was 
purified by silica gel column chromatography (1-5% MeOH in DCM sat with aq NH4OH) to 
provide (-)-4 (LRMS M+H+ = 339.30, 8.6 mg, 25%) and (+)-5 (LRMS M+H+ = 339.30, 20.5 mg, 
60%) as colorless oils. 
Procedure for the preparation of (+)-5 from (+)-15a 
The α, β-unsaturated aldehyde 15a (50 mg, 0.1 mmol) was placed in a round bottom flask equipped 
with a magnetic stir and a reflux condenser. The THF (18 mL) and 2 N aq HCl (2 mL) was added 
to the round bottom flask. The mixture, which resulted, was held at reflux for 5 h. After that, the 
solvent was removed under reduced pressure and ice cold water was added to the flask. The pH of 
the solution was brought to 8-9 with cold aq NH4OH. The solution was extracted with DCM (4 x 
20 mL) and the organic layer was washed with brine and dried (Na2SO4). The solvent was removed 
under reduced pressure to provide a mixture of aldehydes as a colorless oil (31 mg, 90% crude). 
The residue was dried under high vacuum for 5 h before dissolving in 5 mL of dry THF. Potassium 
tert-butoxide (22.7 mg, 0.2 mmol) was added to the above solution and it was left stirring at rt for 
12 h. After that, the solvent was removed under reduced pressure and the residue was dissolved in 
DCM (10 mL) and ice cold water (5 mL). The organic layer was separated and the aq layer was 
extracted with another 5 mL of DCM. The combined organic layers were washed with brine and 
dried (Na2SO4) to provide 32.8 mg (96%) of crude 5 which was purified by silica gel column 
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chromatography (1-5% MeOH in DCM sat. with aq NH4OH) to provide the aldehyde (+)-5 (28.7 
mg, 84%) as a white waxy solid.  
Procedure for the conversion of (-)-4 into (+)-5 
To a solution of (-)-talcarpine 4 (5 mg, 0.01 mmol) in THF (2 mL), potassium tert-butoxide (2.3 
mg, 0.02 mmol) was added and the solution, which resulted, was stirred at rt for 5 h. After that, 
the THF was removed under reduced pressure and the residue was dissolved in DCM (5 mL) and 
to this ice cold water (5 mL) was added. The organic layer was separated and the aq layer was 
extracted with another 3 mL of DCM. The combined DCM layers were washed with brine (3 x 20 
mL) and dried (Na2SO4). The solvent was evaporated under reduced pressure to provide a light 
yellow residue which was purified by silica gel column chromatography (1-5% MeOH in DCM 
sat. with aq NH4OH) to provide (+)-5 (2.8 mg, 82%) as a white waxy solid. 
 
(-)-Talcarpine (4) 
 
1H NMR (500 MHz, CDCl3): see Table 1; 13C NMR (75 MHz, CDCl3): see Table 2; HRMS (ESI) 
m/z (M+H)+ Calcd for C21H27N2O2 339.2067, found 339.2075; Rf: 0.42 (silica gel, 5 % MeOH in 
DCM);  
 
Note: To the best of our knowledge there are at least two different values for the optical rotation 
of the minor diastereomer, (-)-talcarpine 4, present in the literature. In the first report of 4 by 
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Schmid et al, there was no optical rotation reported.4 Wong et al. reported the optical rotation to 
be [α]D25 = -49 (CHCl3, c 0.077)5 and Kam et al. reported the rotation as [α]D25 = -26 (CHCl3, c 
0.12).2 
 
Optical rotation: Synthetic sample, this report []D25 (c 0.1 CHCl3): -30.0; natural sample, 
reported by Kam et al, 20042 []D25 (c 0.12 CHCl3): -26; natural sample, reported by Wong et al, 
19965 []25D (c 0.077 CHCl3): -49. The characterization data of the synthetic talcarpine were in 
complete agreement with that of natural (-)-talcarpine 4, reported by Kam et al.2  
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Comparison between Natural and Synthetic (-)-Talcarpine (4) 
Table 1: 1H NMR Spectral Data for Natural and Synthetic (-)-Talcarpine (4) in CDCl3 
aThere are typos and missing proton signals in the 1H NMR reported by Wong et al.5 
 
 
 
H# 
1H Natural2 by Kam et al 
(400 MHz) 
1H Natural5 by Wong et al 
(270 MHz)a 
1H Synthetic (this report) 
(500 MHz) 
3 3.98 (1H, m) 4.05-3.92 (1H, m) 4.00-3.95 (1H, m) 
5 2.90 (1H, d, J = 7 Hz) 2.89 (1H, d, J = 7 Hz) 2.90 (1H, d, J = 6.8 Hz) 
6 2.45 (1H, d, J = 16 Hz) 
3.27 (1H, dd, J = 16, 7 Hz) 
-a 
3.24 (1H, dd, J = 16, 7 Hz) 
2.45 (1H, d, J = 16.7 Hz) 
3.27 (1H, dd, J = 16.4, 6.8 Hz) 
9 7.49 (1H, br d, J = 8 Hz) 7.48 (1H, br d, J = 7 Hz) 7.48 (1H, br d, J = 7.8 Hz) 
10 7.10 (1H, td, J = 8, 1 Hz) 7.09 (1H, br t, J = 7 Hz) 7.12-7.07 (1H, m) 
11 7.19 (1H, td, J = 8, 1 Hz) 7.19 (br t, J = 7 Hz) 7.21-7.17 (1H, m) 
12 7.29 (1H, br d, J = 8 Hz) 7.28 (1H, br d, J = 7 Hz) 7.29 (1H, br d, J = 8.2 Hz) 
14 1.45 (1H, ddd, J = 12, 4, 3 
Hz) 
2.50 (1H, td, J = 12, 4 Hz) 
1.48-1.40 (1H, m) 
2.55-2.41 (1H, m) 
1.47-1.42 (1H,  m) 
2.50 (1H, td, J = 12.9, 3.9 Hz) 
15 2.20 (1H, m) 2.24-2.15 (1H, m) 2.22-2.16 (1H, m) 
16 2.06 (1H, dt, J = 11, 5 Hz) 2.09-2.00 (1H, m) 2.08-2.02 (1H, m) 
17 3.89 (1H, dd, J = 12, 5 Hz) 
4.14 (1H, t, J = 12 Hz) 
3.89 1H, dd, J = 11, 5 Hz) 
4.13 (1H, t, J = 11 Hz) 
3.89 (1H, dd, J = 11.4, 4.9 Hz) 
4.13 (1H, t, J = 11.7 Hz) 
19 3.98 (1H, m) 4.05-3.92 (1H, m)a 4.00-3.95 (1H, m) 
20 1.79 (1H, br s,) 1.78 (1H, br s) 1.79 (1H, br s) 
21 9.95 (1H, d, J = 3 Hz) 9.94 (1H, d, J = 3 Hz) 9.95 (1H, d, J = 3.2 Hz) 
18-Me 1.30 (3H, d, J = 7 Hz) 1.30 (3 H, J = 6.8 Hz) 1.30 (3H, d, J = 6.7 Hz) 
N(1)-Me 3.62 (3H, s) 3.62 (3H, s) 3.62 (3H, s) 
N(4)-Me 2.32 (3H, s) 2.32 (3H, s) 2.32 (3H, s) 
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Table 2: Comparison of the 13C NMR Spectral Data for Natural and Synthetic (-)-Talcarpine 
(4) in CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C# 
 
 
13C Natural2 
(100 MHz) 
Kam et al. 
13C Natural5 
(67.8 MHz) 
Wong et al. 
13C Synthetic 
(this report) 
(75 MHz) 
 
2 132.8 132.6 132.6 
3 53.5 53.5 53.5 
5 54.5 54.4 54.5 
6 22.5 22.4 22.5 
7 106.6 106.6 106.6 
8 126.2 126.3 126.4 
9 118.1 118.1 118.1 
10 118.9 118.9 118.9 
11 121.0 120.9 121.0 
12 108.7 108.7 108.8 
13 137.2 136.9 137.0 
14 30.1 30.0 30.0 
15 27.0 27.0 27.0 
16 39.4 39.4 39.4 
17 68.8 68.8 68.8 
18 19.2 19.2 19.2 
19 69.4 69.4 69.5 
20 54.6 54.5 54.6 
21 204.7 204.7 204.7 
N(4)-Me 41.8 41.7 41.8 
N(1)-Me 29.1 28.9 29.0 
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(+)-N(4)-Methyl-N(4), 21-secotalpinine (5) 
 
 
1H NMR (500 MHz, CDCl3): see Table 3; 13C NMR (125 MHz, CDCl3): see Table 4; HRMS 
(ESI) m/z (M+H)+ Calcd for C21H27N2O2 339.2067, found 339.2073; Rf: 0.24 (5 % MeOH in 
DCM); The characterization data of the synthetic (+)-5 were in complete agreement with that of 
natural (+)-5.2 
 
Optical rotation: Synthetic sample, this report []25D (c 0.61 CHCl3): +34.43; Natural sample, 
original report (2004) []25D (c 0.45 CHCl3): +19; Natural sample, revised (2017) []25D (c 0.33 
CHCl3): +36. The optical rotation value of (+)-5 was revised via a personal communication with 
Professor Toh-Seok Kam and it is excellent agreement with the synthetic (+)-5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
248 
 
Comparison between Natural and Synthetic (+)-5 
Table 3: 1H NMR Spectral Data for Natural and Synthetic (+)-N(4)-Methyl-N(4), 21-
secotalpinine (5) in CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H# 
 
 
1H Natural2 
(400 MHz) 
1H Synthetic (this report) 
(500 MHz) 
3 3.93 (1H, m) 4.00-3.92 (1H, m) 
5 2.96 (1H, d, J = 7 Hz) 3.0 (1H, d, J = 6.2 Hz) 
6 2.49 (1H, d, J = 16 Hz) 
3.30 (1H, dd, J = 16, 7 Hz) 
2.52 (1H, d, J = 16.5 Hz) 
3.34 (1H, dd, J = 16.5, 7 Hz) 
9 7.52 (1H, br d, J = 8 Hz) 7.55 (1H, br d, J = 7.8 Hz) 
10 7.13 (1H, td, J = 8 Hz) 7.18-7.14 (1H, m) 
11 7.21 (1H, td, J = 8, 1 Hz) 7.27-7.23 (1H, m) 
12 7.31 (1H, br d, J = 8 Hz) 7.34 (1H, br d, J = 8.1 Hz) 
14 1.28 (1H, m) 
2.37 (1H, m) 
1.30 (1H, br d, J = 8.8 Hz)) 
2.44-2.38 (1H, m) 
15 2.37 (1H, m) 2.44-2.38 (1H, m) 
16 1.93 (1H, m) 1.98-1.93 (1H, m) 
17 3.75 (1H, dd, J = 12, 5 Hz) 
4.06 (1H, t, J = 12 Hz) 
3.79 (1H, dd, J = 11.7, 4.5 Hz) 
4.10 (1H, t, J = 11.7 Hz) 
19 3.93 (1H, m) 4.00-3.92 (1H, m) 
20 2.37 (1H, m) 2.44-2.38 (1H, m) 
21 9.41 (1H, br s) 9.95 (1H, br s) 
18-Me 1.20 (3H, d, J = 7 Hz) 1.23 (3H, d, J = 6.0 Hz) 
N(1)-
Me 
3.58 (3H, s) 3.62 (3H, s) 
N(4)-
Me 
2.31 (3H, s) 2.35 (3H, s) 
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Table 4: Comparison of the 13C NMR Spectral Data for Natural and Synthetic (+)-N(4)-
Methyl-N(4), 21-secotalpinine (5) in CDCl3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C# 
 
 
13C Natural2 
(100 MHz) 
13C 
Synthetic 
(this report) 
(125 MHz) 
 
2 132.8 132.9 
3 53.1 53.2 
5 54.9 55.0 
6 22.4 22.5 
7 106.6 106.7 
8 126.2 126.3 
9 117.9 118.0 
10 118.9 119.0 
11 121.0 121.1 
12 108.9 109.0 
13 137.0 137.0 
14 26.7 26.8 
15 26.1 26.2 
16 42.5 42.6 
17 67.1 67.2 
18 20.2 20.3 
19 67.8 67.9 
20 57.7 57.9 
21 203.0 203.3 
N(4)-Me 41.6 41.7 
N(1)-Me 29.0 29.1 
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Procedure for the Synthesis of (-)-Macrocarpine A (1) from (-)-Talcarpine (4) 
A solution of the aldehyde (-)-4 (12 mg, 0.035 mmol) in dry ethanol (2 mL) was cooled to 0 oC 
and stirred for 5 min. To that above solution, NaBH4 (1.5 mg, 0.039 mmol) was added at 0 
oC and 
the mixture, which resulted, was stirred at 0 oC for 5 h. After completion of the reaction, as 
indicated by TLC (silica gel) and LRMS, the reaction mixture was diluted with DCM (10 mL) and 
water (5 mL). The organic layer was separated and the aq layer was extracted with another portion 
of DCM (10 mL). The combined organic layers were washed with brine and dried (Na2SO4). The 
solvent was removed under reduced pressure to provide a colorless oil. This material was purified 
by column chromatography (silica gel, 1-5% MeOH in DCM sat. aq NH4OH) to provide (-)-1 
(LRMS M+H+ = 341.15) as waxy white solid (12 mg, 99%). 
(-)-Macrocarpine A (1) 
 
1H NMR: see Table 5; 13C NMR: see Table 6; HRMS (ESI) m/z (M+H)+ Calcd for C21H29N2O2 
341.2224, found 341.2228; Rf: 0.14 (5 % MeOH in DCM), 0.6 (5% MeOH in EtOAc, sat. aq 
NH4OH);  
 
Optical rotation: The synthetic sample, this report []25D (c 0.25 CHCl3): -28.0; The natural 
sample, original report (2004)2 []25D (c 0.11 CHCl3): +117; The natural sample, revised (2016) 
[]25D (c 0.25 CHCl3): -28.0. The optical rotation value was revised via a personal communication 
251 
 
with professor Toh-Seok Kam and the synthetic (-)-macrocarpine A (1) was in excellent agreement 
with natural (-)-macrocarpine A (1).2 
Comparison between Natural and Synthetic (-)-Macrocarpine A (1) 
Table 5: Comparison of the 1H NMR Spectral Data for Natural and Synthetic (-)-
Macrocarpine A (1) in CDCl3 
 
H# 
 
 
1H Natural2 
(400 MHz) 
1H Synthetic (this report) 
(500 MHz) 
3 3.96 (1H, m) 4.0-3.91 (1H, m) 
5 2.87 (1H, d, J = 7 Hz) 2.85 (1H, d, J = 6.9 Hz) 
6 2.47 (1H, d, J = 17 Hz) 
3.25 (1H, dd, J = 17, 7 Hz) 
2.47 (1H, d, J = 16.5 Hz) 
3.25 (1H, dd, J = 17, 7 Hz) 
9 7.49 (1H, br d, J = 8 Hz) 7.50 (1H, br d, J = 7.7 Hz) 
10 7.10 (1H, td, J = 8, 1 Hz) 7.13-7.07 (1H,m) 
11 7.19 (1H, td, J = 8, 1 Hz) 7.22-7.16 (1H, m) 
12 7.29 (1H, br d, J = 8 Hz) 7.29 (1H, br d, J = 8 Hz) 
14 1.42 (1H, ddd, J = 13, 5, 2 
Hz) 
2.50 (1H, td, J = 13, 4 Hz) 
1.42 (1H, ddd, J = 12.7, 4.4, 1.8 Hz) 
2.50 (1H, td, J = 12.9, 4.1 Hz) 
15 2.06 (1H, dt, J =13, 5 Hz)) 2.07-1.97 (1H, m) 
16 2.15 (1H, dt, J = 11, 5 Hz) 2.20-2.10 (1H, m) 
17 3.79 (1H, dd, J = 11, 5 Hz) 
4.07 (1H, t, J = 11 Hz) 
3.81-3.75 (1H, m) 
4.07 (1H, t, J = 11.7 Hz) 
19 3.96 (1H, m) 4.0-3.91 (1H, m) 
20 1.07 (1H, m) 1.07 (1H, m) 
21 3.69 (1H, dd, J = 11, 4 Hz) 
3.81 (1H, dd, J = 11, 6 Hz) 
3.69 (1H, dd, J = 11.2, 3.7 Hz) 
3.81-3.75 (1H, m) 
18-Me 1.24 (3H, d, J = 7 Hz) 1.24 (3H, d, J = 6.6 Hz) 
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Table 6: Comparison of the 13C NMR Spectral Data for Natural and Synthetic (-)-
Macrocarpine A (1) in CDCl3 
 
N(1)-Me 3.62 (3H, s) 3.63 (3H, s) 
N(4)-Me 2.31 (3H, s) 2.31 (3H, s) 
 
C# 
 
 
13C Natural2 
(100 MHz) 
13C 
Synthetic 
(this report) 
(75 MHz) 
 
2 133.2 133.2 
3 53.7 53.6 
5 54.6 54.5 
6 22.6 22.5 
7 106.6 106.6 
8 126.4 126.4 
9 118.1 118.1 
10 118.8 118.8 
11 120.8 120.8 
12 108.7 108.7 
13 136.9 136.9 
14 30.7 30.8 
15 28.6 28.7 
16 39.3 39.3 
17 68.9 96.0 
18 18.8 18.8 
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Procedure for Synthesis of (-)-Macrocarpine B (2) from (+)-N(4)-Methyl-N(4), 21-
secotalpinine (5) 
 
A solution of the aldehyde (+)-5 (20 mg, 0.06 mmol) in dry ethanol (3 mL) was cooled to 0 oC and 
stirred for 5 min. To that above solution, NaBH4 (2.4 mg, 0.065 mmol) was added at 0 
oC and the 
reaction, which resulted, was stirred at 0 oC for 5 h. After completion of the reaction as indicated 
by TLC and LRMS, the reaction was diluted with DCM (10 mL) and water (5 mL). The organic 
layer was separated and the aq layer was extracted with another portion of DCM (10 mL). The 
combined organic layers were washed with brine and dried (Na2SO4). The solvent was removed 
under reduced pressure to provide a colorless oil. This material was purified by column 
chromatography (silica gel, 1-5% MeOH in DCM sat. aq NH4OH) to provide (-)-2 (LRMS M+H
+ 
= 341.15) as waxy white solid (19.9 mg, 99%). 
 
(-)-Macrocarpine B (2) 
 
19 71.2 71.2 
20 43.6 43.5 
21 63.1 63.2 
N(4)-Me 41.7 41.7 
N(1)-Me 29.0 29.0 
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1H NMR: see Table 7; 13C NMR: see Table 8; HRMS (ESI) m/z (M+H)+ Calcd for C21H29N2O2 
341.2224, found 341.2223; Rf: 0.4 (silica gel, 10 % MeOH in DCM), 0.1 (silica gel, 5% MeOH 
in DCM);  
 
Optical rotation: The synthetic sample, this report []25D (c 1.0 CHCl3): -49.0; The natural sample 
[]25D (c 0.34 CHCl3): -51; The characterization data of the synthetic (-)-2 were in complete 
agreement with that of natural (-)-2.2 
Comparison between Natural and Synthetic (-)-Macrocarpine B (2) 
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Table 7: Comparison of the 1H NMR Spectral Data for Natural and Synthetic (-)-
Macrocarpine B (2) in CDCl3 
 
H# 
 
 
1H Natural2 
(400 MHz) 
1H Synthetic (this report) 
(300 MHz) 
3 3.98 (1H, t, J =3 Hz) 3.98 (1H, br t, J =3.1 Hz) 
5 2.91 (1H, d, J = 7 Hz) 2.91 (1H, d, J = 6.9 Hz) 
6 2.43 (1H, d, J = 17 Hz) 
3.26 (1H, dd, J = 17, 7 Hz) 
2.43 (1H, d, J = 16.5 Hz) 
3.36-3.21 (1H, m) 
9 7.49 (1H, br d, J = 8 Hz) 7.50 (1H, br d, J = 7.6 Hz) 
10 7.10 (1H, td, J = 8, 1 Hz) 7.14-7.07 (1H, m) 
11 7.18 (1H, td, J = 8, 1 Hz) 7.19 (1H, br t, J = 7.1 Hz) 
12 7.29 (1H, br d, J = 8 Hz) 7.29 (1H, br d, J = 8.0 Hz) 
14 1.54 (1H, ddd, J = 12, 4, 3 
Hz) 
2.29 (1H, m) 
1.58-1.49 (1H, m) 
2.29-2.22 (1H, m) 
15 1.97 (1H, dt, J =13, 4 Hz)) 2.02-1.92 (1H, m) 
16 1.86 (1H, dt, J = 11, 4 Hz) 1.90-1.81 (1H, m) 
17 3.73 (1H, dd, J = 11, 4 Hz) 
4.06 (1H, t, J = 11 Hz) 
3.73 (1H, dd, J = 11.4, 4.6 Hz) 
4.07 (1H, t, J = 11.6 Hz) 
19 3.49 (1H, m) 3.54-3.44 (1H, m) 
20 1.46 (1H, m) 1.49-1.40 (1H, m) 
21 3.31 (1H, dd, J = 11, 8 Hz) 3.36-3.21 (1H, m) 
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Table 8: Comparison of the 1H NMR Spectral Data for Natural and Synthetic (-)-
Macrocarpine B (2) in CDCl3 
3.49 (1H, m) 3.54-3.44 (1H, m) 
18-Me 1.15 (3H, d, J = 6 Hz) 1.16 (3H, d, J = 6.1 Hz) 
N(1)-Me 3.62 (3H, s) 3.62 (3H, s) 
N(4)-Me 2.30 (3H, s) 2.31 (3H, s) 
 
C# 
 
 
13C Natural2 
(100 MHz) 
13C 
Synthetic 
(this report) 
(75 MHz) 
 
2 133.2 133.3 
3 53.6 53.6 
5 55.1 55.0 
6 22.5 22.5 
7 106.7 106.7 
8 126.4 126.4 
9 117.9 117.9 
10 118.8 118.8 
11 120.7 120.7 
12 108.8 108.8 
13 137.0 137.0 
14 25.3 25.4 
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Preparation of (-)-Macrocarpine C (3) from (-)-Macrocarpine B (2) 
In a round bottom flask, the alcohol (-)-2 (10 mg, 0.03 mmol) was dissolved in DCM (2 mL). To 
that above solution, acetic anhydride (5 μL, 0.044 mmol) and pyridine (7 μL, 0.088 mmol) were 
added and the solution, which resulted, was stirred at rt for 6 h, until the disappearance of the SM 
as indicated by TLC (silica gel) and LRMS. The reaction mixture was diluted with DCM (10 mL) 
and water (5 mL). The organic layer was separated and the aq layer was extracted with another 
portion of DCM (5 mL). The combined organic layers were washed with brine and dried (Na2SO4). 
The solvent was removed under reduced pressure to provide a brownish residue which was purified 
by column chromatography (silica gel, 1-3% MeOH in DCM sat aq NH4OH) to provide (-)-
macrocarpine C 3 (LRMS M+H+ = 383.30) as a colorless oil (10.3 mg, 92%). 
 
 
15 26.7 27.0 
16 43.7 43.5 
17 67.6 67.6 
18 20.2 20.3 
19 70.5 70.5 
20 46.8 46.8 
21 61.6 61.7 
N(4)-Me 41.7 41.7 
N(1)-Me 29.0 29.0 
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Macrocarpine C (3) 
 
 
1H NMR: see Table 9; 13C NMR: see Table 10; HRMS (ESI) m/z (M+H)+ Calcd for C23H31N2O3 
383.2329, found 383.2327; Rf: 0.6 (silica gel, 10 % MeOH in DCM);  
 
Optical rotation: Synthetic material, this report []D25 (c 1.0 CHCl3): -39; Natural sample []D25 
(c 1.55 CHCl3): -35; The characterization data of the synthetic (-)-3 were in complete agreement 
with that of natural (-)-3.2 
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Comparison between Natural and Synthetic (-)-Macrocarpine C (3) 
Table 9: Comparison of the 1H NMR Spectral Data for Natural and Synthetic Macrocarpine 
C (3) in CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H# 
 
 
1H Natural2 
(400 MHz) 
1H Synthetic (this report) 
(300 MHz) 
3 3.97 (1H, t, J = 4 Hz) 4.03-3.98 (1H, m) 
5 2.91 (1H, d, J = 7 Hz) 2.94 (1H, d, J = 6.7 Hz) 
6 2.45 (1H, d, J = 17 Hz) 
3.27 (1H, dd, J = 17, 7 Hz) 
2.48 (1H, d, J = 16.5 Hz) 
3.28 (1H, dd, J = 16.5, 6.9 Hz) 
9 7.49 (1H, dd, J = 8, 1 Hz) 7.50 (1H, d, J = 7.6 Hz) 
10 7.09 (1H, td, J = 8, 1 Hz) 7.13-7.07 (1H, m) 
11 7.17 (1H, td, J = 8, 1 Hz) 7.18 (1H, br t, J = 7.3 Hz) 
12 7.27 (1H, dd, J = 8, 1 Hz) 7.28 (1H, br d, J = 8.1 Hz) 
14 1.39 (1H, dt, J = 13, 4 Hz) 
2.26 (1H, td, J = 13, 4 Hz) 
1.45-1.37 (1H, m) 
2.32-2.24 (1H, m) 
15 1.86 (1H, m) 1.93-1.79 (1H, m) 
16 1.86 (1H, m) 1.93-1.79 (1H, m) 
17 3.74 (1H, dd, J = 11, 4 Hz) 
4.07 (1H, t, J = 11 Hz) 
3.74 (1H, dd, J = 11.4, 4.5 Hz) 
4.10 (1H, t, J = 11.5 Hz) 
19 3.51 (1H, dq, J = 10, 6 Hz) 3.57-3.48 (1H, m) 
20 1.69 (1H, m) 1.75-1.69 (1H, m) 
21 3.83 (1H, d, J = 7 Hz) 
3.83 (1H, d, J = 7 Hz) 
3.83 (2H, d, J = 7.1 Hz) 
23 1.68 (3H, s) 1.68 (3H, s) 
18-Me 1.13 (3H, d, J = 6 Hz) 1.14 (3H, d, J = 6.1 Hz) 
N(1)-Me 3.60 (3H, s) 3.61 (3H, s) 
N(4)-Me 2.34 (3H, s) 2.37 (3H, s) 
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Table 10: Comparison of the 13C NMR Spectral Data for Natural and Synthetic 
Macrocarpine C (3) in CDCl3 
 
 
C# 
 
 
13C Natural2 
(100 MHz) 
13C 
Synthetic 
(this report) 
(75 MHz) 
 
2 133.0 132.7 
3 53.5 53.7 
5 54.9 55.0 
6 22.4 22.5 
7 106.7 106.8 
8 126.3 126.2 
9 117.9 117.9 
10 118.8 118.9 
11 120.8 120.9 
12 108.5 108.6 
13 136.9 137.0 
14 25.0 25.0 
15 27.1 27.1 
16 43.4 43.4 
17 67.5 67.5 
18 20.1 20.1 
19 70.3 70.4 
20 43.2 43.2 
21 62.9 62.9 
22 170.8 170.7 
23 20.3 20.4 
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Preparation of ketone 16b from alkyne 2913,14  
 
 
 
An oven dried flask fitted with an addition funnel was cooled under argon and charged with the 
alkyne 29 (2.10 g, 7.55 mmol) and freshly distilled CH2Cl2 (50 mL) and hexanes (7.0 mL) were 
added to dissolve 29. The flask was cooled to 0 °C with ice and I-B(Cy)2 (30.2 mL, 15.1 mmol, 
0.5 M solution in hexanes) was added dropwise every 0.5 h in three portions, over a total period 
of 1.5 h. After the last addition, the reaction mixture was allowed to stir at 0 °C for another 0.5 h, 
after which the ice bath was removed and the mixture was stirred at rt for 2 h. After stirring at rt 
for 2 h, another 0.5 eq of I-B(Cy)2 (7.6 mL, 3.78 mmol) was added dropwise at rt and the mixture 
was allowed to stir for another 2 h. After this 2 h, the mixture was treated with glacial acetic acid 
(4.8 ml, 83.1 mmol) at 0 °C and stirred at rt for 1.25 h. At this point the flask was again cooled to 
0 °C and a solution of cold aq 3 M NaOH (40.3 mL, 121 mmol) and 30% H2O2 (2.6 mL, 23 mmol) 
was added and the stirring was maintained for 1 h at rt. The biphasic solution, which resulted, was 
transferred to a bigger flask, diluted with CH2Cl2 (200 mL) and water (50 mL), after which the 
two layers were separated. The aq layer was extracted with another 200 mL of CH2Cl2. The 
combined CH2Cl2 layers were treated sequentially with solutions of 5% KF in methanol (160 mL) 
and 5% aq sodium bisulfite (160 mL) under vigorous stirring for 5 min. The aq layer was separated, 
N(4)-Me 41.6 41.6 
N(1)-Me 28.9 29.0 
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extracted with CH2Cl2 (2 x 80 mL), after which the combined organic layers were washed with 
brine, dried (Na2SO4), filtered and concentrated under reduced pressure. The purification by 
chromatography on silica gel (EtOAc/hexanes, 1: 4) afforded the vinyl iodide 19b (2.94 g, 76%) 
as a white solid. 
In a sealed tube with a magnetic stir bar, a mixture of vinyl iodide 19b (420 mg, 1.0 mmol), CuI 
(190 mg, 1.0 mmol), cis-1,2- cyclohexanediol (116 mg, 1.0 mmol), Cs2CO3 (1.30 g, 4.0 mmol) 
and TEMPO (468 mg, 3.0 mmol) was dissolved in dry DMF (2.0 mL). The mixture was degassed 
under reduced pressure at rt and refilled with argon (3-4 times). The reaction mixture was then 
placed in a pre-heated oil bath (130 oC) and heated under argon for 10 h. At this point, TLC (silica 
gel, EtOAc/hexane = 1: 3 indicated the absence of starting material 19b). The mixture was cooled 
to rt and diluted with EtOAc (10 mL) and water. The aq layer was separated and extracted with 
EtOAc (2 x 10 mL). The combined organic layer was washed with water (2 x 50 mL), brine (3 x 
50 mL) and dried (Na2SO4). The solvent was removed under reduced pressure and the residue was 
purified by chromatography on neutral alumina (EtOAc/hexane = 1:3) to provide the cross-
coupling product 16b (240 mg, 82%). The indole 16b gave colorless crystals from EtOAc which 
were used for X-ray analysis (see X-ray data in Appendix D). 
(6S,10S)-12-((R)-3-Iodobut-3-en-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta-
[b]indol-9(6H)-one (19b) 
 
1H NMR (300 MHz, CDCl3) δ 7.98 (brs, 1H), 7.50 (d, 1H, J = 7.6 Hz), 7.37 
(d, 1H, J = 7.9 Hz), 7.13-7.28 (m, 2H), 6.39 (s, 1H) 5.91 (s, 1H), 4.36-4.40 
(m, 1H), 3.86 (d, 1H, J = 6.5 Hz), 3.17 (dd, 1H, J = 17.0, 6.6 Hz), 2.65-2.71 
(m, 2H),  2.50-2.60 (m, 2H), 2.04-2.20 (m, 2H), 1.17 (d, 3H, J = 6.1 Hz); 13C NMR (75 MHz, 
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CDCl3) δ 210.4 (C), 135.8 (C), 132.8 (C), 126.9 (C), 126.2 (CH2), 122.2 (C), 121.1 (CH), 119.8 
(CH), 118.2 (CH), 111.0 (CH), 107.6 (C), 62.3 (CH), 61.7 (CH), 46.5 (CH), 34.5 (CH2), 30.8 
(CH2), 20.7 (CH2), 19.8 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for C18H20IN2O 407.0615, found 
407.0617 
 
(6S,8S,11aS)-8-Methyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-methanoindolo[3,2-
b]quinolizin-11(5H)-one (16b) 
 
 
1H NMR  (300 MHz, CD3OD): δ 7.42 (d, 1H, J = 7.7 Hz), 7.29 (d, 1H, J = 
8.0 Hz), 7.06-7.11 (m, 1H), 6.98-7.03 (m, 1H), 5.14 (d, 1H, J = 2.2 Hz), 5.06 
(d, 1H, J = 1.6 Hz), 4.57-4.61 (m, 1H), 3.99-4.06 (m, 1H), 3.71 (d, 1H, J = 
6.0 Hz), 3.25-3.34 (m, 1H, merged with solvent), 2.98-3.05 (m, 2H), 2.56-2.64 (m, 1H), 2.09-2.16 
(m, 1H), 1.66 (d, 3H, J = 7.1 Hz). The structure of this compound was further confirmed by X-ray 
crystallographic analysis (see X-ray in Appendix D). 
Preparation of aldehyde 30 from ketone 16b 
A mixture of anhydrous potassium tert-butoxide (4.73 g, 42.6 mmol) and methoxy-
methyltriphenylphosphonium chloride (13.49 g, 39.34 mmol) in dry benzene (100 mL) was 
allowed to stir at rt for 1 h. The pentacyclic ketone 16b (1.5 g, 5.39 mmol) in THF (20 mL) was 
then added to the above red colored solution dropwise at 0 °C. The mixture, which resulted, was 
stirred at rt for 12 h. After 12 h at rt, analysis of the mixture by TLC (silica gel) indicated the 
absence of starting material 16b. The mixture was then diluted with EtOAc (100 mL) and the 
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reaction was quenched with water (50 mL). The aq layer was extracted with EtOAc (2 x 30 mL), 
and the combined organic layers were washed with brine (2 x 30 mL) and dried (Na2SO4). The 
solvent was removed under reduced pressure to afford the enol ethers as a brownish red oil. The 
baseline materials (silica gel, TLC) were removed by percolation through a wash column of silica 
gel. The solvent was removed under reduced pressure and the residue was dissolved (without 
further purification) in a solution of THF/H2O (1:1, 28 mL). To the above mixture, a solution of 
conc HCl (12 N) was added and the mixture, which resulted, was stirred at 55 °C (oil bath 
temperature) for 6 h. The reaction mixture was then cooled to 0 °C and extracted with ethyl ether 
(4 x 30 mL) to remove the phosphorous byproducts, after which the aq layer was brought to pH 8 
with an ice-cold solution of 14% aq NH4OH. The aq layer was extracted with EtOAc (3 x 25 mL), 
and the combined organic layers were washed with brine (2 x 50 mL) and dried (Na2SO4). The 
solvent was removed under reduced pressure to afford the α-aldehyde 30 as a brownish oil (1.42 
g crude). This material was purified by silica gel column chromatography (5% MeOH in DCM) to 
provide pure 30 (LRMS M+H+ = 293.20) as a colorless oil (1.26 g, 80% in two steps). This material 
could be used for the next transformation without purification. 
(6S,8R,11R,11aS)-8-Methyl-9-methylene-5,6,8,9,10,11,11a,12-octahydro-6,10-methanoi-
ndolo[3,2-b]quinolizine-11-carbaldehyde (30) 
 
 
1H NMR (300 MHz, CDCl3): δ 9.64 (s, 1H), 8.00 (br s, 1H), 7.47 (br d, 1H, 
J = 7.5 Hz), 7.32 (br d d, 1H, J = 7.7 Hz), 7.21-7.07 (m, 2H), 4.93 (d, 1H, J = 
2.0 Hz), 4.85 (d, 1H, J = 1.3 Hz), 4.39 (br d, 1H, J = 9.0 Hz), 3.71 (q, 1H, J = 
7.1 Hz), 3.66-3.59 (m, 1H), 3.22 (dd, 1H, J = 15.7, 5.1 Hz), 2.86-2.81 (m, 1H), 2.64 (br d, 1H, J = 
265 
 
15.7 Hz), 2.48 (d, 1H, J = 7.5 Hz), 2.17-2.07 (m, 1H), 1.82-1.73 (m, 1H), 1.45 (d, 3H, J = 7.1 Hz); 
Rf: 0.25 (silica gel, 10% MeOH in DCM); HRMS (ESI) m/z (M + H)+ calcd for C19H21N2O, 
293.1648, found 293.1647. This material was used for the next step without further 
characterization. 
Preparation of alcohol 31 from aldehyde 30 
The aldehyde 30 (600 mg, 2.05 mmol) was dissolved in EtOH (10 mL). Then NaBH4 (116 mg, 
3.08 mmol) was added to the above solution in one portion at 0 C. The mixture, which resulted, 
was then stirred at 0 C for 3 h. The reaction mixture was diluted with CH2Cl2 (100 mL) and 
poured into ice-cold water (50 mL). The aq layer was extracted with additional CH2Cl2 (3  20 
mL), and the combined organic layers were washed with brine (3 x 50 mL) and dried (K2CO3). 
The solvent was removed under reduced pressure to afford the crude product, which was purified 
by chromatography on silica gel (10% MeOH in DCM) to provide alcohol 31 (LRMS M+H+ = 
295.25) as a colorless oil (571 mg, 90%). 
((6S,8R,11R,11aS)-8-Methyl-9-methylene-5,6,8,9,10,11,11a,12-octahydro-6,10-
methanoindolo[3,2-b]quinolizin-11-yl)methanol (31) 
 
1H NMR (300 MHz, CD3OD): δ 7.43 (d, 1H, J = 7.7 Hz), 7.32 (d, 1H, J = 
8.0 Hz), 7.13-7.06 (m, 1H), 7.05-6.98 (m, 1H), 5.04-4.97 (m, 2H), 4.54 (br 
d, 1H, J = 9.3 Hz), 3.80 (q, 1H, J = 6.9 Hz), 3.52 (br d, 2H, J = 7.3 Hz), 3.17 
(dd, 1H, J = 15.7, 5.2 Hz), 2.97-2.89 (m, 1H), 2.81 (br d, 1H, J = 15.8 Hz), 2.54-2.49 (m, 1H), 
2.27-2.16 (m, 1H), 1.93-1.73 (m, 2H), 1.5345 (d, 3H, J = 7.1 Hz); 13C NMR (75 MHz, CD3OD): 
δ 148.8, 137.0, 136.3, 127.1, 121.0, 118.6, 117.3, 110.7, 108.0, 103.0, 63.8, 59.5, 57.9, 44.6, 42.6, 
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35.2, 33.3, 26.2, 18.4; HRMS (ESI) m/z (M + H)+ calcd for C19H23N2O, 295.1805, found 295.1807; 
[]D25 (c 0.3 CHCl3): +46.67; Rf: 0.15 (silica gel, 10% MeOH in DCM); 
Preparation of O-TIPS ether 17 from alcohol 31 
A solution of the alcohol 31 (100 mg, 0.34 mmol) in dry CH2Cl2 (10 mL) was cooled to 0 C, after 
which 2, 6-lutidine (119 μL, 1.02 mmol) was added, and this was followed by the addition of 
TIPSOTf (137 μL, 0.51 mmol) to the stirred solution. The mixture was then allowed to stir for an 
additional 2 h at 0 C, after which cold water (2 mL) was added to quench the reaction. The reaction 
mixture was diluted with CH2Cl2 (50 mL) and poured into cold water (20 mL). The aq layer was 
extracted with additional CH2Cl2 (2  50 mL), and the combined organic layers were washed with 
brine (3 x 20 mL) and dried (Na2SO4). The solvent was removed under reduced pressure to afford 
the crude product, which was dried in vacuo to remove the extra 2,6-lutidine before the solid was 
purified by chromatography on silica gel (5-10% MeOH in DCM) to provide the O-TIPS ether 17 
(LRMS M+H+ = 451.40) as a white solid (141 mg, 92%). 
(6S,8R,11R,11aS)-8-Methyl-9-methylene-11-(((triisopropylsilyl)oxy)methyl)-
5,6,8,9,10,11,11a,12-octahydro-6,10-methanoindolo[3,2-b]quinolizine (17) 
 
1H NMR (300 MHz, CDCl3): δ 8.42 (br s, 1H), 7.47 (br d, 1H, J = 7.5 Hz), 
7.35 (br d, 1H, J = 7.7 Hz), 7.20-7.06 (m, 2H), 4.87 (br d, 2H, J = 15.0 
Hz), 4.41 (br d, 1H, J = 9.6 Hz), 3.71-3.53 (m, 3H), 3.19 (dd, 1H, J = 15.5, 
4.7 Hz), 2.92-2.82 (m, 1H), 2.76 (br d, 1H, J = 15.5 Hz), 2.45 (br s, 1H), 2.16-2.04 (m, 1H), 1.94-
1.83 (m, 1H), 1.79-1.69 (m, 1H), 1.34-1.21 (m, 3H), 1.10-0.98 (m, 21H); 13C NMR (75 MHz, 
CDCl3): δ 137.3, 136.5, 127.7, 121.5, 119.3, 118.1, 111.0, 107.8, 104.9, 66.0, 59.5, 57.9, 44.6, 
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42.9, 35.6, 34.1, 27.0, 19.7, 18.0, 11.9; HRMS (ESI) m/z (M + H)+ calcd for C28H43N2OSi, 
451.3139, found 451.3135; []D25 (c 0.6 CHCl3): +68.33; Rf: 0.48 (silica gel, 10% MeOH in 
DCM). 
Preparation of monol 18 from methine 17 
To a solution of the alkenic O-TIPS ether 17 (100 mg, 0.222 mmol) in dry THF (10 mL) was added 
BH3∙DMS (189 μL, 2.0 mmol) at rt. The mixture, which resulted, was stirred at rt for 2 h. The 
reaction mixture was then quenched by careful addition of ice cold water (8 mL) at 0 °C (initial 
addition of water resulted in a large amount of effervescence). At this point NaBO3∙4H2O (819 
mg, 5.3 mmol) was added to the mixture in one portion at 0 °C. The mixture, which resulted, was 
allowed to stir at rt for 2 h after which EtOAc (100 mL) and H2O (25 mL) were added. The organic 
layer was separated, washed with water (2 x 20 mL), brine (2 x 20 mL) and dried (Na2SO4). The 
EtOAc was then removed under reduced pressure to provide the Nb-BH3 complex as a mixture of 
isomers. The above mixture of isomers was dissolved in freshly distilled MeOH (20 mL) and 
Na2CO3 (118 mg, 1.11 mmol) was added. The mixture was heated at 60 °C (oil bath) for 5 h under 
vigorous stirring. The reaction mixture, which resulted, was cooled to rt, followed by filtration 
through a bed of celite to remove the solids. The filtrate was concentrated under reduced pressure 
to provide a turbid oil which was redissolved in CH2Cl2. The CH2Cl2 layer was washed with H2O 
(10 mL), brine (4 x 10 mL) and dried (Na2SO4). The solvent was removed under reduced pressure 
to afford a crude solid, which was purified by flash chromatography (silica gel, 5-10% MeOH in 
DCM) to furnish the primary alcohol 18 (79 mg, 76%) as a colorless oil (LRMS [M+H]+ = 469.45). 
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((6S,8R,9S,11R,11aS)-8-Methyl-11-(((triisopropylsilyl)oxy)methyl)-5,6,8,9,10,11,11a,12-
octahydro-6,10-methanoindolo[3,2-b]quinolizin-9-yl)methanol (18) 
 
1H NMR (500 MHz, CD3OD): δ 7.32 (d, 1H, J = 7.7 Hz), 7.28 (d, 1H, J = 
8.1 Hz), 7.05 (t, 1H, J = 7.5 Hz), 6.98-6.94 (m, 1H), 4.57 (d, 1H, J = 9.8 
Hz), 3.88 (t, 1H, J = 9.4 Hz), 3.74-3.69 (m, 1H), 3.66-3.61 (m, 1H), 3.59-
3.53 (m, 1H), 3.39-3.33 (m, 1H), 3.17-3.09 (m, 2H), 2.99 (br d, 1H, J = 15.5 Hz), 2.10-2.02 (m, 
2H), 1.96-1.88 (m, 1H), 1.74-1.67 (m, 1H), 1.64-1.57 (m, 1H), 1.44 (d, 3H, J = 6.8 Hz), 1.04-0.98 
(m, 21H); 13C NMR (75 MHz, CDCl3): δ 137.0, 135.1, 127.0, 121.3, 121.3, 118.8, 117.4, 110.9, 
102.9, 66.8, 65.4, 60.3, 59.6, 46.2, 45.3, 41.6, 36.7, 27.3, 26.5, 19.3, 17.2, 11.7; HRMS (ESI) m/z 
(M + H)+ calcd for C28H45N2O2Si, 469.3245, found 469.3234; []D25 (c 0.47 CHCl3): +51.1; Rf: 
0.2 (silica gel, 10% MeOH in DCM). 
Preparation of tosylate 32 from alcohol 18 
A flame dried round bottom flask was charged with freshly distilled CH2Cl2 (10 mL) and primary 
alcohol 18 (50 mg, 0.11 mmol), after which the mixture was cooled to -10 (outside bath 
temperature). Triethylamine (74 μL, 0.53 mmol) and DMAP (1.3 mg, 0.011 mmol) were added, 
and after a few minutes of stirring, tosyl chloride (51 mg, 0.27 mmol) was added in one portion. 
The reaction mixture was allowed to stir at -10 °C for 45 min and the solution was allowed to 
slowly warm to rt. After the reaction mixture was stirred for 3 h at rt, analysis by TLC (silica gel) 
was carried out, after which the reaction mixture was quenched with a large excess of water (100 
mL). Then the mixture was allowed to stir vigorously for 45 min. After 45 min the two layers were 
separated. The CH2Cl2 layer was dried over MgSO4, filtered and concentrated under reduced 
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pressure to furnish 32 (62 mg crude) as a waxy white solid, which was purified by silica gel 
chromatography (5-10% MeOH in DCM) to provide pure 32 as white waxy solid (56.5 mg, 85%). 
 
((6S,8R,9S,11R,11aS)-8-Methyl-11-(((triisopropylsilyl)oxy)methyl)-5,6,8,9,10,11,11a,12-
octahydro-6,10-methanoindolo[3,2-b]quinolizin-9-yl)methyl 4-methylbenzenesulfonate (32) 
 
1H NMR (500 MHz, CDCl3): δ 7.89 (br s, 1H), 7.83 (br d, 2H, J = 8.2 
Hz), 7.45 (d, 1H, J = 7.7 Hz), 7.39 (d, 2H, J = 8.0 Hz), 7.31 (d, 1H, J = 
7.9 Hz), 7.17-7.13 (m, 1H), 7.11-7.07 (m, 1H), 4.25-4.20 (m, 1H), 4.18-
4.08 (m, 2H), 3.73 (dd, 1H, J = 9.9, 8.0 Hz), 3.54 (dd, 1H, J = 10.0, 7.4 Hz), 3.08 (dd, 1H, J = 
15.3, 5.3 Hz), 2.93-2.88 (m, 1H), 2.80-2.70 (m, 2H), 2.50 (s, 3H), 2.02-1.98 (m, 1H), 1.80 (t, 1H, 
J = 10.5 Hz), 1.73 (q, 1H, J = 7.8 Hz), 1.63-1.57 (m, 1H), 1.55 (dt, 1H, J = 12.2, 3.3 Hz), 1.35 (d, 
3H, J = 6.8 Hz), 1.05-1.01 (m, 21H); 13C NMR (75 MHz, CDCl3): δ 144.9, 138.1, 136.3, 133.0, 
129.9, 128.0, 127.8, 121.3, 119.3, 118.1, 110.8, 105.0, 74.6, 67.0, 59.0, 58.9, 44.1, 43.4, 41.0, 38.4, 
27.8, 27.7, 21.7, 21.3, 18.0, 11.8; HRMS (ESI) m/z (M + H)+ calcd for C35H51N2O4SiS, 623.3333, 
found 623.3332; []D25 (c 0.1 CHCl3): -30.0; Rf: 0.55 (silica gel, 10% MeOH in DCM). 
 
Synthesis of (+)-dihydroperaksine (8) from (+)-18 
The removal of the TIPS protecting group using the common fluoride source TBAF furnished the 
desired product in good yield and a clean reaction but it was not possible to remove the TBAF 
from the compound. As a consequence large peaks from the TBAF were observed in the 1H NMR 
(and MS) that hindered the characterization of the desired compound. Consequently, it was decided 
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to use aq HF as the fluoride source where up the fluoride can be removed as TIPS fluoride under 
reduced pressure (Corey et al.). 
To a solution of the O-TIPS ether (+)-18 (16 mg, 0.034 mmol) in acetonitrile (4 mL), 0.4 mL of 
48% aq HF was added at 0 oC. The solution, which resulted, was stirred at 0 oC for 40 min (caution: 
glassware should not be used with HF, Teflon or plasticware should be used). At that time, 
TLC (silica gel, UV and CAN stain) and LRMS indicated the disappearance of starting material. 
The solvent was removed under reduced pressure and the residue was dried in vacuo. The residue 
was further purified by silica gel column chromatography (5-10% MeOH in DCM) to furnish the 
diol 8 (LRMS M+H+ = 313.20) as a white solid 9.5 mg, 89%). 
(+)-Dihydroperaksine (8) 
 
1H NMR (500 MHz, CD3OD): δ 7.45 (d, 1H, J = 7.8 Hz), 7.34 (d, 1H, J = 
8.1 Hz), 7.12 (t, 1H, J = 7.2 Hz), 7.03 (t, 1H, J = 7.2 Hz), 4.64 (br d, 1H, J 
= 8.9 Hz), 3.80-3.71 (m, 2H), 3.70-3.63 (m, 2H), 3.39-3.35 (m, 1H), 3.22 
(dd, 1H, J = 15.7, 5.2 Hz), 3.17 (t, 1H, J = 6.2 Hz), 2.94 (br d, 1H, J = 15.8 Hz), 2.22-2.17 (m, 
1H), 2.14 (t, 1H, J = 11.3 Hz), 1.95-1.88 (m, 1H), 1.79-1.74 (m, 1H), 1.71-1.66 (m, 1H), 1.52 (d, 
3H, J = 6.9 Hz); 13C NMR (75 MHz, CD3OD): δ 137.0 (C), 135.4 (C), 127.0 (C), 121.2 (CH), 
118.7 (CH), 117.4 (CH), 110.8 (CH), 102.8 (C), 65.3 (CH2), 64.6 (CH2), 59.6 (2 x CH), 59.5 (CH), 
46.4 (CH), 45.2 (CH), 41.5 (CH), 36.8 (CH2), 26.9 (CH), 26.2 (CH2), 19.2 (CH3); HRMS (ESI) 
m/z (M + H)+ calcd for C19H25N2O2, 313.1911, found 313.1913; []D25: Synthetic, this report = 
+40.0 (c 0.1 MeOH), Natural alkaloid10 = +40.0 (c 1.0, Py); Rf: 0.1 (silica gel, 10% MeOH in 
DCM). 
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Synthesis of (-)-Deoxyperaksine (9) from (-)-32 
To a solution of the tosylate (-)-32 (10 mg, 0.016 mmol) in THF (5 mL), TBAF (24 μL, 0.024 
mmol, 1.0 M solution in THF) was added at -30 oC. The solution, which resulted, was stirred at -
30 oC to rt for 1 h, until the complete consumption of 32, as indicated by TLC (silica gel) and 
LRMS. The reaction mixture was diluted with 30 mL of EtOAc and 5 mL of water. The aq layer 
was separated and extracted with another 5 mL of EtOAc. The combined EtOAc layers were 
washed with brine (2 x 20 mL) and dried (Na2SO4) to furnish the ether (-)-9 as a colorless oil which 
was purified by column chromatography (silica gel, 2-5% MeOH in DCM) to furnish pure (-)-9  
(LRMS M+H+ = 295.15) as a white solid (3.9 mg, 82%). 
(-)-Deoxyperksine 
 
1H NMR (500 MHz, CDCl3): δ 7.73 (br s, 1H), 7.49 (d, 1H, J = 7.6 
Hz), 7.33 (d, 1H, J = 7.9 Hz), 7.18-7.14 (m, 1H), 7.13-7.09 (m, 1H), 
4.23 (br d, 1H, J = 9.5 Hz), 3.78-3.73 (m, 2H), 3.52-3.46 (m, 2H), 3.40 
(br d, 1H, J = 10.9 Hz), 3.22 (dd, 1H, J = 15.6, 5.9 Hz), 3.19-3.13 (m, 1H), 2.61 (br d, 1H, J = 15.7 
Hz), 1.82 (br t, 1H, J = 11.6 Hz), 1.67-1.63 (m, 1H), 1.55-1.49 (m, 1H), 1.40 (d, 3H, J = 7.0 Hz), 
1.37-1.32 (m, 1H), 1.23-1.18 (m, 1H);  
1H NMR (500 MHz, CD3OD): δ 7.42 (d, 1H, J = 7.8 Hz), 7.30 (d, 1H, J = 8.0 Hz), 7.07 (t, 1H, J 
= 7.1 Hz), 7.02-6.98 (m, 1H), 4.30-4.25 (m, 1H), 3.77-3.70 (m, 2H), 3.52 (dd, 1H, J = 11.2, 1.7 
Hz), 3.45-3.40 (m, 2H), 3.19 (dd, 1H, J = 15.7, 5.8 Hz), 3.10-3.05 (m, 1H), 2.67 (br d, 1H, J = 
15.5 Hz), 1.99-1.93 (m, 1H), 1.74-1.70 (m, 1H), 1.58-1.53 (m, 1H), 1.42 (d, 3H, J = 7.1 Hz), 1.40-
1.37 (m, 1H), 1.33-1.28 (m, 1H);  
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13C NMR (75 MHz, CD3OD): δ 139.3 (C), 138.3 (C), 128.7 (C), 122.0 (CH), 119.7 (CH), 118.6 
(CH), 111.9 (CH), 103.7 (C), 71.5 (CH2), 71.5 (CH2), 58.9 (CH), 56.6 (CH), 43.7 (CH), 40.5 (CH), 
37.2 (CH), 34.5 (CH2), 30.5 (CH), 27.8 (CH2), 20.3 (CH3); HRMS (ESI) m/z (M + H)
+ calcd for 
C19H23N2O, 295.1805, found 295.1801; []D25 = -17.14 (c 0.17 CHCl3); Rf: 0.4 (silica gel, 10% 
MeOH in DCM, NH4OH). 
 
5. Spectra and X-ray Data: See Appendix D for X-ray data for compound 16b. See 
Appendix E for the NMR spectra for the synthetic alkaloids 1-5, 8, and 9. 
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Chapter 6 
The Total Synthesis of Macrocarpines F and G, Talpinine, O-Acetyltalpinine, as well as N4-
Methyltalpinine 
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1. Introduction 
Macrocarpine F (1)1 and macrocarpine G (2)1 are two macroline alkaloids bearing Na-CH3 and Nb-
H substitituents. After the synthesis of Na-CH3, Nb-CH3 alkaloids macrocarpines A-C (3, 4, and 
7),2 it was felt that the Nb-H substitution in macrocaprines F 1 and G 2 would be accessible via an 
Nb-demethylation process from macrocarpine A (3)
3 and B (4),3 respectively (Scheme 1). 
 
 
Scheme 1. Retrosynthetic analysis for the synthesis of macrocarpines F 1 and G 2 from 
macrocarpines A 3 and B 4, respectively. 
 
2. Results and Discussion 
The Nb-methyl function is inert to many chemical transformations and aggressive reagents 
consequently, it is considered as a persistent protecting group for amines.4 In addition, it is an 
additional challenge to remove a methyl group on amines in functionally rich and sterically 
hindered systems such as macrocarpines A 1 and B 2. In order to remove the Nb-methyl group 
regioselectively, it was decided to attempt a number of available methods present in the literature. 
The use of cyanogen bromide (Von Braun reaction)5 and carbonochloridates6 (chloroformates) are 
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well-known for regioselective dealkylation of akylamines. It was also reported that the 
chloroformates are one of the best methods for this purpose due to better selectivity, as well as 
cleaner, and milder reaction conditions. In addition, one looked for inspiration from similar 
transformations in related systems. Inspired by the methods in the total synthesis of isoalstonisine 
by Fonseca7 (Scheme 2) wherein the chloroformate was successfully used to N-dealkylate the Nb-
methyl group at the final stage of the synthesis, it was decided to employ the well-known N-
dealkylation process developed by Olofson8 et al. This process employes an excess of ACE-Cl in 
1,2-DCE at reflux. The so formed quaternary ammonium carbamate upon refluxing in methanol, 
followed by a basic work-up would provide the desired Nb-demethylated products 1 and 2. 
 
 
Scheme 2. Synthesis of (+)-isoalstonisine by N-dealkylation by Fonseca9 
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Scheme 3. Synthesis of macrocarpines F (1) and G (2) by Nb-demethylation process using ACE-
Cl 
2.1 Synthesis of Macrocarpines F (1) and Macrocarpine G (2) 
As planned, macrocarpine A (3) and B (4) (individually) were reacted with 10 equivalents of ACE-
Cl in refluxing 1,2-dichloroethane. After that, the reaction mixture was dissolved in dry methanol 
and heated at reflux and this was followed by basic work-up with cold aq 1 N NaOH. It was 
observed that the C-20α hydroxymethyl compound 4 (macrocarpine B) remained unchanged 
(LRMS: M+H+ = 341) even after prolonged heating at reflux (up to 72 h) ligand 4 did not form 
the quaternary ammonium carbamate salt and the subsequent decarboxylation did not proceed. On 
the other hand, the C-20β hydroxymethyl compound, macrocarpine A 3, furnished the Nb-
demethylated secondary amine, macrocarpine F (1, LRMS: M+H+ = 327), along with unreacted 
starting material 3, which resulted in a 90% yield (based on recovered starting material). An LC-
MS analysis of the reaction mixture indicated that the desired product 1 and the starting material 
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3 were present in a ratio of 88 to 12 (see Figure 1). Consequently, the O-acetyl variant of 
macrocarpine B (4), macrocarpine C (7, MW = 382.5) was subjected to the same conditions used 
for macrocarpine B 4. It was observed that the desired Nb-demethylated secondary amine 2 formed 
(LRMS: M+H+ = 327), and this was accompanied by the deacetylated compound macrocarpine B 
4 (LRMS: M+H+ = 341).  
 
 
Figure 1. LC-MS analysis of the ACE-Cl mediated Nb-demethylation of macrocarpine A (1) 
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From these observations, it was concluded that in the C-20α hydroxymethyl group in tertiary amine 
4, was too close to the amine function which created some steric congestion, which probably 
hindered the amine function from reacting with the chloroformate. More importantly, from 
molecular models it is clear a hydrogen bond between the tertiary amine function in 4 with the 
primary alcohol would also retard the amine from reacting with the chloroformate. This was 
evident from the fact that both macrocarpine A 3 and the O-acetyl version of macrocarpine B 
(macrocarpine C, 7) did react to form the desired Nb-demethylated products 1 and 2, respectively.  
A proposed mechanism of the Nb-demethylation of Olofson
8,9 employed here for macrocarpine A 
(3) is shown in Scheme 4. 
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Scheme 4. The proposed mechanism of the ACE-Cl mediated Nb-demethylation of macrocarpine 
A 3 to provide macrocarpine F 1. 
 
2.1.1 Macrocarpine F (1) 
1H NMR: see Table 1; 13C NMR: see Table 2; [note: complete structural assignment was done 
based on 1H, 13C, DEPT-135, COSY, and HSQC NMRs, see Appendix F for NMR spectra) 
HRMS: (ESI) m/z (M+H)+ calcd for C20H27N2O2 327.2067, found 327.2060; Rf: 0.1 (silica gel, 
5% MeOH in DCM/NH4OH); [Note: The optical rotation was not measured due to the loss of 
material during re-purification] 
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Table 1. Comparison between the 1H NMR of natural1 and synthetic macrocarpine F (1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[*] There is a typographical error in the natural1 macrocarpine F at H-12; [#] merged with chloroform 
peak. Confirmed from COSY and HSQC NMRs; [$] overlapped peaks 
 
H# 
1H Natural1 
(400 MHz) 
1H Synthetic 
(300 MHz) 
3 4.27 (m) 4.37 (br s) 
5 3.21 (m) 3.23-3.15 (m) 
6β 
6α 
2.63 (d, J = 15 Hz) 
3.17 (m) 
2.68 (br d, J = 14.7 Hz) 
3.30-3.23 (m) 
9 7.46 (br d, J = 8 Hz) 7.49 (d, J = 7.6 Hz) 
10 7.07 (br t, J = 8 Hz) 7.14-7.06  (m) 
11 7.18 (br t, J = 8 Hz) 7.23-7.16 (m) 
12 7.75 (br d, J = 8 Hz)* 7.32-7.23 (d, J = 8.1 Hz)# 
14β 
14α 
1.35 (m) 
2.45 (td, J = 12, 4 Hz) 
1.31-1.25 (m)$ 
1.46-1.35 (m) 
15 2.10 (m) 2.19-2.11 (m)$ 
16 2.08 (m) 2.28-2.12 (m)$ 
17β 
17α 
3.78 (dd, J = 11, 5 Hz) 
4.07 (t, J = 11 Hz) 
3.88-3.79 (m) 
4.19-4.08 (t, J = 11.6 Hz) 
19 3.94 (qd, J = 6.8, 2 Hz) 4.02-3.90 (m) 
20 1.04 (m) 1.13-1.01 (m) 
21 3.65 (dd, J = 11, 4 Hz) 3.75-3.65 (m) 
21ʹ 3.72 (dd, J = 11, 6 Hz) 3.88-3.79  (m)$ 
18-Me 1.21 (d, J = 6.8 Hz) 1.29-1.19 (m)$ 
N(1)-
Me 
3.52 (s) 3.61 (s) 
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Table 2. Comparison between the 13C NMR of natural1 and synthetic macrocarpine F (1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[#] quaternary carbon (C-13) was not visible in 13C NMR spectrum at this concentration
 
C# 
 
 
13C Natural1 
(100 MHz) 
13C and 
DEPT-135 
Synthetic 
(75 MHz) 
 
2 136.4 136.3 
3 46.5 46.5 
5 48.2 48.2 
6 28.5 28.4 
7 107.7 107.9 
8 126.6 126.2 
9 118.1 118.1 
10 119.1 119.0 
11 121.2 121.1 
12 108.9 108.8 
13 136.8 -# 
14 29.8 29.7 
15 29.0 29.5 
16 38.1 38.3 
17 68.6 68.6 
18 18.9 18.8 
19 71.3 71.4 
20 44.1 43.9 
21 62.5 63.1 
N(1)-Me 29.0 29.0 
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2.1.2 Macrocarpine G (2) 
1H NMR: see Table 3; Rf: 0.1 (silica gel, 5% MEOH in DCM/NH4OH); [α]D25: Synthetic = +12.0 
(c 0.5, CHCl3); Natural
1: = +7 (c 1.1, CHCl3); HRMS: (ESI) m/z (M+H)
+ calcd for C20H26N2O2 
327.2067, found 327.2074. [Note: 13C NMR measurement was attempted but due to very small 
amount of sample available, it was not successful even after a longer experiment time. The full 
structural assignement was done based on 1H, COSY, NOESY (see Figure 2 for important NOE 
confirmation) and comparison with the spectra of the natural alkaloid1].  
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Table 3. Comparison between the 1H NMR of natural1 and synthetic macrocarpine G (2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* overlapped peaks 
 
H# 
1H Natural1 
(400 MHz) 
1H Synthetic 
(500 MHz) 
3 4.27 (br t, J = 3 Hz) 4.35 (br s) 
5 3.25 (m) 3.31 (d, J = 7.3 Hz) 
6β 
6α 
2.58 (d, J = 16 Hz) 
3.18 (dd, J = 16, 7 Hz) 
2.65 (br d, J = 16.2 Hz) 
3.25-3.19 (m) 
9 7.46 (br d, J = 7.5 Hz) 7.49 (d, J = 7.9 Hz) 
10 7.08 (td, J = 7.5, 1 Hz) 7.10 (t, J = 7.5 Hz) 
11 7.17 (td, J = 7.5, 1 Hz) 7.19 (t, J = 7.5 Hz) 
12 7.24 (br d, J = 7.5 Hz) 7.29 (d, J = 8.1 Hz) 
14β 
14α 
1.49 (dt, J = 12, 2 Hz) 
2.18 (td, J = 12, 4 Hz) 
1.58-1.53 (m)* 
2.28 (td, J = 12.6, 3.8 Hz) 
15 2.02 (m) 2.15-2.08 (m) 
16 1.81 (dt, J = 12, 5 Hz) 1.91-1.86 (m)* 
17β 
17α 
3.72 (dd, J = 12, 4 Hz) 
4.03 (t, J = 12 Hz) 
3.78 (dd, J = 11.4, 4.4 Hz) 
4.10 (br t, J = 12.2 Hz) 
19 3.46 (m) 3.58-3.54 (m)* 
20 1.37 (m) 1.52-1.45 (m)* 
21 3.22 (m) 3.39-3.34 (m) 
21ʹ 3.40 (dd, J = 11, 5 Hz) 3.51 (dd, J = 11.0, 5.3 Hz)* 
18-Me 1.11 (d, J = 6 Hz) 1.17 (d, 6.1 Hz) 
N(1)-Me 3.52 (s) 3.63 (s) 
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Figure 2: Selected NOE that confirms C-20 stereochemistry of macrocarpine G  
 
 
2.3 Synthesis of Talpinine (8) 
Talpinine10 is a sarpagine-macroline alkaloid containing a hemiaminal (carbinolamine) function at 
C-21. Retrosynthetically, the hemiaminal function at C-21 would originate from an intramolecular 
cyclization between the secondary Nb-nitrogen atom (as in 9) with the C-20α formyl function 
(Scheme 5). The secondary amine 9 would be available from the tertiary amine 10 (termed, N4-
methyl-N4,21-secotalpinine). The same Nb-demethylation reaction employed for the synthesis of 
macrocarpines F (1) and G (2) should also be useful in this case.  
 
 
Scheme 5. Retrosynthetic analysis for the synthesis of talpinine 8 by Na-demethylation of tertiary 
amine 10.  
 
As planned, the C-20α aldehyde 10 was subjected to the Olofson8 Nb-demethylation conditions 
which furnished the demethylated secondary amine 9 in situ and it subsequently cyclized in an 
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intramolecular fashion to form the desired hemiaminal present in talpinine 8. During the initial 
trials it was observed that the starting tertiary amine 10 was somewhat unreactive with the 
chloroformate (ACE-Cl) and the conversion was very slow. It was felt that using a bulky and non-
nucleophilic base such as pempidine (1,2,2,6,6-pentamethylpiperidine) would facilitate the 
carbamate formation at the initial stage of the demethylation process by scavenging any residual 
protons present in the reaction solution. By using a stoichiometric amount of pempidine and an 
excess of ACE-Cl in DCE at reflux (for 18 h), it was observed that the corresponding carbamates 
(11, LRMS: M+ = 445; 12, LRMS: (M+H)+ =  431) formed but the starting tertiary amine (10, 
LRMS: (M+H)+ = 339) still remained (Figure 3). This indicated that the first intermediate 11, 
which formed by the reaction between the tertiary amine nitrogen with the ACE-Cl carbonyl 
function, was present as the major product in the reaction mixture (after 18 h), while the Nb-
demethylated carbamate 12 was present as the minor product. Gratifyingly, this observation 
indicated that the reaction was progressing, albeit slowly. Accordingly, the reaction mixture was 
subjected to prolonged heat (up to 42 h) which completed the conversion, as indicated by the 
absence of the starting material 10 on analysis by LC-MS. After the subsequent decarboxylation 
reaction in refluxing methanol was followed by an alkaline workup, this process furnished the 
secondary amine 9. The amine Nb-nitrogen atom reacted with the C-21 formyl function ultimately 
to form the hemiaminal present in talpinine 8. Examination of the 1H NMR spectrum confirmed 
the absence of the formyl function (at δ 9.44 ppm) and the presence of the H-21 (at carbinolamine 
carbon, C-21) at δ 4.71 ppm. 
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Figure 3. Nb-demethylation of 10 using ACE-Cl 
 
The C-20β aldehyde function containing indole base 13, was also subjected to the same conditions 
to check whether the stereochemistry at the C-20 function played a significant role in the initial 
carbamate formation. It was found that talcarpine 13 also underwent demethylation and furnished 
the same product, talpinine 8. This indicated that the C-20 aldehyde undergoes epimerization under 
these conditions to the α-stereochemistry and then cyclizes. 
 
 
Scheme 6. Synthesis of talpinine 8 
 
The spectral and optical properties of synthetic talpinine were in excellent agreement with the 
literature10,11 values for natural product (-)-8. 
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Talpinine 8 
1H NMR (300 MHz, CDCl3) 1.38-1.20 (6H, m), 1.87-1.79 (1H, m), 1.93-1.86 (1H, m), 2.65 (1H, 
d, J = 15.6 Hz), , 3.21 (1H, dd, J = 15.6, 6.0 Hz), 3.52-3.41(2H, m), 3.59 (3H, s), 3.72-3.62 (1H, 
m), 4.10-3.99 (1H, m), 4.43(1H, d, J = 7.9 Hz), 4.71 (1H, m), 7.12-7.05 (1H, m), 7.19 (1H, t, J = 
7.7 Hz), 7.31-7.27 (1H, m, merged with chloroform peak), 7.47 (1H, d, J = 7.5 Hz); 13C NMR (75 
MHz, CDCl3) δ 15.7, 23.3, 26.3, 29.2, 31.9, 35.2, 40.2, 43.6, 49.8, 64.0, 72.6, 87.9, 103.3, 108.7, 
118.3, 118.9, 120.9, 127.3, 137.5, 139.1; [α]D25 = -30.0 (c 0.2, CHCl3), Natural10: [α]D25 = -30 (c 
0.302, CHCl3); HRMS: (ESI) m/z (M+H)
+ calcd for C20H25N2O2 325.1911, found 325.1919; Rf: 
0.1 (silica gel, 5% MeOH in DCM/NH4OH) 
 
2.4 Synthesis of O-Acetyltalpinine (14) 
O-Acetyltalpinine (14)1 contains an acetyl function at the C-21 hydroxyl function of talpinine 8. 
A simple acetylation of talpinine 8 with acetic anhydride in the presence of excess pyridine 
furnished O-acetyltalpinine 14 in 85% yield. The spectra and optical properties of the synthetic 
alkaloid were in agreement with the literature values for the natural product. There was an 
unidentified minor impurity in the synthetic, sample as indicated by examination of the 1H NMR 
spectrum but the compound appeared as single spot on TLC (silica gel). In addition, only the 
desired compound’s (14) peak  (LRMS M+H+ = 367) was observed in the LCMS spectrum. The 
minor impurity could not be removed after several chromatographic purifications. Further attempts 
for the synthesis or purification of this impurity could not be undertaken due to the lack of material. 
In spite of the presence of the impurity, the synthetic O-acetyltalpinine 14 was fully characterized 
and the structural assignment could be done to confirm the synthesis unambiguously, by high 
resolution NMR spectroscopy. 
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Scheme 7. Synthesis of O-acetyltalpinine 14 from talpinine 8 
 
O-Acetyltalpinine 14 
 
 
 
 
1H NMR: see Table 4; 13C NMR: see Table 5; Rf: 0.3 (silica gel, 5% MeOH in DCM/NH4OH); 
Synthetic: [α]D25 = -9.1 (c 0.12, CHCl3)*; Natural1: [α]D25 = -8 (c 0.2, CHCl3); HRMS: (ESI) 
m/z (M+H)+ calcd for C22H27N2O3 367.2016, found 367.1995. 
(*Note: The full structural assignment was based on 1H, 13C, and HSQC NMR correlations, as well as by 
comparison with spectra of the natural alkaloid. The synthetic sample contained an unidentified minor 
impurity that was seen in the 1H and HSQC NMR spectra. The impurity persisted even after multiple 
purification cycles. Further attempts could not be made to determine its structure due to the lack of 
material.) 
 
290 
 
O-Acetyltalpinine 14 
Table 4. Comparison between the 1H NMR spectra of natural1 and synthetic O-acetyltalpinine 14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[*] = merged peaks 
 
 
 
 
H# 
1H Natural 
(400 MHz) 
1H Synthetic 
(500 MHz) 
3 4.48 (br dd, J = 10, 2 Hz) 4.46 (br d, J = 9.3 Hz) 
5 3.52 (br t, J = 5.5 Hz) 3.56 (br t, J = 5.5 Hz) 
6β 
6α 
2.66 (d, J = 15.6 Hz) 
3.20 (dd, J = 15.6, 5.5 Hz) 
2.62 (br d, J = 15.8 Hz) 
3.18 (dd, J = 15.2, 5.9 Hz) 
9 7.47 (br d, J = 7.5 Hz) 7.47 (d, J = 7.7 Hz) 
10 7.09 (br td, J = 7.5 Hz) 7.09 (t, J = 7.4 Hz) 
11 7.19 (td, J = 7.5, 1 Hz) 7.18 (t, J = 7.6 Hz) 
12 7.29 (br d, J = 7.5 Hz) 7.29 (d, J = 8.2 Hz) 
14β 
14α 
1.52 (ddd, J = 12, 4, 2.8 Hz) 
1.89 (ddd, J = 12, 10, 1.6 
Hz) 
1.53-1.47 (m) 
1.91-1.83 (m)* 
15 2.00 (m) 2.03-1.97 (m) 
16 1.30 (m) 1.30 (m)* 
17β 
17α 
3.47 (dd, J = 11, 2 Hz) 
3.71 (dd, J = 11, 1 Hz) 
3.47 (dd, J = 11.4, 1.9 Hz) 
3.71 (dd, J = 11.4, 1.1 Hz) 
19 4.34 (q, J = 7 Hz) 4.34 (q, J = 7.0 Hz) 
20 1.34 (m) 1.34-1.31 (m)* 
21 5.63 (br d, J = 2 Hz) 5.61 (m) 
18-Me 1.30 (d, J = 7 Hz) 1.30 (d, 6.8 Hz) 
N(1)-
Me 
3.66 (s) 3.66 (s) 
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Table 5. Comparison between the 13C NMR spectrum of natural1 and synthetic O-acetyltalpinine 
14 
 
 
C# 
 
 
13C Natural1 
(100 MHz) 
13C 
Synthetic 
(125 MHz) 
 
2 138.9 -* 
3 41.7 41.7 
5 50.3 50.3 
6 26.6 26.6 
7 103.1 130.1 
8 127.2 127.2 
9 118.1 118.1 
10 120.9 120.9 
11 118.8 118.9 
12 108.7 108.7 
13 137.4 137.4 
14 32.3 32.3 
15 23.2 23.2 
16 35.2 35.2 
17 63.8 63.8 
18 15.6 15.7 
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* The peak for C-2 did not show up in the 13C NMR spectrum at this concentration
19 71.6 71.6 
20 43.6 43.6 
21 88.9 88.9 
N(1)-Me 29.3 29.3 
21-OAc 21.2 21.3 
21-OAc 169.6 169.6 
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2.5 Synthesis of N4-Methyltalpinine (15) 
The N4-methyltalpinine
12 is a quaternary ammonium alkaloid containing a methyl function at the 
Nb-nitrogen atom of talpinine. From a retrosynthetic point of view, the most obvious precursor for 
N4-methyltalpinine would be talpinine itself, which would be accessible by an Nb-methylation 
process with a methyl halide (Scheme 8). Although, the counter anion for the quaternary 
ammonium ion in the natural sample was not known,12 the synthetic N4-methyltalpinine would 
have the counter anion corresponding to the methyl halide used. Another possible way to accessing 
N4-methyltalpinine would be the intramolecular reaction between the tertiary Nb-amine nitrogen 
atom with the C-21 carbonyl function of N4-methyl-N4,21-secotalpinine 10. However, potential 
steric hindrance and conformational restriction of the tertiary Nb-nitrogen atom could deter it from 
reacting with the aldehyde function to furnish the hemiaminal (carbinolamine) function present in 
the desired N4-methyltalpinine. The carbonyl function in 10 could be further activated towards the 
nucleophilic addition by means of a Lewis or BrØnsted acid catalyst.  
 
Scheme 8. Retrosynthetic analysis for the synthesis of N4-methyltalpinine 15 from talpinine 8 
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As planned, talpinine 8 was treated with iodomethane in methanol at rt in the dark for 16 h. A 1H 
NMR spectrum of the reaction mixture in deuterated methanol indicated the disappearance of the 
aldehydic proton (at δ 9.44 ppm), whereas, a broad multiplet at δ 5.0-4.9 ppm appeared, which 
was expected for the hemiaminal proton (H-21 on the carbinolamine carbon, C-21). This result 
was encouraging. However, the NMR spectra of the crude reaction mixture was not clean enough 
for full characterization and for comparison with the natural alkaloid.12 Consequently, silica gel 
chromatography (5% MeOH in DCM/sat NH4OH) was attempted in order to obtain a pure sample 
of synthetic N4-methyltalpinine. Unfortunately, the compound that was isolated by 
chromatography lacked the hemiaminal proton peak at ~δ 5 ppm, as well as the aldehydic proton 
peak at δ 9.44 ppm. Intrigued by this result, attempts were taken to identify this product. The 
product was found to be identical to N4-methyl-N4,21-secotalpinine 10 in deuterated methanol 
(Scheme 9). One important observation was made. In deuterated methanol the aldehyde peak of 
10 was not well defined in comparison to the 1H NMR spectrum of 10 in CDCl3 (see Figure 4).  
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Figure 4. 1H NMR spectra of the crude reaction mixture and alkaloid 10 in CD3OD 
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Scheme 9. Attempted synthesis of N4-methyltalpinine  
 
Upon further investigation of this result it was found that while the C-20β aldehyde of alkaloid 
talcarpine 13 exhibited a well define aldehyde peak (δ 9.9 ppm) in deuterated methanol; the C-20α 
aldehyde of the alkaloid N4-methyl-N4,21-secotalpinine 10 exhibited a broaden aldehyde peak (~δ 
9.3 ppm) in deuterated methanol. On the other hand, both talcarpine and secotalpinine showed 
well-defined sharp singlets for the aldehyde protons in CDCl3 at δ9.9 ppm and δ9.4 ppm, 
respectively (Figure 5). 
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Figure 5. Comparison between the 1H NMR spectra of talcarpine 13 and N4-methyl-N4,21-
secotalpinine in CD3OD and CDCl3 
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This result indicated that while the C-20β aldehyde in talcarpine 13 remained as an aldehyde 
moiety in methanol, there was an equilibrium mixture in case of N4-methyl-N4,21-secotalpinine 
10. Furthermore, it was observed that the aldehyde peak broadened or sharpened in a temperature 
dependent manner. At higher temperature, the aldehyde peak was found to be broader than the 
aldehyde peak at lower temperatures (see Figure 6). 
 
 
Figure 6. Temperature dependence of the broadness of the aldehydic peak of 10.  
 
Furthermore, it was determined the aldehyde peak broadened after the epimerization of talcarpine 
13 into secotalpinine 10. Talcarpine 13 was treated with triethylamine in methanol at rt. It was 
observed that the aldehyde peak of talcarpine 10 (at δ 9.9 ppm) gradually diminished and a broad 
peak corresponding to the C-20α aldehyde appeared at δ ~9.3 ppm. This experiment indicated that 
the β-aldehyde function in  talcarpine 13 epimerized in the presence of a base and gradually formed 
the corresponding α-aldehyde 10, which is the thermodynamically more stable epimer. As soon as 
the α-aldehyde 10 was formed, it reacted with the tertiary amine, which was in the vicinity and 
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formed an equilibrium favoring the cyclized form. As a result this altered the sharp peak for the 
aldehyde to a broader peak (Figure 8).  
 
 
Figure 7. Epimerization of talcarpine 13 into N4-methyl-N4,21-secotalpinine 10 under basic 
conditions 
 
Figure 8. Epimerization of 13 in the presence of triethylamine to form 16 via 10 
 
From the experiemnts described above it was felt that the indole base 10 would stay in an 
Zwitterionic form with 16 in methanol (Figure 8). In the presence of dry HCl in solution the oxygen 
atom would be protonated and the chloride ion would act as the counter anion for the quaternary 
ammonium nitrogen atom. This would lead to the desired stable N4-methyltalpinine as a chloride 
salt (Scheme 10) if silica gel chromatography was avoided. Consequently, the N4-methyl-N4,21-
secotalpinine was stirred with dry HCl (4.0 M solution in dioxane) at rt. The deuterated chloroform 
300 
 
was used as the solvent instead of CD3OD to avoid any peak overlap with the peak at δ 4.87 ppm 
(residual moisture) with the desired H-21 peaks at δ 5.00-4.95 ppm. After adding a catalytic 
amount of dry HCl, a small broad peak at δ 5.0 ppm appeared, which indicated the conversion 
began, albeit in very small amount (entry b, Figure 9). After adding 2 additional equivalents of 
HCl it was observed that the multiplet at δ 5 ppm increased in intensity, while the aldehydic peak 
at δ9.44 ppm began to diminish in intensity (entry c, Figure 9). After standing at rt for an additional 
2 h, examination of the 1H NMR spectrum indicated that the aldehydic peak was completely gone 
and the spectrum appeared much cleaner (entry d, Figure 9). After that, the solvent was removed 
under reduced pressure and the alkaloid was dissolved in deuterated methanol for comparison with 
the literature values (see Figure 10 in Appendix F). A 1H NMR spectrum of the residue in CD3OD 
was found to be identical to that of the literature values.12 All other spectroscopic and optical 
rotation values were in excellent agreement with the literature values12 for the desired alkaloid N4-
methyltalpinine 15.1 Caution: In Zwitterionic molecules such as 15/16, it is best to avoid silica gel 
chromatography.  
 
Scheme 10. Synthesis of N4-methyltalpinine 15 from the indole base 10 
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Figure 9. Progress of the reaction of dry HCl with indole base 10 (1H NMR spectra) 
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N4-methyltalpinine 15 
1H NMR: see Table 6; 13C NMR: see Table 7; [α]D25: Synthetic = -9.1 (c 0.11, EtOH); Natural12: 
= -10 (c 0.1, MeOH); HRMS: (ESI) m/z M+ calculated for C21H27N2O2 339.2067, found 339.2036 
Table 6. Comparison between the 1H NMR spectra of natural and synthetic N4-methyltalpinine 
15 in CD3OD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H# 
1H Natural12 
(400 MHz) 
1H Synthetic 
(500 MHz) 
3 4.99 (1H, d, J = 10.7 Hz) 4.99 (1H, d, J = 10.4 Hz) 
5 3.91 (1H, t, J = 5.4 Hz) 3.92 (1H, t, J = 5.5 Hz) 
6β 
6α 
3.09 (1H, d, J = 16.6 Hz) 
3.36 (1H, dd, J = 17.4, 5.3 Hz) 
3.09 (1H, d, J = 17.4 Hz) 
3.36 (1H, dd, J = 17.2, 5.4 Hz) 
9 7.53 (1H, d, J = 7.9 Hz) 7.53 (1H, d, J = 7.9 Hz) 
10 7.12 (1H, t, J = 7.8 Hz) 7.12 (1H, t, J = 7.6 Hz) 
11 7.25 (1H, t, J = 7.7 Hz) 7.25 (1H, t, J = 7.7 Hz) 
12 7.43 (1H, d, J = 8.2 Hz) 7.43 (1H, d, J = 8.3 Hz) 
14β 
14α 
1.98 (1H, ddd, J = 13.2, 5.0, 1.8 Hz) 
2.47 (1H, br t, J = 12.2 Hz) 
1.96 (1H, ddd, J = 13.3, 5.0, 1.8 Hz) 
2.47 (1H, m) 
15 2.36 (1H, br s) 2.36 (1H, m) 
16 1.77 (1H, br s) 1.77 (1H, br s) 
17β 
17α 
3.80 (1H, d, J = 11.7 Hz) 
3.54 (1H, dd, J = 11.9, 2.1 Hz) 
3.80 (1H, d, J = 11.7 Hz) 
3.54 (1H, dd, J = 11.9, 2.2 Hz) 
19 4.15 (1H, q, J = 6.8 Hz) 4.15 (1H, q, J = 6.9 Hz) 
20 2.04 (1H, br s) 2.04 (1H, br s) 
21 4.95 (1H, d, J = 1.9 Hz) 4.95 (1H, d, J = 1.7 Hz) 
18-Me 1.38 (3H, d, J = 6.8 Hz) 1.38 (3H, d, J = 6.8 Hz) 
N(1)-Me 3.73 (3H, s) 3.73 (3H, s) 
N(4)-Me 3.07 (3H, s) 3.07 (3H, s) 
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Table 7. Comparison between the 13C NMR spectra of synthetic and natural12 N4-metyltalpinine 
in CD3OD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C# 
 
 
13C 
Natural12 
(100 MHz) 
13C 
Synthetic 
(125 MHz) 
 
2 134.2 134.2 
3 53.1 53.1 
5 61.3 61.3 
6 24.7 24.7 
7 101.2 101.6 
8 127.3 127.3 
9 119.5 119.5 
10 121.0 121.0 
11 123.7 123.7 
12 110.6 110.6 
13 139.7 139.7 
14 32.4 32.3 
15 22.7 22.6 
16 38.2 38.2 
17 63.1 63.1 
18 15.7 15.7 
19 72.7 72.7 
20 48.2 48.2 
21 98.4 98.4 
N(4)-Me 43.5 43.5 
N(1)-Me 29.9 29.9 
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3. Conclusion 
The first total synthesis of several bioactive indole alkaloids has been successfully completed in 
stereospecific fashion. Macrocarpines F and G, and bioactive alkaloid O-acetyltalpinine, as well 
as the potent NFκB inhibitor N4-methyltalpinine have been synthesized for the first time. The other 
bioactive alkaloid talpinine has been previously synthesized by Yu et al.11 (see General 
Introuction), but the strategy developed here is shorter and in higher yield. 
 
4. Experimental Section 
 
Macrocarpine F 1 
The indole 3 (3 mg, 0.009 mmol) was dissolved in dry 1,2-dichloroethane (2 mL) in a thick walled 
vessel that can be sealed with a screw cap. The ACE-Cl (1-chloroethyl chloroformate, 12.6 mg, 
0.09 mmol) was added to the above solution at 0 oC under argon. The reaction vessel was sealed 
and heated at 90 oC (oil bath) for 72 h. The reaction was then cooled to rt and the solvent was 
removed under reduced pressure. Then distilled methanol (5 mL) was added to the residue and the 
solution, which resulted, was heated at reflux under argon for 6 h with stirring. After that, the 
solvent was removed under reduced pressure and the residue was dissolved in EtOAc (5 mL) and 
brought to pH 8 with cold aq 1 N NaOH. The organic layer was separated and the aq layer was 
extracted with additional EtOAc (2 x 5 mL). The combined organic layers were washed with brine 
and dried (K2CO3). The solvent was removed under reduced pressure to give a brown residue. The 
residue was purified by column chromatography (silica gel) with 0-5% MeOH in CH2Cl2/sat 
NH4OH to provide macrocarpine F 1 as a colorless residue (2.3 mg, 80%). The spectroscopic data 
of the synthetic alkaloid were in excellent agreement with that of the natural product.1 
305 
 
Macrocarpine G 2 
The indole 7 (4 mg, 0.01 mmol) was dissolved in dry 1,2-dichloroethane (3 mL) in a thick walled 
vessel that can be sealed with a screw cap cap. The ACE-Cl (1-chloroethyl chloroformate, 14.9 
mg, 0.10 mmol) was added to the above solution at 0 oC under argon. The reaction vessel was 
sealed and heated at 90 oC (oil bath) for 72 h. The reaction mixture was then cooled to rt and the 
solvent was removed under reduced pressure. Then distilled methanol (5 mL) was added to the 
residue and the solution, which resulted, was heated at reflux under argon for 6 h with stirring. 
After that, the solvent was removed under reduced pressure and the residue was dissolved in 
EtOAc (5 mL) and brought to pH 8 with cold aq 1 N NaOH. The organic layer was separated and 
the aq layer was extracted with additional EtOAc (2 x 5 mL). The combined organic layers were 
washed with brine and dried (K2CO3). The solvent was removed under reduced pressure to give a 
brown residue. The residue was purified by column chromatography (silica gel) with 0-5% MeOH 
in CH2Cl2/sat NH4OH to provide macrocarpine G 2 as a colorless residue (1.9 mg, 55%) 
accompanied by macrocarpine B 4 (0.9 mg, 25%). The optical rotation and spectroscopic data 
were in agreement with that of the natural product.1 
 
Talpinine 8 
The indole 10 or 13 (6 mg, 0.018 mmol) was dissolved in dry 1,2-dichloroethane (4 mL) in a thick 
walled vessel that can be sealed with a screw cap. The ACE-Cl (1-chloroethyl chloroformate, 25.3 
mg, 0.18 mmol) and pempidine (2.7 mg, 0.018 mmol) were added to the above solution at 0 oC 
under argon. The reaction vessel was sealed and heated at 90 oC (oil bath) for 42 h. The reaction 
was then cooled to rt and the solvent was removed under reduced pressure. Then distilled methanol 
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(5 mL) was added to the residue and the solution, which resulted, was heated at reflux under argon 
for 6 h with stirring. After that, the solvent was removed under reduced pressure and the residue 
was dissolved in EtOAc (5 mL) and brought to pH 8 with cold aq 1 N NaOH. The organic layer 
was separated and the aq layer was extracted with additional EtOAc (2 x 5 mL). The combined 
organic layers were washed with brine and dried (K2CO3). The solvent was removed under reduced 
pressure to give a brown residue. The residue was purified by chromatography (silica gel) with 0-
5% MeOH in CH2Cl2/sat NH4OH to provide talpinine 8 as a colorless oil (4.3 mg, 75%). The 
spectral data were in excellent agreement with that of the natural product.10,11 
 
O-Acetyltalpinine 14 
To a mixture of Ac2O and pyridine (1:1, 0.5 mL), talpinine 8 (1 mg, 0.003 mmol) was added at rt 
under argon. The solution, which resulted, was stirred at rt for 2 h. After that, a cold solution of 
saturated aq Na2CO3 (2 mL) was added to the above reaction. The solution was extracted with 
CH2Cl2 (3 x 3 mL). The combined organic layers were washed with brine. The solvent was 
removed under reduced pressure and the residue was purified by column chromatography (silica 
gel) in a Pasteur pipette with 0-3% MeOH in CH2Cl2 to afford O-acetyltalpinine 14 (0.96 mg, 
85%) as a colorless waxy residue. The spectral data for 14 were identical to that of the natural 
product.1 
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N4-Methyltalpinine 15 
[Preparation of the HCl solution for NMR titration: Anhydrous HCl (0.3 mL, 4.0 M solution 
in dioxane) was dissolved in 5.0 mL of CDCl3. The solution, which resulted, was gradually added 
via a micropipette into the reaction vessel.] 
The indole 10 (1.0 mg, 0.003 mmol) was dissolved in dry CDCl3 (1.0 mL) in an oven dried NMR 
tube (5 mm OD). The above HCl solution (25 μL in total) was added to the NMR tube via a 
micropipette. The reaction, which resulted, was kept at rt for 2 h. After that, examination of the 1H 
NMR spectrum indicated complete conversion of the aldehyde into the desired product. The 
solvent was removed under reduced pressure to afford the N4-methyltalpinine 15 as chloride salt 
(1.1 mg, 99%) as a colorless residue. This residue was used for characterization without any 
purification. The optical rotation and spectroscopic data for the synthetic N4-methyltalpinine 15 
were in excellent agreement with the values reported in the literature for the natural product12 by 
Kinghorn et al. 
 
5. Spectra Section:  See Appendix F for the NMR spectra of synthetic alkaloids 1, 2, 8, 14, 
and 15 
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General Conclusion and Future Direction 
 
In the Part I of this dissertation an improved and shorter access to the important azabicyclo[3.3.1] 
framework of the sarpagine/macroline-related indole alkaloids has been described. By employing 
a bulky alkyl substituent on the Nb-nitrogen atom of D-tryptophan derivatives, this provided a more 
direct access toward the important key intermediates. The crucial intermediates toward a number 
of alkaloids from this group could be synthesized in a two-step shorter process and in higher yields 
(see Chapter 1). More importantly, on further investigation of the improved process, an 
unprecedented stereoselectivity in the Pictet-Spengler reaction was realized and enabled access to 
the key intermediates from either of the starting amino acid ester chiral auxiliaries (see Chapter 2). 
Furthermore, the ambidextrous nature of the recently developed Pictet-Spengler reaction permitted 
the synthesis of a series of important intermediates enantiomeric to the intermediates toward the 
natural alkaloids. This route would eventually provide entry into the unnatural enantiomers of the 
alkaloids in enantiospecific fashion (see Chapter 3) for biological screening.  
Described in Part II of this dissertation is the completion of the total synthesis of fourteen C-19 
methyl substituted sarpagine/macroline alkaloids. A more efficient method for the enolate-driven 
metal-mediated cross-coupling process greatly improved (82-89% with CuI as the catalyst) the 
intramolecular α-vinylation of the ketone by replacing catalytic palladium (60-68% yield with Pd 
catalyst) with CuI. This enabled an much better entry into the pentacyclic framework with all the 
substituents and stereocenters required for most of the alkaloids in this group in place. To illustrate 
the effectiveness of this method the first total synthesis of macrocarpines D and E have been 
completed (see Chapter 4). In addition, application of the improved entry into the azabicyclo[3.3.1] 
moiety via the modified P-S/Dieckmann protocol, accompanied by the copper mediated cross-
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coupling process, provided the total synthesis of talcarpine, N4-methyl-N4,21-secotalpinine, and 
macrocarpines A-C. The examination of the optical rotations and spectral data resulted in the 
correction of optical rotation values for macrocarpine A and N4-methyl-N4,21-secotalpinine, which 
were reported incorrectly earlier by others. Furthermore, to illustrate the versatality of the synthetic 
method described herein, the synthesis of two sarpagine alkaloids with the C-19α methyl 
substitution pattern, termed dihydroperaksine and deoxyperaksine, have also been completed (see 
Chapter 5). This is the first stereospecific synthesis of alkaloids in this series, which contained 
either an α-methyl or β-methyl substituent at C-19. 
Finally, a late stage demethylation of the Nb-methyl function furnished the total synthesis of 
macrocarpines F and G from macrocarpine A and macrocarpine C, respectively. A similar 
transformation also furnished talpinine from both N4-methyl-N4,21-secotalpinine and talcarpine. 
O-Acetyltalpinine has been accessed from talpinine by acetylation. Furthermore, a facile acid 
mediated hemiaminal formation process furnished the unusual quaternary hemiaminal containing 
alkaloid N4-methyltalpinine from N4-methyl-N4,21-secotalpinine in excellent yield (see Chapter 
6).  
In summary, a total of fourteen alkaloids, which comprise macrocarpines A-G, talcarpine, N4-
methyl-N4,21-secotalpinine, talpinine, O-acetyltalpinine, as well as N4-methyltalpinine has been 
completed. Several of these alkaloids exhibited potential and important biological activity. In 
addition, the unnatural enantiomers of the bioactive alkaloids would also be accessible from the 
enantiomeric series of intermediates that have been synthesized from both D- and L-tryptophan in 
stereospecific fashion. Furthermore, the other bioactive alkaloids, which form this subgroup of 
bases (see General Introduction) would also be accessible by employing the synthetic strategy 
described herein. 
311 
 
Further investigation to extend the synthetic strategy, as well as to fully understand some of the 
transformations which could not be investigated to the full extent due to the lack of time and 
required material, will be of interest. It would be important to fully understand and rationalize the 
outcomes of the ambidextrous Pictet-Spengler reaction with the help of Density Field Theory 
(DFT) calculations and other computational methods. Further investigation would also be fruitful 
in understanding the copper-mediated cross-coupling process and the actual role of TEMPO in the 
complete formation of the desired α-vinaltion product. Elucidation of the complete mechanism of 
several competing reaction pathways would also be of interest in this process. In addition, the total 
synthesis of several alkaloids (e.g., rauvomines A and B, rauvovertine C) with important 
bioactivity and unusual structures would be easily accessible from the key intermediates prepared 
here in either enantiomeric form.  
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III Appendix A (Chapter 1) 
Single Crystal X-ray Analysis 
The X-ray crystallographic work was supported by NIDA through Interagency Agreement #Y1-
DA1101 with the Naval Research Laboratory (NRL). 
The single-crystal X-ray diffraction data on compounds 12b and 25 were collected using Mo Kα 
radiation and a Bruker APEX II area detector.  The single-crystal X-ray diffraction data on 
compounds 13a, and 13b were collected using Cu Kα radiation and a Bruker Bruker Photon 100 
CMOS area detector. All crystals were prepared for data collection by coating with high viscosity 
microscope oil and mounted on a micro-mesh mount (MiteGen, Inc.). The data for 25 were 
collected at 150 K, data for compounds 12b, 13a, and 13b data were collected at 293 K. 
Corrections were applied for Lorentz, polarization, and absorption effects. The structures were 
solved by direct methods and refined by full-matrix least squares on F2 values using the programs 
found in the SHELXL suite (Bruker, SHELXL v2014.7, 2014, Bruker AXS Inc., Madison, WI). 
The parameters refined included atomic coordinates and anisotropic thermal parameters for all 
non-hydrogen atoms. The H atoms were included using a riding model. The complete information 
on data collection and refinement is available in the corresponding sections. 
The 0.660 x 0.456 x 0.236 mm3 crystal of 12b was orthorhombic in space group P212121, with unit 
cell dimensions a = 8.2529(2) Å, b = 13.1314(4) Å, c = 22.8333(6) Å,  = 90,  = 90, and  = 
90. Data was 99.9% complete to 25° θ (~0.83 Å) with an average redundancy of 7.93. The final 
anisotropic full matrix least-squares refinement on F2 with 281 variables converged at R1 = 3.53%, 
for the observed data and wR2 = 8.88% for all data.   
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The 0.220 x 0.167 x 0.082 mm3 crystal of 13a was monoclinic in space group P21, with unit cell 
dimensions a = 9.4596(5) Å, b = 8.0074(3) Å, c = 18.4232(7) Å,  = 90,  = 98.023(3), and  = 
90. Data was 92.7% complete to 67.7° θ (~0.83 Å) with an average redundancy of 3.49. The final 
anisotropic full matrix least-squares refinement on F2 with 326 variables converged at R1 = 4.94%, 
for the observed data and wR2 = 13.85% for all data.   
The 0.226 x 0.212 x 0.061 mm3 crystal of 13b was triclinic in space group P1, with unit cell 
dimensions a = 7.5923(2) Å, b = 10.1456(3) Å, c = 18.6690(6) Å,  = 78.6760(10),  = 
89.2370(10), and  = 87.1770(10). Data was 86.0% complete to 67.7° θ (~0.83 Å) with an 
average redundancy of 2.57. The final anisotropic full matrix least-squares refinement on F2 with 
576 variables converged at R1 = 3.39%, for the observed data and wR2 = 8.63% for all data.   
The 0.733 x 0.708 x 0.586 mm3 crystal of 25 was monoclinic in space group P21, with unit cell 
dimensions a = 8.6453(9) Å, b = 8.3913(8) Å, c = 10.2653(11) Å,  = 90,  = 93.327(3), and  
= 90. Data was 100% complete to 25° θ (~0.83 Å) with an average redundancy of 4.5. The final 
anisotropic full matrix least-squares refinement on F2 with 205 variables converged at R1 = 3.35%, 
for the observed data and wR2 = 8.48% for all data. 
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X-ray Crystal Data for 12b 
 
Table A1. Crystal data and structure refinement for 12b. 
Empirical formula  C27H38N2OSi 
Formula weight  434.68 
Temperature  296(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 8.2529(2) Å α= 90°. 
 b = 13.1314(4) Å β= 90°. 
 c = 22.8333(6) Å γ = 90°. 
Volume 2474.49(12) Å3 
Z 4 
Density (20 °C) 1.167 Mg/m3 
Absorption coefficient 0.116 mm-1 
F(000) 944 
Crystal size 0.660 x 0.456 x 0.236 mm3 
θ range for data collection 2.915 to 29.135°. 
Index ranges -11<=h<=11, -17<=k<=17, -30<=l<=30 
Reflections collected 27470 
Independent reflections 6639 [R(int) = 0.0374] 
Completeness to θ = 25.000° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7458 and 0.6641 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6639 / 0 / 281 
Goodness-of-fit on F2 1.017 
Final R indices [I>2σ(I)] R1 = 0.0353, wR2 = 0.0836 
R indices (all data) R1 = 0.0465, wR2 = 0.0888 
Absolute structure parameter 0.02(4) 
Largest diff. peak and hole 0.310 and -0.149 e.Å-3 
 
 
Table A2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
for 12b. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
C(1) 5326(2) 3037(2) 5793(1) 25(1) 
C(2) 6697(2) 2508(2) 5459(1) 25(1) 
O(3) 9381(2) 1989(1) 5695(1) 31(1) 
C(3) 7970(2) 2039(2) 5848(1) 22(1) 
C(4) 7448(2) 1582(2) 6430(1) 22(1) 
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C(5) 6799(2) 488(2) 6350(1) 25(1) 
C(6) 5062(2) 512(1) 6150(1) 23(1) 
C(7) 4051(2) -269(2) 5904(1) 25(1) 
C(8) 4272(3) -1290(2) 5746(1) 31(1) 
C(9) 3017(3) -1808(2) 5482(1) 38(1) 
C(10) 1533(3) -1329(2) 5367(1) 39(1) 
C(11) 1268(3) -324(2) 5515(1) 33(1) 
C(12) 2538(2) 199(2) 5782(1) 25(1) 
N(13) 2643(2) 1209(1) 5946(1) 24(1) 
C(14) 4180(2) 1389(2) 6170(1) 23(1) 
C(15) 4833(2) 2414(1) 6333(1) 22(1) 
N(16) 6304(2) 2305(1) 6702(1) 21(1) 
C(17) 5884(2) 2091(2) 7322(1) 23(1) 
C(17A) 5293(2) 3072(2) 7614(1) 30(1) 
C(18) 7297(2) 1683(2) 7645(1) 24(1) 
C(19) 8409(2) 1337(2) 7924(1) 26(1) 
Si(20) 10069(1) 705(1) 8326(1) 21(1) 
C(21) 10584(2) -486(2) 7902(1) 28(1) 
C(22) 11067(3) -221(2) 7269(1) 37(1) 
C(23) 9213(3) -1271(2) 7903(1) 43(1) 
C(24) 9353(2) 467(2) 9099(1) 27(1) 
C(25) 7548(3) 230(2) 9151(1) 43(1) 
C(26) 10360(3) -354(2) 9405(1) 40(1) 
C(27) 11870(2) 1593(2) 8323(1) 25(1) 
C(28) 13417(3) 1089(2) 8560(1) 35(1) 
C(29) 11509(3) 2586(2) 8647(1) 34(1) 
C(1)-C(2)  1.531(3) C(1)-C(15)  1.534(3) 
C(1)-H(1A)  0.9700 C(1)-H(1B)  0.9700 
C(2)-C(3)  1.506(3) C(2)-H(2A)  0.9700 
C(2)-H(2B)  0.9700 O(3)-C(3)  1.217(2) 
C(3)-C(4)  1.522(3) C(4)-N(16)  1.476(2) 
C(4)-C(5)  1.545(3) C(4)-H(4A)  0.9800 
C(5)-C(6)  1.505(3) C(5)-H(5A)  0.9700 
C(5)-H(5B)  0.9700 C(6)-C(14)  1.363(3) 
C(6)-C(7)  1.437(3) C(7)-C(8)  1.399(3) 
C(7)-C(12)  1.419(3) C(8)-C(9)  1.379(3) 
C(8)-H(8A)  0.9300 C(9)-C(10)  1.402(4) 
C(9)-H(9A)  0.9300 C(10)-C(11)  1.379(3) 
C(10)-H(10A)  0.9300 C(11)-C(12)  1.394(3) 
C(11)-H(11A)  0.9300 C(12)-N(13)  1.380(3) 
N(13)-C(14)  1.388(2) N(13)-H(13A)  0.8600 
C(14)-C(15)  1.498(3) C(15)-N(16)  1.484(2) 
C(15)-H(15A)  0.9800 N(16)-C(17)  1.484(2) 
C(17)-C(18)  1.480(3) C(17)-C(17A)  1.531(3) 
C(17)-H(17A)  0.9800 C(17A)-H(17B)  0.9600 
C(17A)-H(17C)  0.9600 C(17A)-H(17D)  0.9600 
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C(18)-C(19)  1.206(3) C(19)-Si(20)  1.846(2) 
Si(20)-C(21)  1.887(2) Si(20)-C(24)  1.888(2) 
Si(20)-C(27)  1.8885(19) C(21)-C(23)  1.530(3) 
C(21)-C(22)  1.541(3) C(21)-H(21A)  0.9800 
C(22)-H(22A)  0.9600 C(22)-H(22B)  0.9600 
C(22)-H(22C)  0.9600 C(23)-H(23A)  0.9600 
C(23)-H(23B)  0.9600 C(23)-H(23C)  0.9600 
C(24)-C(25)  1.527(3) C(24)-C(26)  1.531(3) 
C(24)-H(24A)  0.9800 C(25)-H(25A)  0.9600 
C(25)-H(25B)  0.9600 C(25)-H(25C)  0.9600 
C(26)-H(26A)  0.9600 C(26)-H(26B)  0.9600 
C(26)-H(26C)  0.9600 C(27)-C(29)  1.529(3) 
C(27)-C(28)  1.537(3) C(27)-H(27A)  0.9800 
C(28)-H(28A)  0.9600 C(28)-H(28B)  0.9600 
C(28)-H(28C)  0.9600 C(29)-H(29A)  0.9600 
C(29)-H(29B)  0.9600 C(29)-H(29C)  0.9600 
C(2)-C(1)-C(15)  110.76(16) C(2)-C(1)-H(1A) 109.5 
C(15)-C(1)-H(1A) 109.5 C(2)-C(1)-H(1B) 109.5 
C(15)-C(1)-H(1B) 109.5 H(1A)-C(1)-H(1B) 108.1 
C(3)-C(2)-C(1) 114.07(15) C(3)-C(2)-H(2A) 108.7 
C(1)-C(2)-H(2A) 108.7 C(3)-C(2)-H(2B) 108.7 
C(1)-C(2)-H(2B) 108.7 H(2A)-C(2)-H(2B) 107.6 
O(3)-C(3)-C(2) 121.36(18) O(3)-C(3)-C(4) 120.00(17) 
C(2)-C(3)-C(4) 118.59(15) N(16)-C(4)-C(3) 107.17(15) 
N(16)-C(4)-C(5) 115.24(15) C(3)-C(4)-C(5) 111.18(15) 
N(16)-C(4)-H(4A) 107.7 C(3)-C(4)-H(4A) 107.7 
C(5)-C(4)-H(4A) 107.7 C(6)-C(5)-C(4) 110.26(15) 
C(6)-C(5)-H(5A) 109.6 C(4)-C(5)-H(5A) 109.6 
C(6)-C(5)-H(5B) 109.6 C(4)-C(5)-H(5B) 109.6 
H(5A)-C(5)-H(5B) 108.1 C(14)-C(6)-C(7) 107.84(17) 
C(14)-C(6)-C(5) 121.13(17) C(7)-C(6)-C(5) 131.02(17) 
C(8)-C(7)-C(12) 118.65(19) C(8)-C(7)-C(6) 135.12(19) 
C(12)-C(7)-C(6) 106.13(18) C(9)-C(8)-C(7) 119.2(2) 
C(9)-C(8)-H(8A) 120.4 C(7)-C(8)-H(8A) 120.4 
C(8)-C(9)-C(10) 121.1(2) C(8)-C(9)-H(9A) 119.5 
C(10)-C(9)-H(9A) 119.5 C(11)-C(10)-C(9) 121.5(2) 
C(11)-C(10)-H(10A) 119.3 C(9)-C(10)-H(10A) 119.3 
C(10)-C(11)-C(12) 117.3(2) C(10)-C(11)-H(11A) 121.3 
C(12)-C(11)-H(11A) 121.3 N(13)-C(12)-C(11) 129.73(19) 
N(13)-C(12)-C(7) 107.96(17) C(11)-C(12)-C(7) 122.2(2) 
C(12)-N(13)-C(14) 108.68(16) C(12)-N(13)-H(13A) 125.7 
C(14)-N(13)-H(13A) 125.7 C(6)-C(14)-N(13) 109.40(18) 
C(6)-C(14)-C(15) 125.12(17) N(13)-C(14)-C(15) 125.03(17) 
N(16)-C(15)-C(14) 110.43(15) N(16)-C(15)-C(1) 106.92(14) 
C(14)-C(15)-C(1) 111.94(15) N(16)-C(15)-H(15A) 109.2 
C(14)-C(15)-H(15A) 109.2 C(1)-C(15)-H(15A) 109.2 
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C(4)-N(16)-C(15) 110.28(14) C(4)-N(16)-C(17) 115.38(14) 
C(15)-N(16)-C(17) 111.65(13) C(18)-C(17)-N(16) 111.08(15) 
C(18)-C(17)-C(17A) 109.84(16) N(16)-C(17)-C(17A) 109.27(16) 
C(18)-C(17)-H(17A) 108.9 N(16)-C(17)-H(17A) 108.9 
C(17A)-C(17)-H(17A) 108.9 C(17)-C(17A)-H(17B) 109.5 
C(17)-C(17A)-H(17C) 109.5 H(17B)-C(17A)-
H(17C) 109.5 
C(17)-C(17A)-H(17D) 109.5 H(17B)-C(17A)-
H(17D) 109.5 
H(17C)-C(17A)-H(17D) 109.5 C(19)-C(18)-C(17) 177.5(2) 
C(18)-C(19)-Si(20) 175.3(2) C(19)-Si(20)-C(21) 106.56(9) 
C(19)-Si(20)-C(24) 107.84(9) C(21)-Si(20)-C(24) 114.35(9) 
C(19)-Si(20)-C(27) 107.77(9) C(21)-Si(20)-C(27) 109.45(9) 
C(24)-Si(20)-C(27) 110.59(9) C(23)-C(21)-C(22) 110.21(18) 
C(23)-C(21)-Si(20) 113.01(15) C(22)-C(21)-Si(20) 110.57(15) 
C(23)-C(21)-H(21A) 107.6 C(22)-C(21)-H(21A) 107.6 
Si(20)-C(21)-H(21A) 107.6 C(21)-C(22)-H(22A) 109.5 
C(21)-C(22)-H(22B) 109.5 H(22A)-C(22)-H(22B) 109.5 
C(21)-C(22)-H(22C) 109.5 H(22A)-C(22)-H(22C) 109.5 
H(22B)-C(22)-H(22C) 109.5 C(21)-C(23)-H(23A) 109.5 
C(21)-C(23)-H(23B) 109.5 H(23A)-C(23)-H(23B) 109.5 
C(21)-C(23)-H(23C) 109.5 H(23A)-C(23)-H(23C) 109.5 
H(23B)-C(23)-H(23C) 109.5 C(25)-C(24)-C(26) 110.51(19) 
C(25)-C(24)-Si(20) 114.32(15) C(26)-C(24)-Si(20) 111.97(15) 
C(25)-C(24)-H(24A) 106.5 C(26)-C(24)-H(24A) 106.5 
Si(20)-C(24)-H(24A) 106.5 C(24)-C(25)-H(25A) 109.5 
C(24)-C(25)-H(25B) 109.5 H(25A)-C(25)-H(25B) 109.5 
C(24)-C(25)-H(25C) 109.5 H(25A)-C(25)-H(25C) 109.5 
H(25B)-C(25)-H(25C) 109.5 C(24)-C(26)-H(26A) 109.5 
C(24)-C(26)-H(26B) 109.5 H(26A)-C(26)-H(26B) 109.5 
C(24)-C(26)-H(26C) 109.5 H(26A)-C(26)-H(26C) 109.5 
H(26B)-C(26)-H(26C) 109.5 C(29)-C(27)-C(28) 110.98(18) 
C(29)-C(27)-Si(20) 111.83(14) C(28)-C(27)-Si(20) 112.73(14) 
C(29)-C(27)-H(27A) 107.0 C(28)-C(27)-H(27A) 107.0 
Si(20)-C(27)-H(27A) 107.0 C(27)-C(28)-H(28A) 109.5 
C(27)-C(28)-H(28B) 109.5 H(28A)-C(28)-H(28B) 109.5 
C(27)-C(28)-H(28C) 109.5 H(28A)-C(28)-H(28C) 109.5 
H(28B)-C(28)-H(28C) 109.5 C(27)-C(29)-H(29A) 109.5 
C(27)-C(29)-H(29B) 109.5 H(29A)-C(29)-H(29B) 109.5 
C(27)-C(29)-H(29C) 109.5 H(29A)-C(29)-H(29C) 109.5 
H(29B)-C(29)-H(29C) 109.5 
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Table A3. Anisotropic displacement parameters (Å2x 103) for 12b. The anisotropic 
displacement factor exponent takes the form: -2 2[h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 24(1)  27(1) 23(1)  1(1) -6(1)  4(1) 
C(2) 25(1)  31(1) 19(1)  4(1) -3(1)  0(1) 
O(3) 22(1)  44(1) 28(1)  6(1) 4(1)  6(1) 
C(3) 21(1)  24(1) 21(1)  -3(1) 0(1)  2(1) 
C(4) 16(1)  31(1) 18(1)  1(1) -2(1)  5(1) 
C(5) 20(1)  29(1) 25(1)  5(1) -2(1)  5(1) 
C(6) 20(1)  28(1) 20(1)  4(1) -1(1)  1(1) 
C(7) 25(1)  31(1) 19(1)  5(1) 1(1)  -2(1) 
C(8) 35(1)  30(1) 29(1)  5(1) 2(1)  -1(1) 
C(9) 46(1)  34(1) 35(1)  -3(1) 4(1)  -9(1) 
C(10) 36(1)  45(1) 35(1)  -5(1) 2(1)  -16(1) 
C(11) 24(1)  48(1) 28(1)  -1(1) 0(1)  -7(1) 
C(12) 22(1)  35(1) 19(1)  3(1) 2(1)  -3(1) 
N(13) 16(1)  33(1) 24(1)  3(1) -3(1)  3(1) 
C(14) 17(1)  32(1) 18(1)  3(1) -2(1)  2(1) 
C(15) 16(1)  29(1) 20(1)  1(1) -3(1)  6(1) 
N(16) 17(1)  30(1) 16(1)  1(1) -2(1)  4(1) 
C(17) 17(1)  33(1) 19(1)  1(1) -2(1)  0(1) 
C(17A) 27(1)  41(1) 22(1)  -4(1) -1(1)  7(1) 
C(18) 23(1)  32(1) 18(1)  1(1) 0(1)  -1(1) 
C(19) 23(1)  34(1) 20(1)  2(1) 0(1)  1(1) 
Si(20) 18(1)  26(1) 18(1)  2(1) -2(1)  -1(1) 
C(21) 27(1)  30(1) 26(1)  -2(1) -5(1)  1(1) 
C(22) 39(1)  46(1) 27(1)  -5(1) 1(1)  7(1) 
C(23) 43(1)  39(1) 47(1)  -12(1) -2(1)  -10(1) 
C(24) 28(1)  30(1) 23(1)  2(1) 0(1)  -5(1) 
C(25) 31(1)  57(2) 41(1)  8(1) 9(1)  -6(1) 
C(26) 46(1)  44(1) 28(1)  14(1) -6(1)  -2(1) 
C(27) 21(1)  28(1) 25(1)  6(1) -2(1)  -1(1) 
C(28) 22(1)  37(1) 45(1)  8(1) -6(1)  -3(1) 
C(29) 30(1)  33(1) 39(1)  -3(1) -1(1)  -5(1) 
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Table A4. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
12b. 
_____________________________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
 
H(1A) 4397 3118 5537 30 
H(1B) 5679 3709 5915 30 
H(2A) 6234 1979 5214 30 
H(2B) 7212 3001 5204 30 
H(4A) 8409 1545 6682 26 
H(5A) 7454 132 6062 30 
H(5B) 6875 122 6718 30 
H(8A) 5254 -1614 5819 38 
H(9A) 3158 -2487 5378 46 
H(10A) 708 -1697 5188 46 
H(11A) 280 -9 5440 40 
H(13A) 1882 1653 5914 29 
H(15A) 4006 2789 6553 26 
H(17A) 5010 1586 7333 28 
H(17B) 5164 2960 8027 45 
H(17C) 4272 3269 7447 45 
H(17D) 6073 3604 7551 45 
H(21A) 11526 -801 8091 33 
H(22A) 11927 272 7273 56 
H(22B) 11427 -825 7071 56 
H(22C) 10148 57 7066 56 
H(23A) 8922 -1430 8300 64 
H(23B) 8289 -995 7703 64 
H(23C) 9568 -1878 7708 64 
H(24A) 9535 1101 9316 32 
H(25A) 6934 751 8957 65 
H(25B) 7326 -416 8971 65 
H(25C) 7248 206 9557 65 
H(26A) 11490 -194 9369 59 
H(26B) 10071 -381 9812 59 
H(26C) 10149 -1003 9227 59 
H(27A) 12081 1772 7913 30 
H(28A) 13618 468 8350 52 
H(28B) 14318 1543 8509 52 
H(28C) 13281 940 8969 52 
H(29A) 10540 2886 8492 51 
H(29B) 11363 2446 9056 51 
H(29C) 12399 3049 8597 51 
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Table A5. Torsion angles [°] for 12b. 
______________________________________________________________________________ 
C(15)-C(1)-C(2)-C(3) -40.4(2) C(1)-C(2)-C(3)-O(3) -148.12(19) 
C(1)-C(2)-C(3)-C(4) 34.5(2) O(3)-C(3)-C(4)-N(16) 138.52(18) 
C(2)-C(3)-C(4)-N(16) -44.1(2) O(3)-C(3)-C(4)-C(5) -94.7(2) 
C(2)-C(3)-C(4)-C(5) 82.7(2) N(16)-C(4)-C(5)-C(6) 40.7(2) 
C(3)-C(4)-C(5)-C(6) -81.46(19) C(4)-C(5)-C(6)-C(14) -12.7(2) 
C(4)-C(5)-C(6)-C(7) 165.45(18) C(14)-C(6)-C(7)-C(8) 176.1(2) 
C(5)-C(6)-C(7)-C(8) -2.2(4) C(14)-C(6)-C(7)-C(12) 0.1(2) 
C(5)-C(6)-C(7)-C(12) -178.25(18) C(12)-C(7)-C(8)-C(9) -0.3(3) 
C(6)-C(7)-C(8)-C(9) -176.1(2) C(7)-C(8)-C(9)-C(10) 0.2(3) 
C(8)-C(9)-C(10)-C(11) -0.2(4) C(9)-C(10)-C(11)-C(12) 0.2(3) 
C(10)-C(11)-C(12)-N(13) 176.1(2) C(10)-C(11)-C(12)-C(7) -0.4(3) 
C(8)-C(7)-C(12)-N(13) -176.73(17) C(6)-C(7)-C(12)-N(13) 0.1(2) 
C(8)-C(7)-C(12)-C(11) 0.4(3) C(6)-C(7)-C(12)-C(11) 177.28(18) 
C(11)-C(12)-N(13)-C(14) -177.1(2) C(7)-C(12)-N(13)-C(14) -0.3(2) 
C(7)-C(6)-C(14)-N(13) -0.2(2) C(5)-C(6)-C(14)-N(13) 178.29(15) 
C(7)-C(6)-C(14)-C(15) -172.80(17) C(5)-C(6)-C(14)-C(15) 5.7(3) 
C(12)-N(13)-C(14)-C(6) 0.3(2) C(12)-N(13)-C(14)-C(15) 172.88(17) 
C(6)-C(14)-C(15)-N(16) -24.0(2) N(13)-C(14)-C(15)-N(16) 164.56(16) 
C(6)-C(14)-C(15)-C(1) 95.0(2) N(13)-C(14)-C(15)-C(1) -76.4(2) 
C(2)-C(1)-C(15)-N(16) 58.40(19) C(2)-C(1)-C(15)-C(14) -62.7(2) 
C(3)-C(4)-N(16)-C(15) 63.12(18) C(5)-C(4)-N(16)-C(15) -61.2(2) 
C(3)-C(4)-N(16)-C(17) -169.25(15) C(5)-C(4)-N(16)-C(17) 66.4(2) 
C(14)-C(15)-N(16)-C(4) 49.26(19) C(1)-C(15)-N(16)-C(4) -72.76(18) 
C(14)-C(15)-N(16)-C(17) -80.41(19) C(1)-C(15)-N(16)-C(17) 157.57(16) 
C(4)-N(16)-C(17)-C(18) 36.0(2) C(15)-N(16)-C(17)-C(18) 162.96(16) 
C(4)-N(16)-C(17)-C(17A) 157.36(15) C(15)-N(16)-C(17)-C(17A)-75.70(18) 
C(19)-Si(20)-C(21)-C(23) -66.11(18) C(24)-Si(20)-C(21)-C(23) 52.92(18) 
C(27)-Si(20)-C(21)-C(23) 177.62(16) C(19)-Si(20)-C(21)-C(22) 57.96(16) 
C(24)-Si(20)-C(21)-C(22) 177.00(14) C(27)-Si(20)-C(21)-C(22) -58.30(17) 
C(19)-Si(20)-C(24)-C(25) 33.8(2) C(21)-Si(20)-C(24)-C(25) -84.49(19) 
C(27)-Si(20)-C(24)-C(25) 151.42(17) C(19)-Si(20)-C(24)-C(26) 160.48(15) 
C(21)-Si(20)-C(24)-C(26) 42.17(18) C(27)-Si(20)-C(24)-C(26) -81.92(17) 
C(19)-Si(20)-C(27)-C(29) 63.07(17) C(21)-Si(20)-C(27)-C(29) 178.58(14) 
C(24)-Si(20)-C(27)-C(29) -54.57(17) C(19)-Si(20)-C(27)-C(28) -171.05(16) 
C(21)-Si(20)-C(27)-C(28) -55.55(18) C(24)-Si(20)-C(27)-C(28) 71.30(18) 
_____________________________________________________________________________ 
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Table A6.  Hydrogen bonds for 12b [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(13)-H(13A)...O(3)#1 0.86 2.17 2.937(2) 148.4 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y,z  
 
X-ray Crystal Data for 13a  
 
Table A7. Crystal data and structure refinement for 13a. 
 
Empirical formula  C25H39ClN2O2Si 
Formula weight  463.12 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 9.4596(5) Å α= 90°. 
 b = 8.0074(3) Å β= 98.023(3)°. 
 c = 18.4232(7) Å γ= 90°. 
Volume 1381.84(10) Å3 
Z 2 
Density (20 °C) 1.113 Mg/m3 
Absorption coefficient 1.800 mm-1 
F(000) 500 
Crystal size 0.220 x 0.167 x 0.082 mm3 
θ range for data collection 5.602 to 68.758°. 
Index ranges -11<=h<=9, -9<=k<=9, -20<=l<=21 
Reflections collected 8129 
Independent reflections 4166 [R(int) = 0.0462] 
Completeness to θ = 67.679° 92.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7531 and 0.6026 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4166 / 259 / 326 
Goodness-of-fit on F2 1.043 
Final R indices [I>2σ(I)] R1 = 0.0494, wR2 = 0.1158 
R indices (all data) R1 = 0.0857, wR2 = 0.1385 
Absolute structure parameter 0.068(14) 
Largest diff. peak and hole 0.213 and -0.192 e.Å-3 
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Table A8. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
for 13a. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Cl(1) 5836(13) 4263(17) 5814(7) 75(2) 
Cl(1B) 5395(13) 4080(14) 5834(7) 86(3) 
C(1) 9457(8) 2054(8) 4290(4) 87(2) 
N(2) 10488(6) 1550(6) 3898(4) 96(2) 
C(3) 9956(7) 1596(7) 3175(4) 83(2) 
C(4) 10574(9) 1200(9) 2563(5) 112(2) 
C(5) 9783(13) 1301(11) 1899(5) 132(3) 
C(6) 8357(12) 1818(11) 1825(4) 126(3) 
C(7) 7710(8) 2229(8) 2428(3) 93(2) 
C(8) 8521(6) 2136(6) 3114(3) 72(1) 
C(9) 8223(6) 2446(6) 3843(3) 71(1) 
C(10) 6848(7) 2965(7) 4091(3) 76(1) 
O(11B) 7926(5) 6467(5) 3380(2) 91(1) 
O(11A) 7808(5) 6575(6) 4575(3) 110(2) 
C(11A) 7433(6) 6025(7) 3973(3) 71(1) 
C(11) 6313(5) 4680(6) 3817(3) 64(1) 
C(11B) 8976(9) 7793(9) 3443(5) 129(3) 
N(12) 5050(4) 5194(5) 4179(2) 64(1) 
C(13) 3657(5) 4380(6) 3864(2) 65(1) 
C(13A) 2493(7) 5077(7) 4259(3) 81(2) 
C(14) 3406(6) 4719(6) 3072(3) 68(1) 
C(15) 3239(6) 5061(7) 2430(3) 73(1) 
Si(1) 3049(2) 5846(2) 1484(1) 82(1) 
C(16) 1286(10) 6979(14) 1307(5) 138(3) 
C(17) 1027(12) 7830(18) 558(6) 196(6) 
C(18) 55(11) 6001(18) 1509(9) 204(6) 
C(19) 4484(9) 7463(11) 1492(4) 121(2) 
C(20) 5996(10) 6670(20) 1555(7) 217(7) 
C(21) 4434(15) 8768(15) 2083(6) 195(5) 
C(22A) 2810(20) 4007(18) 840(8) 106(6) 
C(23A) 3040(40) 4520(60) 77(11) 144(10) 
C(24A) 3870(40) 2690(30) 1143(13) 207(17) 
C(22B) 3670(30) 4210(20) 866(12) 136(9) 
C(24B) 3070(40) 2470(30) 887(12) 192(15) 
C(23B) 3880(50) 4770(70) 105(15) 230(30) 
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Table A9. Bond lengths [Å] and angles [°] for 13a. 
______________________________________________________________________________ 
C(1)-N(2)  1.353(9) C(1)-C(9)  1.368(8) 
C(1)-H(1)  0.9300 N(2)-C(3)  1.356(9) 
N(2)-H(2)  0.8600 C(3)-C(4)  1.377(10) 
C(3)-C(8)  1.414(9) C(4)-C(5)  1.344(12) 
C(4)-H(4)  0.9300 C(5)-C(6)  1.400(13) 
C(5)-H(5)  0.9300 C(6)-C(7)  1.382(10) 
C(6)-H(6)  0.9300 C(7)-C(8)  1.385(8) 
C(7)-H(7)  0.9300 C(8)-C(9)  1.431(8) 
C(9)-C(10)  1.496(8) C(10)-C(11)  1.525(7) 
C(10)-H(10A)  0.9700 C(10)-H(10B)  0.9700 
O(11B)-C(11A)  1.296(7) O(11B)-C(11B)  1.448(7) 
O(11A)-C(11A)  1.199(7) C(11A)-C(11)  1.509(7) 
C(11)-N(12)  1.505(7) C(11)-H(11)  0.9800 
C(11B)-H(11A)  0.9600 C(11B)-H(11B)  0.9600 
C(11B)-H(11C)  0.9600 N(12)-C(13)  1.511(6) 
N(12)-H(12A)  0.8900 N(12)-H(12B)  0.8900 
C(13)-C(14)  1.471(7) C(13)-C(13A)  1.508(8) 
C(13)-H(13)  0.9800 C(13A)-H(13A)  0.9600 
C(13A)-H(13B)  0.9600 C(13A)-H(13C)  0.9600 
C(14)-C(15)  1.203(7) C(15)-Si(1)  1.839(6) 
Si(1)-C(19)  1.874(9) Si(1)-C(22B)  1.883(11) 
Si(1)-C(22A)  1.885(11) Si(1)-C(16)  1.886(9) 
C(16)-C(18)  1.493(15) C(16)-C(17)  1.528(13) 
C(16)-H(16)  0.9800 C(17)-H(17A)  0.9600 
C(17)-H(17B)  0.9600 C(17)-H(17C)  0.9600 
C(18)-H(18A)  0.9600 C(18)-H(18B)  0.9600 
C(18)-H(18C)  0.9600 C(19)-C(21)  1.515(14) 
C(19)-C(20)  1.555(13) C(19)-H(19)  0.9800 
C(20)-H(20A)  0.9600 C(20)-H(20B)  0.9600 
C(20)-H(20C)  0.9600 C(21)-H(21A)  0.9600 
C(21)-H(21B)  0.9600 C(21)-H(21C)  0.9600 
C(22A)-C(23A)  1.510(12) C(22A)-C(24A)  1.510(13) 
C(22A)-H(22A)  0.9800 C(23A)-H(23A)  0.9600 
C(23A)-H(23B)  0.9600 C(23A)-H(23C)  0.9600 
C(24A)-H(24A)  0.9600 C(24A)-H(24B)  0.9600 
C(24A)-H(24C)  0.9600 C(22B)-C(24B)  1.508(13) 
C(22B)-C(23B)  1.511(12) C(22B)-H(22B)  0.9800 
C(24B)-H(24D)  0.9600 C(24B)-H(24E)  0.9600 
C(24B)-H(24F)  0.9600 C(23B)-H(23D)  0.9600 
C(23B)-H(23E)  0.9600 C(23B)-H(23F)  0.9600 
N(2)-C(1)-C(9) 111.4(6) N(2)-C(1)-H(1) 124.3 
C(9)-C(1)-H(1) 124.3 C(1)-N(2)-C(3) 108.6(6) 
C(1)-N(2)-H(2) 125.7 C(3)-N(2)-H(2) 125.7 
N(2)-C(3)-C(4) 130.9(7) N(2)-C(3)-C(8) 107.9(6) 
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C(4)-C(3)-C(8) 121.2(7) C(5)-C(4)-C(3) 119.0(8) 
C(5)-C(4)-H(4) 120.5 C(3)-C(4)-H(4) 120.5 
C(4)-C(5)-C(6) 120.9(8) C(4)-C(5)-H(5) 119.5 
C(6)-C(5)-H(5) 119.5 C(7)-C(6)-C(5) 121.4(8) 
C(7)-C(6)-H(6) 119.3 C(5)-C(6)-H(6) 119.3 
C(6)-C(7)-C(8) 118.0(7) C(6)-C(7)-H(7) 121.0 
C(8)-C(7)-H(7) 121.0 C(7)-C(8)-C(3) 119.5(6) 
C(7)-C(8)-C(9) 133.6(6) C(3)-C(8)-C(9) 106.9(5) 
C(1)-C(9)-C(8) 105.1(6) C(1)-C(9)-C(10) 125.8(6) 
C(8)-C(9)-C(10) 128.9(5) C(9)-C(10)-C(11) 114.3(4) 
C(9)-C(10)-H(10A) 108.7 C(11)-C(10)-H(10A) 108.7 
C(9)-C(10)-H(10B) 108.7 C(11)-C(10)-H(10B) 108.7 
H(10A)-C(10)-H(10B) 107.6 C(11A)-O(11B)-C(11B) 117.1(5) 
O(11A)-C(11A)-O(11B) 125.8(5) O(11A)-C(11A)-C(11) 123.1(5) 
O(11B)-C(11A)-C(11) 111.1(4) N(12)-C(11)-C(11A) 107.5(4) 
N(12)-C(11)-C(10) 110.3(4) C(11A)-C(11)-C(10) 112.9(4) 
N(12)-C(11)-H(11) 108.7 C(11A)-C(11)-H(11) 108.7 
C(10)-C(11)-H(11) 108.7 O(11B)-C(11B)-H(11A) 109.5 
O(11B)-C(11B)-H(11B) 109.5 H(11A)-C(11B)-H(11B) 109.5 
O(11B)-C(11B)-H(11C) 109.5 H(11A)-C(11B)-H(11C) 109.5 
H(11B)-C(11B)-H(11C) 109.5 C(11)-N(12)-C(13) 114.6(4) 
C(11)-N(12)-H(12A) 108.6 C(13)-N(12)-H(12A) 108.6 
C(11)-N(12)-H(12B) 108.6 C(13)-N(12)-H(12B) 108.6 
H(12A)-N(12)-H(12B) 107.6 C(14)-C(13)-C(13A) 112.5(4) 
C(14)-C(13)-N(12) 108.2(4) C(13A)-C(13)-N(12) 108.1(4) 
C(14)-C(13)-H(13) 109.3 C(13A)-C(13)-H(13) 109.3 
N(12)-C(13)-H(13) 109.3 C(13)-C(13A)-H(13A) 109.5 
C(13)-C(13A)-H(13B) 109.5 H(13A)-C(13A)-H(13B) 109.5 
C(13)-C(13A)-H(13C) 109.5 H(13A)-C(13A)-H(13C) 109.5 
H(13B)-C(13A)-H(13C) 109.5 C(15)-C(14)-C(13) 177.0(5) 
C(14)-C(15)-Si(1) 172.9(5) C(15)-Si(1)-C(19) 104.7(3) 
C(15)-Si(1)-C(22B) 109.7(7) C(19)-Si(1)-C(22B) 101.4(8) 
C(15)-Si(1)-C(22A) 108.4(6) C(19)-Si(1)-C(22A) 124.7(7) 
C(15)-Si(1)-C(16) 107.2(4) C(19)-Si(1)-C(16) 106.9(4) 
C(22B)-Si(1)-C(16) 125.0(10) C(22A)-Si(1)-C(16) 103.9(6) 
C(18)-C(16)-C(17) 115.3(9) C(18)-C(16)-Si(1) 114.0(8) 
C(17)-C(16)-Si(1) 113.4(8) C(18)-C(16)-H(16) 104.2 
C(17)-C(16)-H(16) 104.2 Si(1)-C(16)-H(16) 104.2 
C(16)-C(17)-H(17A) 109.5 C(16)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 C(16)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 H(17B)-C(17)-H(17C) 109.5 
C(16)-C(18)-H(18A) 109.5 C(16)-C(18)-H(18B) 109.5 
H(18A)-C(18)-H(18B) 109.5 C(16)-C(18)-H(18C) 109.5 
H(18A)-C(18)-H(18C) 109.5 H(18B)-C(18)-H(18C) 109.5 
C(21)-C(19)-C(20) 110.4(10) C(21)-C(19)-Si(1) 112.8(7) 
C(20)-C(19)-Si(1) 112.1(8) C(21)-C(19)-H(19) 107.1 
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C(20)-C(19)-H(19) 107.1 Si(1)-C(19)-H(19) 107.1 
C(19)-C(20)-H(20A) 109.5 C(19)-C(20)-H(20B) 109.5 
H(20A)-C(20)-H(20B) 109.5 C(19)-C(20)-H(20C) 109.5 
H(20A)-C(20)-H(20C) 109.5 H(20B)-C(20)-H(20C) 109.5 
C(19)-C(21)-H(21A) 109.5 C(19)-C(21)-H(21B) 109.5 
H(21A)-C(21)-H(21B) 109.5 C(19)-C(21)-H(21C) 109.5 
H(21A)-C(21)-H(21C) 109.5 H(21B)-C(21)-H(21C) 109.5 
C(23A)-C(22A)-C(24A) 111(2) C(23A)-C(22A)-Si(1) 110.5(19) 
C(24A)-C(22A)-Si(1) 107.3(12) C(23A)-C(22A)-H(22A) 109.3 
C(24A)-C(22A)-H(22A) 109.3 Si(1)-C(22A)-H(22A) 109.3 
C(22A)-C(23A)-H(23A) 109.5 C(22A)-C(23A)-H(23B) 109.5 
H(23A)-C(23A)-H(23B) 109.5 C(22A)-C(23A)-H(23C) 109.5 
H(23A)-C(23A)-H(23C) 109.5 H(23B)-C(23A)-H(23C) 109.5 
C(22A)-C(24A)-H(24A) 109.5 C(22A)-C(24A)-H(24B) 109.5 
H(24A)-C(24A)-H(24B) 109.5 C(22A)-C(24A)-H(24C) 109.5 
H(24A)-C(24A)-H(24C) 109.5 H(24B)-C(24A)-H(24C) 109.5 
C(24B)-C(22B)-C(23B) 113(3) C(24B)-C(22B)-Si(1) 118.5(18) 
C(23B)-C(22B)-Si(1) 116(2) C(24B)-C(22B)-H(22B) 101.5 
C(23B)-C(22B)-H(22B) 101.5 Si(1)-C(22B)-H(22B) 101.5 
C(22B)-C(24B)-H(24D) 109.5 C(22B)-C(24B)-H(24E) 109.5 
H(24D)-C(24B)-H(24E) 109.5 C(22B)-C(24B)-H(24F) 109.5 
H(24D)-C(24B)-H(24F) 109.5 H(24E)-C(24B)-H(24F) 109.5 
C(22B)-C(23B)-H(23D) 109.5 C(22B)-C(23B)-H(23E) 109.5 
H(23D)-C(23B)-H(23E) 109.5 C(22B)-C(23B)-H(23F) 109.5 
H(23D)-C(23B)-H(23F) 109.5 H(23E)-C(23B)-H(23F) 109.5 
______________________________________________________________________________ 
 
 
Table A10. Anisotropic displacement parameters (Å2x 103) for 13a. The anisotropic 
displacement factor exponent takes the form: -2 2[ h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
Cl(1) 95(5)  84(4) 45(3)  -2(2) 6(3)  10(3) 
Cl(1B) 141(9)  60(3) 59(3)  10(2) 26(5)  28(5) 
C(1) 100(5)  78(4) 80(4)  7(3) -4(3)  -22(3) 
N(2) 80(4)  83(3) 120(4)  10(3) -2(3)  -14(3) 
C(3) 92(4)  53(3) 106(4)  1(3) 18(3)  -14(3) 
C(4) 123(6)  74(4) 149(6)  -1(4) 58(5)  -9(4) 
C(5) 186(8)  104(6) 119(6)  -16(5) 71(6)  -2(6) 
C(6) 178(8)  118(6) 82(5)  -17(4) 22(5)  -7(6) 
C(7) 123(5)  81(4) 72(4)  -8(3) 6(3)  -2(4) 
C(8) 89(4)  53(3) 71(3)  2(2) 6(3)  -10(2) 
C(9) 85(4)  54(3) 72(3)  5(2) 2(3)  -14(2) 
C(10) 94(4)  62(3) 71(3)  4(2) 9(3)  -10(3) 
O(11B) 112(3)  68(2) 93(3)  13(2) 15(2)  -33(2) 
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O(11A) 121(4)  113(3) 89(3)  -14(2) -15(2)  -48(3) 
C(11A) 78(3)  60(3) 69(3)  3(3) -11(2)  -8(2) 
C(11) 83(3)  63(3) 45(3)  1(2) 2(2)  -13(2) 
C(11B) 128(7)  88(5) 170(8)  14(5) 20(5)  -52(4) 
N(12) 90(3)  56(2) 43(2)  0(2) -1(2)  -13(2) 
C(13) 84(3)  60(3) 49(3)  -2(2) 4(2)  -14(2) 
C(13A) 100(4)  72(3) 71(4)  0(3) 19(3)  -12(3) 
C(14) 75(3)  68(3) 57(3)  -8(2) -1(2)  -15(2) 
C(15) 72(3)  90(4) 54(3)  -7(3) -1(2)  -12(3) 
Si(1) 99(1)  94(1) 50(1)  4(1) 1(1)  7(1) 
C(16) 121(6)  155(8) 127(6)  12(6) -22(5)  22(5) 
C(17) 184(10)  250(15) 137(8)  42(8) -44(7)  80(10) 
C(18) 98(7)  191(12) 320(18)  19(11) 18(8)  5(7) 
C(19) 136(6)  135(6) 91(5)  43(4) 15(4)  -3(5) 
C(20) 101(7)  352(19) 196(11)  136(12) 12(6)  13(8) 
C(21) 284(15)  150(9) 147(9)  -10(7) 17(8)  -98(9) 
C(22A) 140(16)  115(13) 63(7)  -6(8) 13(9)  19(10) 
C(23A) 190(20)  190(30) 59(10)  -22(11) 13(11)  30(20) 
C(24A) 330(40)  147(19) 111(16)  -71(13) -71(19)  130(20) 
C(22B) 220(30)  107(11) 92(11)  -3(9) 63(16)  16(14) 
C(24B) 370(40)  123(14) 85(16)  -18(13) 40(20)  -50(20) 
C(23B) 420(80)  190(20) 120(20)  -6(19) 150(40)  20(40) 
 
 
Table A11. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
13a. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
 
H(1) 9573 2124 4798 105 
H(2) 11339 1251 4077 115 
H(4) 11524 868 2609 134 
H(5) 10189 1023 1484 158 
H(6) 7833 1886 1359 151 
H(7) 6758 2558 2376 111 
H(10A) 6973 2967 4622 91 
H(10B) 6123 2142 3924 91 
H(11) 6016 4620 3287 77 
H(11A) 8605 8753 3665 194 
H(11B) 9188 8085 2964 194 
H(11C) 9832 7422 3741 194 
H(12A) 4949 6297 4141 77 
H(12B) 5231 4948 4654 77 
H(13) 3727 3171 3945 78 
H(13A) 2410 6257 4173 121 
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H(13B) 2725 4872 4775 121 
H(13C) 1604 4544 4079 121 
H(16) 1392 7907 1657 165 
H(17A) 900 6997 180 294 
H(17B) 1833 8518 496 294 
H(17C) 185 8510 528 294 
H(18A) -795 6669 1425 306 
H(18B) 241 5697 2018 306 
H(18C) -73 5010 1214 306 
H(19) 4317 8045 1020 145 
H(20A) 6691 7528 1517 325 
H(20B) 6021 5873 1167 325 
H(20C) 6211 6116 2020 325 
H(21A) 4339 8227 2539 292 
H(21B) 3633 9494 1948 292 
H(21C) 5300 9411 2138 292 
H(22A) 1838 3564 826 128 
H(23A) 2293 5278 -121 216 
H(23B) 3018 3553 -230 216 
H(23C) 3945 5069 97 216 
H(24A) 3648 2309 1608 311 
H(24B) 4816 3157 1206 311 
H(24C) 3829 1766 808 311 
H(22B) 4661 4039 1093 163 
H(24D) 2832 2057 396 288 
H(24E) 2231 2491 1125 288 
H(24F) 3772 1750 1155 288 
H(23D) 4399 3939 -120 347 
H(23E) 4400 5805 136 347 
H(23F) 2962 4938 -184 347 
 
______________________________________________________________________________
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Table A12. Torsion angles [°] for 13a. 
______________________________________________________________________________ 
C(9)-C(1)-N(2)-C(3) 0.0(7) C(1)-N(2)-C(3)-C(4) -179.7(6) 
C(1)-N(2)-C(3)-C(8) -0.7(6) N(2)-C(3)-C(4)-C(5) 177.6(7) 
C(8)-C(3)-C(4)-C(5) -1.3(10) C(3)-C(4)-C(5)-C(6) 0.8(12) 
C(4)-C(5)-C(6)-C(7) -0.5(13) C(5)-C(6)-C(7)-C(8) 0.8(11) 
C(6)-C(7)-C(8)-C(3) -1.3(9) C(6)-C(7)-C(8)-C(9) -179.5(6) 
N(2)-C(3)-C(8)-C(7) -177.5(5) C(4)-C(3)-C(8)-C(7) 1.6(8) 
N(2)-C(3)-C(8)-C(9) 1.1(6) C(4)-C(3)-C(8)-C(9) -179.8(5) 
N(2)-C(1)-C(9)-C(8) 0.7(6) N(2)-C(1)-C(9)-C(10) 176.8(5) 
C(7)-C(8)-C(9)-C(1) 177.2(6) C(3)-C(8)-C(9)-C(1) -1.1(6) 
C(7)-C(8)-C(9)-C(10) 1.3(9) C(3)-C(8)-C(9)-C(10) -177.0(5) 
C(1)-C(9)-C(10)-C(11) 121.0(6) C(8)-C(9)-C(10)-C(11) -63.8(7) 
C(11B)-O(11B)-C(11A)-O(11A) -3.0(9) C(11B)-O(11B)-C(11A)-C(11) 
177.9(5) 
O(11A)-C(11A)-C(11)-N(12) 49.1(7) O(11B)-C(11A)-C(11)-N(12) -131.7(5) 
O(11A)-C(11A)-C(11)-C(10) -72.7(7) O(11B)-C(11A)-C(11)-C(10) 106.4(5) 
C(9)-C(10)-C(11)-N(12) -172.0(4) C(9)-C(10)-C(11)-C(11A) -51.7(6) 
C(11A)-C(11)-N(12)-C(13) 158.4(4) C(10)-C(11)-N(12)-C(13) -78.2(5) 
C(11)-N(12)-C(13)-C(14) -55.4(5) C(11)-N(12)-C(13)-C(13A) -177.5(4) 
C(15)-Si(1)-C(16)-C(18) -50.1(10) C(19)-Si(1)-C(16)-C(18) -161.9(9) 
C(22B)-Si(1)-C(16)-C(18) 80.3(12) C(22A)-Si(1)-C(16)-C(18) 64.6(11) 
C(15)-Si(1)-C(16)-C(17) 175.3(8) C(19)-Si(1)-C(16)-C(17) 63.5(9) 
C(22B)-Si(1)-C(16)-C(17) -54.3(13) C(22A)-Si(1)-C(16)-C(17) -70.0(11) 
C(15)-Si(1)-C(19)-C(21) -53.1(8) C(22B)-Si(1)-C(19)-C(21) -167.2(11) 
C(22A)-Si(1)-C(19)-C(21) -178.5(9) C(16)-Si(1)-C(19)-C(21) 60.4(8) 
C(15)-Si(1)-C(19)-C(20) 72.2(7) C(22B)-Si(1)-C(19)-C(20) -41.9(11) 
C(22A)-Si(1)-C(19)-C(20) -53.2(10) C(16)-Si(1)-C(19)-C(20) -174.3(7) 
C(15)-Si(1)-C(22A)-C(23A) -165.0(16) C(19)-Si(1)-C(22A)-C(23A) -41.2(19) 
C(16)-Si(1)-C(22A)-C(23A) 81.2(18) C(15)-Si(1)-C(22A)-C(24A) -44(2) 
C(19)-Si(1)-C(22A)-C(24A) 80(2) C(16)-Si(1)-C(22A)-C(24A) -157(2) 
C(15)-Si(1)-C(22B)-C(24B) 52(3) C(19)-Si(1)-C(22B)-C(24B) 162(2) 
C(16)-Si(1)-C(22B)-C(24B) -78(3) C(15)-Si(1)-C(22B)-C(23B) -168(2) 
C(19)-Si(1)-C(22B)-C(23B) -57(3) C(16)-Si(1)-C(22B)-C(23B) 63(3) 
 
_____________________________________________________________________________ 
 
 
Table A13. Hydrogen bonds for 13a [Å and °]. 
____________________________________________________________________________ 
        D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 
 N(12)-H(12A)...Cl(1B)#3 0.89 2.25 3.139(12) 173.6 
 N(12)-H(12B)...Cl(1) 0.89 2.20 3.091(12) 175.7 
 N(12)-H(12B)...Cl(1B) 0.89 2.27 3.150(13) 171.4 
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____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y-1/2,-z+1    #2 -x+1,y-1/2,-z+1    #3 -x+1,y+1/2,-z+1  
#4 x-1,y,z  
 
 
X-ray Crystal Data for 13b 
 
Table A14. Crystal data and structure refinement for 13b. 
 
Empirical formula  C25H39ClN2O2Si 
Formula weight  463.12 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P1 
Unit cell dimensions a = 7.5923(2) Å α= 78.6760(10)°. 
 b = 10.1456(3) Å β= 89.2370(10)°. 
 c = 18.6690(6) Å γ= 87.1770(10)°. 
Volume 1408.33(7) Å3 
Z 2 
Density (20 °C) 1.092 Mg/m3 
Absorption coefficient 1.766 mm-1 
F(000) 500 
Crystal size 0.226 x 0.212 x 0.061 mm3 
θ range for data collection 2.414 to 74.515°. 
Index ranges -9<=h<=7, -10<=k<=12, -20<=l<=22 
Reflections collected 10787 
Independent reflections 6840 [R(int) = 0.0265] 
Completeness to θ = 67.500° 86.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7538 and 0.6249 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6840 / 3 / 576 
Goodness-of-fit on F2 1.065 
Final R indices [I>2σ(I)] R1 = 0.0339, wR2 = 0.0848 
R indices (all data) R1 = 0.0356, wR2 = 0.0863 
Absolute structure parameter 0.057(8) 
Extinction coefficient 0.0303(10) 
Largest diff. peak and hole 0.205 and -0.191 e.Å-3 
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Table A15. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
for 13b. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Cl(1') 2054(1) 253(1) 5760(1) 51(1) 
Cl(1) 6972(1) 9563(1) 4207(1) 49(1) 
C(1) 10756(6) 4538(4) 5588(2) 74(1) 
N(2) 11327(5) 3338(3) 6009(2) 88(1) 
C(3) 11822(5) 3546(3) 6678(3) 73(1) 
C(4) 12470(7) 2669(5) 7285(4) 104(2) 
C(5) 12777(8) 3166(7) 7884(4) 120(2) 
C(6) 12546(9) 4527(7) 7898(3) 115(2) 
C(7) 11947(6) 5417(5) 7293(3) 85(1) 
C(8) 11566(5) 4941(3) 6667(2) 61(1) 
C(9) 10886(5) 5539(3) 5965(2) 56(1) 
C(10) 10343(5) 6991(3) 5687(2) 56(1) 
C(11) 8865(4) 7491(3) 6153(2) 45(1) 
C(11A) 7298(5) 6630(3) 6168(2) 53(1) 
O(11A) 6168(4) 6798(3) 5718(2) 80(1) 
O(11B) 7449(4) 5611(2) 6736(2) 69(1) 
C(11B) 6368(7) 4486(4) 6729(3) 104(2) 
N(12) 8358(3) 8927(2) 5829(1) 42(1) 
C(13) 6970(4) 9603(3) 6242(2) 46(1) 
C(13A) 6963(6) 11119(3) 5951(2) 66(1) 
C(14) 7330(4) 9257(3) 7025(2) 49(1) 
C(15) 7675(5) 8966(4) 7663(2) 55(1) 
C(16) 10702(5) 7892(4) 8645(2) 64(1) 
Si(1) 8312(1) 8494(1) 8630(1) 54(1) 
C(17) 11500(6) 7696(7) 9408(3) 102(2) 
C(18) 11886(6) 8704(5) 8080(3) 80(1) 
C(19) 7876(6) 10030(5) 9042(2) 76(1) 
C(20) 8977(12) 11191(6) 8685(4) 132(3) 
C(21) 5898(8) 10430(7) 9014(3) 121(2) 
C(22) 6867(6) 7086(5) 9050(2) 79(1) 
C(23) 6894(9) 6754(7) 9890(3) 117(2) 
C(24) 7182(10) 5823(7) 8727(4) 124(2) 
C(1') 5326(5) 5265(3) 4434(2) 57(1) 
N(2') 5792(4) 6496(3) 4055(2) 66(1) 
C(3') 5976(4) 6433(3) 3331(2) 54(1) 
C(4') 6410(6) 7423(4) 2739(3) 74(1) 
C(5') 6493(7) 7079(5) 2073(3) 89(2) 
C(6') 6178(7) 5771(5) 1979(3) 87(1) 
C(7') 5748(5) 4789(4) 2567(2) 68(1) 
C(8') 5626(4) 5114(3) 3260(2) 50(1) 
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C(9') 5220(4) 4390(3) 3973(2) 46(1) 
C(10') 4841(4) 2929(3) 4211(2) 50(1) 
C(11') 3407(4) 2435(3) 3780(2) 43(1) 
C(11C) 1688(5) 3242(3) 3802(2) 52(1) 
O(11C) 586(4) 2975(3) 4264(2) 74(1) 
O(11D) 1644(3) 4292(2) 3261(2) 69(1) 
C(11D) 189(7) 5274(5) 3256(4) 106(2) 
N(12') 3148(3) 984(2) 4104(1) 41(1) 
C(13') 1736(4) 304(3) 3755(2) 44(1) 
C(13B) 2126(6) -1201(3) 3919(2) 62(1) 
C(14') 1612(4) 836(3) 2972(2) 49(1) 
C(15') 1415(5) 1231(4) 2329(2) 56(1) 
Si(1') 832(1) 1728(1) 1355(1) 57(1) 
C(16') 1364(6) 214(5) 940(2) 75(1) 
C(17') 3323(8) -166(7) 973(4) 114(2) 
C(18') 298(11) -983(6) 1269(4) 128(2) 
C(19') -1583(5) 2284(5) 1338(3) 77(1) 
C(20') -2711(6) 1444(6) 1906(3) 94(2) 
C(21') -2352(7) 2480(8) 573(3) 114(2) 
C(22') 2242(6) 3165(5) 943(2) 80(1) 
C(23') 1771(10) 4437(5) 1252(4) 110(2) 
C(24') 2259(8) 3475(7) 103(3) 113(2) 
 
______________________________________________________________________________
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Table A16. Bond lengths [Å] and angles [°] for 13b. 
______________________________________________________________________________ 
C(1)-C(9)  1.352(4) C(1)-N(2)  1.368(6) 
C(1)-H(1)  0.9300 N(2)-C(3)  1.367(6) 
N(2)-H(2)  0.8600 C(3)-C(4)  1.376(8) 
C(3)-C(8)  1.416(5) C(4)-C(5)  1.342(9) 
C(4)-H(4)  0.9300 C(5)-C(6)  1.389(9) 
C(5)-H(5)  0.9300 C(6)-C(7)  1.367(7) 
C(6)-H(6)  0.9300 C(7)-C(8)  1.388(6) 
C(7)-H(7)  0.9300 C(8)-C(9)  1.424(5) 
C(9)-C(10)  1.502(4) C(10)-C(11)  1.537(4) 
C(10)-H(10A)  0.9700 C(10)-H(10B)  0.9700 
C(11)-N(12)  1.497(3) C(11)-C(11A)  1.507(5) 
C(11)-H(11)  0.9800 C(11A)-O(11A)  1.191(5) 
C(11A)-O(11B)  1.329(4) O(11B)-C(11B)  1.440(5) 
C(11B)-H(11A)  0.9600 C(11B)-H(11B)  0.9600 
C(11B)-H(11C)  0.9600 N(12)-C(13)  1.514(4) 
N(12)-H(12A)  0.8900 N(12)-H(12B)  0.8900 
C(13)-C(14)  1.462(5) C(13)-C(13A)  1.526(4) 
C(13)-H(13)  0.9800 C(13A)-H(13A)  0.9600 
C(13A)-H(13B)  0.9600 C(13A)-H(13C)  0.9600 
C(14)-C(15)  1.197(5) C(15)-Si(1)  1.841(4) 
C(16)-C(18)  1.519(6) C(16)-C(17)  1.529(6) 
C(16)-Si(1)  1.885(4) C(16)-H(16)  0.9800 
Si(1)-C(19)  1.881(4) Si(1)-C(22)  1.884(4) 
C(17)-H(17A)  0.9600 C(17)-H(17B)  0.9600 
C(17)-H(17C)  0.9600 C(18)-H(18A)  0.9600 
C(18)-H(18B)  0.9600 C(18)-H(18C)  0.9600 
C(19)-C(20)  1.518(8) C(19)-C(21)  1.534(7) 
C(19)-H(19)  0.9800 C(20)-H(20A)  0.9600 
C(20)-H(20B)  0.9600 C(20)-H(20C)  0.9600 
C(21)-H(21A)  0.9600 C(21)-H(21B)  0.9600 
C(21)-H(21C)  0.9600 C(22)-C(24)  1.527(9) 
C(22)-C(23)  1.539(7) C(22)-H(22)  0.9800 
C(23)-H(23A)  0.9600 C(23)-H(23B)  0.9600 
C(23)-H(23C)  0.9600 C(24)-H(24A)  0.9600 
C(24)-H(24B)  0.9600 C(24)-H(24C)  0.9600 
C(1')-C(9')  1.358(4) C(1')-N(2')  1.370(4) 
C(1')-H(1')  0.9300 N(2')-C(3')  1.371(5) 
N(2')-H(2')  0.8600 C(3')-C(4')  1.387(5) 
C(3')-C(8')  1.409(4) C(4')-C(5')  1.357(7) 
C(4')-H(4')  0.9300 C(5')-C(6')  1.404(7) 
C(5')-H(5')  0.9300 C(6')-C(7')  1.377(6) 
C(6')-H(6')  0.9300 C(7')-C(8')  1.397(5) 
C(7')-H(7')  0.9300 C(8')-C(9')  1.427(5) 
C(9')-C(10')  1.502(4) C(10')-C(11')  1.524(4) 
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C(10')-H(10C)  0.9700 C(10')-H(10D)  0.9700 
C(11')-N(12')  1.499(3) C(11')-C(11C)  1.511(4) 
C(11')-H(11')  0.9800 C(11C)-O(11C)  1.195(4) 
C(11C)-O(11D)  1.316(4) O(11D)-C(11D)  1.450(5) 
C(11D)-H(11D)  0.9600 C(11D)-H(11E)  0.9600 
C(11D)-H(11F)  0.9600 N(12')-C(13')  1.522(4) 
N(12')-H(12C)  0.8900 N(12')-H(12D)  0.8900 
C(13')-C(14')  1.459(5) C(13')-C(13B)  1.513(4) 
C(13')-H(13')  0.9800 C(13B)-H(13D)  0.9600 
C(13B)-H(13E)  0.9600 C(13B)-H(13F)  0.9600 
C(14')-C(15')  1.197(5) C(15')-Si(1')  1.843(4) 
Si(1')-C(16')  1.875(5) Si(1')-C(22')  1.886(4) 
Si(1')-C(19')  1.890(4) C(16')-C(18')  1.516(7) 
C(16')-C(17')  1.517(8) C(16')-H(16')  0.9800 
C(17')-H(17D)  0.9600 C(17')-H(17E)  0.9600 
C(17')-H(17F)  0.9600 C(18')-H(18D)  0.9600 
C(18')-H(18E)  0.9600 C(18')-H(18F)  0.9600 
C(19')-C(20')  1.509(6) C(19')-C(21')  1.522(7) 
C(19')-H(19')  0.9800 C(20')-H(20D)  0.9600 
C(20')-H(20E)  0.9600 C(20')-H(20F)  0.9600 
C(21')-H(21D)  0.9600 C(21')-H(21E)  0.9600 
C(21')-H(21F)  0.9600 C(22')-C(24')  1.537(7) 
C(22')-C(23')  1.539(8) C(22')-H(22')  0.9800 
C(23')-H(23D)  0.9600 C(23')-H(23E)  0.9600 
C(23')-H(23F)  0.9600 C(24')-H(24D)  0.9600 
C(24')-H(24E)  0.9600 C(24')-H(24F)  0.9600 
C(9)-C(1)-N(2) 109.9(4) C(9)-C(1)-H(1) 125.0 
N(2)-C(1)-H(1) 125.0 C(3)-N(2)-C(1) 109.2(3) 
C(3)-N(2)-H(2) 125.4 C(1)-N(2)-H(2) 125.4 
N(2)-C(3)-C(4) 131.4(4) N(2)-C(3)-C(8) 107.1(4) 
C(4)-C(3)-C(8) 121.5(5) C(5)-C(4)-C(3) 117.9(5) 
C(5)-C(4)-H(4) 121.1 C(3)-C(4)-H(4) 121.1 
C(4)-C(5)-C(6) 122.4(5) (4)-C(5)-H(5) 118.8 
C(6)-C(5)-H(5) 118.8 C(7)-C(6)-C(5) 120.4(6) 
C(7)-C(6)-H(6) 119.8 C(5)-C(6)-H(6) 119.8 
C(6)-C(7)-C(8) 119.1(5) C(6)-C(7)-H(7) 120.4 
C(8)-C(7)-H(7) 120.4 C(7)-C(8)-C(3) 118.6(4) 
C(7)-C(8)-C(9) 134.7(3) C(3)-C(8)-C(9) 106.7(3) 
C(1)-C(9)-C(8) 107.1(3) C(1)-C(9)-C(10) 125.2(4) 
C(8)-C(9)-C(10) 127.7(3) C(9)-C(10)-C(11) 112.1(3) 
C(9)-C(10)-H(10A) 109.2 C(11)-C(10)-H(10A) 109.2 
C(9)-C(10)-H(10B) 109.2 C(11)-C(10)-H(10B) 109.2 
H(10A)-C(10)-H(10B) 107.9 N(12)-C(11)-C(11A) 110.2(3) 
N(12)-C(11)-C(10) 109.0(2) C(11A)-C(11)-C(10) 109.5(2) 
N(12)-C(11)-H(11) 109.4 C(11A)-C(11)-H(11) 109.4 
C(10)-C(11)-H(11) 109.4 O(11A)-C(11A)-O(11B) 125.8(3) 
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O(11A)-C(11A)-C(11) 125.2(3) O(11B)-C(11A)-C(11) 108.9(3) 
C(11A)-O(11B)-C(11B) 116.8(4) O(11B)-C(11B)-H(11A) 109.5 
O(11B)-C(11B)-H(11B) 109.5 H(11A)-C(11B)-H(11B) 109.5 
O(11B)-C(11B)-H(11C) 109.5 H(11A)-C(11B)-H(11C) 109.5 
H(11B)-C(11B)-H(11C) 109.5 C(11)-N(12)-C(13) 116.0(2) 
C(11)-N(12)-H(12A) 108.3 C(13)-N(12)-H(12A) 108.3 
C(11)-N(12)-H(12B) 108.3 C(13)-N(12)-H(12B) 108.3 
H(12A)-N(12)-H(12B) 107.4 C(14)-C(13)-N(12) 109.9(2) 
C(14)-C(13)-C(13A) 112.1(3) N(12)-C(13)-C(13A) 108.4(3) 
C(14)-C(13)-H(13) 108.8 N(12)-C(13)-H(13) 108.8 
C(13A)-C(13)-H(13) 108.8 C(13)-C(13A)-H(13A) 109.5 
C(13)-C(13A)-H(13B) 109.5 H(13A)-C(13A)-H(13B) 109.5 
C(13)-C(13A)-H(13C) 109.5 H(13A)-C(13A)-H(13C) 109.5 
H(13B)-C(13A)-H(13C) 109.5 C(15)-C(14)-C(13) 178.1(3) 
C(14)-C(15)-Si(1) 177.3(3) C(18)-C(16)-C(17) 110.9(4) 
C(18)-C(16)-Si(1) 115.9(3) C(17)-C(16)-Si(1) 112.2(3) 
C(18)-C(16)-H(16) 105.7 C(17)-C(16)-H(16) 105.7 
Si(1)-C(16)-H(16) 105.7 C(15)-Si(1)-C(19) 106.87(18) 
C(15)-Si(1)-C(22) 106.04(18) C(19)-Si(1)-C(22) 111.7(2) 
C(15)-Si(1)-C(16) 106.53(17) C(19)-Si(1)-C(16) 114.1(2) 
C(22)-Si(1)-C(16) 111.0(2) C(16)-C(17)-H(17A) 109.5 
C(16)-C(17)-H(17B) 109.5 H(17A)-C(17)-H(17B) 109.5 
C(16)-C(17)-H(17C) 109.5 H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 C(16)-C(18)-H(18A) 109.5 
C(16)-C(18)-H(18B) 109.5 H(18A)-C(18)-H(18B) 109.5 
C(16)-C(18)-H(18C) 109.5 H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 C(20)-C(19)-C(21) 111.8(5) 
C(20)-C(19)-Si(1) 112.1(3) C(21)-C(19)-Si(1) 110.3(4) 
C(20)-C(19)-H(19) 107.5 C(21)-C(19)-H(19) 107.5 
Si(1)-C(19)-H(19) 107.5 C(19)-C(20)-H(20A) 109.5 
C(19)-C(20)-H(20B) 109.5 H(20A)-C(20)-H(20B) 109.5 
C(19)-C(20)-H(20C) 109.5 H(20A)-C(20)-H(20C) 109.5 
H(20B)-C(20)-H(20C) 109.5 C(19)-C(21)-H(21A) 109.5 
C(19)-C(21)-H(21B) 109.5 H(21A)-C(21)-H(21B) 109.5 
C(19)-C(21)-H(21C) 109.5 H(21A)-C(21)-H(21C) 109.5 
H(21B)-C(21)-H(21C) 109.5 C(24)-C(22)-C(23) 111.6(5) 
C(24)-C(22)-Si(1) 113.2(4) C(23)-C(22)-Si(1) 114.2(4) 
C(24)-C(22)-H(22) 105.6 C(23)-C(22)-H(22) 105.6 
Si(1)-C(22)-H(22) 105.6 C(22)-C(23)-H(23A) 109.5 
C(22)-C(23)-H(23B) 109.5 H(23A)-C(23)-H(23B) 109.5 
C(22)-C(23)-H(23C) 109.5 H(23A)-C(23)-H(23C) 109.5 
H(23B)-C(23)-H(23C) 109.5 C(22)-C(24)-H(24A) 109.5 
C(22)-C(24)-H(24B) 109.5 H(24A)-C(24)-H(24B) 109.5 
C(22)-C(24)-H(24C) 109.5 H(24A)-C(24)-H(24C) 109.5 
H(24B)-C(24)-H(24C) 109.5 C(9')-C(1')-N(2') 110.1(3) 
C(9')-C(1')-H(1') 124.9 N(2')-C(1')-H(1') 124.9 
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C(1')-N(2')-C(3') 108.7(3) C(1')-N(2')-H(2') 125.6 
C(3')-N(2')-H(2') 125.6 N(2')-C(3')-C(4') 129.9(3) 
N(2')-C(3')-C(8') 107.5(3) C(4')-C(3')-C(8') 122.6(4) 
C(5')-C(4')-C(3') 117.4(4) C(5')-C(4')-H(4') 121.3 
C(3')-C(4')-H(4') 121.3 C(4')-C(5')-C(6') 121.8(4) 
C(4')-C(5')-H(5') 119.1 C(6')-C(5')-H(5') 119.1 
C(7')-C(6')-C(5') 120.7(5) C(7')-C(6')-H(6') 119.6 
C(5')-C(6')-H(6') 119.6 C(6')-C(7')-C(8') 118.9(4) 
C(6')-C(7')-H(7') 120.5 C(8')-C(7')-H(7') 120.5 
C(7')-C(8')-C(3') 118.5(3) C(7')-C(8')-C(9') 134.6(3) 
C(3')-C(8')-C(9') 106.9(3) C(1')-C(9')-C(8') 106.8(3) 
C(1')-C(9')-C(10') 124.4(3) C(8')-C(9')-C(10') 128.8(3) 
C(9')-C(10')-C(11') 115.1(2) C(9')-C(10')-H(10C) 108.5 
C(11')-C(10')-H(10C) 108.5 C(9')-C(10')-H(10D) 108.5 
C(11')-C(10')-H(10D) 108.5 H(10C)-C(10')-H(10D) 107.5 
N(12')-C(11')-C(11C) 109.6(2) N(12')-C(11')-C(10') 108.2(2) 
C(11C)-C(11')-C(10') 111.6(2) N(12')-C(11')-H(11') 109.1 
C(11C)-C(11')-H(11') 109.1 C(10')-C(11')-H(11') 109.1 
O(11C)-C(11C)-O(11D) 126.2(3) O(11C)-C(11C)-C(11') 124.1(3) 
O(11D)-C(11C)-C(11') 109.6(3) C(11C)-O(11D)-C(11D) 116.9(4) 
O(11D)-C(11D)-H(11D) 109.5 O(11D)-C(11D)-H(11E) 109.5 
H(11D)-C(11D)-H(11E) 109.5 O(11D)-C(11D)-H(11F) 109.5 
H(11D)-C(11D)-H(11F) 109.5 H(11E)-C(11D)-H(11F) 109.5 
C(11')-N(12')-C(13') 116.4(2) C(11')-N(12')-H(12C) 108.2 
C(13')-N(12')-H(12C) 108.2 C(11')-N(12')-H(12D) 108.2 
C(13')-N(12')-H(12D) 108.2 H(12C)-N(12')-H(12D) 107.3 
C(14')-C(13')-C(13B) 111.8(3) C(14')-C(13')-N(12') 111.3(2) 
C(13B)-C(13')-N(12') 109.1(3) C(14')-C(13')-H(13') 108.2 
C(13B)-C(13')-H(13') 108.2 N(12')-C(13')-H(13') 108.2 
C(13')-C(13B)-H(13D) 109.5 C(13')-C(13B)-H(13E) 109.5 
H(13D)-C(13B)-H(13E) 109.5 C(13')-C(13B)-H(13F) 109.5 
H(13D)-C(13B)-H(13F) 109.5 H(13E)-C(13B)-H(13F) 109.5 
C(15')-C(14')-C(13') 175.9(3) C(14')-C(15')-Si(1') 172.4(3) 
C(15')-Si(1')-C(16') 106.22(19) C(15')-Si(1')-C(22') 107.33(18) 
C(16')-Si(1')-C(22') 111.0(2) C(15')-Si(1')-C(19') 105.58(18) 
C(16')-Si(1')-C(19') 114.9(2) C(22')-Si(1')-C(19') 111.3(2) 
C(18')-C(16')-C(17') 110.9(5) C(18')-C(16')-Si(1') 113.0(3) 
C(17')-C(16')-Si(1') 111.7(3) C(18')-C(16')-H(16') 107.0 
C(17')-C(16')-H(16') 107.0 Si(1')-C(16')-H(16') 107.0 
C(16')-C(17')-H(17D) 109.5 C(16')-C(17')-H(17E) 109.5 
H(17D)-C(17')-H(17E) 109.5 C(16')-C(17')-H(17F) 109.5 
H(17D)-C(17')-H(17F) 109.5 H(17E)-C(17')-H(17F) 109.5 
C(16')-C(18')-H(18D) 109.5 C(16')-C(18')-H(18E) 109.5 
H(18D)-C(18')-H(18E) 109.5 C(16')-C(18')-H(18F) 109.5 
H(18D)-C(18')-H(18F) 109.5 H(18E)-C(18')-H(18F) 109.5 
C(20')-C(19')-C(21') 112.5(4) C(20')-C(19')-Si(1') 115.0(3) 
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C(21')-C(19')-Si(1') 111.8(4) C(20')-C(19')-H(19') 105.5 
C(21')-C(19')-H(19') 105.5 Si(1')-C(19')-H(19') 105.5 
C(19')-C(20')-H(20D) 109.5 C(19')-C(20')-H(20E) 109.5 
H(20D)-C(20')-H(20E) 109.5 C(19')-C(20')-H(20F) 109.5 
H(20D)-C(20')-H(20F) 109.5 H(20E)-C(20')-H(20F) 109.5 
C(19')-C(21')-H(21D) 109.5 C(19')-C(21')-H(21E) 109.5 
H(21D)-C(21')-H(21E) 109.5 C(19')-C(21')-H(21F) 109.5 
H(21D)-C(21')-H(21F) 109.5 H(21E)-C(21')-H(21F) 109.5 
C(24')-C(22')-C(23') 111.4(5) C(24')-C(22')-Si(1') 113.9(4) 
C(23')-C(22')-Si(1') 111.8(4) C(24')-C(22')-H(22') 106.4 
C(23')-C(22')-H(22') 106.4 Si(1')-C(22')-H(22') 106.4 
C(22')-C(23')-H(23D) 109.5 C(22')-C(23')-H(23E) 109.5 
H(23D)-C(23')-H(23E) 109.5 C(22')-C(23')-H(23F) 109.5 
H(23D)-C(23')-H(23F) 109.5 H(23E)-C(23')-H(23F) 109.5 
C(22')-C(24')-H(24D) 109.5 C(22')-C(24')-H(24E) 109.5 
H(24D)-C(24')-H(24E) 109.5 C(22')-C(24')-H(24F) 109.5 
H(24D)-C(24')-H(24F) 109.5 H(24E)-C(24')-H(24F) 109.5 
______________________________________________________________________________ 
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Table A17. Anisotropic displacement parameters (Å2x 103) for 13b. The anisotropic 
displacement factor exponent takes the form: -2 2[h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
Cl(1') 63(1)  42(1) 50(1)  -10(1) 2(1)  -9(1) 
Cl(1) 56(1)  45(1) 48(1)  -10(1) -7(1)  0(1) 
C(1) 90(3)  55(2) 83(3)  -33(2) 20(2)  -12(2) 
N(2) 97(3)  46(2) 128(3)  -38(2) 27(2)  -11(2) 
C(3) 69(2)  42(2) 104(3)  -6(2) 27(2)  0(2) 
C(4) 90(3)  57(2) 145(6)  20(3) 32(4)  12(2) 
C(5) 101(4)  120(5) 110(5)  36(4) 12(3)  42(4) 
C(6) 121(4)  131(5) 81(4)  -8(3) -14(3)  50(4) 
C(7) 98(3)  78(3) 80(3)  -22(2) -10(2)  24(2) 
C(8) 62(2)  47(2) 73(2)  -13(2) 11(2)  2(2) 
C(9) 65(2)  42(1) 62(2)  -17(1) 15(2)  -6(1) 
C(10) 72(2)  43(1) 54(2)  -11(1) 15(2)  -7(2) 
C(11) 62(2)  38(1) 37(2)  -6(1) 0(1)  -5(1) 
C(11A) 65(2)  44(2) 52(2)  -12(2) 4(2)  -13(2) 
O(11A) 89(2)  72(2) 80(2)  -12(1) -22(2)  -30(2) 
O(11B) 71(2)  54(1) 76(2)  7(1) 11(1)  -15(1) 
C(11B) 105(3)  59(2) 141(5)  2(3) 17(3)  -32(2) 
N(12) 53(1)  39(1) 36(1)  -6(1) -7(1)  -6(1) 
C(13) 50(2)  47(2) 41(2)  -10(1) -11(1)  2(1) 
C(13A) 90(3)  48(2) 58(2)  -8(2) -13(2)  11(2) 
C(14) 51(2)  51(2) 43(2)  -11(1) -4(1)  3(1) 
C(15) 58(2)  65(2) 43(2)  -12(2) -2(2)  2(2) 
C(16) 55(2)  74(2) 60(2)  -10(2) -2(2)  -1(2) 
Si(1) 52(1)  73(1) 35(1)  -8(1) -3(1)  4(1) 
C(17) 65(3)  159(5) 69(3)  6(3) -10(2)  2(3) 
C(18) 65(2)  101(3) 74(3)  -13(2) 7(2)  -7(2) 
C(19) 85(3)  94(3) 51(2)  -27(2) -6(2)  14(2) 
C(20) 205(8)  81(3) 116(5)  -35(3) 35(5)  -17(4) 
C(21) 109(4)  151(5) 113(4)  -63(4) -21(3)  55(4) 
C(22) 64(2)  108(3) 55(3)  7(2) -4(2)  -12(2) 
C(23) 123(4)  154(5) 58(3)  25(3) 10(3)  -38(4) 
C(24) 157(6)  108(4) 108(5)  -14(3) 4(4)  -62(4) 
C(1') 66(2)  50(2) 59(2)  -16(1) -12(2)  -3(2) 
N(2') 78(2)  42(1) 82(2)  -24(1) -11(2)  -6(1) 
C(3') 51(2)  40(1) 71(2)  -6(1) -10(1)  -2(1) 
C(4') 72(2)  48(2) 96(4)  3(2) -8(2)  -10(2) 
C(5') 87(3)  78(3) 88(4)  22(2) -2(3)  -23(2) 
C(6') 101(3)  99(3) 59(3)  -4(2) 3(2)  -31(3) 
C(7') 78(2)  65(2) 62(2)  -15(2) 1(2)  -18(2) 
C(8') 50(2)  41(1) 58(2)  -9(1) -8(1)  -2(1) 
C(9') 50(2)  40(1) 49(2)  -9(1) -13(1)  -2(1) 
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C(10') 57(2)  41(1) 51(2)  -5(1) -19(1)  1(1) 
C(11') 52(2)  34(1) 41(2)  -5(1) -8(1)  -1(1) 
C(11C) 57(2)  45(2) 56(2)  -15(2) -16(2)  2(2) 
O(11C) 79(2)  74(2) 69(2)  -17(1) 11(1)  16(1) 
O(11D) 60(1)  50(1) 89(2)  9(1) -21(1)  7(1) 
C(11D) 93(3)  73(3) 144(5)  -4(3) -39(3)  31(3) 
N(12') 46(1)  38(1) 37(1)  -6(1) -3(1)  -1(1) 
C(13') 45(1)  47(1) 41(2)  -10(1) 1(1)  -9(1) 
C(13B) 81(2)  44(2) 57(2)  -1(1) -4(2)  -13(2) 
C(14') 54(2)  48(2) 48(2)  -11(1) -7(1)  -11(1) 
C(15') 59(2)  59(2) 49(2)  -9(2) -10(2)  -11(2) 
Si(1') 53(1)  74(1) 43(1)  -4(1) -9(1)  -11(1) 
C(16') 80(3)  94(3) 54(3)  -20(2) -3(2)  -13(2) 
C(17') 108(4)  120(4) 119(5)  -43(4) 1(3)  15(4) 
C(18') 171(6)  99(4) 131(5)  -54(4) 43(5)  -48(4) 
C(19') 61(2)  92(3) 75(3)  -11(2) -9(2)  -1(2) 
C(20') 63(2)  133(4) 85(4)  -16(3) 6(2)  -5(3) 
C(21') 64(3)  176(6) 89(4)  7(4) -25(3)  4(3) 
C(22') 67(2)  93(3) 67(3)  18(2) -13(2)  -20(2) 
C(23') 138(5)  82(3) 107(4)  -4(3) -13(4)  -39(3) 
C(24') 117(4)  141(5) 68(4)  19(3) 6(3)  -38(4) 
______________________________________________________________________________
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Table A18. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
13b. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
 
H(1) 10340 4650 5112 88 
H(2) 11368 2573 5874 105 
H(4) 12688 1760 7280 124 
H(5) 13158 2577 8306 144 
H(6) 12800 4835 8321 137 
H(7) 11797 6329 7301 102 
H(10A) 9942 7104 5187 67 
H(10B) 11358 7536 5689 67 
H(11) 9291 7431 6652 55 
H(11A) 5155 4798 6670 156 
H(11B) 6507 3852 7182 156 
H(11C) 6723 4059 6331 156 
H(12A) 7969 8965 5377 51 
H(12B) 9324 9400 5794 51 
H(13) 5813 9281 6151 55 
H(13A) 5955 11548 6140 99 
H(13B) 6911 11294 5427 99 
H(13C) 8020 11467 6102 99 
H(16) 10711 6992 8527 76 
H(17A) 12636 7236 9412 152 
H(17B) 10739 7171 9755 152 
H(17C) 11625 8557 9537 152 
H(18A) 12052 9563 8206 121 
H(18B) 11346 8835 7608 121 
H(18C) 13007 8228 8070 121 
H(19) 8214 9789 9557 91 
H(20A) 8865 11325 8164 198 
H(20B) 10191 10987 8818 198 
H(20C) 8570 11994 8847 198 
H(21A) 5667 11122 9292 182 
H(21B) 5241 9659 9217 182 
H(21C) 5550 10759 8517 182 
H(22) 5657 7415 8916 94 
H(23A) 6011 6122 10065 175 
H(23B) 6653 7563 10076 175 
H(23C) 8034 6370 10055 175 
H(24A) 8338 5432 8858 185 
H(24B) 7090 6057 8204 185 
H(24C) 6314 5186 8915 185 
H(1') 5114 5058 4935 69 
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H(2') 5943 7194 4241 79 
H(4') 6637 8288 2797 89 
H(5') 6765 7728 1666 107 
H(6') 6262 5566 1516 105 
H(7') 5541 3923 2504 81 
H(10C) 4499 2770 4722 60 
H(10D) 5921 2395 4172 60 
H(11') 3790 2513 3270 52 
H(11D) -900 4822 3325 159 
H(11E) 165 5895 2796 159 
H(11F) 338 5756 3644 159 
H(12C) 2882 921 4575 49 
H(12D) 4170 526 4079 49 
H(13') 598 489 3979 53 
H(13D) 1138 -1646 3778 92 
H(13E) 2334 -1499 4433 92 
H(13F) 3154 -1414 3651 92 
H(16') 1048 464 422 90 
H(17D) 3702 -355 1473 171 
H(17E) 3961 567 704 171 
H(17F) 3546 -950 763 171 
H(18D) 657 -1737 1053 193 
H(18E) -933 -760 1177 193 
H(18F) 494 -1209 1787 193 
H(19') -1624 3181 1460 92 
H(20D) -3876 1859 1899 142 
H(20E) -2201 1380 2380 142 
H(20F) -2773 559 1800 142 
H(21D) -2475 1619 444 171 
H(21E) -1580 3002 231 171 
H(21F) -3488 2944 563 171 
H(22') 3456 2883 1095 95 
H(23D) 2641 5090 1098 165 
H(23E) 1743 4209 1776 165 
H(23F) 634 4806 1075 165 
H(24D) 1131 3867 -73 169 
H(24E) 2496 2656 -73 169 
H(24F) 3159 4094 -68 169 
______________________________________________________________________________
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Table A19. Torsion angles [°] for 13b. 
________________________________________________________________ 
C(9)-C(1)-N(2)-C(3) 0.7(5) C(1)-N(2)-C(3)-C(4) 179.6(4) 
C(1)-N(2)-C(3)-C(8) -0.7(4) N(2)-C(3)-C(4)-C(5) -177.3(5) 
C(8)-C(3)-C(4)-C(5) 3.1(7) C(3)-C(4)-C(5)-C(6) -3.2(9) 
C(4)-C(5)-C(6)-C(7) 1.5(10) C(5)-C(6)-C(7)-C(8) 0.3(9) 
C(6)-C(7)-C(8)-C(3) -0.3(7) C(6)-C(7)-C(8)-C(9) 177.6(5) 
N(2)-C(3)-C(8)-C(7) 178.9(4) C(4)-C(3)-C(8)-C(7) -1.4(6) 
N(2)-C(3)-C(8)-C(9) 0.4(4) C(4)-C(3)-C(8)-C(9) -179.9(4) 
N(2)-C(1)-C(9)-C(8) -0.4(4) N(2)-C(1)-C(9)-C(10) -178.5(3) 
C(7)-C(8)-C(9)-C(1) -178.1(4) C(3)-C(8)-C(9)-C(1) 0.0(4) 
C(7)-C(8)-C(9)-C(10) -0.1(7) C(3)-C(8)-C(9)-C(10) 178.0(3) 
C(1)-C(9)-C(10)-C(11) 118.3(4) C(8)-C(9)-C(10)-C(11) -59.4(5) 
C(9)-C(10)-C(11)-N(12) -178.2(3) C(9)-C(10)-C(11)-C(11A) -57.6(4) 
N(12)-C(11)-C(11A)-O(11A) 34.6(4) C(10)-C(11)-C(11A)-O(11A) -85.3(4) 
N(12)-C(11)-C(11A)-O(11B) -149.5(3) C(10)-C(11)-C(11A)-O(11B) 90.7(3) 
O(11A)-C(11A)-O(11B)-C(11B) 12.8(5) C(11)-C(11A)-O(11B)-C(11B) -
163.1(3) 
C(11A)-C(11)-N(12)-C(13) 62.6(3) C(10)-C(11)-N(12)-C(13) -177.2(3) 
C(11)-N(12)-C(13)-C(14) 43.1(3) C(11)-N(12)-C(13)-C(13A) 165.8(3) 
C(18)-C(16)-Si(1)-C(15) 41.4(4) C(17)-C(16)-Si(1)-C(15) 170.1(3) 
C(18)-C(16)-Si(1)-C(19) -76.3(4) C(17)-C(16)-Si(1)-C(19) 52.4(4) 
C(18)-C(16)-Si(1)-C(22) 156.4(3) C(17)-C(16)-Si(1)-C(22) -74.9(4) 
C(15)-Si(1)-C(19)-C(20) -62.0(5) C(22)-Si(1)-C(19)-C(20) -177.6(4) 
C(16)-Si(1)-C(19)-C(20) 55.5(5) C(15)-Si(1)-C(19)-C(21) 63.3(4) 
C(22)-Si(1)-C(19)-C(21) -52.3(4) C(16)-Si(1)-C(19)-C(21) -179.2(4) 
C(15)-Si(1)-C(22)-C(24) 63.7(4) C(19)-Si(1)-C(22)-C(24) 179.8(4) 
C(16)-Si(1)-C(22)-C(24) -51.6(5) C(15)-Si(1)-C(22)-C(23) -167.1(4) 
C(19)-Si(1)-C(22)-C(23) -51.0(5) C(16)-Si(1)-C(22)-C(23) 77.6(5) 
C(9')-C(1')-N(2')-C(3') 0.7(4) C(1')-N(2')-C(3')-C(4') 179.2(4) 
C(1')-N(2')-C(3')-C(8') -0.5(4) N(2')-C(3')-C(4')-C(5') -179.7(4) 
C(8')-C(3')-C(4')-C(5') 0.0(6) C(3')-C(4')-C(5')-C(6') -0.9(7) 
C(4')-C(5')-C(6')-C(7') 0.9(8) C(5')-C(6')-C(7')-C(8') 0.0(7) 
C(6')-C(7')-C(8')-C(3') -0.9(6) C(6')-C(7')-C(8')-C(9') 179.8(4) 
N(2')-C(3')-C(8')-C(7') -179.3(3) C(4')-C(3')-C(8')-C(7') 0.9(5) 
N(2')-C(3')-C(8')-C(9') 0.2(4) C(4')-C(3')-C(8')-C(9') -179.6(3) 
N(2')-C(1')-C(9')-C(8') -0.5(4) N(2')-C(1')-C(9')-C(10') 176.4(3) 
C(7')-C(8')-C(9')-C(1') 179.6(4) C(3')-C(8')-C(9')-C(1') 0.2(3) 
C(7')-C(8')-C(9')-C(10') 2.9(6) C(3')-C(8')-C(9')-C(10') -176.5(3) 
C(1')-C(9')-C(10')-C(11') 131.2(3) C(8')-C(9')-C(10')-C(11') -52.6(4) 
C(9')-C(10')-C(11')-N(12') -177.8(2) C(9')-C(10')-C(11')-C(11C) -57.1(4) 
N(12')-C(11')-C(11C)-O(11C) 31.2(4) C(10')-C(11')-C(11C)-O(11C) -88.7(4) 
N(12')-C(11')-C(11C)-O(11D) -151.5(3) C(10')-C(11')-C(11C)-O(11D) 88.6(3) 
O(11C)-C(11C)-O(11D)-C(11D) 5.1(6) C(11')-C(11C)-O(11D)-C(11D) -
172.1(3) 
C(11C)-C(11')-N(12')-C(13') 57.1(3) C(10')-C(11')-N(12')-C(13') 179.0(2) 
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C(11')-N(12')-C(13')-C(14') 33.4(3) C(11')-N(12')-C(13')-C(13B) 157.3(3) 
C(15')-Si(1')-C(16')-C(18') 62.0(5) C(22')-Si(1')-C(16')-C(18') 178.4(4) 
C(19')-Si(1')-C(16')-C(18') -54.3(5) C(15')-Si(1')-C(16')-C(17') -63.8(4) 
C(22')-Si(1')-C(16')-C(17') 52.5(4) C(19')-Si(1')-C(16')-C(17') 179.9(4) 
C(15')-Si(1')-C(19')-C(20') -39.5(4) C(16')-Si(1')-C(19')-C(20') 77.2(4) 
C(22')-Si(1')-C(19')-C(20') -155.6(4) C(15')-Si(1')-C(19')-C(21') -169.4(4) 
C(16')-Si(1')-C(19')-C(21') -52.8(5) C(22')-Si(1')-C(19')-C(21') 74.4(4) 
C(15')-Si(1')-C(22')-C(24') 165.8(4) C(16')-Si(1')-C(22')-C(24') 50.1(5) 
C(19')-Si(1')-C(22')-C(24') -79.1(5) C(15')-Si(1')-C(22')-C(23') -66.8(4) 
C(16')-Si(1')-C(22')-C(23') 177.5(4) C(19')-Si(1')-C(22')-C(23') 48.3(4) 
 
______________________________________________________________________________ 
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Table A20. Hydrogen bonds for 13b [Å and °]. 
____________________________________________________________________________ 
        D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(12)-H(12A)...Cl(1) 0.89 2.28 3.154(2) 167.3 
 N(12)-H(12B)...Cl(1')#2 0.89 2.28 3.161(2) 170.0 
 N(12')-H(12C)...Cl(1') 0.89 2.27 3.146(2) 166.4 
 N(12')-H(12D)...Cl(1)#3 0.89 2.29 3.169(2) 168.0 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z    #2 x+1,y+1,z    #3 x,y-1,z    #4 x-1,y-1,z  
 
X-ray Crystal Data for 25 
Table A21. Crystal data and structure refinement for 25. 
Empirical formula  C19H20N2O 
Formula weight  292.37 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 8.6453(9) Å α= 90°. 
 b = 8.3913(8) Å β= 93.327(3)°. 
 c = 10.2653(11) Å γ= 90°. 
Volume 743.44(13) Å3 
Z 2 
Density (-123 °C) 1.306 Mg/m3 
Absorption coefficient 0.081 mm-1 
F(000) 312 
Crystal size 0.733 x 0.708 x 0.586 mm3 
θ range for data collection 1.987 to 29.204°. 
Index ranges -11<=h<=11, -11<=k<=11, -13<=l<=14 
Reflections collected 16701 
Independent reflections 16701 [Rint = 0.0263] 
Completeness to θ = 25.000° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 16701 / 1 / 205 
Goodness-of-fit on F2 1.021 
Final R indices [I>2σ(I)] R1 = 0.0335, wR2 = 0.0832 
R indices (all data) R1 = 0.0353, wR2 = 0.0848 
Absolute structure parameter 0.0(4) 
Largest diff. peak and hole 0.253 and -0.206 e.Å-3 
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Table A22. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
for 25. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
N(1) 9940(2) 6522(2) 2310(2) 16(1) 
C(2) 8984(2) 7863(2) 2738(2) 16(1) 
C(3) 7738(2) 8334(2) 1687(2) 19(1) 
C(4) 6678(2) 6914(2) 1353(2) 23(1) 
C(5) 7454(2) 5297(2) 1348(2) 19(1) 
O(5) 6815(2) 4164(2) 821(1) 30(1) 
C(6) 8999(2) 5065(2) 2138(2) 17(1) 
C(7) 8673(2) 4404(2) 3500(2) 18(1) 
C(8) 8122(2) 5748(2) 4314(2) 17(1) 
C(9) 7259(2) 5734(2) 5464(2) 18(1) 
C(10) 6801(2) 4539(2) 6317(2) 21(1) 
C(11) 5960(2) 4969(2) 7368(2) 23(1) 
C(12) 5526(2) 6559(2) 7569(2) 23(1) 
C(13) 5971(2) 7766(2) 6752(2) 22(1) 
C(14) 6873(2) 7341(2) 5719(2) 18(1) 
N(15) 7495(2) 8293(2) 4784(2) 18(1) 
C(15) 7470(2) 10025(2) 4794(2) 22(1) 
C(16) 8259(2) 7304(2) 3950(2) 17(1) 
C(17) 10858(2) 6910(2) 1180(2) 17(1) 
C(18) 10025(2) 6640(2) -105(2) 18(1) 
C(19) 9345(2) 6410(2) -1121(2) 22(1) 
C(20) 12377(2) 5976(2) 1266(2) 21(1) 
 
 
 
Table A23. Bond lengths [Å] and angles [°] for 25. 
_____________________________________________________ 
N(1)-C(6)  1.474(2) N(1)-C(2)  1.478(2) 
N(1)-C(17)  1.479(2) C(2)-C(16)  1.501(3) 
C(2)-C(3)  1.531(2) C(2)-H(2A)  1.0000 
C(3)-C(4)  1.529(3) C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 C(4)-C(5)  1.514(3) 
C(4)-H(4A)  0.9900 C(4)-H(4B)  0.9900 
C(5)-O(5)  1.211(2) C(5)-C(6)  1.534(3) 
C(6)-C(7)  1.544(3) C(6)-H(6A)  1.0000 
C(7)-C(8)  1.498(2) C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 C(8)-C(16)  1.365(2) 
C(8)-C(9)  1.432(3) C(9)-C(10)  1.403(2) 
C(9)-C(14)  1.417(2) C(10)-C(11)  1.383(3) 
C(10)-H(10A)  0.9500 C(11)-C(12)  1.404(3) 
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C(11)-H(11A)  0.9500 C(12)-C(13)  1.383(3) 
C(12)-H(12A)  0.9500 C(13)-C(14)  1.398(3) 
C(13)-H(13A)  0.9500 C(14)-N(15)  1.381(2) 
N(15)-C(16)  1.387(2) N(15)-C(15)  1.454(2) 
C(15)-H(15A)  0.9800 C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 C(17)-C(18)  1.483(3) 
C(17)-C(20)  1.527(2) C(17)-H(17A)  1.0000 
C(18)-C(19)  1.183(3) C(19)-H(19)  0.91(3) 
C(20)-H(20A)  0.9800 C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
C(6)-N(1)-C(2) 110.65(12) C(6)-N(1)-C(17) 113.96(14) 
C(2)-N(1)-C(17) 113.57(13) N(1)-C(2)-C(16) 105.99(14) 
N(1)-C(2)-C(3) 111.71(14) C(16)-C(2)-C(3) 110.77(14) 
N(1)-C(2)-H(2A) 109.4 C(16)-C(2)-H(2A) 109.4 
C(3)-C(2)-H(2A) 109.4 C(4)-C(3)-C(2) 110.18(15) 
C(4)-C(3)-H(3A) 109.6 C(2)-C(3)-H(3A) 109.6 
C(4)-C(3)-H(3B) 109.6 C(2)-C(3)-H(3B) 109.6 
H(3A)-C(3)-H(3B) 108.1 C(5)-C(4)-C(3) 116.04(14) 
C(5)-C(4)-H(4A) 108.3 C(3)-C(4)-H(4A) 108.3 
C(5)-C(4)-H(4B) 108.3 C(3)-C(4)-H(4B) 108.3 
H(4A)-C(4)-H(4B) 107.4O(5)-C(5)-C(4) 120.93(16) 
O(5)-C(5)-C(6) 119.83(17 )C(4)-C(5)-C(6) 118.97(15) 
N(1)-C(6)-C(5) 114.56(14) N(1)-C(6)-C(7) 108.55(14) 
C(5)-C(6)-C(7) 108.99(14) N(1)-C(6)-H(6A) 108.2 
C(5)-C(6)-H(6A) 108.2 C(7)-C(6)-H(6A) 108.2 
C(8)-C(7)-C(6) 108.34(14) C(8)-C(7)-H(7A) 110.0 
C(6)-C(7)-H(7A) 110.0 C(8)-C(7)-H(7B) 110.0 
C(6)-C(7)-H(7B) 110.0 H(7A)-C(7)-H(7B) 108.4 
C(16)-C(8)-C(9) 106.93(16) C(16)-C(8)-C(7) 122.13(16) 
C(9)-C(8)-C(7) 130.64(15) C(10)-C(9)-C(14) 119.11(16) 
C(10)-C(9)-C(8) 134.38(17) C(14)-C(9)-C(8) 106.50(15) 
C(11)-C(10)-C(9) 118.72(17) C(11)-C(10)-H(10A) 120.6 
C(9)-C(10)-H(10A) 120.6 C(10)-C(11)-C(12) 121.27(18) 
C(10)-C(11)-H(11A) 119.4 C(12)-C(11)-H(11A) 119.4 
C(13)-C(12)-C(11) 121.34(17) C(13)-C(12)-H(12A) 119.3 
C(11)-C(12)-H(12A) 119.3 C(12)-C(13)-C(14) 117.41(18) 
C(12)-C(13)-H(13A) 121.3 C(14)-C(13)-H(13A) 121.3 
N(15)-C(14)-C(13) 129.52(17) N(15)-C(14)-C(9) 108.44(15) 
C(13)-C(14)-C(9) 122.03(17) C(14)-N(15)-C(16) 107.57(14) 
C(14)-N(15)-C(15) 124.54(16) C(16)-N(15)-C(15) 127.58(16) 
N(15)-C(15)-H(15A) 109.5 N(15)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15B) 109.5 N(15)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 H(15B)-C(15)-H(15C) 109.5 
C(8)-C(16)-N(15) 110.53(16) C(8)-C(16)-C(2) 124.98(16) 
N(15)-C(16)-C(2) 124.18(15) N(1)-C(17)-C(18) 114.15(14) 
N(1)-C(17)-C(20) 109.87(14) C(18)-C(17)-C(20) 110.17(15) 
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N(1)-C(17)-H(17A) 107.5 C(18)-C(17)-H(17A) 107.5 
C(20)-C(17)-H(17A) 107.5 C(19)-C(18)-C(17) 179.0(2) 
C(18)-C(19)-H(19) 175.5(16) C(17)-C(20)-H(20A) 109.5 
C(17)-C(20)-H(20B) 109.5 H(20A)-C(20)-H(20B) 109.5 
C(17)-C(20)-H(20C) 109.5 H(20A)-C(20)-H(20C) 109.5 
H(20B)-C(20)-H(20C) 109.5 
 
______________________________________________________________________________ 
 
 
Table A24. Anisotropic displacement parameters (Å2x 103) for 25. The anisotropic 
displacement factor exponent takes the form: -2 2[h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
N(1) 16(1)  12(1) 19(1)  0(1) 3(1)  -1(1) 
C(2) 18(1)  12(1) 19(1)  -1(1) 1(1)  0(1) 
C(3) 20(1)  17(1) 19(1)  2(1) 2(1)  3(1) 
C(4) 18(1)  25(1) 25(1)  -1(1) -2(1)  1(1) 
C(5) 19(1)  21(1) 18(1)  -1(1) 4(1)  -4(1) 
O(5) 30(1)  26(1) 33(1)  -5(1) -1(1)  -10(1) 
C(6) 18(1)  13(1) 20(1)  -2(1) 2(1)  -2(1) 
C(7) 22(1)  12(1) 21(1)  1(1) 3(1)  0(1) 
C(8) 19(1)  14(1) 19(1)  0(1) 1(1)  0(1) 
C(9) 16(1)  19(1) 18(1)  -1(1) -1(1)  0(1) 
C(10) 21(1)  19(1) 21(1)  2(1) 0(1)  -3(1) 
C(11) 20(1)  27(1) 22(1)  4(1) 0(1)  -5(1) 
C(12) 18(1)  33(1) 18(1)  -3(1) 1(1)  -3(1) 
C(13) 20(1)  24(1) 21(1)  -5(1) 0(1)  0(1) 
C(14) 17(1)  18(1) 17(1)  -1(1) -1(1)  -2(1) 
N(15) 22(1)  14(1) 18(1)  -2(1) 2(1)  1(1) 
C(15) 28(1)  13(1) 23(1)  -3(1) 0(1)  2(1) 
C(16) 18(1)  16(1) 16(1)  -1(1) 0(1)  1(1) 
C(17) 16(1)  16(1) 20(1)  1(1) 2(1)  -2(1) 
C(18) 16(1)  16(1) 23(1)  2(1) 4(1)  0(1) 
C(19) 22(1)  19(1) 25(1)  1(1) -1(1)  -1(1) 
C(20) 16(1)  24(1) 23(1)  -1(1) 0(1)  2(1) 
 
______________________________________________________________________________
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Table A25. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 
25. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(2A) 9664 8802 2951 19 
H(3A) 7117 9229 2005 22 
H(3B) 8236 8692 893 22 
H(4A) 5860 6885 1988 27 
H(4B) 6163 7099 479 27 
H(6A) 9620 4255 1680 20 
H(7A) 7873 3560 3417 22 
H(7B) 9630 3936 3917 22 
H(10A) 7063 3456 6175 25 
H(11A) 5670 4174 7965 27 
H(12A) 4914 6812 8280 28 
H(13A) 5676 8841 6887 26 
H(15A) 8018 10430 4053 32 
H(15B) 7982 10415 5609 32 
H(15C) 6394 10398 4726 32 
H(17A) 11125 8068 1237 21 
H(19) 8840(30) 6310(30) -1920(30) 33 
H(20A) 12984 6247 520 32 
H(20B) 12152 4831 1256 32 
H(20C) 12968 6251 2078 32 
______________________________________________________________________________
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Table A26. Torsion angles [°] for 25. 
______________________________________________________________________________ 
C(6)-N(1)-C(2)-C(16) 55.34(18) C(17)-N(1)-C(2)-C(16) -175.02(14) 
C(6)-N(1)-C(2)-C(3) -65.39(18) C(17)-N(1)-C(2)-C(3) 64.24(18) 
N(1)-C(2)-C(3)-C(4) 59.02(18) C(16)-C(2)-C(3)-C(4) -58.89(19) 
C(2)-C(3)-C(4)-C(5) -37.0(2) C(3)-C(4)-C(5)-O(5) -163.13(18) 
C(3)-C(4)-C(5)-C(6) 22.9(2) C(2)-N(1)-C(6)-C(5) 47.9(2) 
C(17)-N(1)-C(6)-C(5) -81.57(18) C(2)-N(1)-C(6)-C(7) -74.20(17) 
C(17)-N(1)-C(6)-C(7) 156.37(14) O(5)-C(5)-C(6)-N(1) 158.15(16) 
C(4)-C(5)-C(6)-N(1) -27.8(2) O(5)-C(5)-C(6)-C(7) -80.0(2) 
C(4)-C(5)-C(6)-C(7) 93.98(18) N(1)-C(6)-C(7)-C(8) 48.18(17) 
C(5)-C(6)-C(7)-C(8) -77.22(17) C(6)-C(7)-C(8)-C(16) -13.4(2) 
C(6)-C(7)-C(8)-C(9) 159.48(18) C(16)-C(8)-C(9)-C(10) -176.85(19) 
C(7)-C(8)-C(9)-C(10) 9.5(3) C(16)-C(8)-C(9)-C(14) 1.66(19) 
C(7)-C(8)-C(9)-C(14) -172.03(18) C(14)-C(9)-C(10)-C(11) 1.2(3) 
C(8)-C(9)-C(10)-C(11) 179.52(19) C(9)-C(10)-C(11)-C(12) 1.8(3) 
C(10)-C(11)-C(12)-C(13) -2.4(3) C(11)-C(12)-C(13)-C(14) -0.1(3) 
C(12)-C(13)-C(14)-N(15) -178.56(18) C(12)-C(13)-C(14)-C(9) 3.2(3) 
C(10)-C(9)-C(14)-N(15) 177.66(15) C(8)-C(9)-C(14)-N(15) -1.12(19) 
C(10)-C(9)-C(14)-C(13) -3.8(3) C(8)-C(9)-C(14)-C(13) 177.46(17) 
C(13)-C(14)-N(15)-C(16) -178.28(18) C(9)-C(14)-N(15)-C(16) 0.2(2) 
C(13)-C(14)-N(15)-C(15) 7.7(3) C(9)-C(14)-N(15)-C(15) -173.84(17) 
C(9)-C(8)-C(16)-N(15) -1.6(2) C(7)-C(8)-C(16)-N(15) 172.72(16) 
C(9)-C(8)-C(16)-C(2) -175.46(16) C(7)-C(8)-C(16)-C(2) -1.1(3) 
C(14)-N(15)-C(16)-C(8) 0.9(2) C(15)-N(15)-C(16)-C(8) 174.70(17) 
C(14)-N(15)-C(16)-C(2) 174.83(16) C(15)-N(15)-C(16)-C(2) -11.4(3) 
N(1)-C(2)-C(16)-C(8) -18.8(2) C(3)-C(2)-C(16)-C(8) 102.6(2) 
N(1)-C(2)-C(16)-N(15) 168.22(16) C(3)-C(2)-C(16)-N(15) -70.4(2) 
C(6)-N(1)-C(17)-C(18) 40.3(2) C(2)-N(1)-C(17)-C(18) -87.64(18) 
C(6)-N(1)-C(17)-C(20) -84.01(17) C(2)-N(1)-C(17)-C(20) 148.04(15) 
 
______________________________________________________________________________ 
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IV Appendix B (Chapter 4) 
 
Single Crystal X-ray Diffraction Analysis of compounds 22, 23, 23ʹ, and 19 
 
Table B1.  Crystal data and structure refinement for 22. 
 
Empirical formula  C19H21IN2O 
Formula weight  420.28 
Temperature  150(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.2720(10) Å α= 90° 
 b = 9.1963(12) Å β= 101.735(5)° 
 c = 13.4788(18) Å γ = 90° 
Volume 882.6(2) Å3 
Z 2 
Density (calculated) 1.582 Mg/m3 
Absorption coefficient 14.293 mm-1 
F(000) 420 
Crystal size 0.439 x 0.062 x 0.036 mm3 
Theta range for data collection 3.349 to 68.197° 
Index ranges -8<=h<=8, -10<=k<=10, -16<=l<=13 
Reflections collected 3852 
Independent reflections 2307 [R(int) = 0.0513] 
Completeness to theta = 67.679° 92.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7531 and 0.3189 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2307 / 1 / 211 
Goodness-of-fit on F2 1.127 
Final R indices [I>2sigma(I)] R1 = 0.0648, wR2 = 0.1865 
R indices (all data) R1 = 0.0650, wR2 = 0.1873 
Absolute structure parameter 0.278(13) 
Extinction coefficient 0.0038(12) 
Largest diff. peak and hole 1.681 and -1.225 e.Å-3
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Table B2.  Atomic coordinates (x 104) and equivalent  isotropic displacement parameters (Å2 x 
103) for 22.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_________________________________________________________________________ 
x y z U(eq) 
______________________________________________________________________________ 
O(1) 1045(8) 6867(8) 7940(6) 33(2) 
C(1) 808(12) 5584(11) 7903(8) 28(2) 
C(2) -1111(11) 4867(13) 7708(9) 36(2) 
C(3) -1344(11) 3575(13) 6979(8) 36(2) 
C(4) 572(10) 2835(9) 6997(6) 24(2) 
C(5) 1583(10) 3428(10) 6213(7) 24(2) 
N(6) 1074(9) 3167(8) 5187(6) 23(2) 
C(6) -425(12) 2184(10) 4690(8) 34(2) 
C(7) 2305(11) 3874(10) 4708(9) 24(2) 
C(8) 2396(12) 3920(10) 3689(8) 28(2) 
C(9) 3779(14) 4779(14) 3419(9) 38(2) 
C(10) 5029(13) 5572(12) 4155(9) 36(2) 
C(11) 4997(12) 5502(12) 5165(8) 30(2) 
C(12) 3614(10) 4631(10) 5461(8) 25(2) 
C(13) 3107(10) 4353(10) 6415(8) 24(2) 
C(14) 3875(10) 4882(11) 7451(7) 27(2) 
C(15) 2473(12) 4515(11) 8135(9) 25(2) 
N(16) 1738(9) 3040(9) 8030(6) 26(2) 
C(17) 3213(14) 1940(12) 8333(8) 34(2) 
C(18) 4247(13) 2251(15) 9397(8) 41(3) 
I(18) 2558(1) 2479(2) 10483(1) 54(1) 
C(19) 6118(14) 2291(18) 9690(10) 51(3) 
C(20) 2422(17) 371(14) 8244(12) 44(3) 
______________________________________________________________________________ 
 
 
Table B3.  Bond lengths [Å] and angles [°] for 22. 
______________________________________________________________________________ 
O(1)-C(1)  1.192(13) C(1)-C(2)  1.518(12) 
C(1)-C(15)  1.541(12) C(2)-C(3)  1.529(16) 
C(2)-H(2A)  0.9900 C(2)-H(2B)  0.9900 
C(3)-C(4)  1.546(11) C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 C(4)-N(16)  1.488(11) 
C(4)-C(5)  1.506(11) C(4)-H(4A)  1.0000 
C(5)-N(6)  1.378(12) C(5)-C(13)  1.380(12) 
N(6)-C(7)  1.370(13) N(6)-C(6)  1.469(11) 
C(6)-H(6A)  0.9800 C(6)-H(6B)  0.9800 
C(6)-H(6C)  0.9800 C(7)-C(8)  1.390(14) 
C(7)-C(12)  1.424(13) C(8)-C(9)  1.384(14) 
C(8)-H(8A)  0.9500 C(9)-C(10)  1.406(17) 
C(9)-H(9A)  0.9500 C(10)-C(11)  1.367(16) 
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C(10)-H(10A)  0.9500 C(11)-C(12)  1.405(13) 
C(11)-H(11A)  0.9500 C(12)-C(13)  1.432(14) 
C(13)-C(14)  1.476(14) C(14)-C(15)  1.545(13) 
C(14)-H(14A)  0.9900 C(14)-H(14B)  0.9900 
C(15)-N(16)  1.455(12) C(15)-H(15A)  1.0000 
N(16)-C(17)  1.471(12) C(17)-C(18)  1.504(15) 
C(17)-C(20)  1.548(15) C(17)-H(17A)  1.0000 
C(18)-C(19)  1.338(14) C(18)-I(18)  2.105(11) 
C(19)-H(19A)  0.9500 C(19)-H(19B)  0.9500 
C(20)-H(20A)  0.9800 C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 O(1)-C(1)-C(2) 123.9(9) 
O(1)-C(1)-C(15) 121.4(9) C(2)-C(1)-C(15) 114.5(9) 
C(1)-C(2)-C(3) 115.2(7) C(1)-C(2)-H(2A) 108.5 
C(3)-C(2)-H(2A) 108.5 C(1)-C(2)-H(2B) 108.5 
C(3)-C(2)-H(2B) 108.5 H(2A)-C(2)-H(2B) 107.5 
C(2)-C(3)-C(4) 110.5(7) C(2)-C(3)-H(3A) 109.5 
C(4)-C(3)-H(3A) 109.5 C(2)-C(3)-H(3B) 109.5 
C(4)-C(3)-H(3B) 109.5 H(3A)-C(3)-H(3B) 108.1 
N(16)-C(4)-C(5) 110.1(7) N(16)-C(4)-C(3) 107.4(7) 
C(5)-C(4)-C(3) 113.3(8) N(16)-C(4)-H(4A) 108.6 
C(5)-C(4)-H(4A) 108.6 C(3)-C(4)-H(4A) 108.6 
N(6)-C(5)-C(13) 110.3(8) N(6)-C(5)-C(4) 124.8(7) 
C(13)-C(5)-C(4) 124.9(8) C(7)-N(6)-C(5) 108.8(7) 
C(7)-N(6)-C(6) 124.9(8) C(5)-N(6)-C(6) 126.0(8) 
N(6)-C(6)-H(6A) 109.5 N(6)-C(6)-H(6B) 109.5 
H(6A)-C(6)-H(6B) 109.5 N(6)-C(6)-H(6C) 109.5 
H(6A)-C(6)-H(6C) 109.5 H(6B)-C(6)-H(6C) 109.5 
N(6)-C(7)-C(8) 130.4(8) N(6)-C(7)-C(12) 107.6(9) 
C(8)-C(7)-C(12) 122.0(9) C(9)-C(8)-C(7) 117.4(9) 
C(9)-C(8)-H(8A) 121.3 C(7)-C(8)-H(8A) 121.3 
C(8)-C(9)-C(10) 120.7(11) C(8)-C(9)-H(9A) 119.6 
C(10)-C(9)-H(9A) 119.6 C(11)-C(10)-C(9) 122.6(10) 
C(11)-C(10)-H(10A) 118.7 C(9)-C(10)-H(10A) 118.7 
C(10)-C(11)-C(12) 117.9(9) C(10)-C(11)-H(11A) 121.1 
C(12)-C(11)-H(11A) 121.1 C(11)-C(12)-C(7) 119.3(10) 
C(11)-C(12)-C(13) 133.4(9) C(7)-C(12)-C(13) 107.2(8) 
C(5)-C(13)-C(12) 106.0(8) C(5)-C(13)-C(14) 121.6(9) 
C(12)-C(13)-C(14) 132.3(8) C(13)-C(14)-C(15) 108.9(7) 
C(13)-C(14)-H(14A) 109.9 C(15)-C(14)-H(14A) 109.9 
C(13)-C(14)-H(14B) 109.9 C(15)-C(14)-H(14B) 109.9 
H(14A)-C(14)-H(14B) 108.3 N(16)-C(15)-C(1) 108.5(7) 
N(16)-C(15)-C(14) 114.8(9) C(1)-C(15)-C(14) 109.0(8) 
N(16)-C(15)-H(15A) 108.1 C(1)-C(15)-H(15A) 108.1 
C(14)-C(15)-H(15A) 108.1 C(15)-N(16)-C(17) 112.5(7) 
C(15)-N(16)-C(4) 109.7(8) C(17)-N(16)-C(4) 114.7(8) 
N(16)-C(17)-C(18) 109.2(9) N(16)-C(17)-C(20) 112.4(8) 
353 
 
C(18)-C(17)-C(20) 110.9(10) N(16)-C(17)-H(17A) 108.1 
C(18)-C(17)-H(17A) 108.1 C(20)-C(17)-H(17A) 108.1 
C(19)-C(18)-C(17) 124.6(11) C(19)-C(18)-I(18) 119.6(9) 
C(17)-C(18)-I(18) 115.7(7) C(18)-C(19)-H(19A) 120.0 
C(18)-C(19)-H(19B) 120.0 H(19A)-C(19)-H(19B) 120.0 
C(17)-C(20)-H(20A) 109.5 C(17)-C(20)-H(20B) 109.5 
H(20A)-C(20)-H(20B) 109.5 C(17)-C(20)-H(20C) 109.5 
H(20A)-C(20)-H(20C) 109.5 H(20B)-C(20)-H(20C) 109.5 
______________________________________________________________________________ 
  
 
 
Table B4.  Anisotropic displacement parameters (Å2 x 103) for 22.  The anisotropic displacement 
factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 37(3)  22(3) 40(5)  -1(3) 5(2)  2(2) 
C(1) 38(4)  22(5) 26(5)  -4(4) 13(3)  7(3) 
C(2) 27(3)  41(6) 44(6)  -7(5) 16(3)  4(4) 
C(3) 29(4)  43(5) 40(6)  -5(5) 13(3)  -6(4) 
C(4) 32(3)  24(5) 18(4)  -1(3) 9(3)  -6(3) 
C(5) 26(3)  24(5) 25(5)  1(4) 13(3)  0(3) 
N(6) 30(3)  14(3) 27(4)  -1(3) 9(3)  -1(3) 
C(6) 46(4)  22(6) 37(5)  -7(4) 13(3)  -18(4) 
C(7) 32(4)  15(5) 27(5)  -2(4) 10(3)  -3(3) 
C(8) 42(4)  21(5) 22(5)  4(4) 11(3)  -1(3) 
C(9) 51(5)  42(6) 26(6)  8(5) 20(4)  -3(4) 
C(10) 41(4)  34(5) 39(6)  5(5) 19(4)  -6(4) 
C(11) 32(3)  30(4) 29(6)  7(4) 8(3)  -7(4) 
C(12) 24(3)  24(4) 28(5)  1(4) 10(3)  2(3) 
C(13) 25(3)  23(5) 25(5)  8(4) 8(3)  0(3) 
C(14) 25(3)  26(5) 30(5)  7(4) 9(3)  -6(3) 
C(15) 33(4)  21(5) 23(5)  -2(4) 9(3)  -2(4) 
N(16) 33(3)  15(3) 30(4)  -4(3) 8(3)  3(3) 
C(17) 50(5)  27(5) 26(6)  0(4) 12(4)  5(4) 
C(18) 48(4)  44(7) 31(5)  7(6) 13(4)  7(5) 
I(18) 81(1)  54(1) 32(1)  8(1) 22(1)  -5(1) 
C(19) 46(4)  51(8) 51(7)  9(7) -2(4)  5(5) 
C(20) 52(6)  28(6) 51(8)  -1(6) 7(5)  -7(5) 
______________________________________________________________________________  
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Table B5.  Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for 
22. 
______________________________________________________________________________  
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(2A) -2067 5607 7433 43 
H(2B) -1372 4532 8364 43 
H(3A) -1881 3915 6283 43 
H(3B) -2225 2863 7176 43 
H(4A) 358 1770 6873 28 
H(6A) -1355 2071 5119 52 
H(6B) 113 1233 4586 52 
H(6C) -1034 2593 4034 52 
H(8A) 1544 3382 3196 33 
H(9A) 3883 4834 2729 46 
H(10A) 5932 6181 3943 44 
H(11A) 5881 6024 5651 36 
H(14A) 4074 5947 7440 32 
H(14B) 5100 4412 7719 32 
H(15A) 3126 4660 8856 30 
H(17A) 4126 2028 7873 40 
H(19A) 6890 2117 9212 61 
H(19B) 6675 2495 10377 61 
H(20A) 3426 -314 8525 66 
H(20B) 1932 140 7530 66 
H(20C) 1408 295 8622 66 
 
______________________________________________________________________________
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Table B6.  Torsion angles [°] for 22. 
______________________________________________________________________________
__  
O(1)-C(1)-C(2)-C(3) 137.6(12) C(15)-C(1)-C(2)-C(3) -46.9(13) 
C(1)-C(2)-C(3)-C(4) 27.0(13) C(2)-C(3)-C(4)-N(16) 30.2(11) 
C(2)-C(3)-C(4)-C(5) -91.7(10) N(16)-C(4)-C(5)-N(6) 166.8(8) 
C(3)-C(4)-C(5)-N(6) -72.8(11) N(16)-C(4)-C(5)-C(13) -15.7(11) 
C(3)-C(4)-C(5)-C(13) 104.6(10) C(13)-C(5)-N(6)-C(7) 2.3(10) 
C(4)-C(5)-N(6)-C(7) -180.0(8) C(13)-C(5)-N(6)-C(6) 177.0(8) 
C(4)-C(5)-N(6)-C(6) -5.3(14) C(5)-N(6)-C(7)-C(8) 178.7(9) 
C(6)-N(6)-C(7)-C(8) 3.9(15) C(5)-N(6)-C(7)-C(12) -1.1(10) 
C(6)-N(6)-C(7)-C(12) -175.9(8) N(6)-C(7)-C(8)-C(9) 177.8(10) 
C(12)-C(7)-C(8)-C(9) -2.4(14) C(7)-C(8)-C(9)-C(10) -0.1(16) 
C(8)-C(9)-C(10)-C(11) 2.3(17) C(9)-C(10)-C(11)-C(12) -1.9(16) 
C(10)-C(11)-C(12)-C(7) -0.5(15) C(10)-C(11)-C(12)-C(13)-176.7(10) 
N(6)-C(7)-C(12)-C(11) -177.4(9) C(8)-C(7)-C(12)-C(11) 2.7(14) 
N(6)-C(7)-C(12)-C(13) -0.3(10) C(8)-C(7)-C(12)-C(13) 179.8(8) 
N(6)-C(5)-C(13)-C(12) -2.4(10) C(4)-C(5)-C(13)-C(12) 179.8(8) 
N(6)-C(5)-C(13)-C(14) 176.4(8) C(4)-C(5)-C(13)-C(14) -1.4(13) 
C(11)-C(12)-C(13)-C(5) 178.2(10) C(7)-C(12)-C(13)-C(5) 1.7(9) 
C(11)-C(12)-C(13)-C(14) -0.4(18) C(7)-C(12)-C(13)-C(14) -177.0(9) 
C(5)-C(13)-C(14)-C(15) -12.2(12) C(12)-C(13)-C(14)-C(15) 166.3(9) 
O(1)-C(1)-C(15)-N(16) 179.9(11) C(2)-C(1)-C(15)-N(16) 4.2(13) 
O(1)-C(1)-C(15)-C(14) -54.4(13) C(2)-C(1)-C(15)-C(14) 129.9(9) 
C(13)-C(14)-C(15)-N(16) 46.0(10) C(13)-C(14)-C(15)-C(1) -75.9(10) 
C(1)-C(15)-N(16)-C(17) -174.5(9) C(14)-C(15)-N(16)-C(17) 63.3(11) 
C(1)-C(15)-N(16)-C(4) 56.6(10) C(14)-C(15)-N(16)-C(4) -65.6(9) 
C(5)-C(4)-N(16)-C(15) 46.6(9) C(3)-C(4)-N(16)-C(15) -77.2(9) 
C(5)-C(4)-N(16)-C(17) -81.1(10) C(3)-C(4)-N(16)-C(17) 155.1(8) 
C(15)-N(16)-C(17)-C(18) 55.2(11) C(4)-N(16)-C(17)-C(18) -178.5(8) 
C(15)-N(16)-C(17)-C(20) 178.7(9) C(4)-N(16)-C(17)-C(20) -55.0(12) 
N(16)-C(17)-C(18)-C(19)-131.6(14) C(20)-C(17)-C(18)-C(19) 104.0(15) 
N(16)-C(17)-C(18)-I(18) 52.9(11) C(20)-C(17)-C(18)-I(18) -71.5(11) 
______________________________________________________________________________ 
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Table B7.  Crystal data and structure refinement for 23. 
 
Empirical formula  C19H20N2O 
Formula weight  292.37 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 6.8328(5) Å α= 90° 
 b = 11.6515(6) Å β= 90° 
 c = 19.2975(7) Å γ = 90° 
Volume 1536.32(15) Å3 
Z 4 
Density (calculated) 1.264 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 624 
Crystal size 0.551 x 0.241 x 0.109 mm3 
Theta range for data collection 2.042 to 29.147°. 
Index ranges -9<=h<=9, -15<=k<=15, -26<=l<=26 
Reflections collected 12917 
Independent reflections 4097 [R(int) = 0.0291] 
Completeness to theta = 25.000° 99.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4097 / 0 / 201 
Goodness-of-fit on F2 1.116 
Final R indices [I>2sigma(I)] R1 = 0.0351, wR2 = 0.0861 
R indices (all data) R1 = 0.0425, wR2 = 0.1031 
Absolute structure parameter -0.8(5) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.293 and -0.359 e.Å-3 
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Table B8.  Atomic coordinates  (x 104) and equivalent isotropic displacement parameters (Å2 x 
103) for 23.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________________
 x y z U(eq) 
______________________________________________________________________________ 
N(1) 5237(2) 2088(1) 2412(1) 19(1) 
C(2) 5643(3) 1860(2) 1666(1) 24(1) 
C(2A) 7805(3) 1597(2) 1542(1) 33(1) 
C(3) 4866(3) 2851(2) 1227(1) 25(1) 
C(3A) 4704(3) 2840(2) 544(1) 39(1) 
C(4) 4259(2) 3859(2) 1672(1) 21(1) 
C(5) 6001(3) 4157(2) 2153(1) 20(1) 
C(6) 6327(2) 3124(2) 2654(1) 18(1) 
C(7) 5611(2) 3390(2) 3370(1) 18(1) 
N(8) 6589(2) 4089(1) 3838(1) 19(1) 
C(8) 8499(2) 4618(2) 3752(1) 24(1) 
C(9) 5491(2) 4141(2) 4440(1) 20(1) 
C(10) 5887(3) 4693(2) 5066(1) 25(1) 
C(11) 4548(3) 4549(2) 5597(1) 29(1) 
C(12) 2868(3) 3868(2) 5514(1) 28(1) 
C(13) 2451(3) 3337(2) 4889(1) 24(1) 
C(14) 3777(3) 3468(2) 4339(1) 19(1) 
C(15) 3884(2) 3017(2) 3649(1) 18(1) 
C(16) 2504(3) 2274(2) 3251(1) 21(1) 
C(17) 3108(2) 2308(2) 2489(1) 19(1) 
O(18) 1048(2) 3941(1) 2209(1) 30(1) 
C(18) 2597(3) 3445(2) 2135(1) 20(1) 
______________________________________________________________________________ 
 
 
 
 
Table B9.  Bond lengths [Å] and angles [°] for 23. 
______________________________________________________________________________
__  
N(1)-C(17)  1.484(2) N(1)-C(2)  1.489(2) 
N(1)-C(6)  1.493(2) C(2)-C(3)  1.527(3) 
C(2)-C(2A)  1.528(3) C(2)-H(2A)  0.9800 
C(2A)-H(2AA)  0.9600 C(2A)-H(2AB)  0.9600 
C(2A)-H(2AC)  0.9600 C(3)-C(3A)  1.321(3) 
C(3)-C(4)  1.513(3) C(3A)-H(3AA)  0.9300 
C(3A)-H(3AB)  0.9300 C(4)-C(18)  1.524(2) 
C(4)-C(5)  1.548(2) C(4)-H(4A)  0.9800 
C(5)-C(6)  1.560(2) C(5)-H(5A)  0.9700 
C(5)-H(5B)  0.9700 C(6)-C(7)  1.497(2) 
C(6)-H(6A)  0.9800 C(7)-C(15)  1.368(2) 
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C(7)-N(8)  1.387(2) N(8)-C(9)  1.385(2) 
N(8)-C(8)  1.453(2) C(8)-H(8A)  0.9600 
C(8)-H(8B)  0.9600 C(8)-H(8C)  0.9600 
C(9)-C(10)  1.395(3) C(9)-C(14)  1.424(2) 
C(10)-C(11)  1.384(3) C(10)-H(10A)  0.9300 
C(11)-C(12)  1.405(3) C(11)-H(11A)  0.9300 
C(12)-C(13)  1.385(3) C(12)-H(12A)  0.9300 
C(13)-C(14)  1.404(3) C(13)-H(13A)  0.9300 
C(14)-C(15)  1.433(2) C(15)-C(16)  1.493(2) 
C(16)-C(17)  1.527(2) C(16)-H(16A)  0.9700 
C(16)-H(16B)  0.9700 C(17)-C(18)  1.530(3) 
C(17)-H(17A)  0.9800 O(18)-C(18)  1.214(2) 
C(17)-N(1)-C(2) 108.06(14) C(17)-N(1)-C(6) 108.54(13) 
C(2)-N(1)-C(6) 110.72(14) N(1)-C(2)-C(3) 109.72(15) 
N(1)-C(2)-C(2A) 111.60(16) C(3)-C(2)-C(2A) 113.56(17) 
N(1)-C(2)-H(2A) 107.2 C(3)-C(2)-H(2A) 107.2 
C(2A)-C(2)-H(2A) 107.2 C(2)-C(2A)-H(2AA) 109.5 
C(2)-C(2A)-H(2AB) 109.5 H(2AA)-C(2A)-H(2AB) 109.5 
C(2)-C(2A)-H(2AC) 109.5 H(2AA)-C(2A)-H(2AC) 109.5 
H(2AB)-C(2A)-H(2AC) 109.5 C(3A)-C(3)-C(4) 123.39(19) 
C(3A)-C(3)-C(2) 125.14(19) C(4)-C(3)-C(2) 111.46(16) 
C(3)-C(3A)-H(3AA) 120.0 C(3)-C(3A)-H(3AB) 120.0 
H(3AA)-C(3A)-H(3AB) 120.0 C(3)-C(4)-C(18) 106.96(15) 
C(3)-C(4)-C(5) 107.69(15) C(18)-C(4)-C(5) 107.01(14) 
C(3)-C(4)-H(4A) 111.6 C(18)-C(4)-H(4A) 111.6 
C(5)-C(4)-H(4A) 111.6 C(4)-C(5)-C(6) 107.95(14) 
C(4)-C(5)-H(5A) 110.1 C(6)-C(5)-H(5A) 110.1 
C(4)-C(5)-H(5B) 110.1 C(6)-C(5)-H(5B) 110.1 
H(5A)-C(5)-H(5B) 108.4 N(1)-C(6)-C(7) 107.05(14) 
N(1)-C(6)-C(5) 110.99(14) C(7)-C(6)-C(5) 111.45(14) 
N(1)-C(6)-H(6A) 109.1 C(7)-C(6)-H(6A) 109.1 
C(5)-C(6)-H(6A) 109.1 C(15)-C(7)-N(8) 110.23(15) 
C(15)-C(7)-C(6) 125.36(16) N(8)-C(7)-C(6) 124.38(15) 
C(9)-N(8)-C(7) 108.16(14) C(9)-N(8)-C(8) 124.23(15) 
C(7)-N(8)-C(8) 127.45(15) N(8)-C(8)-H(8A) 109.5 
N(8)-C(8)-H(8B) 109.5 H(8A)-C(8)-H(8B) 109.5 
N(8)-C(8)-H(8C) 109.5 H(8A)-C(8)-H(8C) 109.5 
H(8B)-C(8)-H(8C) 109.5 N(8)-C(9)-C(10) 129.97(17) 
N(8)-C(9)-C(14) 107.81(15) C(10)-C(9)-C(14) 122.19(16) 
C(11)-C(10)-C(9) 117.19(18) C(11)-C(10)-H(10A) 121.4 
C(9)-C(10)-H(10A) 121.4 C(10)-C(11)-C(12) 121.63(19) 
C(10)-C(11)-H(11A) 119.2 C(12)-C(11)-H(11A) 119.2 
C(13)-C(12)-C(11) 121.31(18) C(13)-C(12)-H(12A) 119.3 
C(11)-C(12)-H(12A) 119.3 C(12)-C(13)-C(14) 118.53(18) 
C(12)-C(13)-H(13A) 120.7 C(14)-C(13)-H(13A) 120.7 
C(13)-C(14)-C(9) 119.11(17) C(13)-C(14)-C(15) 134.10(17) 
359 
 
C(9)-C(14)-C(15) 106.73(15) C(7)-C(15)-C(14) 107.04(16) 
C(7)-C(15)-C(16) 121.79(15) C(14)-C(15)-C(16) 131.16(16) 
C(15)-C(16)-C(17) 108.02(14) C(15)-C(16)-H(16A) 110.1 
C(17)-C(16)-H(16A) 110.1 C(15)-C(16)-H(16B) 110.1 
C(17)-C(16)-H(16B) 110.1 H(16A)-C(16)-H(16B) 108.4 
N(1)-C(17)-C(16) 110.94(15) N(1)-C(17)-C(18) 109.16(14) 
C(16)-C(17)-C(18) 112.95(15) N(1)-C(17)-H(17A) 107.9 
C(16)-C(17)-H(17A) 107.9 C(18)-C(17)-H(17A) 107.9 
O(18)-C(18)-C(4) 124.58(17) O(18)-C(18)-C(17) 123.98(17) 
C(4)-C(18)-C(17) 111.43(15) 
  
______________________________________________________________________________ 
 
 
Table B10.  Anisotropic displacement parameters (Å2 x 103) for 23. The anisotropic displacement 
factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N(1) 16(1)  16(1) 25(1)  -1(1) 4(1)  0(1) 
C(2) 22(1)  22(1) 27(1)  -6(1) 4(1)  0(1) 
C(2A) 26(1)  36(1) 37(1)  -5(1) 9(1)  8(1) 
C(3) 19(1)  30(1) 26(1)  -2(1) 2(1)  -2(1) 
C(3A) 47(1)  43(1) 28(1)  -5(1) 1(1)  0(1) 
C(4) 18(1)  22(1) 23(1)  3(1) 0(1)  1(1) 
C(5) 19(1)  18(1) 23(1)  0(1) 3(1)  -2(1) 
C(6) 13(1)  17(1) 24(1)  1(1) 1(1)  1(1) 
C(7) 15(1)  16(1) 22(1)  2(1) -1(1)  1(1) 
N(8) 17(1)  22(1) 20(1)  1(1) -1(1)  -2(1) 
C(8) 15(1)  27(1) 31(1)  1(1) -2(1)  -3(1) 
C(9) 20(1)  19(1) 22(1)  5(1) -1(1)  3(1) 
C(10) 27(1)  22(1) 26(1)  0(1) -5(1)  1(1) 
C(11) 38(1)  27(1) 22(1)  -1(1) -2(1)  7(1) 
C(12) 35(1)  26(1) 22(1)  3(1) 8(1)  6(1) 
C(13) 24(1)  21(1) 25(1)  5(1) 4(1)  2(1) 
C(14) 20(1)  16(1) 20(1)  5(1) 0(1)  2(1) 
C(15) 17(1)  16(1) 21(1)  2(1) 1(1)  1(1) 
C(16) 18(1)  19(1) 25(1)  -1(1) 4(1)  -4(1) 
C(17) 15(1)  19(1) 24(1)  -3(1) 1(1)  -3(1) 
O(18) 18(1)  37(1) 33(1)  3(1) 1(1)  7(1) 
C(18) 16(1)  24(1) 21(1)  -3(1) -2(1)  -1(1) 
 
______________________________________________________________________________ 
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Table B11.  Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
23. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(2A) 4901 1173 1537 28 
H(2AA) 8248 1044 1875 49 
H(2AB) 8556 2289 1588 49 
H(2AC) 7971 1294 1083 49 
H(3AA) 4196 3475 314 47 
H(3AB) 5099 2198 295 47 
H(4A) 3864 4518 1390 25 
H(5A) 5714 4847 2415 24 
H(5B) 7170 4291 1880 24 
H(6A) 7727 2945 2674 22 
H(8A) 8398 5428 3839 37 
H(8B) 8955 4494 3288 37 
H(8C) 9405 4283 4074 37 
H(10A) 7004 5139 5124 30 
H(11A) 4767 4912 6019 35 
H(12A) 2018 3773 5886 34 
H(13A) 1319 2904 4835 28 
H(16A) 1175 2554 3302 25 
H(16B) 2557 1493 3423 25 
H(17A) 2405 1694 2247 23 
______________________________________________________________________________
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Table B12.  Torsion angles [°] for 23. 
______________________________________________________________________________ 
C(17)-N(1)-C(2)-C(3) 54.52(19) C(6)-N(1)-C(2)-C(3) -64.21(18) 
C(17)-N(1)-C(2)-C(2A) -178.70(16) C(6)-N(1)-C(2)-C(2A) 62.6(2) 
N(1)-C(2)-C(3)-C(3A) -168.63(18) C(2A)-C(2)-C(3)-C(3A) 65.7(3) 
N(1)-C(2)-C(3)-C(4) 10.4(2) C(2A)-C(2)-C(3)-C(4) -115.27(18) 
C(3A)-C(3)-C(4)-C(18) 116.7(2) C(2)-C(3)-C(4)-C(18) -62.37(18) 
C(3A)-C(3)-C(4)-C(5) -128.6(2) C(2)-C(3)-C(4)-C(5) 52.36(19) 
C(3)-C(4)-C(5)-C(6) -65.27(18) C(18)-C(4)-C(5)-C(6) 49.43(18) 
C(17)-N(1)-C(6)-C(7) 53.33(17) C(2)-N(1)-C(6)-C(7) 171.78(13) 
C(17)-N(1)-C(6)-C(5) -68.50(18) C(2)-N(1)-C(6)-C(5) 49.95(18) 
C(4)-C(5)-C(6)-N(1) 13.80(19) C(4)-C(5)-C(6)-C(7) -105.42(16) 
N(1)-C(6)-C(7)-C(15) -19.8(2) C(5)-C(6)-C(7)-C(15) 101.8(2) 
N(1)-C(6)-C(7)-N(8) 162.52(15) C(5)-C(6)-C(7)-N(8) -75.9(2) 
C(15)-C(7)-N(8)-C(9) 1.7(2) C(6)-C(7)-N(8)-C(9) 179.69(15) 
C(15)-C(7)-N(8)-C(8) 177.33(16) C(6)-C(7)-N(8)-C(8) -4.7(3) 
C(7)-N(8)-C(9)-C(10) 177.30(18) C(8)-N(8)-C(9)-C(10) 1.5(3) 
C(7)-N(8)-C(9)-C(14) -0.75(19) C(8)-N(8)-C(9)-C(14) -176.57(15) 
N(8)-C(9)-C(10)-C(11) -176.89(18) C(14)-C(9)-C(10)-C(11) 0.9(3) 
C(9)-C(10)-C(11)-C(12) 0.5(3) C(10)-C(11)-C(12)-C(13) -1.8(3) 
C(11)-C(12)-C(13)-C(14) 1.6(3) C(12)-C(13)-C(14)-C(9) -0.2(3) 
C(12)-C(13)-C(14)-C(15) 176.52(19) N(8)-C(9)-C(14)-C(13) 177.14(16) 
C(10)-C(9)-C(14)-C(13) -1.1(3) N(8)-C(9)-C(14)-C(15) -0.39(19) 
C(10)-C(9)-C(14)-C(15) -178.62(16) N(8)-C(7)-C(15)-C(14) -1.90(19) 
C(6)-C(7)-C(15)-C(14) -179.88(15) N(8)-C(7)-C(15)-C(16) 178.33(16) 
C(6)-C(7)-C(15)-C(16) 0.3(3) C(13)-C(14)-C(15)-C(7) -175.60(19) 
C(9)-C(14)-C(15)-C(7) 1.39(19) C(13)-C(14)-C(15)-C(16) 4.1(3) 
C(9)-C(14)-C(15)-C(16) -178.87(18) C(7)-C(15)-C(16)-C(17) -14.3(2) 
C(14)-C(15)-C(16)-C(17) 166.02(18) C(2)-N(1)-C(17)-C(16) 166.88(14) 
C(6)-N(1)-C(17)-C(16) -73.00(18) C(2)-N(1)-C(17)-C(18) -68.02(18) 
C(6)-N(1)-C(17)-C(18) 52.10(18) C(15)-C(16)-C(17)-N(1) 49.4(2) 
C(15)-C(16)-C(17)-C(18) -73.55(18) C(3)-C(4)-C(18)-O(18) -130.30(19) 
C(5)-C(4)-C(18)-O(18) 114.5(2) C(3)-C(4)-C(18)-C(17) 48.73(19) 
C(5)-C(4)-C(18)-C(17) -66.45(18) N(1)-C(17)-C(18)-O(18) -167.38(17) 
C(16)-C(17)-C(18)-O(18) -43.5(2) N(1)-C(17)-C(18)-C(4) 13.6(2) 
C(16)-C(17)-C(18)-C(4) 137.49(15) 
______________________________________________________________________________ 
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Table B13.  Crystal data and structure refinement for 23'. 
 
Empirical formula  C57H60N6O5.04 
Formula weight  909.69 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Trigonal 
Space group  R3 
Unit cell dimensions a = 24.3565(13) Å α= 90° 
 b = 24.3565(13) Å β= 90° 
 c = 7.2166(5) Å γ = 120° 
Volume 3707.6(5) Å3 
Z 3 
Density (calculated) 1.222 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 1453 
Crystal size 0.400 x 0.135 x 0.122 mm3 
Theta range for data collection 1.672 to 29.147°. 
Index ranges -33<=h<=24, -33<=k<=30, -9<=l<=5 
Reflections collected 6956 
Independent reflections 3408 [R(int) = 0.1067] 
Completeness to theta = 25.000° 99.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3408 / 1 / 212 
Goodness-of-fit on F2 1.316 
Final R indices [I>2sigma(I)] R1 = 0.1273, wR2 = 0.3285 
R indices (all data) R1 = 0.1425, wR2 = 0.3465 
Absolute structure parameter 1.4(10) 
Extinction coefficient 0.005(3) 
Largest diff. peak and hole 1.758 and -0.404 e.Å-3 
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Table B14.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 
103) for 23'.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
N(1) 4694(3) 8469(3) 3446(9) 35(1) 
C(2) 4445(3) 8858(4) 2661(11) 37(2) 
C(2A) 4296(6) 8736(6) 592(14) 63(3) 
C(3) 4824(4) 9566(4) 2991(11) 42(2) 
C(4) 5404(4) 9865(4) 3726(11) 40(2) 
C(5) 5776(3) 9550(3) 4354(11) 38(2) 
C(6) 5867(3) 9196(3) 2754(11) 36(2) 
C(7) 5262(3) 8518(3) 2527(10) 30(1) 
C(8) 5368(3) 8024(3) 3400(10) 31(1) 
N(9) 5726(3) 7790(3) 2598(9) 32(1) 
C(9) 6069(4) 7996(4) 895(13) 47(2) 
C(10) 5723(3) 7357(3) 3800(10) 32(1) 
C(11) 6013(3) 6987(3) 3627(12) 40(2) 
C(12) 5940(3) 6583(3) 5051(14) 43(2) 
C(13) 5568(4) 6528(4) 6602(12) 42(2) 
C(14) 5277(4) 6892(3) 6782(11) 38(2) 
C(15) 5355(3) 7306(3) 5354(11) 36(2) 
C(16) 5136(3) 7752(3) 5059(10) 35(2) 
C(17) 4731(4) 7922(4) 6197(12) 41(2) 
C(18) 4788(3) 8535(3) 5443(11) 35(2) 
C(19) 5424(3) 9120(3) 5971(10) 33(1) 
O(19) 5610(3) 9232(3) 7558(8) 54(2) 
O(1S) 2982(8) 7106(8) 400(20) 52(6) 
O(2S) 3636(7) 7264(7) 2620(20) 23(6) 
______________________________________________________________________________
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Table B15.  Bond lengths [Å] and angles [°] for 23'. 
______________________________________________________________________________ 
N(1)-C(18)  1.455(10) N(1)-C(2)  1.470(9) 
N(1)-C(7)  1.484(8) C(2)-C(3)  1.513(11) 
C(2)-C(2A)  1.530(12) C(2)-H(2A)  1.0000 
C(2A)-H(2AA)  0.9800 C(2A)-H(2AB)  0.9800 
C(2A)-H(2AC)  0.9800 C(3)-C(4)  1.335(12) 
C(3)-H(3A)  0.9500 C(4)-C(5)  1.518(10) 
C(4)-H(4A)  0.9500 C(5)-C(19)  1.516(11) 
C(5)-C(6)  1.523(11) C(5)-H(5A)  1.0000 
C(6)-C(7)  1.578(10) C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 C(7)-C(8)  1.491(9) 
C(7)-H(7A)  1.0000 C(8)-C(16)  1.348(10) 
C(8)-N(9)  1.386(8) N(9)-C(10)  1.363(9) 
N(9)-C(9)  1.428(10) C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 C(9)-H(9C)  0.9800 
C(10)-C(11)  1.400(10) C(10)-C(15)  1.403(10) 
C(11)-C(12)  1.372(13) C(11)-H(11A)  0.9500 
C(12)-C(13)  1.404(13) C(12)-H(12A)  0.9500 
C(13)-C(14)  1.390(11) C(13)-H(13A)  0.9500 
C(14)-C(15)  1.388(11) C(14)-H(14A)  0.9500 
C(15)-C(16)  1.443(10) C(16)-C(17)  1.493(10) 
C(17)-C(18)  1.530(10) C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 C(18)-C(19)  1.539(10) 
C(18)-H(18A)  1.0000 C(19)-O(19)  1.212(9) 
C(18)-N(1)-C(2) 113.7(5) C(18)-N(1)-C(7) 110.2(5) 
C(2)-N(1)-C(7) 116.4(6) N(1)-C(2)-C(3) 117.5(6) 
N(1)-C(2)-C(2A) 112.6(6) C(3)-C(2)-C(2A) 109.0(7) 
N(1)-C(2)-H(2A) 105.6 C(3)-C(2)-H(2A) 105.6 
C(2A)-C(2)-H(2A) 105.6 C(2)-C(2A)-H(2AA) 109.5 
C(2)-C(2A)-H(2AB) 109.5 H(2AA)-C(2A)-H(2AB) 109.5 
C(2)-C(2A)-H(2AC) 109.5 H(2AA)-C(2A)-H(2AC) 109.5 
H(2AB)-C(2A)-H(2AC) 109.5 C(4)-C(3)-C(2) 124.1(7) 
C(4)-C(3)-H(3A) 118.0 C(2)-C(3)-H(3A) 118.0 
C(3)-C(4)-C(5) 125.4(7) C(3)-C(4)-H(4A) 117.3 
C(5)-C(4)-H(4A) 117.3 C(19)-C(5)-C(4) 107.7(6) 
C(19)-C(5)-C(6) 112.6(6) C(4)-C(5)-C(6) 110.6(6) 
C(19)-C(5)-H(5A) 108.6 C(4)-C(5)-H(5A) 108.6 
C(6)-C(5)-H(5A) 108.6 C(5)-C(6)-C(7) 110.3(5) 
C(5)-C(6)-H(6A) 109.6 C(7)-C(6)-H(6A) 109.6 
C(5)-C(6)-H(6B) 109.6 C(7)-C(6)-H(6B) 109.6 
H(6A)-C(6)-H(6B) 108.1 N(1)-C(7)-C(8) 106.1(5) 
N(1)-C(7)-C(6) 112.6(5) C(8)-C(7)-C(6) 110.7(5) 
N(1)-C(7)-H(7A) 109.2 C(8)-C(7)-H(7A) 109.2 
C(6)-C(7)-H(7A) 109.2 C(16)-C(8)-N(9) 111.3(6) 
C(16)-C(8)-C(7) 125.0(6) N(9)-C(8)-C(7) 123.7(6) 
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C(10)-N(9)-C(8) 107.0(6) C(10)-N(9)-C(9) 126.6(6) 
C(8)-N(9)-C(9) 126.3(6) N(9)-C(9)-H(9A) 109.5 
N(9)-C(9)-H(9B) 109.5 H(9A)-C(9)-H(9B) 109.5 
N(9)-C(9)-H(9C) 109.5 H(9A)-C(9)-H(9C) 109.5 
H(9B)-C(9)-H(9C) 109.5 N(9)-C(10)-C(11) 129.2(7) 
C(11)-C(12)-H(12A) 119.6 C(13)-C(12)-H(12A) 119.6 
N(9)-C(10)-C(15) 109.4(6) C(11)-C(10)-C(15) 121.5(7) 
C(12)-C(11)-C(10) 117.9(7) C(12)-C(11)-H(11A) 121.0 
C(10)-C(11)-H(11A) 121.0 C(11)-C(12)-C(13) 120.7(7) 
C(14)-C(13)-C(12) 121.7(7) C(14)-C(13)-H(13A) 119.1 
C(12)-C(13)-H(13A) 119.1 C(15)-C(14)-C(13) 117.8(7) 
C(15)-C(14)-H(14A) 121.1 C(13)-C(14)-H(14A) 121.1 
C(14)-C(15)-C(10) 120.4(7) C(14)-C(15)-C(16) 133.5(7) 
C(10)-C(15)-C(16) 106.1(6) C(8)-C(16)-C(15) 106.2(6) 
C(8)-C(16)-C(17) 121.6(6) C(15)-C(16)-C(17) 132.2(6) 
C(16)-C(17)-C(18) 109.1(6) C(16)-C(17)-H(17A) 109.9 
C(18)-C(17)-H(17A) 109.9 C(16)-C(17)-H(17B) 109.9 
C(18)-C(17)-H(17B) 109.9 H(17A)-C(17)-H(17B) 108.3 
N(1)-C(18)-C(17) 108.1(6) N(1)-C(18)-C(19) 112.1(6) 
C(17)-C(18)-C(19) 111.9(6) N(1)-C(18)-H(18A) 108.2 
C(17)-C(18)-H(18A) 108.2 C(19)-C(18)-H(18A) 108.2 
O(19)-C(19)-C(5) 123.6(7) O(19)-C(19)-C(18) 122.2(7) 
C(5)-C(19)-C(18) 114.1(6) 
______________________________________________________________________________ 
 
 
 
 
Table B16.  Anisotropic displacement parameters (Å2 x 103) for 23'. The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N(1) 28(3)  37(3) 45(4)  0(2) 5(2)  20(2) 
C(2) 34(3)  45(4) 40(4)  -9(3) -12(3)  25(3) 
C(2A) 80(7)  76(7) 56(6)  -17(5) -32(5)  57(6) 
C(3) 48(4)  46(4) 43(4)  12(3) 10(3)  31(4) 
C(4) 47(4)  34(3) 42(4)  -2(3) 4(3)  23(3) 
C(5) 30(3)  33(3) 48(4)  -7(3) -4(3)  14(3) 
C(6) 34(3)  35(3) 40(4)  5(3) 7(3)  18(3) 
C(7) 28(3)  30(3) 33(3)  -1(3) 3(3)  15(2) 
C(8) 31(3)  29(3) 34(3)  -2(3) 7(3)  17(3) 
N(9) 30(3)  28(2) 40(3)  1(2) 5(2)  14(2) 
C(9) 52(4)  44(4) 51(5)  7(4) 21(4)  28(4) 
C(10) 20(2)  28(3) 38(4)  -1(3) 4(2)  6(2) 
C(11) 23(3)  30(3) 57(5)  -8(3) 5(3)  5(2) 
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C(12) 26(3)  29(3) 75(6)  -7(3) -3(3)  15(3) 
C(13) 42(4)  38(4) 47(4)  4(3) -2(3)  22(3) 
C(14) 37(3)  31(3) 40(4)  2(3) 2(3)  13(3) 
C(15) 21(3)  34(3) 48(4)  4(3) 6(3)  11(2) 
C(16) 29(3)  34(3) 41(4)  11(3) 7(3)  16(3) 
C(17) 40(4)  37(4) 48(4)  14(3) 19(3)  20(3) 
C(18) 33(3)  41(3) 39(4)  2(3) 3(3)  25(3) 
C(19) 37(3)  40(3) 35(3)  -6(3) -3(3)  29(3) 
O(19) 60(4)  71(4) 42(3)  -6(3) -6(3)  41(3) 
______________________________________________________________________________  
 
 
 
Table b17.  Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for 
23'. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________
114375 
H(2A) 4028 8711 3284 45 
H(2AA) 4073 8278 357 94 
H(2AB) 4692 8941 -118 94 
H(2AC) 4027 8909 213 94 
H(3A) 4636 9812 2654 50 
H(4A) 5601 10312 3869 48 
H(5A) 6203 9887 4794 45 
H(6A) 6244 9152 2992 44 
H(6B) 5941 9440 1593 44 
H(7A) 5171 8421 1178 36 
H(9A) 5981 7627 140 71 
H(9B) 6524 8244 1157 71 
H(9C) 5937 8260 221 71 
H(11A) 6253 7015 2556 48 
H(12A) 6143 6337 4986 52 
H(13A) 5514 6236 7553 50 
H(14A) 5032 6857 7847 45 
H(17A) 4870 7982 7506 49 
H(17B) 4284 7576 6141 49 
H(18A) 4439 8586 5993 42 
______________________________________________________________________________
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Table B18.  Torsion angles [°] for 23'. 
______________________________________________________________________________ 
C(18)-N(1)-C(2)-C(3) 57.2(9) C(7)-N(1)-C(2)-C(3) -72.5(8) 
C(18)-N(1)-C(2)-C(2A) -174.9(8) C(7)-N(1)-C(2)-C(2A) 55.4(9) 
N(1)-C(2)-C(3)-C(4) 9.3(12) C(2A)-C(2)-C(3)-C(4) -120.3(9) 
C(2)-C(3)-C(4)-C(5) -0.3(13) C(3)-C(4)-C(5)-C(19) -65.1(10) 
C(3)-C(4)-C(5)-C(6) 58.3(10) C(19)-C(5)-C(6)-C(7) 37.6(8) 
C(4)-C(5)-C(6)-C(7) -83.1(7) C(18)-N(1)-C(7)-C(8) 55.9(7) 
C(2)-N(1)-C(7)-C(8) -172.7(6) C(18)-N(1)-C(7)-C(6) -65.2(7) 
C(2)-N(1)-C(7)-C(6) 66.2(8) C(5)-C(6)-C(7)-N(1) 18.8(8) 
C(5)-C(6)-C(7)-C(8) -99.7(7) N(1)-C(7)-C(8)-C(16) -20.0(9) 
C(6)-C(7)-C(8)-C(16) 102.3(8) N(1)-C(7)-C(8)-N(9) 160.4(6) 
C(6)-C(7)-C(8)-N(9) -77.2(8) C(16)-C(8)-N(9)-C(10) -0.4(8) 
C(7)-C(8)-N(9)-C(10) 179.2(6) C(16)-C(8)-N(9)-C(9) -176.4(7) 
C(7)-C(8)-N(9)-C(9) 3.1(11) C(8)-N(9)-C(10)-C(11) 179.7(7) 
C(9)-N(9)-C(10)-C(11) -4.3(12) C(8)-N(9)-C(10)-C(15) 1.0(7) 
C(9)-N(9)-C(10)-C(15) 177.0(7) N(9)-C(10)-C(11)-C(12) 179.8(7) 
C(15)-C(10)-C(11)-C(12) -1.7(10) C(10)-C(11)-C(12)-C(13) 2.1(10) 
C(11)-C(12)-C(13)-C(14) -1.9(12) C(12)-C(13)-C(14)-C(15) 1.2(11) 
C(13)-C(14)-C(15)-C(10) -0.7(11) C(13)-C(14)-C(15)-C(16)-179.4(7) 
N(9)-C(10)-C(15)-C(14) 179.8(7) C(11)-C(10)-C(15)-C(14) 1.0(10) 
N(9)-C(10)-C(15)-C(16) -1.2(8) C(11)-C(10)-C(15)-C(16) 180.0(6) 
N(9)-C(8)-C(16)-C(15) -0.3(8) C(7)-C(8)-C(16)-C(15) -179.9(6) 
N(9)-C(8)-C(16)-C(17) -179.7(7) C(7)-C(8)-C(16)-C(17) 0.8(12) 
C(14)-C(15)-C(16)-C(8) 179.7(8) C(10)-C(15)-C(16)-C(8) 0.9(8) 
C(14)-C(15)-C(16)-C(17) -1.1(15) C(10)-C(15)-C(16)-C(17)-179.8(8) 
C(8)-C(16)-C(17)-C(18) -14.7(10) C(15)-C(16)-C(17)-C(18) 166.1(7) 
C(2)-N(1)-C(18)-C(17) 153.2(6) C(7)-N(1)-C(18)-C(17) -74.1(7) 
C(2)-N(1)-C(18)-C(19) -83.0(7) C(7)-N(1)-C(18)-C(19) 49.7(7) 
C(16)-C(17)-C(18)-N(1) 49.0(8) C(16)-C(17)-C(18)-C(19) -74.9(8) 
C(4)-C(5)-C(19)-O(19) -108.4(7) C(6)-C(5)-C(19)-O(19) 129.3(7) 
C(4)-C(5)-C(19)-C(18) 69.0(7) C(6)-C(5)-C(19)-C(18) -53.2(7) 
N(1)-C(18)-C(19)-O(19) -174.5(6) C(17)-C(18)-C(19)-O(19) -52.9(9) 
N(1)-C(18)-C(19)-C(5) 8.0(7) C(17)-C(18)-C(19)-C(5) 129.7(6) 
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 Table B19.  Crystal data and structure refinement for 19. 
 
Empirical formula  C19H20N2O 
Formula weight  292.37 
Temperature  150(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 10.3077(3) Å α= 90° 
 b = 7.8255(2) Å β= 117.8590(10)° 
 c = 10.6948(3) Å γ = 90° 
Volume 762.69(4) Å3 
Z 2 
Density (calculated) 1.274 Mg/m3 
Absorption coefficient 0.622 mm-1 
F(000) 312 
Crystal size 0.997 x 0.516 x 0.334 mm3 
Theta range for data collection 4.68 to 68.20°. 
Index ranges -12<=h<=12, -8<=k<=9, -11<=l<=12 
Reflections collected 4369 
Independent reflections 2288 [R(int) = 0.0369] 
Completeness to theta = 68.20° 97.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7530 and 0.6194 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2288 / 1 / 202 
Goodness-of-fit on F2 1.111 
Final R indices [I>2sigma(I)] R1 = 0.0430, wR2 = 0.1160 
R indices (all data) R1 = 0.0430, wR2 = 0.1160 
Absolute structure parameter -0.1(3) 
Extinction coefficient 0.078(4) 
Largest diff. peak and hole 0.278 and -0.267 e.Å-3 
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Table B20.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 
103) for 19.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
N(1) 10925(2) 7985(2) 3995(2) 19(1) 
C(2) 12109(2) 9290(3) 4420(2) 21(1) 
C(2A) 13621(2) 8477(3) 5104(2) 25(1) 
C(3) 11810(2) 10447(3) 3167(2) 23(1) 
C(3A) 12774(2) 11404(4) 3009(3) 37(1) 
C(4) 10210(2) 10320(3) 2049(2) 22(1) 
C(5) 10049(2) 8533(3) 1454(2) 20(1) 
O(5) 9561(2) 8198(2) 213(2) 30(1) 
C(6) 10632(2) 7171(3) 2629(2) 20(1) 
C(7) 9594(2) 5644(3) 2283(2) 23(1) 
C(8) 8294(2) 6183(3) 2470(2) 22(1) 
C(9) 6840(2) 5490(3) 1945(2) 24(1) 
C(10) 6098(3) 4055(3) 1129(2) 32(1) 
C(11) 4639(3) 3826(3) 773(2) 38(1) 
C(12) 3882(2) 4984(4) 1196(2) 36(1) 
C(13) 4569(2) 6411(3) 1994(2) 31(1) 
C(14) 6055(2) 6621(3) 2361(2) 24(1) 
N(15) 6984(2) 7941(2) 3130(2) 23(1) 
C(15) 6580(2) 9415(3) 3681(3) 34(1) 
C(16) 8330(2) 7643(2) 3170(2) 19(1) 
C(17) 9570(2) 8889(3) 3792(2) 19(1) 
C(18) 9252(2) 10475(3) 2800(2) 22(1) 
______________________________________________________________________________
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Table B20.  Bond lengths [Å] and angles [°] for 19. 
______________________________________________________________________________ 
N(1)-C(17)  1.488(3) N(1)-C(6)  1.489(2) 
N(1)-C(2)  1.491(3) C(2)-C(2A)  1.517(3) 
C(2)-C(3)  1.524(3) C(2)-H(2A)  1.0000 
C(2A)-H(2AA)  0.9800 C(2A)-H(2AB)  0.9800 
C(2A)-H(2AC)  0.9800 C(3)-C(3A)  1.317(3) 
C(3)-C(4)  1.522(2) C(3A)-H(3AA)  0.9500 
C(3A)-H(3AB)  0.9500 C(4)-C(5)  1.513(3) 
C(4)-C(18)  1.541(3) C(4)-H(4A)  1.0000 
C(5)-O(5)  1.208(2) C(5)-C(6)  1.539(3) 
C(6)-C(7)  1.529(3) C(6)-H(6A)  1.0000 
C(7)-C(8)  1.504(3) C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 C(8)-C(16)  1.357(3) 
C(8)-C(9)  1.439(3) C(9)-C(14)  1.404(3) 
C(9)-C(10)  1.409(3) C(10)-C(11)  1.380(3) 
C(10)-H(10A)  0.9500 C(11)-C(12)  1.401(4) 
C(11)-H(11A)  0.9500 C(12)-C(13)  1.383(4) 
C(12)-H(12A)  0.9500 C(13)-C(14)  1.402(3) 
C(13)-H(13A)  0.9500 C(14)-N(15)  1.387(3) 
N(15)-C(16)  1.388(3) N(15)-C(15)  1.443(3) 
C(15)-H(15A)  0.9800 C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 C(16)-C(17)  1.494(3) 
C(17)-C(18)  1.565(3) C(17)-H(17A)  1.0000 
C(18)-H(18A)  0.9900 C(18)-H(18B)  0.9900 
C(17)-N(1)-C(6) 108.31(14) C(17)-N(1)-C(2) 107.30(16) 
C(6)-N(1)-C(2) 110.73(15) N(1)-C(2)-C(2A) 111.69(17) 
N(1)-C(2)-C(3) 109.77(15) C(2A)-C(2)-C(3) 114.42(17) 
N(1)-C(2)-H(2A) 106.8 C(2A)-C(2)-H(2A) 106.8 
C(3)-C(2)-H(2A) 106.8 C(2)-C(2A)-H(2AA) 109.5 
C(2)-C(2A)-H(2AB) 109.5 H(2AA)-C(2A)-H(2AB) 109.5 
C(2)-C(2A)-H(2AC) 109.5 H(2AA)-C(2A)-H(2AC) 109.5 
H(2AB)-C(2A)-H(2AC) 109.5 C(3A)-C(3)-C(4) 122.8(2) 
C(3A)-C(3)-C(2) 126.56(18) C(4)-C(3)-C(2) 110.61(16) 
C(3)-C(3A)-H(3AA) 120.0 C(3)-C(3A)-H(3AB) 120.0 
H(3AA)-C(3A)-H(3AB) 120.0 C(5)-C(4)-C(3) 104.85(17) 
C(5)-C(4)-C(18) 108.69(16) C(3)-C(4)-C(18) 107.95(16) 
C(5)-C(4)-H(4A) 111.7 C(3)-C(4)-H(4A) 111.7 
C(18)-C(4)-H(4A) 111.7 O(5)-C(5)-C(4) 124.74(19) 
O(5)-C(5)-C(6) 123.39(19) C(4)-C(5)-C(6) 111.84(16) 
N(1)-C(6)-C(7) 111.71(16) N(1)-C(6)-C(5) 109.14(16) 
C(7)-C(6)-C(5) 112.38(15) N(1)-C(6)-H(6A) 107.8 
C(7)-C(6)-H(6A) 107.8 C(5)-C(6)-H(6A) 107.8 
C(8)-C(7)-C(6) 108.32(17) C(8)-C(7)-H(7A) 110.0 
C(6)-C(7)-H(7A) 110.0 C(8)-C(7)-H(7B) 110.0 
C(6)-C(7)-H(7B) 110.0 H(7A)-C(7)-H(7B) 108.4 
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C(16)-C(8)-C(9) 106.68(18) C(16)-C(8)-C(7) 120.87(18) 
C(9)-C(8)-C(7) 132.30(19) C(14)-C(9)-C(10) 118.2(2) 
C(14)-C(9)-C(8) 106.78(18) C(10)-C(9)-C(8) 135.0(2) 
C(11)-C(10)-C(9) 118.7(2) C(11)-C(10)-H(10A) 120.7 
C(9)-C(10)-H(10A) 120.7 C(10)-C(11)-C(12) 121.8(2) 
C(10)-C(11)-H(11A) 119.1 C(12)-C(11)-H(11A) 119.1 
C(13)-C(12)-C(11) 121.3(2) C(13)-C(12)-H(12A) 119.4 
C(11)-C(12)-H(12A) 119.4 C(12)-C(13)-C(14) 116.4(2) 
C(12)-C(13)-H(13A) 121.8 C(14)-C(13)-H(13A) 121.8 
N(15)-C(14)-C(13) 127.9(2) N(15)-C(14)-C(9) 108.48(17) 
C(13)-C(14)-C(9) 123.6(2) C(14)-N(15)-C(16) 107.23(17) 
C(14)-N(15)-C(15) 125.93(17) C(16)-N(15)-C(15) 126.67(17) 
N(15)-C(15)-H(15A) 109.5 N(15)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15B) 109.5 N(15)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 H(15B)-C(15)-H(15C) 109.5 
C(8)-C(16)-N(15) 110.82(18) C(8)-C(16)-C(17) 126.31(18) 
N(15)-C(16)-C(17) 122.62(17) N(1)-C(17)-C(16) 107.67(16) 
N(1)-C(17)-C(18) 111.15(16) C(16)-C(17)-C(18) 110.56(16) 
N(1)-C(17)-H(17A) 109.1 C(16)-C(17)-H(17A) 109.1 
C(18)-C(17)-H(17A) 109.1 C(4)-C(18)-C(17) 107.99(16) 
C(4)-C(18)-H(18A) 110.1 C(17)-C(18)-H(18A) 110.1 
C(4)-C(18)-H(18B) 110.1 C(17)-C(18)-H(18B) 110.1 
H(18A)-C(18)-H(18B) 108.4 
______________________________________________________________________________ 
  
 
 
 
Table B22.  Anisotropic displacement parameters (Å2 x 103) for 19.  The anisotropic displacement 
factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N(1) 19(1)  21(1) 18(1)  -1(1) 9(1)  -1(1) 
C(2) 20(1)  21(1) 20(1)  2(1) 7(1)  -1(1) 
C(2A) 20(1)  29(1) 23(1)  1(1) 7(1)  1(1) 
C(3) 21(1)  23(1) 23(1)  3(1) 10(1)  1(1) 
C(3A) 25(1)  42(1) 37(1)  13(1) 10(1)  -7(1) 
C(4) 22(1)  21(1) 21(1)  5(1) 9(1)  0(1) 
C(5) 16(1)  27(1) 19(1)  1(1) 9(1)  0(1) 
O(5) 35(1)  37(1) 18(1)  -1(1) 12(1)  3(1) 
C(6) 23(1)  20(1) 21(1)  0(1) 12(1)  3(1) 
C(7) 30(1)  20(1) 24(1)  0(1) 15(1)  1(1) 
C(8) 27(1)  20(1) 18(1)  0(1) 11(1)  -2(1) 
C(9) 31(1)  24(1) 17(1)  2(1) 11(1)  -6(1) 
C(10) 44(1)  25(1) 24(1)  -4(1) 13(1)  -10(1) 
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C(11) 42(1)  38(1) 23(1)  -4(1) 6(1)  -22(1) 
C(12) 30(1)  46(2) 25(1)  3(1) 7(1)  -15(1) 
C(13) 26(1)  41(1) 25(1)  4(1) 10(1)  -7(1) 
C(14) 27(1)  26(1) 19(1)  2(1) 11(1)  -6(1) 
N(15) 23(1)  23(1) 26(1)  -4(1) 14(1)  -3(1) 
C(15) 29(1)  32(1) 48(2)  -10(1) 23(1)  -1(1) 
C(16) 23(1)  19(1) 18(1)  1(1) 12(1)  -3(1) 
C(17) 23(1)  18(1) 19(1)  -3(1) 11(1)  -3(1) 
C(18) 22(1)  20(1) 24(1)  0(1) 10(1)  0(1) 
______________________________________________________________________________  
 
 
 
Table B23.  Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for 
19. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(2A) 12048 10024 5156 25 
H(2AA) 13783 7898 5978 38 
H(2AB) 14368 9363 5324 38 
H(2AC) 13687 7644 4452 38 
H(3AA) 12482 12053 2170 44 
H(3AB) 13763 11445 3735 44 
H(4A) 9952 11209 1298 26 
H(6A) 11587 6741 2724 24 
H(7A) 9266 5269 1296 28 
H(7B) 10106 4678 2922 28 
H(10A) 6592 3260 829 38 
H(11A) 4133 2858 227 46 
H(12A) 2877 4784 930 43 
H(13A) 4062 7206 2279 38 
H(15A) 6171 9040 4299 52 
H(15B) 5844 10085 2896 52 
H(15C) 7450 10121 4224 52 
H(17A) 9695 9279 4732 23 
H(18A) 8201 10504 2094 27 
H(18B) 9491 11542 3361 27 
______________________________________________________________________________
373 
 
Table B24.  Torsion angles [°] for 19. 
______________________________________________________________________________ 
C(17)-N(1)-C(2)-C(2A) 161.60(17) C(6)-N(1)-C(2)-C(2A) -80.4(2) 
C(17)-N(1)-C(2)-C(3) -70.39(19) C(6)-N(1)-C(2)-C(3) 47.6(2) 
N(1)-C(2)-C(3)-C(3A) -159.7(2) C(2A)-C(2)-C(3)-C(3A) -33.2(3) 
N(1)-C(2)-C(3)-C(4) 18.4(2) C(2A)-C(2)-C(3)-C(4) 144.92(18) 
C(3A)-C(3)-C(4)-C(5) 109.7(3) C(2)-C(3)-C(4)-C(5) -68.5(2) 
C(3A)-C(3)-C(4)-C(18) -134.5(2) C(2)-C(3)-C(4)-C(18) 47.3(2) 
C(3)-C(4)-C(5)-O(5) -126.6(2) C(18)-C(4)-C(5)-O(5) 118.2(2) 
C(3)-C(4)-C(5)-C(6) 51.5(2) C(18)-C(4)-C(5)-C(6) -63.71(19) 
C(17)-N(1)-C(6)-C(7) -71.3(2) C(2)-N(1)-C(6)-C(7) 171.26(15) 
C(17)-N(1)-C(6)-C(5) 53.6(2) C(2)-N(1)-C(6)-C(5) -63.84(19) 
O(5)-C(5)-C(6)-N(1) -171.14(17) C(4)-C(5)-C(6)-N(1) 10.7(2) 
O(5)-C(5)-C(6)-C(7) -46.6(3) C(4)-C(5)-C(6)-C(7) 135.23(18) 
N(1)-C(6)-C(7)-C(8) 48.7(2) C(5)-C(6)-C(7)-C(8) -74.3(2) 
C(6)-C(7)-C(8)-C(16) -14.7(3) C(6)-C(7)-C(8)-C(9) 160.2(2) 
C(16)-C(8)-C(9)-C(14) 0.7(2) C(7)-C(8)-C(9)-C(14) -174.7(2) 
C(16)-C(8)-C(9)-C(10) 178.4(2) C(7)-C(8)-C(9)-C(10) 3.0(4) 
C(14)-C(9)-C(10)-C(11) 0.1(3) C(8)-C(9)-C(10)-C(11) -177.4(2) 
C(9)-C(10)-C(11)-C(12) 0.3(3) C(10)-C(11)-C(12)-C(13) -0.1(4) 
C(11)-C(12)-C(13)-C(14) -0.5(3) C(12)-C(13)-C(14)-N(15) 179.0(2) 
C(12)-C(13)-C(14)-C(9) 0.9(3) C(10)-C(9)-C(14)-N(15) -179.15(18) 
C(8)-C(9)-C(14)-N(15) -1.0(2) C(10)-C(9)-C(14)-C(13) -0.8(3) 
C(8)-C(9)-C(14)-C(13) 177.4(2) C(13)-C(14)-N(15)-C(16)-177.4(2) 
C(9)-C(14)-N(15)-C(16) 0.9(2) C(13)-C(14)-N(15)-C(15) -1.9(4) 
C(9)-C(14)-N(15)-C(15) 176.4(2) C(9)-C(8)-C(16)-N(15) -0.1(2) 
C(7)-C(8)-C(16)-N(15) 175.94(18) C(9)-C(8)-C(16)-C(17) -174.37(19) 
C(7)-C(8)-C(16)-C(17) 1.7(3) C(14)-N(15)-C(16)-C(8) -0.5(2) 
C(15)-N(15)-C(16)-C(8) -175.9(2) C(14)-N(15)-C(16)-C(17) 174.01(17) 
C(15)-N(15)-C(16)-C(17) -1.4(3) C(6)-N(1)-C(17)-C(16) 52.5(2) 
C(2)-N(1)-C(17)-C(16) 172.12(15) C(6)-N(1)-C(17)-C(18) -68.7(2) 
C(2)-N(1)-C(17)-C(18) 50.90(19) C(8)-C(16)-C(17)-N(1) -20.7(3) 
N(15)-C(16)-C(17)-N(1) 165.63(17) C(8)-C(16)-C(17)-C(18) 100.8(2) 
N(15)-C(16)-C(17)-C(18) -72.8(2) C(5)-C(4)-C(18)-C(17) 48.27(19) 
C(3)-C(4)-C(18)-C(17) -64.9(2) N(1)-C(17)-C(18)-C(4) 14.5(2) 
C(16)-C(17)-C(18)-C(4) -105.05(18) 
______________________________________________________________________________ 
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V Appendix C (Chapter 4) 
NMR and Mass Spectra of the Synthetic Macrocarpines D (4) and E (5) 
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1H NMR spectrum of macrocarpine D (4) (500 MHz, CDCl3) 
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13C NMR spectrum of macrocarpine D (4) (75 MHz, CDCl3) 
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DEPT-135 spectrum of macrocarpine D (4) (75 MHz, CDCl3) 
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HSQC NMR spectrum of macrocarpine D (4) (300, 75 MHz, CDCl3) 
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HRMS (ESI) spectrum of macrocarpine D (4) 
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1H NMR spectrum of macrocarpine E (5) (300 MHz, CDCl3) 
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13C NMR spectrum of macrocarpine E (5) (75 MHz, CDCl3) 
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COSY NMR of macrocarpine E (5) (300 MHz, CDCl3) 
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HSQC NMR spectrum of macrocarpine E (5) (300, 75 MHz, CDCl3) 
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HRMS (ESI) spectrum of macrocarpine E (5) 
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VI Appendix D (Chapter 5) 
 
The X-ray crystallographic work was supported by NIDA through Interagency Agreement #Y1-
DA1101 with the Naval Research Laboratory (NRL). 
 
Single Crystal X-ray Diffraction Data for Compound 16b 
The single-crystal X-ray diffraction data on compounds 12b, 16b, and 25 were collected using Mo 
Kα radiation and a Bruker APEX II area detector at 150 K. Corrections were applied for Lorentz, 
polarization, and absorption effects. The structures were solved by direct methods and refined by 
full-matrix least squares on F2 values using the programs found in the SHELXL suite (Bruker, 
SHELXL v2014.7, 2014, Bruker AXS Inc., Madison, WI). The parameters refined included atomic 
coordinates and anisotropic thermal parameters for all non-hydrogen atoms. The H atoms were 
included using a riding model. The complete information on data collection and refinement is 
available in the correcposnding sections. 
The 0.245 x 0.150 x 0.030 mm3 crystal of 16b was monoclinic in space group P21, with unit cell 
dimensions a = 9.4487(5) Å, b = 7.3559(4) Å, c = 10.8092(6) Å,  = 90,  = 106.408(2), and  
= 90. Data was 99.8% complete to 25.242° θ (~0.83 Å) with an average redundancy of 3.83. The 
final anisotropic full matrix least-squares refinement on F2 with 191 variables converged at R1 = 
0.0379%, for the observed data and wR2 = 0.0927% for all data.   
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Table D1. Crystal data and structure refinement for 16b. 
 
Empirical formula  C18H18N2O 
Formula weight  278.34 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 9.4487(5) Å a= 90°. 
 b = 7.3559(4) Å b= 106.408(2)°. 
 c = 10.8092(6) Å g = 90°. 
Volume 720.68(7) Å3 
Z 2 
Density (-123°C) 1.283 Mg/m3 
Absorption coefficient 0.080 mm-1 
F(000) 296 
Crystal size 0.245 x 0.150 x 0.030 mm3 
θ range for data collection 3.377 to 30.007°. 
Index ranges -12<=h<=12, -10<=k<=10, -13<=l<=14 
Reflections collected 8644 
Independent reflections 3900 [R(int) = 0.0237] 
Completeness to θ = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7460 and 0.6948 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3900 / 1 / 191 
Goodness-of-fit on F2 1.020 
Final R indices [I>2σ(I)] R1 = 0.0379, wR2 = 0.0881 
R indices (all data) R1 = 0.0450, wR2 = 0.0927 
Largest diff. peak and hole 0.228 and -0.205 e.Å-3 
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Table D2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
for 16b. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
O(1) 6240(2) 4527(2) 795(2) 37(1) 
C(1) 5311(2) 4659(3) 1365(2) 26(1) 
C(2) 5016(2) 6411(3) 2021(2) 22(1) 
N(3) 3958(2) 6018(2) 2782(2) 20(1) 
C(4A) 1354(2) 5151(3) 2582(2) 28(1) 
C(4) 2514(2) 5502(3) 1873(2) 24(1) 
C(5) 2719(2) 3852(3) 1080(2) 27(1) 
C(5A) 1646(3) 3042(4) 188(2) 42(1) 
C(6) 4279(2) 3136(3) 1488(2) 25(1) 
C(7) 4612(2) 2688(2) 2942(2) 23(1) 
C(8) 4560(2) 4483(2) 3692(2) 18(1) 
C(9) 6067(2) 5039(2) 4475(2) 18(1) 
N(10) 6806(2) 4286(2) 5654(1) 19(1) 
C(11) 8183(2) 5102(2) 6064(2) 20(1) 
C(12) 9309(2) 4894(3) 7215(2) 25(1) 
C(13) 10595(2) 5875(3) 7352(2) 30(1) 
C(14) 10762(2) 7052(3) 6381(2) 30(1) 
C(15) 9629(2) 7305(3) 5259(2) 26(1) 
C(16) 8311(2) 6337(3) 5101(2) 22(1) 
C(17) 6937(2) 6280(3) 4101(2) 20(1) 
C(18) 6427(2) 7293(3) 2852(2) 23(1) 
______________________________________________________________________________
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Table D3. Bond lengths [Å] and angles [°] for 16b. 
___________________________________________________________________________ 
O(1)-C(1)  1.210(2) C(1)-C(6)  1.515(3) 
C(1)-C(2)  1.535(3) C(2)-N(3)  1.491(2) 
C(2)-C(18)  1.526(3) C(2)-H(2)  1.0000 
N(3)-C(4)  1.488(2) N(3)-C(8)  1.500(2) 
C(4A)-C(4)  1.526(3) C(4A)-H(4A)  0.9800 
C(4A)-H(4B)  0.9800 C(4A)-H(4C)  0.9800 
C(4)-C(5)  1.530(3) C(4)-H(4)  1.0000 
C(5)-C(5A)  1.327(3) C(5)-C(6)  1.509(3) 
C(5A)-H(5A)  0.9500 C(5A)-H(5B)  0.9500 
C(6)-C(7)  1.548(3) C(6)-H(6)  1.0000 
C(7)-C(8)  1.557(3) C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 C(8)-C(9)  1.493(2) 
C(8)-H(8)  1.0000 C(9)-C(17)  1.364(2) 
C(9)-N(10)  1.384(2) N(10)-C(11)  1.387(2) 
N(10)-H(10)  0.8800 C(11)-C(12)  1.398(2) 
C(11)-C(16)  1.413(3) C(12)-C(13)  1.384(3) 
C(12)-H(12)  0.9500 C(13)-C(14)  1.404(3) 
C(13)-H(13)  0.9500 C(14)-C(15)  1.385(3) 
C(14)-H(14)  0.9500 C(15)-C(16)  1.402(3) 
C(15)-H(15)  0.9500 C(16)-C(17)  1.436(3) 
C(17)-C(18)  1.497(3) C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
O(1)-C(1)-C(6) 124.24(18) O(1)-C(1)-C(2) 123.71(18) 
C(6)-C(1)-C(2) 112.03(16) N(3)-C(2)-C(18) 111.58(14) 
N(3)-C(2)-C(1) 109.24(15) C(18)-C(2)-C(1) 112.73(16) 
N(3)-C(2)-H(2) 107.7 C(18)-C(2)-H(2) 107.7 
C(1)-C(2)-H(2) 107.7 C(4)-N(3)-C(2) 108.52(14) 
C(4)-N(3)-C(8) 110.37(14) C(2)-N(3)-C(8) 108.61(14) 
C(4)-C(4A)-H(4A) 109.5 C(4)-C(4A)-H(4B) 109.5 
H(4A)-C(4A)-H(4B) 109.5 C(4)-C(4A)-H(4C) 109.5 
H(4A)-C(4A)-H(4C) 109.5 H(4B)-C(4A)-H(4C) 109.5 
N(3)-C(4)-C(4A) 111.49(15) N(3)-C(4)-C(5) 109.54(15) 
C(4A)-C(4)-C(5) 111.72(16) N(3)-C(4)-H(4) 108.0 
C(4A)-C(4)-H(4) 108.0 C(5)-C(4)-H(4) 108.0 
C(5A)-C(5)-C(6) 122.6(2) C(5A)-C(5)-C(4) 124.9(2) 
C(6)-C(5)-C(4) 112.42(16) C(5)-C(5A)-H(5A) 120.0 
C(5)-C(5A)-H(5B) 120.0 H(5A)-C(5A)-H(5B) 120.0 
C(5)-C(6)-C(1) 108.41(16) C(5)-C(6)-C(7) 105.81(15) 
C(1)-C(6)-C(7) 107.13(15) C(5)-C(6)-H(6) 111.7 
C(1)-C(6)-H(6) 111.7 C(7)-C(6)-H(6) 111.7 
C(6)-C(7)-C(8) 108.75(14) C(6)-C(7)-H(7A) 109.9 
C(8)-C(7)-H(7A) 109.9 C(6)-C(7)-H(7B) 109.9 
C(8)-C(7)-H(7B) 109.9 H(7A)-C(7)-H(7B) 108.3 
C(9)-C(8)-N(3) 106.81(14) C(9)-C(8)-C(7) 111.20(14) 
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N(3)-C(8)-C(7) 111.00(13) C(9)-C(8)-H(8) 109.3 
N(3)-C(8)-H(8) 109.3 C(7)-C(8)-H(8) 109.3 
C(17)-C(9)-N(10) 110.55(15) C(17)-C(9)-C(8) 125.01(16) 
N(10)-C(9)-C(8) 124.36(15) C(9)-N(10)-C(11) 107.78(15) 
C(9)-N(10)-H(10) 126.1 C(11)-N(10)-H(10) 126.1 
N(10)-C(11)-C(12) 130.32(17) N(10)-C(11)-C(16) 108.05(15) 
C(12)-C(11)-C(16) 121.60(17) C(13)-C(12)-C(11) 117.59(18) 
C(13)-C(12)-H(12) 121.2 C(11)-C(12)-H(12) 121.2 
C(12)-C(13)-C(14) 121.46(19) C(12)-C(13)-H(13) 119.3 
C(14)-C(13)-H(13) 119.3 C(15)-C(14)-C(13) 121.00(19) 
C(15)-C(14)-H(14) 119.5 C(13)-C(14)-H(14) 119.5 
C(14)-C(15)-C(16) 118.64(19) C(14)-C(15)-H(15) 120.7 
C(16)-C(15)-H(15) 120.7 C(15)-C(16)-C(11) 119.61(17) 
C(15)-C(16)-C(17) 133.59(18) C(11)-C(16)-C(17) 106.80(15) 
C(9)-C(17)-C(16) 106.78(16) C(9)-C(17)-C(18) 122.17(16) 
C(16)-C(17)-C(18) 131.05(16) C(17)-C(18)-C(2) 108.96(15) 
C(17)-C(18)-H(18A) 109.9 C(2)-C(18)-H(18A) 109.9 
C(17)-C(18)-H(18B) 109.9 C(2)-C(18)-H(18B) 109.9 
H(18A)-C(18)-H(18B) 108.3 
______________________________________________________________________________ 
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Table D4. Anisotropic displacement parameters (Å2x 103) for 16b. The anisotropic 
displacement factor exponent takes the form: -2p2[h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
O(1) 45(1)  37(1) 40(1)  -3(1) 27(1)  -3(1) 
C(1) 32(1)  25(1) 22(1)  2(1) 10(1)  -1(1) 
C(2) 26(1)  20(1) 21(1)  4(1) 8(1)  0(1) 
N(3) 20(1)  18(1) 20(1)  4(1) 5(1)  1(1) 
C(4A) 21(1)  28(1) 34(1)  2(1) 5(1)  1(1) 
C(4) 23(1)  24(1) 23(1)  6(1) 2(1)  2(1) 
C(5) 32(1)  31(1) 18(1)  4(1) 4(1)  -2(1) 
C(5A) 39(1)  52(2) 29(1)  -7(1) -1(1)  -3(1) 
C(6) 33(1)  23(1) 21(1)  -3(1) 9(1)  -3(1) 
C(7) 26(1)  16(1) 25(1)  2(1) 5(1)  -1(1) 
C(8) 19(1)  17(1) 19(1)  3(1) 6(1)  -1(1) 
C(9) 20(1)  17(1) 18(1)  -1(1) 6(1)  1(1) 
N(10) 18(1)  18(1) 20(1)  1(1) 5(1)  -1(1) 
C(11) 18(1)  18(1) 25(1)  -4(1) 8(1)  1(1) 
C(12) 24(1)  23(1) 27(1)  -1(1) 4(1)  1(1) 
C(13) 21(1)  28(1) 35(1)  -6(1) 1(1)  2(1) 
C(14) 19(1)  27(1) 45(1)  -7(1) 10(1)  -4(1) 
C(15) 23(1)  22(1) 36(1)  -2(1) 13(1)  -3(1) 
C(16) 21(1)  19(1) 26(1)  -3(1) 9(1)  -1(1) 
C(17) 21(1)  19(1) 22(1)  -1(1) 9(1)  0(1) 
C(18) 27(1)  21(1) 25(1)  4(1) 11(1)  -3(1) 
______________________________________________________________________________
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Table D5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
16b. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
 
H(2) 4532 7295 1328 27 
H(4A) 1553 3982 3032 42 
H(4B) 373 5121 1959 42 
H(4C) 1391 6125 3209 42 
H(4) 2166 6540 1266 29 
H(5A) 1846 1968 -221 51 
H(5B) 678 3537 -42 51 
H(6) 4396 2044 974 30 
H(7A) 5600 2124 3258 27 
H(7B) 3872 1818 3080 27 
H(8) 3918 4301 4276 22 
H(10) 6464 3440 6068 22 
H(12) 9197 4109 7878 30 
H(13) 11381 5749 8121 36 
H(14) 11666 7685 6495 36 
H(15) 9742 8117 4610 31 
H(18A) 7200 7257 2397 28 
H(18B) 6236 8580 3020 28 
______________________________________________________________________________
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Table D6. Torsion angles [°] for 16b. 
_____________________________________________________________________________ 
O(1)-C(1)-C(2)-N(3) -172.06(18) C(6)-C(1)-C(2)-N(3) 9.4(2) 
O(1)-C(1)-C(2)-C(18) -47.4(3) C(6)-C(1)-C(2)-C(18) 134.04(16) 
C(18)-C(2)-N(3)-C(4) 169.19(15) C(1)-C(2)-N(3)-C(4) -65.48(18) 
C(18)-C(2)-N(3)-C(8) -70.80(18) C(1)-C(2)-N(3)-C(8) 54.52(18) 
C(2)-N(3)-C(4)-C(4A) -177.73(15) C(8)-N(3)-C(4)-C(4A) 63.37(19) 
C(2)-N(3)-C(4)-C(5) 58.09(18) C(8)-N(3)-C(4)-C(5) -60.81(18) 
N(3)-C(4)-C(5)-C(5A) 179.5(2) C(4A)-C(4)-C(5)-C(5A) 55.4(3) 
N(3)-C(4)-C(5)-C(6) 3.7(2) C(4A)-C(4)-C(5)-C(6) -120.35(18) 
C(5A)-C(5)-C(6)-C(1) 126.6(2) C(4)-C(5)-C(6)-C(1) -57.5(2) 
C(5A)-C(5)-C(6)-C(7) -118.8(2) C(4)-C(5)-C(6)-C(7) 57.2(2) 
O(1)-C(1)-C(6)-C(5) -128.7(2) C(2)-C(1)-C(6)-C(5) 49.9(2) 
O(1)-C(1)-C(6)-C(7) 117.5(2) C(2)-C(1)-C(6)-C(7) -63.9(2) 
C(5)-C(6)-C(7)-C(8) -63.71(19) C(1)-C(6)-C(7)-C(8) 51.8(2) 
C(4)-N(3)-C(8)-C(9) 174.39(14) C(2)-N(3)-C(8)-C(9) 55.54(17) 
C(4)-N(3)-C(8)-C(7) 53.02(19) C(2)-N(3)-C(8)-C(7) -65.83(18) 
C(6)-C(7)-C(8)-C(9) -109.07(17) C(6)-C(7)-C(8)-N(3) 9.7(2) 
N(3)-C(8)-C(9)-C(17) -24.1(2) C(7)-C(8)-C(9)-C(17) 97.1(2) 
N(3)-C(8)-C(9)-N(10) 159.68(15) C(7)-C(8)-C(9)-N(10) -79.1(2) 
C(17)-C(9)-N(10)-C(11) 1.5(2) C(8)-C(9)-N(10)-C(11) 178.14(16) 
C(9)-N(10)-C(11)-C(12) 176.16(18) C(9)-N(10)-C(11)-C(16) -1.90(19) 
N(10)-C(11)-C(12)-C(13) 178.84(18) C(16)-C(11)-C(12)-
C(13) -3.3(3) 
C(11)-C(12)-C(13)-C(14) 0.6(3) C(12)-C(13)-C(14)-
C(15) 1.5(3) 
C(13)-C(14)-C(15)-C(16) -1.0(3) C(14)-C(15)-C(16)-
C(11) -1.7(3) 
C(14)-C(15)-C(16)-C(17) 179.0(2) N(10)-C(11)-C(16)-
C(15) -177.85(16) 
C(12)-C(11)-C(16)-C(15) 3.9(3) N(10)-C(11)-C(16)-
C(17) 1.62(19) 
C(12)-C(11)-C(16)-C(17) -176.64(16) N(10)-C(9)-C(17)-C(16) -0.4(2) 
C(8)-C(9)-C(17)-C(16) -177.08(16) N(10)-C(9)-C(17)-C(18) 179.24(16) 
C(8)-C(9)-C(17)-C(18) 2.6(3) C(15)-C(16)-C(17)-C(9) 178.6(2) 
C(11)-C(16)-C(17)-C(9) -0.7(2) C(15)-C(16)-C(17)-
C(18) -1.0(3) 
C(11)-C(16)-C(17)-C(18) 179.63(19) C(9)-C(17)-C(18)-C(2) -12.3(2) 
C(16)-C(17)-C(18)-C(2) 167.34(18) N(3)-C(2)-C(18)-C(17) 45.4(2) 
C(1)-C(2)-C(18)-C(17) -77.99(18) 
____________________________________________________________________________ 
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Table D7. Hydrogen bonds for 16b [Å and °]. 
____________________________________________________________________________ 
       D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(10)-H(10)...N(3)#1 0.88 2.27 3.138(2) 168.5 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y-1/2,-z+1  
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VII Appendix E (Chapter 5) 
NMR spectra of the synthetic alkaloids 1-5, 8, and 9 
 
 
1H NMR spectrum of macrocarpine A (1) (300 MHZ, CDCl3) 
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13C NMR spectrum of macrocarpine A (1) (75 MHz, CDCl3) 
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13C vs 13C-APT spectra of 1 (75 MHz, CDCl3) 
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COSY NMR spectrum of macrocarpine A 1 (300 MHz, CDCl3) 
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HSQC NMR spectrum of macrocarpine A 1 (300 MHz, 75 MHz, CDCl3) 
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NOESY NMR spectrum of macrocarpine A 1 (300 MHZ, CDCl3) 
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1H NMR spectrum of macrocarpine B 2 (300 MHz, CDCl3) 
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13C NMR spectrum of macrocarpine B 2 (75 MHz, CDCl3) 
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COSY NMR spectrum of macrocarpine B 2 (300 MHz, CDCl3) 
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HSQC NMR spectrum of macrocarpine B 2 (300 MHz, 75 MHz, CDCl3) 
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1H NMR spectrum of macrocarpine C 3 (300 MHz, CDCl3) 
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13C NMR spectrum of macrocarpine C 3 (75 MHz, CDCl3) 
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HSQC NMR spectrum of macrocarpine C 3 (300 MHz, 75 MHz, CDCl3) 
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1H NMR spectrum of talcarpine 4 (500 MHz, CDCl3) 
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13C NMR spectrum of talcarpine 4 (75 MHz, CDCl3) 
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13C vs 13C-APT NMR spectra of talcarpine 4 (75 MHz, CDCl3) 
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COSY NMR spectrum of talcarpine 4 (300 MHz, CDCl3) 
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1H NMR spectrum of 5 (500 MHz, CDCl3) 
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13C NMR spectrum of 5 (125 MHz, CDCl3) 
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COSY NMR spectrum of 5 (500 MHz, CDCl3) 
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HSQC NMR spectrum of 5 (500 MHz, 125 MHz, CDCl3) 
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NOESY NMR spectrum of 5 (500 MHz, CDCl3) 
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1H NMR spectrum of (+)-8 (500 MHz, CD3OD) 
417 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1H NMR spectrum of (+)-8 (125 MHz, CD3OD) 
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1H NMR spectrum of (+)-8 (500 MHz, CD3OD) 
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1H NMR spectrum of (+)-8 (300 MHz, CD3OD) 
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 13C NMR spectrum of (+)-8 (75 MHz, CD3OD) 
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13C NMR vs DEPT-135 and DEPT 90 spectra of (+)-8 (75 MHz, CD3OD) 
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 COSY NMR spectrum of (+)-8 (500 MHz, CD3OD) 
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 COSY NMR spectrum of (+)-8 (300 MHz, CD3OD) 
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 HSQC NMR spectrum of (+)-8 (300 MHz, 75 MHz, CD3OD) 
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 NOESY NMR spectrum of (+)-8 (300 MHz, CD3OD 
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1D-NOE spectra of (+)-8, irradiation of H-3 (300 MHz, CD3OD) 
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1D-NOE spectra of (+)-8, irradiation of H-18 (300 MHz, CD3OD) 
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1H NMR spectrum of (-)-9 (500 MHz, CDCl3) 
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1H NMR spectrum of (-)-9 (500 MHz, CDCl3) 
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1H NMR spectrum of (-)-9 (500 MHz, CD3OD) 
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13C NMR spectrum of (-)-9 (75 MHz, CD3OD) 
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13C NMR spectrum of (-)-9 (75 MHz, CD3OD) 
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13C vs DEPT 135 and DEPT-90 spectra of (-)-9 (75 MHz, CD3OD) 
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COSY NMR spectrum of (-)-9 (500 MHz, CDCl3) 
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HSQC NMR spectrum of (-)-9 (500 MHz, 125 MHz, CDCl3) 
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 NOESY NMR spectrum of (-)-9 (500 MHz, CDCl3) 
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1D NOE NMR Spectrum of (-)-9 to confirm α-configuration of the C-19 methyl function 
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1D NOE spectra of 15a to confirm the olefin geometry 
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VIII Appendix F (Chapter 6) 
 
NMR spectra of the synthetic alkaloids 1, 2, 8, 14, and 15 
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1H NMR spectrum of macrocarpine F 1 (300 MHz, CDCl3); Assignment is based on 
1H, DEPT-
135, COSY and HSQC NMR correlations 
441 
 
 
COSY NMR spectrum of macrocarpine F 1 (300 MHz, CDCl3) 
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HSQC NMR spectrum of macrocarpine F 1 (300, 75 MHz, CDCl3) 
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13C and DEPT-135 NMR spectra of macrocarpine F 1 (75 MHz, CDCl3) 
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 1H NMR spectrum of synthetic macrocarpine G 2 (500 MHz, CDCl3) 
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COSY NMR spectrum of synthetic macrocarpine G 2 (500 MHz, CDCl3) 
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NOESY NMR spectrum of macrocarpine G 2 (500 MHz, CDCl3) 
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1H NMR spectrum of talpinine 8 (300 MHz, CDCl3) 
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COSY NMR spectrum of talpinine 8 (300 MHz, CDCl3) 
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HSQC NMR spectrum of talpinine 8 (300, 75 MHz, CDCl3) 
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13C NMR spectrum of talpinine 8 (75 MHz, CDCl3) 
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Assigned 1H spectrum of O-acetyltalpinine 14 (500 MHz, CDCl3). Assignment was based 
on 1H, 13C and HSQC NMR correlations 
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13C NMR spectrum δ 180-70 ppm (125 MHz, CDCl3) of O-acetyltalpinine 14 
(Assignment is based on 1H, 13C and HSQC NMR correlations) 
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13C NMR spectrum δ 75-0 ppm (125 MHz, CDCl3) of O-acetyltalpinine 14 
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Assigned HSQC NMR spectrum of O-Acetyltalpinine 14 (500, 125 MHz, CDCl3) 
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Figure 10. Comparison between the 1H NMR spectra of natural12 and synthetic N4-methyl 
talpinine 15. (Note: The spectrum of natural N4-methyltalpinine is reused with permission from 
Elsevier, License no: 4467260919785, Nov 13, 2018) 
 
Natural N4-methyltalpinine12 
Synthetic N4-methyltalpinine 
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1H NMR spectrum of synthetic N4-methyltalpinine 15 (500 MHz, CD3OD) 
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13C NMR spectrum of synthetic N4-methyltalpinine 15 (125 MHz, CD3OD) 
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COSY NMR spectrum of synthetic N4-methyltalpinine 15 (500 MHz, CD3OD) 
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HSQC NMR spectrum of synthetic N4-methyltalpinine 15 (500, 125 MHz, CD3OD) 
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HMBC NMR spectrum of synthetic N4-methyltalpinine 15 (500, 125 MHz, CD3OD) 
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NOESY NMR spectrum of synthetic N4-methyltalpinine 15 (500 MHz, CD3OD) 
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IX Appendix G (Chapter 3) 
Comparisons between the NMR spectra of the enantiomeric pairs (15 vs 24), (16 vs 25), (17 vs 26), (18 
vs 27), (19 vs 29), (20 vs 28), (21 vs 30), (22 vs 31), and (23 vs 32) 
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Comparison between the 1H NMR spectra of (+)-24 and (-)-15 (500 MHz, CDCl3) 
464 
 
 
Comparison between the 13C NMR spectra of (+)-24 and (-)-15 (125 MHz, CDCl3) [marked peaks at δ 137.9, 
129.1, 128.2, and 125.3 are from residual toluene] 
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Comparison between the 1H NMR spectra of (+)-25 and (-)-16 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-25 and (-)-16 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (-)-26 and (+)-17 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (-)-26 and (+)-17 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (+)-27 and (-)-18 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-27 and (-)-18 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (+)-29 and (-)-19 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-29 and (-)-19 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (+)-28 and (-)-20 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-28 and (-)-20 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (+)-30 and (-)-21 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-30 and (-)-21 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (+)-31 and (-)-22 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-31 and (-)-22 (125 MHz, CDCl3) 
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Comparison between the 1H NMR spectra of (+)-32 and (-)-23 (500 MHz, CDCl3) 
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Comparison between the 13C NMR spectra of (+)-32 and (-)-23 (125 MHz, CDCl3) 
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